TTDTargetID	Target_Name	Indication	ICD9	ICD10
T00039	mRNA of connective tissue growth factor	Fibrosis	709.2	L90.5
T00100	Ubiquitin-activating enzyme	Solid tumours	140-199, 210-229	C00-D48
T00140	Arachidonate 5-lipoxygenase	Allergy	995.3	T78.4
T00140	Arachidonate 5-lipoxygenase	Arthritis	710-719	M00-M25
T00140	Arachidonate 5-lipoxygenase	Asthma		J45
T00140	Arachidonate 5-lipoxygenase	Atherosclerosis	414.0, 440	I70
T00140	Arachidonate 5-lipoxygenase	Atopic dermatitis	691.8, 692.9	L00-L99
T00140	Arachidonate 5-lipoxygenase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T00140	Arachidonate 5-lipoxygenase	Dermatitis	692.9	L20-L30
T00140	Arachidonate 5-lipoxygenase	Fungal infections	110-118	B35-B49
T00140	Arachidonate 5-lipoxygenase	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T00140	Arachidonate 5-lipoxygenase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T00140	Arachidonate 5-lipoxygenase	Lymphatic filariasis	125	B74
T00140	Arachidonate 5-lipoxygenase	Osteoarthritis	715	M15-M19, M47
T00140	Arachidonate 5-lipoxygenase	Pruritus	698	L29
T00140	Arachidonate 5-lipoxygenase	Psoriasis	696	L40
T00140	Arachidonate 5-lipoxygenase	Respiratory disease		J00-J99
T00140	Arachidonate 5-lipoxygenase	Rheumatoid arthritis	710-719, 714	M05-M06
T00140	Arachidonate 5-lipoxygenase	Rhinitis	472.0, 477	J00, J30, J31.0
T00140	Arachidonate 5-lipoxygenase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T00140	Arachidonate 5-lipoxygenase	Unspecified		
T00176	Ubiquitin-protein ligase E3 Mdm2	Acute myeloid leukemia	205	C92.0
T00176	Ubiquitin-protein ligase E3 Mdm2	Cancer	140-229	C00-C96
T00176	Ubiquitin-protein ligase E3 Mdm2	Hematological malignancies	200-209	C81-C86
T00176	Ubiquitin-protein ligase E3 Mdm2	Non-small cell lung cancer; Prostate cancer	185	C33-C34, C61
T00176	Ubiquitin-protein ligase E3 Mdm2	Solid tumours	140-199, 210-229	C00-D48
T00178	Interferon alpha	Systemic lupus erythematosus	710	M32
T00238	mRNA of Nuclear factor kappa B	Ulcerative colitis	556	K51
T00239	Interleukin-4	Asthma; Pulmonary tuberculosis		J45, A15-A19
T00417	GABA(B) receptor	Anesthesia narcolepsy	338, 347	G47.4, R20.0
T00417	GABA(B) receptor	Multiple scierosis	340	G35
T00419	Fast skeletal muscle troponin complex	Muscle fatigue	780.7	R53
T00419	Fast skeletal muscle troponin complex	Muscular atrophy	728.2	M62.5
T00420	HIV REV protein	Human immunodeficiency virus infection	279.3	B20-B26
T00477	Serine Racemase	Neurodegenerations; Epilepsy; Neuropathic pain; Drug addiction; Schizophrenia	295, 303-304, 330-337, 338, 345, 356.0, 356.8,780	F10-F19, F20, G30-G32, G40, G64, G90.0, R52, G89
T00484	Interleukin-23 receptor	Autoimmune diabetes		E08-E13
T00484	Interleukin-23 receptor	Cancer	140-229	C00-C96
T00484	Interleukin-23 receptor	Inflammatory bowel disease	555, 556	K50, K51
T00484	Interleukin-23 receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T00494	ATP-binding cassette, sub-family A, member 1	Coronary artery disease	410-414, 429.2	I20-I25
T00494	ATP-binding cassette, sub-family A, member 1	Dyslipidaemias	272	E78
T00494	ATP-binding cassette, sub-family A, member 1	Lipid metabolism disorder		E75-E78
T00523	Urate transporter	Hyperuricosuria		E79
T00663	Mitogen-activated protein kinase 10	Central nervous system injury		P11.9
T00750	Galactoside 3(4)-L-fucosyltransferase	Fallopian tube cancer		C57.0, D28.2
T00864	Nicotinic acid receptor 1	Acute ischemic stroke	434.91	I61-I63
T00864	Nicotinic acid receptor 1	Arteriosclerosis	440	I70
T00864	Nicotinic acid receptor 1	Atherosclerosis	414.0, 440	I70
T00864	Nicotinic acid receptor 1	Cardiovascular disorder		I00-I99
T00864	Nicotinic acid receptor 1	Hyperlipidaemia	272.0-272.4	E78
T00864	Nicotinic acid receptor 1	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T00864	Nicotinic acid receptor 1	Type 2 diabetes	250	E11
T00895	Protein kinase C, epsilon type	Ischemic reperfusion injury		I00-I99
T00938	DHICA oxidase	Melanoma	172	C43
T00972	HIV envelopeglycoprotein gp120	Human immunodeficiency virus infection	279.3	B20-B26
T00972	HIV envelopeglycoprotein gp120	Unspecified		
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Autoimmune diabetes		E08-E13
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Bone metastases	198.5	C79.51
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Cancer	140-229	C00-C96
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Hodgkin's lymphoma		C81
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Rheumatoid arthritis	710-719, 714	M05-M06
T01110	Colony stimulating factor-1 receptor (CSF-1R)	Solid tumours	140-199, 210-229	C00-D48
T01141	MicroRNA miR-191	Hepatocellular carcinoma	155	C22.0
T01232	Stem or T cell	Congestive heart failure	428	I50
T01232	Stem or T cell	Insulin dependent diabetes		E10
T01280	beta-site APP-cleaving enzyme 2	Focal segmental glomerulosclerosis		N00-N08
T01283	Tumor susceptibility gene protein 101	Influenza virus		J11.1
T01318	Dihydroorotate dehydrogenase, mitochondrial	Fungal infections	110-118	B35-B49
T01318	Dihydroorotate dehydrogenase, mitochondrial	Malaria		B54
T01318	Dihydroorotate dehydrogenase, mitochondrial	Multiple scierosis; Active rheumatoid arthritis	340, 714	G35, M05, M06
T01358	DNA damage in cancer cell	Breast cancer	174, 175	C50
T01447	NEDD8-activating enzyme	Advanced malignancies	140-229	C00-C96
T01575	Sphingosine 1 phosphate lyase 1	Autoimmune diabetes		E08-E13
T01575	Sphingosine 1 phosphate lyase 1	Rheumatoid arthritis	710-719, 714	M05-M06
T01777	Alpha-2C adrenergic receptor	Alcohol use disorders	303	F10.2
T01777	Alpha-2C adrenergic receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T01777	Alpha-2C adrenergic receptor	Alzheimer disease	331	G30
T01777	Alpha-2C adrenergic receptor	Asthma		J45
T01777	Alpha-2C adrenergic receptor	Contusion		S36.220S
T01777	Alpha-2C adrenergic receptor	Depression	311	F30-F39
T01777	Alpha-2C adrenergic receptor	Diabetic nephropathy; Fibromyalgia	250.4, 729.1	E11.21, M79.7
T01777	Alpha-2C adrenergic receptor	Erythema	695	L51-L54
T01777	Alpha-2C adrenergic receptor	Glaucoma	365	H40-H42
T01777	Alpha-2C adrenergic receptor	Heart failure	428	I50
T01777	Alpha-2C adrenergic receptor	Hypertension	401	I10-I16
T01777	Alpha-2C adrenergic receptor	Hypotension	458, 796.3	I95
T01777	Alpha-2C adrenergic receptor	Male sexual disorders		F52
T01777	Alpha-2C adrenergic receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T01777	Alpha-2C adrenergic receptor	Obesity	278	E66
T01777	Alpha-2C adrenergic receptor	Ocular disease		H00-H59
T01777	Alpha-2C adrenergic receptor	Ocular hypertension	365.04	H40.0
T01777	Alpha-2C adrenergic receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T01777	Alpha-2C adrenergic receptor	Peptic ulcer	531-534	K25-K27
T01777	Alpha-2C adrenergic receptor	Poison intoxication		T36-T50
T01822	Heme	Malaria		B54
T01840	protease	Alpha-1 antitrypsin deficiency	273.4	E88.0
T01840	protease	Alzheimer disease	331	G30
T01840	protease	Cancer	140-229	C00-C96
T01840	protease	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T01840	protease	Coagulation		I80-I82
T01840	protease	Cystic fibrosis	277	E84
T01840	protease	Rheumatoid arthritis	710-719, 714	M05-M06
T01851	Integrin beta-1	Non-small cell lung cancer		C33-C34
T01865	Hexose transporter 1	Infection of P. falciparum 	84	B50-B54
T01908	Tissue kallikrein	Atopic dermatitis	691.8, 692.9	L00-L99
T01973	RON	Cancer	140-229	C00-C96
T01973	RON	Solid tumours	140-199, 210-229	C00-D48
T02119	Arylsulfatase B	Mucopolysaccharidosis VI	277.5	E76.2
T02134	Glutamate--cysteine ligase regulatorysubunit	Cancer; Malaria	140-229	C00-C96, B54
T02221	Nucleoside DNA polymerase	Cytomegalovirus infection		B25
T02246	Iron	Acute iron or aluminum toxicity		T56
T02246	Iron	Anemia	280-285	D50-D64
T02246	Iron	Cardiovascular disorder		I00-I99
T02246	Iron	Iron deficiency anaemia		D50
T02246	Iron	Iron overload		R79.0
T02246	Iron	Transfusional iron overload due to thalassaemia syndromes	275.03	R79.0
T02253	Cholinergic activityy	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T02258	DNA-directed DNA polymerase	Cancer	140-229	C00-C96
T02318	Tumor necrosis factor ligand superfamily member 13B	Lymphoma	202.8, 208.9	C81-C86
T02318	Tumor necrosis factor ligand superfamily member 13B	Multiple myeloma	203	C90
T02318	Tumor necrosis factor ligand superfamily member 13B	Rheumatold arthritis; Idiopathic thrombocytopenic purpura	287.31, 710-719, 714	D69.3, M00-M25, M05-M06
T02318	Tumor necrosis factor ligand superfamily member 13B	Systemic lupus erythematosus	710	M32
T02333	Growth hormone receptor	Acromegaly	253	E22.0
T02333	Growth hormone receptor	Dwarfism		E23.0, E34.2, E45.0, Q77.4
T02333	Growth hormone receptor	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10-I16, I50
T02333	Growth hormone receptor	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
T02333	Growth hormone receptor	Obesity	278	E66
T02333	Growth hormone receptor	Unspecified		
T02532	T-cell surface antigen CD2	Cancer; Psoriasis	140-229, 696	L40
T02532	T-cell surface antigen CD2	Lymphoma	202.8, 208.9	C81-C86
T02546	Sodium channel protein type 4 subunit alpha	Nervous and musculoskeletal disorders		R25-R29
T02546	Sodium channel protein type 4 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T02551	D(3) dopamine receptor	Cocaine addiction	304.2	F14.2
T02551	D(3) dopamine receptor	Drug abuse	303-304	F10-F19
T02551	D(3) dopamine receptor	Emesis; Gastric motility disorder	294.1, 307.23, 314.00, 314.01, 320-322, 323, 331.0, 332, 333.4, 340, 344.1, 344.81, 348.0, 536.8, 787	F02.2, F02.3, F90, F95.2, G00-G37, G83.5, G93.0
T02551	D(3) dopamine receptor	Female sexual dysfunction	302.7	F52
T02551	D(3) dopamine receptor	Male sexual disorders		F52
T02551	D(3) dopamine receptor	Psychotic disorders	290-299	F20-F29
T02551	D(3) dopamine receptor	Schizophrenia	295	F20
T02551	D(3) dopamine receptor	Unspecified		
T02562	Prostaglandin E synthase	Alzheimer disease	331	G30
T02591	HIV env	HIV-1 infection	001-139, 042	B20-B24
T02591	HIV env	Human immunodeficiency virus infection	279.3	B20-B26
T02598	Leukocyte	Inflammatory disorder		
T02617	Transferrin	Cancer	140-229	C00-C96
T02677	Baculoviral IAP repeat-containing protein 5	Cancer	140-229	C00-C96
T02677	Baculoviral IAP repeat-containing protein 5	Ovarian cancer	183	C56
T02677	Baculoviral IAP repeat-containing protein 5	Solid tumours	140-199, 210-229	C00-D48
T02686	multiple oncokinase	Glioblastoma multiforme	191	C71
T02702	Bacterial DHFR	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T02703	Nitric oxide synthase, inducible	Asthma		J45
T02703	Nitric oxide synthase, inducible	Coronary artery disease	410-414, 429.2	I20-I25
T02703	Nitric oxide synthase, inducible	Diabetic kidney disease		E11.22
T02703	Nitric oxide synthase, inducible	Endotoxic shock		R57.8
T02703	Nitric oxide synthase, inducible	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T02703	Nitric oxide synthase, inducible	Osteoarthritis	715	M15-M19, M47
T02703	Nitric oxide synthase, inducible	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T02703	Nitric oxide synthase, inducible	Restenosis		I51.89
T02703	Nitric oxide synthase, inducible	Septic shock	785.52	A41.9
T02719	Metabotropic glutamate receptor3	Alzheimer disease; Major depressive disorder	331, 296.2, 296.3, 710.0	G30, F32, F33, M32
T02719	Metabotropic glutamate receptor3	Anxiety disorder	300, 311	F32, F40-F42
T02719	Metabotropic glutamate receptor3	Schizophrenia	295	F20
T02728	Neurotensin receptor type 1	Acute or chronic pain	338,780	R52, G89
T02728	Neurotensin receptor type 1	Alcohol use disorders	303	F10.2
T02728	Neurotensin receptor type 1	Inflammatory bowel disease	555, 556	K50, K51
T02728	Neurotensin receptor type 1	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T02728	Neurotensin receptor type 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T02752	C-C chemokine receptor type 3	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T02752	C-C chemokine receptor type 3	Asthma		J45
T02762	Replacing the 17 beta-estradiol and progesterone hormones the body has stopped producing as the result of menopause	Endometriosis	617	N80
T02777	SUR2-type K(ATP) channel	Angina pectoris	413	I20
T02777	SUR2-type K(ATP) channel	Diabetes	253.5, 588.1	E23.2, N25.1
T02779	mRNA	Systemic lupus erythematosus	710	M32
T02808	Interferon beta ligand	Acute lung injury	518	J80
T02808	Interferon beta ligand	Autoimmune diabetes		E08-E13
T02808	Interferon beta ligand	Glioblastoma multiforme	191	C71
T02808	Interferon beta ligand	Multiple scierosis	340	G35
T02808	Interferon beta ligand	Type 2 diabetes	250	E11
T02808	Interferon beta ligand	Unspecified		
T02890	Luteinizing hormone-releasing hormone	Prostate cancer	185	C61
T03006	Acetylcholine release inhibitor and neuromuscular blockor	Cervical cancer	180	C53
T03046	Pancreatic cancer caused by mutated versions of the RAS protein	Ras mutation positive pancreas cancer	157.0-157.9	C25
T03313	Interleukin-2 receptor alpha chain	Autoimmune diabetes		E08-E13
T03313	Interleukin-2 receptor alpha chain	Chronic lymphocytic leukaemia		C91
T03313	Interleukin-2 receptor alpha chain	Heart transplant rejection	996	T86
T03313	Interleukin-2 receptor alpha chain	Hodgkin's lymphoma		C81
T03313	Interleukin-2 receptor alpha chain	Human immunodeficiency virus infection	279.3	B20-B26
T03313	Interleukin-2 receptor alpha chain	Organ transplant rejection	279.5, 996	D89.8, T86
T03346	Interleukin-4 receptor alpha chain	Asthma		J45
T03346	Interleukin-4 receptor alpha chain	Asthma; Atopic dermatitis	493, 691.8, 692.9	J45, L20-L30
T03346	Interleukin-4 receptor alpha chain	Cancer	140-229	C00-C96
T03346	Interleukin-4 receptor alpha chain	Moderate-to-severe atopic dermatitis		L20
T03346	Interleukin-4 receptor alpha chain	Pulmonary fibrosis	515, 516.3	J84.1
T03403	Cyclooxygenase	Ankylosing spondylitis	720	M08.1, M45
T03403	Cyclooxygenase	Arthritis	710-719	M00-M25
T03403	Cyclooxygenase	Asthma		J45
T03403	Cyclooxygenase	Atopic dermatitis	691.8, 692.9	L00-L99
T03403	Cyclooxygenase	Back pain	724.5,338,780	M54, G89, R52
T03403	Cyclooxygenase	Cardiovascular disorder		I00-I99
T03403	Cyclooxygenase	Cerebrovascular ischaemia	434.91	I61-I63
T03403	Cyclooxygenase	Chemotherapy or radiotherapy-induced mucositis	338, 528.0,780	K12.3, R52, G89
T03403	Cyclooxygenase	Dysmenorrhea	625.3	N94.4-N94.6
T03403	Cyclooxygenase	Hyperglyceridemic	790.29	R73.9
T03403	Cyclooxygenase	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
T03403	Cyclooxygenase	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T03403	Cyclooxygenase	Inflammatory bowel disease	555, 556	K50, K51
T03403	Cyclooxygenase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T03403	Cyclooxygenase	Joint and muscular pain; Ankylosing spondylitis	719.4, 729.1, 338, 780, 720	M25.5, M79.1, G89, R52, M08.1, M45
T03403	Cyclooxygenase	Migraine	346	G43
T03403	Cyclooxygenase	Osteoarthritis	715	M15-M19, M47
T03403	Cyclooxygenase	Osteoarthritis of knee		M15-M19, M47
T03403	Cyclooxygenase	Otitis media		H65-H67
T03403	Cyclooxygenase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T03403	Cyclooxygenase	Platelet aggregatory		D69.1
T03403	Cyclooxygenase	Postoperative inflammation undergone cataract extraction		
T03403	Cyclooxygenase	Rheumatoid arthritis	710-719, 714	M05-M06
T03403	Cyclooxygenase	Type 2 diabetes; Early nephropathy; Claudication	250, 250.00, 250.02, 250.4, 338, 437.6, 443.9, 453, 580-599, 671.5, 671.9,780	E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T03403	Cyclooxygenase	Unspecified		
T03410	Mycobacterium tuberculosis membrane protein mmpL3	Asthma		J45
T03410	Mycobacterium tuberculosis membrane protein mmpL3	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T03500	MMP-12	Aortic aneurysm		I71
T03500	MMP-12	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T03500	MMP-12	Atherosclerosis	414.0, 440	I70
T03500	MMP-12	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T03500	MMP-12	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T03573	CD32b	Autoimmune diabetes		E08-E13
T03634	CBP	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1, 238.7	C92.0, C92.1, D46
T03644	Alpha-synuclein	Alzheimer disease	331	G30
T03644	Alpha-synuclein	Parkinson's disease	332	G20
T03661	Adenosine deaminase	Chronic pain	338.2,780	R52.1-R52.2, G89
T03661	Adenosine deaminase	Hairy cell leukemia	202.4	C91.4
T03661	Adenosine deaminase	Hematological malignancies	200-209	C81-C86
T03661	Adenosine deaminase	Immunodeficiency	279.3	D84.9
T03691	Leukotriene A-4 hydrolase	Acute myeloid leukemia	205	C92.0
T03691	Leukotriene A-4 hydrolase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T03691	Leukotriene A-4 hydrolase	Myocardial infarction	410	I21, I22
T03790	Unspecified enzyme	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T03790	Unspecified enzyme	Colorectal cancer	153, 154	C18-C21
T03790	Unspecified enzyme	Diabetes	253.5, 588.1	E23.2, N25.1
T03790	Unspecified enzyme	Haematological malignancies	200-209	C81-C86
T03790	Unspecified enzyme	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T03790	Unspecified enzyme	Lysosomal storage disease		E75-E77
T03790	Unspecified enzyme	Mycobacterium infection		A31
T03790	Unspecified enzyme	Obesity	278	E66
T03790	Unspecified enzyme	Onchocerciasis		B73
T03871	mRNA of H-ras	Cancer	140-229	C00-C96
T03896	Hepatitis C virus serine protease NS3/4A	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T03896	Hepatitis C virus serine protease NS3/4A	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T03917	Sodium/potassium-transporting ATPase	Congestive cardiac insufficiency; Arrhythmias; Heart failure	427, 428	I47-I49, I50
T03963	Voltage-gated ion channel	Asthma		J45
T03985	Bacteria topoisomerase	Acquired immune deficiency syndrome	42	B20
T04079	Plasmodial phospholipid metabolism	Malaria		B54
T04084	mRNA of ERBB3	Cancer	140-229	C00-C96
T04183	P-glycoprotein mediated multidrugresistance	Cancer	140-229	C00-C96
T04321	Staphylococcus aureus alpha hemolysin	Hospital-acquired pneumonia		J18.9
T04321	Staphylococcus aureus alpha hemolysin	Hospital-acquired pneumonia; Ventilator-associated pneumonia		J18.9, J95
T04321	Staphylococcus aureus alpha hemolysin	Mucolytic		J00-J99
T04321	Staphylococcus aureus alpha hemolysin	Pneumonia due to methicillin susceptible staphylococcus aureus		J15.211
T04321	Staphylococcus aureus alpha hemolysin	Ventilator-associated pneumonia		J95
T04361	Mitogen-activated protein kinase kinase kinase 7	Mantle cell lymphoma	200.4, 202.8, 203.0, 208.9	C81-C86, C85.7, C90.0, C91-C95
T04389	ATPase	Angina pectoris	413	I20
T04389	ATPase	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T04394	Vasopressin receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T04394	Vasopressin receptor	Diuretic		Y54.5
T04394	Vasopressin receptor	Heart failure	428	I50
T04394	Vasopressin receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T04507	Presynaptic density protein 95	Cerebrovascular ischaemia	434.91	I61-I63
T04689	Nicotinic acetylcholine receptor subunit alpha-1	Muscle relaxant		N39.3, N39.4, R32
T04741	Phosphoribosylaminoimidazolecarboxamide formyltransferase	Cancer	140-229	C00-C96
T04773	Stromal cell-derived factor 1	Heart failure	428	I50
T04773	Stromal cell-derived factor 1	Macular degeneration	362.5	H35.3
T04820	Cyclin-dependent protein kinase Pfmrk	Malaria		B54
T04883	Cyclooxygenase-3	Analgesia	338	R52, G89
T04883	Cyclooxygenase-3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T04902	Calpain	Alzheimer disease	331	G30
T04902	Calpain	Cerebral infarction		I63
T04902	Calpain	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T04911	Hepatitis C virus protein NS4B	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T04977	Oxalate oxidase	Hyperoxaluria		E74.8
T05031	PI3K beta	Cancer	140-229	C00-C96
T05031	PI3K beta	Solid tumours	140-199, 210-229	C00-D48
T05031	PI3K beta	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T05114	Chymase	Atopic dermatitis	691.8, 692.9	L00-L99
T05114	Chymase	Cardiovascular disorder		I00-I99
T05114	Chymase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T05114	Chymase	Heart failure	428	I50
T05152	Hepatitis C virus NS5B polymerase	HCV genotypes 1-6		B17.1, B18.2
T05152	Hepatitis C virus NS5B polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T05152	Hepatitis C virus NS5B polymerase	Hepatitis virus infection	573.3	K75.9
T05152	Hepatitis C virus NS5B polymerase	Unspecified		
T05196	Uric acid	Gout	274.00274.1274.8274.9	M10
T05290	Malignant cancer cells	Acute lymphoblastic leukemia	204.0, 556	C91.0
T05351	MARCKS protein	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T05409	Neutral endopeptidase	Chronic pain	338.2,780	R52.1-R52.2, G89
T05409	Neutral endopeptidase	Female sexual dysfunction	302.7	F52
T05409	Neutral endopeptidase	Heart failure	428	I50
T05409	Neutral endopeptidase	Hypertension	401	I10-I16
T05409	Neutral endopeptidase	Hypotension	458, 796.3	I95
T05409	Neutral endopeptidase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T05563	H5N1 pandemic influenza virus	Influenza virus		J11.1
T05643	Leucine-rich repeat neuronal protein 1	Multiple scierosis	340	G35
T05661	Lecithin-cholesterol acyltransferase	Acute coronary syndrome	444	I74
T05849	Gastrin/cholecystokinin type B receptor	Anxiety disorder	300, 311	F32, F40-F42
T05849	Gastrin/cholecystokinin type B receptor	Caerulein stimulated gastric and pancreatic secretion		
T05849	Gastrin/cholecystokinin type B receptor	Cancer	140-229	C00-C96
T05849	Gastrin/cholecystokinin type B receptor	Diagnostic imaging	331	G30, I73.9
T05849	Gastrin/cholecystokinin type B receptor	Duodenal ulcers		K25-K27
T05849	Gastrin/cholecystokinin type B receptor	Gastroesophageal reflux disease	140-229, 530	K21
T05849	Gastrin/cholecystokinin type B receptor	Gastrointestinal disease		K00-K93
T05849	Gastrin/cholecystokinin type B receptor	Intestine cancer		C17-C20, C26
T05849	Gastrin/cholecystokinin type B receptor	Medullary thyroid cancer	193	C73
T05849	Gastrin/cholecystokinin type B receptor	Stomach disease		K30-K31
T05849	Gastrin/cholecystokinin type B receptor	Stomach ulcer		K25-K27
T05849	Gastrin/cholecystokinin type B receptor	Type 1 diabetes	250	E10
T05849	Gastrin/cholecystokinin type B receptor	Ulcerative colitis	556	K51
T05849	Gastrin/cholecystokinin type B receptor	Unspecified		
T05890	Rhinovirus capsid protein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T05904	Phosphodiesterase 8	Inflammatory disorder		
T05938	Mucin 16	Fallopian tube cancer; Peritoneal cancer; Ovarian cancer	140-229, 183.2, 221.0, 183	C57, D28, C56
T05938	Mucin 16	Ovarian cancer	183	C56
T06011	Transforming growth factor-beta	Anemia	280-285	D50-D64
T06037	mRNA of human Jun-N-terminal kinase-2 (JNK2)	Cancer	140-229	C00-C96
T06042	Sinus node If channel	Angina pectoris	413	I20
T06046	Nitric-oxide synthase, endothelial	Angina pectoris	413	I20
T06046	Nitric-oxide synthase, endothelial	Angina; Coronary artery disease	410-414, 413, 429.2	I20, I20-I25
T06046	Nitric-oxide synthase, endothelial	Brain injury		S09.90
T06046	Nitric-oxide synthase, endothelial	Hypertension; Angina	401, 413	I10-I16, I20
T06046	Nitric-oxide synthase, endothelial	Hypotension	458, 796.3	I95
T06046	Nitric-oxide synthase, endothelial	Myocardial infarction	410	I21, I22
T06046	Nitric-oxide synthase, endothelial	Pulmonary hypertension	416	I27.0, I27.2
T06063	DNA polymerase (HSV-2)	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T06093	Rho associated protein kinase 2	Rheumatoid arthritis	710-719, 714	M05-M06
T06182	VIP 2 receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T06182	VIP 2 receptor	Hypertension	401	I10-I16
T06182	VIP 2 receptor	Unspecified		
T06273	Poly [ADP-ribose] polymerase-1	Ataxia telangiectasia		G11.3
T06273	Poly [ADP-ribose] polymerase-1	Brain ischaemia	435, 437	G45.9, I67.8
T06273	Poly [ADP-ribose] polymerase-1	Cancer	140-229	C00-C96
T06273	Poly [ADP-ribose] polymerase-1	Cerebrovascular disorders		I60-I69
T06273	Poly [ADP-ribose] polymerase-1	Cerebrovascular ischaemia	434.91	I61-I63
T06273	Poly [ADP-ribose] polymerase-1	Inflammatory skin condition		L00-L99
T06273	Poly [ADP-ribose] polymerase-1	Melanoma	172	C43
T06273	Poly [ADP-ribose] polymerase-1	Myocardial infarction	410	I21, I22
T06273	Poly [ADP-ribose] polymerase-1	Ovarian cancer	183	C56
T06273	Poly [ADP-ribose] polymerase-1	Permanent and transient stroke	434.91, 435.9	G45.9, I61-I63
T06273	Poly [ADP-ribose] polymerase-1	Recurrent epithelial ovarian or primary peritoneal cancer		C78
T06320	Galectin	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
T06365	Alanine glyoxylate aminotransferase	Hyperoxaluria		E74.8
T06413	mRNA of PKC-alpha	Non-small cell lung cancer		C33-C34
T06421	Interferon-alpha/beta receptor	Advanced renal cell carcinoma	189	C64
T06421	Interferon-alpha/beta receptor	Endometriosis	617	N80
T06421	Interferon-alpha/beta receptor	Hairy cell leukemia	202.4	C91.4
T06421	Interferon-alpha/beta receptor	Hairy cell leukemia, malignant melanoma; Chronic myelogenous leukaemia	172, 202.4, 208.9, 205.1	C43, C91-C95, C91.4, C92.1
T06421	Interferon-alpha/beta receptor	Hairy cell leukemia; HCV infection	202.4, 070.4, 070.5, 070.70	C91.4, B17.1, B18.2
T06421	Interferon-alpha/beta receptor	Multiple scierosis	340	G35
T06421	Interferon-alpha/beta receptor	Systemic lupus erythematosus; Myositis	695, 710.0, 729.1	L51-L54, M32, M60
T06438	Oxidoreductase	Ulcerative colitis	556	K51
T06446	Leukotriene biosynthesis	Asthma		J45
T06475	Nucleolin	Cancer	140-229	C00-C96
T06475	Nucleolin	Leukemia	208.9	C90-C95
T06489	Release of ACh	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T06575	Choriogonadotropin beta chain	Bladder cancer	188	C67
T06671	Interleukin-18	B-cell non-hodgkin's lymphoma; Rheumatoid arthritis	200, 202, 202.8, 710-719, 714	C81-C86, C82-C85, M00-M25, M05-M06
T06671	Interleukin-18	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T06671	Interleukin-18	Non-hodgkin's lymphoma; Ovarian cancer	183	C85, C56
T06671	Interleukin-18	Type 2 diabetes	250	E11
T06770	Transmembrane glycoprotein gp41	HIV-1 infection	001-139, 042	B20-B24
T06770	Transmembrane glycoprotein gp41	Human immunodeficiency virus infection	279.3	B20-B26
T06770	Transmembrane glycoprotein gp41	Unspecified		
T06841	Interleukin-23 ligand	Ankylosing spondylitis	720	M08.1, M45
T06841	Interleukin-23 ligand	Asthma		J45
T06841	Interleukin-23 ligand	Crohn's disease	555	K50
T06841	Interleukin-23 ligand	Hairy cell leukemia; Psoriasis	202.4, 696	C91.4, L40
T06841	Interleukin-23 ligand	Moderate-to-severe plaque psoriasis	696	L40
T06841	Interleukin-23 ligand	Rheumatoid arthritis	710-719, 714	M05-M06
T06850	Ghrelin	Type 1 diabetes	250	E10
T06955	C-Cchemokine receptor type 4	Asthma		J45
T06955	C-Cchemokine receptor type 4	Atopic dermatitis	691.8, 692.9	L00-L99
T06955	C-Cchemokine receptor type 4	Autoimmune diabetes		E08-E13
T07035	mRNA of IE2 region of cytomegalovirus	CMV retinitis	78.5	B25.8, H30.9
T07035	mRNA of IE2 region of cytomegalovirus	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T07045	Pituitary adenylate cyclase-activating polypeptide 38	Nerve injury		T14.4
T07063	Sodium/iodide cotransporter	Prostate cancer	185	C61
T07082	Respiratory syncytial virus genomic RNA	Upper and lower respiratory tract disease	460-519	J00-J99
T07087	Focal adhesion kinase-2	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T07102	Rho-associated protein kinase 1	Atherosclerosis	414.0, 440	I70
T07102	Rho-associated protein kinase 1	Cancer	140-229	C00-C96
T07102	Rho-associated protein kinase 1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T07102	Rho-associated protein kinase 1	Diabetic nephropathy	250.4	E11.21
T07102	Rho-associated protein kinase 1	Glaucoma	365	H40-H42
T07102	Rho-associated protein kinase 1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T07102	Rho-associated protein kinase 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T07102	Rho-associated protein kinase 1	Pulmonary arterial hypertension	416	I27.0, I27.2
T07137	4-hydroxyphenylpyruvate dioxygenase	Hereditary tyrosinemia type 1	270.2	E70.2
T07137	4-hydroxyphenylpyruvate dioxygenase	Respiratory syncytial virus infection	79.6	B97.4
T07173	Neurotrophic tyrosine kinase receptor 1	Advanced solid malignancies	140-199, 140-239, 210-229	D10-D36, D3A
T07173	Neurotrophic tyrosine kinase receptor 1	Alzheimer disease	331	G30
T07173	Neurotrophic tyrosine kinase receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T07173	Neurotrophic tyrosine kinase receptor 1	Psoriasis	696	L40
T07173	Neurotrophic tyrosine kinase receptor 1	Solid tumours	140-199, 210-229	C00-D48
T07279	Serine/threonine-proteinkinase pim-2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T07279	Serine/threonine-proteinkinase pim-2	Multiple myeloma	203	C90
T07279	Serine/threonine-proteinkinase pim-2	Solid tumours	140-199, 210-229	C00-D48
T07289	Duffy antigen chemokine receptor	Malaria		B54
T07303	Vascular endothelial growth factor receptor 3	Cancer	140-229	C00-C96
T07303	Vascular endothelial growth factor receptor 3	Hepatocellular carcinoma	155	C22.0
T07303	Vascular endothelial growth factor receptor 3	Prostate cancer; Lung cancer	140-229, 162, 185	C33-C34, C61
T07303	Vascular endothelial growth factor receptor 3	Solid tumours	140-199, 210-229	C00-D48
T07303	Vascular endothelial growth factor receptor 3	Vascular restinosis following vascular graft surgery		T82.858A
T07374	Beta microseminoprotein	Hormone refractory prostate cancer	140-229, 185	C61
T07394	Notch	Solid tumours	140-199, 210-229	C00-D48
T07400	Advanced glycosylation end product-specific receptor	Alzheimer disease	331	G30
T07400	Advanced glycosylation end product-specific receptor	Dementia	290-294	F01-F07
T07400	Advanced glycosylation end product-specific receptor	Diabetic kidney disease; Diabetic nephropathy	250.4	E11.22, E11.21
T07400	Advanced glycosylation end product-specific receptor	Hypotension	458, 796.3	I95
T07403	Integrin alpha-4/beta-7	Crohn's disease	555	K50
T07403	Integrin alpha-4/beta-7	Rheumatoid arthritis	710-719, 714	M05-M06
T07485	Respiratorysyncytial virus protein F	Respiratory syncytial virus infection	79.6	B97.4
T07485	Respiratorysyncytial virus protein F	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T07507	Myosin-7	Deafness		H90-H91
T07533	Apolipoprotein B-100	High cholesterol level	272	E78.0
T07601	Cyclophilin	Duchenne muscular dystrophy		G71.0
T07601	Cyclophilin	Ocular inflammation	370.33	H16.229
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Angina pectoris	413	I20
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Asthma		J45
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Cardiovascular disorder		I00-I99
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Chronic obstructive pulmonary disease; Raynaud's disease	490-492, 494-496, 443	J40-J44, J47, I73.0
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Colorectal cancer	153, 154	C18-C21
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Erectile dysfunction; Hypertension; Raynaud's disease	302.72, 607.84, 401, 443	F52.2, N48.4, I10-I16, I73.0
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Hypertension	401	I10-I16
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Spasm	728.85	R25.2
T07663	CGMP-specific 3',5'-cyclic phosphodiesterase	Unspecified		
T07694	Unspecified protease	Atopic dermatitis	691.8, 692.9	L00-L99
T07694	Unspecified protease	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T07806	5-hydroxytryptamine 1B receptor	Anxiety disorder	300, 311	F32, F40-F42
T07806	5-hydroxytryptamine 1B receptor	Chronic schizophrenics	295	F20
T07806	5-hydroxytryptamine 1B receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T07806	5-hydroxytryptamine 1B receptor	Migraine headaches	346	G43
T07806	5-hydroxytryptamine 1B receptor	Mood disorder		F30-F39
T07806	5-hydroxytryptamine 1B receptor	Psychotic disorders	290-299	F20-F29
T07861	Inhibiting IL-1 synthesis and/orrelease	Asthma		J45
T07958	Erythropoietin ligand	Anemia	280-285	D50-D64
T07958	Erythropoietin ligand	Cerebrovascular ischaemia	434.91	I61-I63
T07958	Erythropoietin ligand	Depression; Diabetic neuropathy; Mood disorder	311, 250, 250.6, 356.0, 356.8	F30-F39, E11.40
T07958	Erythropoietin ligand	Unspecified		
T07974	HCV polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T07974	HCV polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T08133	Transient receptor potential channel 6, subfamily V	Ovarian cancer	183	C56
T08156	Interferon alpha 5 ligand	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T08156	Interferon alpha 5 ligand	Infections	001-139	A00-B99
T08231	CD74	Chronic lymphocytic leukaemia		C91
T08298	Granzyme B	Aortic aneurysm		I71
T08306	CD79b	Diffuse large B-cell lymphoma	200	C83.3
T08306	CD79b	Hematological malignancies	200-209	C81-C86
T08306	CD79b	Non-hodgkin's lymphoma		C85
T08306	CD79b	Non-hodgkin's lymphoma; Diffuse large B-cell lymphoma	200, 200.0, 202	C82-C85, C83.3
T08383	Beta-hydroxybutyrate	Memory loss		F03
T08391	Tyrosine-protein kinase JAK2	Anemia	280-285	D50-D64
T08391	Tyrosine-protein kinase JAK2	Cancer	140-229	C00-C96
T08391	Tyrosine-protein kinase JAK2	Leukemia	208.9	C90-C95
T08391	Tyrosine-protein kinase JAK2	Multiple scierosis	340	G35
T08391	Tyrosine-protein kinase JAK2	Myelofibrosis	208.9, 289.83, 709.2	C94.4, D47.4
T08391	Tyrosine-protein kinase JAK2	Myeloproliferative disorder		C94.6
T08391	Tyrosine-protein kinase JAK2	Myeloproliferative neoplasm; Breast cancer	205.1, 238.4, 289.89, 289.9, 174, 175	D47.1, C50
T08391	Tyrosine-protein kinase JAK2	Polycythemia vera	238.4	D45
T08391	Tyrosine-protein kinase JAK2	Renal transplantation; Multiple myeloma	279.5, 203	D89.8, C90
T08404	Helicase-primase	Herpes simplex virus infection	54	B00
T08441	Viral maturaton	Human immunodeficiency virus infection	279.3	B20-B26
T08583	Thrombomodulin	Disseminated intravascular coagulation	286.6	D65
T08743	Aminopeptidase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T08856	Neutrophil collagenase	Multiple scierosis	340	G35
T08884	Thrombospondin relate anonymous protein	Malaria		B54
T08898	Adrenocorticotropic hormone receptor	Adrenocortical insufficiency	255.4	E27.1-E27.4
T08922	Acetyl-CoA carboxylase 2	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T08922	Acetyl-CoA carboxylase 2	Obesity	278	E66
T08922	Acetyl-CoA carboxylase 2	Parkinson's disease	332	G20
T08922	Acetyl-CoA carboxylase 2	Sebaceous gland disease		L73.8
T08922	Acetyl-CoA carboxylase 2	Type 2 diabetes	250	E11
T09005	Corynebacterium diphtheriae CRM197 protein	Meningococcal infection a c y and w-135		A39.0
T09005	Corynebacterium diphtheriae CRM197 protein	Streptococcus pneumoniae infection		J13
T09058	5T4 ONCOFETAL antigen	Breast cancer	174, 175	C50
T09058	5T4 ONCOFETAL antigen	Cancer	140-229	C00-C96
T09058	5T4 ONCOFETAL antigen	Hormone refractory prostate cancer	140-229, 185	C61
T09058	5T4 ONCOFETAL antigen	Solid tumours	140-199, 210-229	C00-D48
T09092	Interleukin-10	Endometriosis	617	N80
T09092	Interleukin-10	Inflammatory bowel disease; Psoriasis; Rheumatoid arthritis	555, 556, 696, 710-719, 714	K50, K51, L40, M00-M25, M05-M06
T09092	Interleukin-10	Scar tissue		L00-L99
T09092	Interleukin-10	Solid tumours	140-199, 210-229	C00-D48
T09130	Muscarinic receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T09130	Muscarinic receptor	Alzheimer disease	331	G30
T09130	Muscarinic receptor	Amnesia		F04
T09130	Muscarinic receptor	Asthma		J45
T09130	Muscarinic receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T09130	Muscarinic receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T09130	Muscarinic receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
T09130	Muscarinic receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T09130	Muscarinic receptor	Xerostomia	527.7	K11.7, R68.2
T09227	Protein tyrosine phosphatase	Type 1 diabetes	250	E10
T09323	Downregulating angiotensin II-induced endothelin-1 gene expression	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T09347	Ca2+ dependent or involving processes	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T09407	Grass pollen allergen	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T09423	ATP-sensitive inward rectifier potassium channel 10	Diabetes	253.5, 588.1	E23.2, N25.1
T09423	ATP-sensitive inward rectifier potassium channel 10	Non-insulin dependent diabetes		E11.9
T09507	mRNA of human apolipoprotein B	Familial hypercholesterolemia	272	E78.0
T09507	mRNA of human apolipoprotein B	Hypercholesterolemia		E78
T09528	C-X-C chemokine receptor type 5	Systemic lupus erythematosus	710	M32
T09538	Alkaline phosphatase, tissue-nonspecific	Anthelmintic		B89
T09538	Alkaline phosphatase, tissue-nonspecific	Colon cancer	153, 154	C50
T09538	Alkaline phosphatase, tissue-nonspecific	Genetic disease		Q00-Q99
T09572	Melanin-concentrating hormone receptor 1	Obesity	278	E66
T09572	Melanin-concentrating hormone receptor 1	Obesity; Anxiety; Depression	278, 300, 311	E66, F32, F40-F42
T09756	Polyamine	Cancer	140-229	C00-C96
T09826	Toposisomerase-1	Acquired immune deficiency syndrome	42	B20
T09826	Toposisomerase-1	Advanced ovarian cancer; Lung cancer	183, 162	C56, C33-C34
T09826	Toposisomerase-1	Bladder cancer	188	C67
T09826	Toposisomerase-1	Breast cancer	174, 175	C50
T09826	Toposisomerase-1	Cancer	140-229	C00-C96
T09826	Toposisomerase-1	Colorectal cancer	153, 154	C18-C21
T09826	Toposisomerase-1	Esophageal cancer	150	C15
T09826	Toposisomerase-1	Gastric cancer	151	C16
T09826	Toposisomerase-1	Glioblastoma multiforme; Myelodysplastic syndrome	191, 238.7	C71, D46
T09826	Toposisomerase-1	Human immunodeficiency virus infection	279.3	B20-B26
T09826	Toposisomerase-1	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T09826	Toposisomerase-1	Metastatic breast cancer		C50
T09826	Toposisomerase-1	Metastatic breast cancer; Metastatic colorectal cancer	153, 154	C50, C18-C21
T09826	Toposisomerase-1	Ovarian cancer	183	C56
T09826	Toposisomerase-1	Solid tumours	140-199, 210-229	C00-D48
T09826	Toposisomerase-1	Unspecified		
T09909	Type-2 angiotensin II receptor	Hypertension	401	I10-I16
T09909	Type-2 angiotensin II receptor	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
T09937	Receptor	Autoimmune diabetes		E08-E13
T09937	Receptor	Ischemic heart diseases	410-414	I20-I25
T09937	Receptor	Oral mucositis	528	K12.3
T09960	C-C chemokinereceptor type 5	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T09960	C-C chemokinereceptor type 5	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
T09960	C-C chemokinereceptor type 5	HIV-1 infection	001-139, 042	B20-B24
T09960	C-C chemokinereceptor type 5	Human immunodeficiency virus infection	279.3	B20-B26
T09960	C-C chemokinereceptor type 5	Infections	001-139	A00-B99
T09960	C-C chemokinereceptor type 5	Rheumatoid arthritis	710-719, 714	M05-M06
T09960	C-C chemokinereceptor type 5	Transplant rejection	279.5, 996	D89.8, T86
T09982	Uptake of luminal sterol across the microvillus membrane	Hyperlipidaemia	272.0-272.4	E78
T10092	Follicle stimulating hormone	Female infertility	628	N97.0
T10092	Follicle stimulating hormone	Infertility	628	N97.0
T10147	Receptor-type protein-tyrosine phosphatase S	Paget's disease	731	M88
T10191	T-cell surface glycoprotein CD4	Cancer	140-229	C00-C96
T10191	T-cell surface glycoprotein CD4	Human immunodeficiency virus infection	279.3	B20-B26
T10191	T-cell surface glycoprotein CD4	Lymphoma	202.8, 208.9	C81-C86
T10191	T-cell surface glycoprotein CD4	Psoriasis; Asthma	696	L40, J45
T10191	T-cell surface glycoprotein CD4	Rheumatoid arthritis	710-719, 714	M05-M06
T10249	Histamine and peptide leukotrienes release	Asthma		J45
T10265	CAMP-specific 3',5'-cyclic phosphodiesterase 4B	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T10339	Lipoxygenase	Arthritis	710-719	M00-M25
T10339	Lipoxygenase	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T10362	Enzyme	Acute intermittent hepatic porphyria		E80.21
T10362	Enzyme	Female genital tract inflammation		N73.9
T10362	Enzyme	Human immunodeficiency virus infection	279.3	B20-B26
T10383	PLD2	Coagulation		I80-I82
T10445	Lipase	Fungal infections	110-118	B35-B49
T10445	Lipase	Obesity	278	E66
T10482	mRNA of Coagulation factor XII	Alzheimer disease	331	G30
T10491	Chemokine receptor 3	Asthma		J45
T10491	Chemokine receptor 3	Cancer	140-229	C00-C96
T10513	Integrin beta-2	Cerebrovascular ischaemia	434.91	I61-I63
T10513	Integrin beta-2	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T10670	Neuropeptide Y receptor type 2	Diabetes	253.5, 588.1	E23.2, N25.1
T10670	Neuropeptide Y receptor type 2	Metabolic disorders	270-279	E70-E89
T10670	Neuropeptide Y receptor type 2	Obesity	278	E66
T10735	Histidine decarboxylase	Pruritus	698	L29
T10735	Histidine decarboxylase	Skin infections	680-709	L00-L99
T10828	Alpha-fetoprotein	Autoimmune diabetes		E08-E13
T10877	CD38	Cancer	140-229	C00-C96
T10877	CD38	Hematological malignancies	200-209	C81-C86
T10877	CD38	Multiple myeloma	203	C90
T10897	Acyl-CoA desaturase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T10897	Acyl-CoA desaturase	Diabetes	253.5, 588.1	E23.2, N25.1
T10897	Acyl-CoA desaturase	Lipid metabolism disorder		E75-E78
T10897	Acyl-CoA desaturase	Type 2 diabetes	250	E11
T10937	mRNA of Human mdm2	Cancer	140-229	C00-C96
T10965	P-selectin	Allergy	995.3	T78.4
T10965	P-selectin	Atherosclerosis; Thrombosis	414.0, 440, 437.6, 453, 671.5, 671.9	I70, I80-I82
T10965	P-selectin	Cancer	140-229	C00-C96
T10965	P-selectin	Delayed graft function; Heart transplantation	996	T86
T10965	P-selectin	Vaso-occlusive crisis	282.62	D57.00
T11005	Interferon omega ligand	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T11011	Corticotropin releasingfactor receptor 2	Anxiety disorder	300, 311	F32, F40-F42
T11011	Corticotropin releasingfactor receptor 2	Congestive heart failure	428	I50
T11011	Corticotropin releasingfactor receptor 2	Eating disorders stimulate food consumption anxiety	307.5	F50
T11011	Corticotropin releasingfactor receptor 2	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
T11069	Lyase	Cancer	140-229	C00-C96
T11069	Lyase	Prostate cancer	185	C61
T11072	5-hydroxytryptamine 1D receptor	Acute migraine	346	G43
T11072	5-hydroxytryptamine 1D receptor	Epilepsy		G40
T11072	5-hydroxytryptamine 1D receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T11072	5-hydroxytryptamine 1D receptor	Migraine	346	G43
T11072	5-hydroxytryptamine 1D receptor	Migraine headaches	346	G43
T11072	5-hydroxytryptamine 1D receptor	Mood disorder		F30-F39
T11072	5-hydroxytryptamine 1D receptor	Severe mood disorders	296	F30-F39
T11164	Secretory phospholipase A2	Rheumatoid arthritis	710-719, 714	M05-M06
T11211	Androgen receptor	Acne vulgaris	706.1	L70.0
T11211	Androgen receptor	Advanced prostate cancer	185	C61
T11211	Androgen receptor	Alcoholic hepatitis	571.1	K70.1
T11211	Androgen receptor	Alopecia	704.09	L65.9
T11211	Androgen receptor	Bladder cancer	188	C67
T11211	Androgen receptor	Cachexia	799.4	R64
T11211	Androgen receptor	Cancer	140-229	C00-C96
T11211	Androgen receptor	Cardiovascular disorder		I00-I99
T11211	Androgen receptor	Castration-resistant prostate cancer	185	C61
T11211	Androgen receptor	Contraception		Z30
T11211	Androgen receptor	Cystic fibrosis	277	E84
T11211	Androgen receptor	Dermatological disease		L00-L99
T11211	Androgen receptor	Endocrine disease		E00-E35
T11211	Androgen receptor	Female androgenresponsive recurrent mammary cancer	174, 175	C50
T11211	Androgen receptor	Heart failure	428	I50
T11211	Androgen receptor	Hormone deficiency		E00-E90
T11211	Androgen receptor	Hormone refractory prostate cancer	140-229, 185	C61
T11211	Androgen receptor	Hypogonadism	257.2	E23.0, E28.3, E29.1
T11211	Androgen receptor	Male hormonal deficiencies		E20-E35
T11211	Androgen receptor	Male hypogonadism; Breast cancer	257.2, 174, 175	E23.0, E28.3, E29.1, C50
T11211	Androgen receptor	Metastatic castration-resistant prostate cancer	140-229, 185	C61
T11211	Androgen receptor	Metastatic prostate cancer	185	C61
T11211	Androgen receptor	Muscle atrophy		M62.5
T11211	Androgen receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T11211	Androgen receptor	Osteoporosis in post-menopausal women	733	M80-M81
T11211	Androgen receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T11211	Androgen receptor	Prostate cancer	185	C61
T11211	Androgen receptor	Prostate hyperplasia		N40
T11211	Androgen receptor	Testosterone deficiency		E29.1
T11211	Androgen receptor	Unspecified		
T11241	Sphingosine-1-phosphate receptor-3	Breast cancer	174, 175	C50
T11253	mRNA of Heatshock 27 kDa protein	Breast cancer; Ovarian cancer; Bladder cancer; Prostate cancer; Lung cancer	140-229, 162, 183, 188	C00-C96, C33-C34, C56, C67
T11256	T-cell ligand	Multile sclerosis		G35
T11283	60 kDa heat shock protein, mitochondrial	Autoimmune diabetes		E08-E13
T11288	Multidrug resistance-associated protein 1	Gout	274.00274.1274.8274.9	M10
T11288	Multidrug resistance-associated protein 1	Gout; Arthritis	274.00274.1274.8274.9, 710-719	M10, M00-M25
T11309	C-C motif chemokine 2	Asthma		J45
T11309	C-C motif chemokine 2	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T11309	C-C motif chemokine 2	Diabetic complication		E08-E13
T11309	C-C motif chemokine 2	Nephritis		N00-N19, N25-N29
T11309	C-C motif chemokine 2	Pulmonary fibrosis	515, 516.3	J84.1
T11388	Cathepsin K	Bone disease		M00-M99
T11388	Cathepsin K	Bone metastases	198.5	C79.51
T11388	Cathepsin K	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T11388	Cathepsin K	Osteopenia	733.9	M85.8
T11388	Cathepsin K	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T11388	Cathepsin K	Ostereoporosis	733	M80-M81
T11388	Cathepsin K	Rheumatoid arthritis	710-719, 714	M05-M06
T11448	Alpha-2A adrenergic receptor	Attention deficit hyperactivity disorder	314	F90
T11448	Alpha-2A adrenergic receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T11448	Alpha-2A adrenergic receptor	Sexual dysfunction	302.7	F52
T11451	Toll-like receptor 9	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T11451	Toll-like receptor 9	Asthma		J45
T11451	Toll-like receptor 9	Asthma; Allergy	204.0, 493, 995.3	C91.0, J45, T78.4
T11451	Toll-like receptor 9	Cancer	140-229	C00-C96
T11451	Toll-like receptor 9	Chronic lymphocytic leukaemia		C91
T11451	Toll-like receptor 9	Colorectal cancer	153, 154	C18-C21
T11451	Toll-like receptor 9	Glioblastoma multiforme	191	C71
T11451	Toll-like receptor 9	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T11451	Toll-like receptor 9	Human immunodeficiency virus infection	279.3	B20-B26
T11451	Toll-like receptor 9	Infections	001-139	A00-B99
T11451	Toll-like receptor 9	Inflammatory bowel disease	555, 556	K50, K51
T11451	Toll-like receptor 9	Influenza virus		J11.1
T11451	Toll-like receptor 9	Leukemia	208.9	C90-C95
T11451	Toll-like receptor 9	Lung cancer	162	C33-C34
T11451	Toll-like receptor 9	Renal cell carcinoma; Solid tumours	140-199, 189, 210-229	C00-C75, C64, C7A, C7B, D10-D36, D3A
T11487	Acetyl-CoA acetyltransferase, mitochondrial	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T11754	Fatty-acid amide hydrolase	Anesthesia	338	R20.0
T11754	Fatty-acid amide hydrolase	Anxiety disorder	300, 311	F32, F40-F42
T11754	Fatty-acid amide hydrolase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T11754	Fatty-acid amide hydrolase	Liver disease	570-574	K70-K77
T11754	Fatty-acid amide hydrolase	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T11754	Fatty-acid amide hydrolase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T11754	Fatty-acid amide hydrolase	Unspecified		
T11822	Retinoic acid receptor	Acne vulgaris	706.1	L70.0
T11822	Retinoic acid receptor	Acute promyelocytic leukemia	205	C92.4
T11822	Retinoic acid receptor	Breast cancer	174, 175	C50
T11822	Retinoic acid receptor	Cancer	140-229	C00-C96
T11822	Retinoic acid receptor	Glioma	191	C71
T11822	Retinoic acid receptor	Hepatocellular carcinoma	155	C22.0
T11822	Retinoic acid receptor	Macular degeneration	362.5	H35.3
T11822	Retinoic acid receptor	Psoriasis	696	L40
T11822	Retinoic acid receptor	Rosacea		L71
T11843	Vitamin K epoxide reductase complex subunit 1	Atrial fibrillation	272, 427.31	E78, I48
T11843	Vitamin K epoxide reductase complex subunit 1	Bleeding; Thromboembolism	444, 453, 437.6, 671.5, 671.9	I74, I80-I82
T11843	Vitamin K epoxide reductase complex subunit 1	Cerebrovascular ischaemia	434.91	I61-I63
T11843	Vitamin K epoxide reductase complex subunit 1	Pulmonary embolism; Blood clotting disorder	415.1, 286	I26, D65-D69
T11843	Vitamin K epoxide reductase complex subunit 1	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T11911	KCa2.1	Myeloneuropathy		G04.1
T11947	Coagulation factor XIII	Graft-versus-host disease	279.5	T86.0
T11947	Coagulation factor XIII	Hemophilia	286	D66-D68
T11947	Coagulation factor XIII	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T12059	Alpha-mannosidase	Alpha-mannosidosis		E77.1
T12119	Voltage-gated sodium channel subunit alpha Nav1.7	Chronic pain	338.2,780	R52.1-R52.2, G89
T12119	Voltage-gated sodium channel subunit alpha Nav1.7	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T12187	D-alanine-D-alanine ligase A	Tuberculosis; Dementia	010-018, 290-294	A15-A19, F01-F07
T12279	mRNA of HPV E2 transactivator protein	Papillomavirus infections		B97.7
T12355	G1/S-specific cyclin D1	Solid tumours	140-199, 210-229	C00-D48
T12427	sodium pump	Cardiovascular disorder		I00-I99
T12475	Gonadotropin-releasing hormone receptor	Acute lymphoblastic leukemia	204.0, 556	C91.0
T12475	Gonadotropin-releasing hormone receptor	Advanced prostate cancer	185	C61
T12475	Gonadotropin-releasing hormone receptor	Cancer	140-229	C00-C96
T12475	Gonadotropin-releasing hormone receptor	Controlled ovarian stimulation	183	C56
T12475	Gonadotropin-releasing hormone receptor	Endometriosis	617	N80
T12475	Gonadotropin-releasing hormone receptor	Esophageal cancer	150	C15
T12475	Gonadotropin-releasing hormone receptor	Female infertility	628	N97.0
T12475	Gonadotropin-releasing hormone receptor	Hormone deficiency		E00-E90
T12475	Gonadotropin-releasing hormone receptor	Hypothalamic hypogonadism	257.2	E23.0, E28.3, E29.1
T12475	Gonadotropin-releasing hormone receptor	Ovulation	256	E28
T12475	Gonadotropin-releasing hormone receptor	Prostate cancer	185	C61
T12475	Gonadotropin-releasing hormone receptor	Prostate disease		N42.9
T12475	Gonadotropin-releasing hormone receptor	Prostate hyperplasia		N40
T12475	Gonadotropin-releasing hormone receptor	Unspecified		
T12475	Gonadotropin-releasing hormone receptor	Uterine leiomyoma	218.9	D25
T12499	Lck tyrosine kinase	Autoimmune diabetes		E08-E13
T12646	Valosin-containing protein p97	Multiple myeloma	203	C90
T12657	Osmotic and stimulant laxatives	Cleansing of the colon before colonoscopy		
T12719	Cytomegalovirus (CMV) replication	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T12767	Telomere	Cancer	140-229	C00-C96
T12819	E3 ubiquitin protein ligase COP1	Heart arrhythmia		I47-I49
T12819	E3 ubiquitin protein ligase COP1	Malaria		B54
T12819	E3 ubiquitin protein ligase COP1	Tachyarrhythmias	427, 785.0	I47-I49, R00.0
T12819	E3 ubiquitin protein ligase COP1	Ventricular arrhythmias	427.1	I47.2
T12837	Protein arginine N-methyltransferase 4	Cancer	140-229	C00-C96
T12909	Dystrophin	Duchenne muscular dystrophy		G71.0
T12966	Troponin C	Congestive heart failure	428	I50
T12966	Troponin C	Skin irritations	709.8	L98.8
T13017	Syndecan-1	Multiple myeloma	203	C90
T13127	Farnesyl protein transferase	Non-small cell lung cancer		C33-C34
T13127	Farnesyl protein transferase	Pancreatic cancer; Colorectal cancer	140-229, 153, 154, 157	C18-C21, C25
T13127	Farnesyl protein transferase	Solid tumours	140-199, 210-229	C00-D48
T13201	Carbonic anhydrase I	Cancer	140-229	C00-C96
T13201	Carbonic anhydrase I	Chronic glaucoma	365	H40-H42
T13201	Carbonic anhydrase I	Glaucoma	365	H40-H42
T13201	Carbonic anhydrase I	Glaucoma; Duodenal ulcers	365, 531-534	H40-H42, K25-K27
T13251	Interleukin-12	Crohn's disease; Inflammatory bowel disease	555, 556	K50, K51
T13251	Interleukin-12	Crohn's disease; Moderate-to-severe rheumatoid arthritis	555, 714	K50, M05-M06
T13251	Interleukin-12	Moderate-to-severe plaque psoriasis	696	L40
T13251	Interleukin-12	Psoriasis	696	L40
T13259	Succinate semialdehyde dehydrogenase, mitochondrial	Diagnostic imaging	331	G30, I73.9
T13259	Succinate semialdehyde dehydrogenase, mitochondrial	Dietary shortage	260-269	E40-E46
T13260	Cytochrome P450 19	Advanced breast cancer	174, 175	C50
T13260	Cytochrome P450 19	Bladder cancer	188	C67
T13260	Cytochrome P450 19	Breast cancer	174, 175	C50
T13260	Cytochrome P450 19	Endometriosis	617	N80
T13260	Cytochrome P450 19	Hormonally-responsive breast cancer	174, 175	C50
T13260	Cytochrome P450 19	Prostate disease		N42.9
T13260	Cytochrome P450 19	Unspecified		
T13348	DNA-(apurinic or apyrimidinic site)lyase	Ocular cancer		C69
T13491	Equilibrative nucleoside transporter 1	Angina pectoris	413	I20
T13551	Synthetic multi-antigen DNA	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T13616	Integrin-linked protein kinase 1	Cancer	140-229	C00-C96
T13726	Retinoic acid receptor RXR-alpha	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
T13741	Opioid growth factor receptor	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T13741	Opioid growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T13852	Sphingosine 1-phosphate receptor 1	Acne vulgaris	706.1	L70.0
T13852	Sphingosine 1-phosphate receptor 1	Advanced non-small cell lung cancer	162	C33-C34
T13852	Sphingosine 1-phosphate receptor 1	Autoimmune diabetes		E08-E13
T13852	Sphingosine 1-phosphate receptor 1	Cancer	140-229	C00-C96
T13852	Sphingosine 1-phosphate receptor 1	Cardiovascular disorder		I00-I99
T13852	Sphingosine 1-phosphate receptor 1	Cutaneous lupus erythematosus	710	M32
T13852	Sphingosine 1-phosphate receptor 1	Hepatocellular carcinoma; Multiple scierosis	155, 340	C22.0, G35
T13852	Sphingosine 1-phosphate receptor 1	Immune disorder		D80-D89
T13852	Sphingosine 1-phosphate receptor 1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T13852	Sphingosine 1-phosphate receptor 1	Macular degeneration	362.5	H35.3
T13852	Sphingosine 1-phosphate receptor 1	Multiple scierosis	340	G35
T13852	Sphingosine 1-phosphate receptor 1	Primary progressive multiple sclerosis	340	G35
T13852	Sphingosine 1-phosphate receptor 1	Psoriasis	696	L40
T13852	Sphingosine 1-phosphate receptor 1	Rheumatoid arthritis	710-719, 714	M05-M06
T13910	Pancreatic beta cell growth factor	Type 1/2 diabetes	250, 278	E08-E13
T13999	Na-K-2Cl cotransporter	Hypertension	401	I10-I16
T13999	Na-K-2Cl cotransporter	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T14056	Netrin (NTN)	Parkinson's disease	332	G20
T14065	Integrin beta-7	Crohn's disease	555	K50
T14065	Integrin beta-7	Ulcerative colitis	556	K51
T14121	Major envelope protein p37	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T14143	Transforming growth factor beta 2	Colorectal cancer	153, 154	C18-C21
T14231	Leucine-rich repeat-containing G protein-coupled receptor 5	Cancer	140-229	C00-C96
T14342	HIV-1 reverse transcriptase	Cancer	140-229	C00-C96
T14342	HIV-1 reverse transcriptase	Hepacivirus infections	070.4, 070.5, 070.70	B17.1, B18.2
T14342	HIV-1 reverse transcriptase	Human immunodeficiency virus infection	279.3	B20-B26
T14342	HIV-1 reverse transcriptase	Solid tumours	140-199, 210-229	C00-D48
T14342	HIV-1 reverse transcriptase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T14463	Sterol O-acyltransferase	Malignant adrenal gland cancer		C74.0
T14541	Clostridium difficile toxin B	Infection C. difficile recurrence		A00-B99
T14557	Interleukin-10 receptor	Inflammatory bowel disease	555, 556	K50, K51
T14557	Interleukin-10 receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T14557	Interleukin-10 receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T14558	Tryptase	Asthma		J45
T14558	Tryptase	Fungal infections	110-118	B35-B49
T14558	Tryptase	Human immunodeficiency virus infection	279.3	B20-B26
T14558	Tryptase	Inflammatory bowel disease	555, 556	K50, K51
T14558	Tryptase	Solid tumours	140-199, 210-229	C00-D48
T14592	CD95	Cancer	140-229	C00-C96
T14592	CD95	Cerebrovascular ischaemia	434.91	I61-I63
T14592	CD95	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T14592	CD95	Multiple myeloma	203	C90
T14592	CD95	Rheumatoid arthritis	710-719, 714	M05-M06
T14597	Receptor protein-tyrosine kinase erbB-2	Asthma; Breast cancer	174, 175	J45, C50
T14597	Receptor protein-tyrosine kinase erbB-2	Bladder cancer	188	C67
T14597	Receptor protein-tyrosine kinase erbB-2	Breast cancer	174, 175	C50
T14597	Receptor protein-tyrosine kinase erbB-2	Breast cancer; Gastric cancer	174, 175, 151	C50, C16
T14597	Receptor protein-tyrosine kinase erbB-2	Cancer	140-229	C00-C96
T14597	Receptor protein-tyrosine kinase erbB-2	Colorectal cancer; HER2-positive urogenital cancer	153, 154, 179-186	C18-C21, C50-C68
T14597	Receptor protein-tyrosine kinase erbB-2	Gastrointestinal cancers	150-159	C15-C26
T14597	Receptor protein-tyrosine kinase erbB-2	Glioblastoma multiforme	191	C71
T14597	Receptor protein-tyrosine kinase erbB-2	Lymphoma	202.8, 208.9	C81-C86
T14597	Receptor protein-tyrosine kinase erbB-2	Non-hodgkin's lymphoma		C85
T14597	Receptor protein-tyrosine kinase erbB-2	Prostate cancer	185	C61
T14597	Receptor protein-tyrosine kinase erbB-2	Retinal venous occlusion		H34.8
T14597	Receptor protein-tyrosine kinase erbB-2	Solid tumours	140-199, 210-229	C00-D48
T14602	Coagulation Factor VIIIa	Angina pectoris	413	I20
T14602	Coagulation Factor VIIIa	Atrial fibrillation	272, 427.31	E78, I48
T14602	Coagulation Factor VIIIa	Blood clotting disorder	286	D65-D69
T14602	Coagulation Factor VIIIa	Factor VIII deficiency		D66
T14602	Coagulation Factor VIIIa	Factor VIII deficiency; Haemophilia A	286	D66
T14602	Coagulation Factor VIIIa	Haemophilia A	286	D66
T14602	Coagulation Factor VIIIa	Hemophilia	286	D66-D68
T14602	Coagulation Factor VIIIa	Hemophilia A	286	D66
T14602	Coagulation Factor VIIIa	Hemophilia; Stroke	286, 434.91, 437.6, 453, 671.5, 671.9	D66-D68, I61-I63, I80-I82
T14602	Coagulation Factor VIIIa	Unspecified		
T14676	APRIL	Lymphoma; Graft rejection in heart transplantation; Idiopathic thrombocytopenic purpura	202.8, 208.9, 287.31, 996	C81-C86, D69.3, T86
T14676	APRIL	Rheumatold arthritis; Multiple sclerosis	340, 710-719, 714	G35, M00-M25, M05-M06
T14731	NAD-dependent deacetylase sirtuin-1	Cancer	140-229	C00-C96
T14731	NAD-dependent deacetylase sirtuin-1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T14731	NAD-dependent deacetylase sirtuin-1	Colon cancer; Hematologic cancers; Type 2 diabetes	140-229, 250, 250.00, 250.02	E08-E13, E11
T14731	NAD-dependent deacetylase sirtuin-1	Huntington's disease	294.1, 333.4	F02.2, G10
T14731	NAD-dependent deacetylase sirtuin-1	Obesity	278	E66
T14731	NAD-dependent deacetylase sirtuin-1	Type 2 diabetes	250	E11
T14755	Tumor necrosis factor ligand superfamily member 5	Autoimmune diabetes		E08-E13
T14755	Tumor necrosis factor ligand superfamily member 5	B-cell lymphoma	202.8	C85.1
T14755	Tumor necrosis factor ligand superfamily member 5	Cancer	140-229	C00-C96
T14755	Tumor necrosis factor ligand superfamily member 5	Chronic lymphocytic leukaemia; Mantle cell lymphoma; Small lymphocytic lymphoma	200.0, 200.4, 202.0, 202.8, 204.0, 204.1V10.60, 208.9	C91, C81-C86, C82, C83.3, C85.7, C91-C95, C91.0, C91.1
T14755	Tumor necrosis factor ligand superfamily member 5	Large B-cell lymphoma; Non-hodgkin's lymphoma	202.8	C81-C86
T14755	Tumor necrosis factor ligand superfamily member 5	Lymphoma	202.8, 208.9	C81-C86
T14755	Tumor necrosis factor ligand superfamily member 5	Prostate cancer	185	C61
T14755	Tumor necrosis factor ligand superfamily member 5	Rheumatoid arthritis	710-719, 714	M05-M06
T14755	Tumor necrosis factor ligand superfamily member 5	Sjogren's syndrome	710.2	M35.0
T14755	Tumor necrosis factor ligand superfamily member 5	Systemic lupus erythematosus	710	M32
T14755	Tumor necrosis factor ligand superfamily member 5	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T14825	mRNA of VEGFR	Choroidal neovascularization; Age-related macular degeneration	362.5	H35.3
T14834	Cytosolic phospholipase A2	Asthma		J45
T14908	Ceramide glucosyltransferase	Fabry's disease	272.7	E75.2
T14908	Ceramide glucosyltransferase	Metabolic disorders	270-279	E70-E89
T14908	Ceramide glucosyltransferase	Type 1 gaucher disease	272.7	E75.22
T14912	Induced myeloid leukemia cell differentiation protein Mcl-1	Cancer	140-229	C00-C96
T14945	Centromeric protein E	Solid tumours	140-199, 210-229	C00-D48
T15000	Cytotoxic T-lymphocyte protein 4	Autoimmune diabetes		E08-E13
T15000	Cytotoxic T-lymphocyte protein 4	Cancer	140-229	C00-C96
T15000	Cytotoxic T-lymphocyte protein 4	Late-stage melanoma; Prostate cancer	172, 185	C43, C61
T15000	Cytotoxic T-lymphocyte protein 4	Rheumatoid arthritis	710-719, 714	M05-M06
T15000	Cytotoxic T-lymphocyte protein 4	Solid tumours	140-199, 210-229	C00-D48
T15023	Neuropilin-1	Solid tumours	140-199, 210-229	C00-D48
T15068	Focal adhesion kinase	Cancer	140-229	C00-C96
T15068	Focal adhesion kinase	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T15068	Focal adhesion kinase	Mesothelioma	163	C45
T15068	Focal adhesion kinase	Solid tumours	140-199, 210-229	C00-D48
T15107	HIV p7 nucleocapsid protein	Human immunodeficiency virus infection	279.3	B20-B26
T15117	adrenergic receptor	Allergic reaction	995.3	T78.4
T15117	adrenergic receptor	Angina pectoris; Hypertension	413, 401	I20, I10-I16
T15117	adrenergic receptor	Attention deficit hyperactivity disorder	314	F90
T15117	adrenergic receptor	Cardiovascular disorder		I00-I99
T15117	adrenergic receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T15117	adrenergic receptor	Cushing's disease	255	E24.0
T15117	adrenergic receptor	Glaucoma	365	H40-H42
T15117	adrenergic receptor	Hypertension	401	I10-I16
T15117	adrenergic receptor	Orthostatic hypotension	458	I95.1
T15146	Hepatitis C virus NS4A protease	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T15167	Collagen I	Scleroderma	701.0710.1	L94.0-L94.1, M34
T15197	Potential penetration	Ophthalmic disease		H00-H59
T15334	Cholesteryl ester transfer protein	Arteriosclerosis	440	I70
T15334	Cholesteryl ester transfer protein	Atherosclerosis	414.0, 440	I70
T15334	Cholesteryl ester transfer protein	Cardiovascular disorder		I00-I99
T15334	Cholesteryl ester transfer protein	Dyslipidaemias	272	E78
T15334	Cholesteryl ester transfer protein	Dyslipidaemias; Hyperlipidaemia	272, 272.0-272.4	E78
T15334	Cholesteryl ester transfer protein	Hyperlipidaemia	272.0-272.4	E78
T15334	Cholesteryl ester transfer protein	Lipid metabolism disorder		E75-E78
T15334	Cholesteryl ester transfer protein	Peripheral vascular disease; Hyperlipidemia	272.0-272.4, 325, 430-459, 443.9	E78, G45-G46, I60-I95, I73.9
T15344	Activation-inducible TNFR family receptor	Melanoma	172	C43
T15344	Activation-inducible TNFR family receptor	Solid tumours	140-199, 210-229	C00-D48
T15352	HIV reverse transcriptase	Breast cancer	174, 175	C50
T15352	HIV reverse transcriptase	Cytomegalovirus infection		B25
T15352	HIV reverse transcriptase	HBV infection	070.2-070.3	B16, B18.0, B18.1
T15352	HIV reverse transcriptase	Hepatitis virus infection; Human immunodeficiency virus infection	573.3, 279.3	K75.9, B20-B26
T15352	HIV reverse transcriptase	Herpes simplex virus infection	54	B00
T15352	HIV reverse transcriptase	HIV infection; Chronic hepatitis b	042, 070.2-070.3	B16, B18.0, B18.1, B20
T15352	HIV reverse transcriptase	HIV-1 infection	001-139, 042	B20-B24
T15352	HIV reverse transcriptase	Human immunodeficiency virus infection	279.3	B20-B26
T15352	HIV reverse transcriptase	Mycobacterium tuberculosis infection		A15-A19
T15352	HIV reverse transcriptase	Sexually transmitted infection		A64
T15352	HIV reverse transcriptase	Unspecified		
T15352	HIV reverse transcriptase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T15377	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2	Heart failure	428	I50
T15439	C5aR	Atopic dermatitis	691.8, 692.9	L00-L99
T15439	C5aR	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T15439	C5aR	Rheumatoid arthritis	710-719, 714	M05-M06
T15439	C5aR	Vasculitis		I77.6, I80
T15494	mRNA of growth hormone receptor	Acromegaly	253	E22.0
T15497	Prostaglandin E2 receptor, EP1 subtype	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T15497	Prostaglandin E2 receptor, EP1 subtype	Pollakiuria		R35
T15497	Prostaglandin E2 receptor, EP1 subtype	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T15497	Prostaglandin E2 receptor, EP1 subtype	Unspecified		
T15556	Plasminogen activator inhibitor-1	Asthma		J45
T15556	Plasminogen activator inhibitor-1	Cancer	140-229	C00-C96
T15556	Plasminogen activator inhibitor-1	Thrombolysis	410, 415.1, 434.91, 459.9	I21-I22, I26, I61-I63, I99.9
T15569	Methylmalonyl-CoA mutase	Lung injury		S00-T98
T15569	Methylmalonyl-CoA mutase	Vitamin B12 deficiency	266.2	E53.8
T15610	Puromycin-sensitive aminopeptidase	Acute myeloid leukemia	205	C92.0
T15639	Zinc-finger proteins (ZFP)	Acne vulgaris	706.1	L70.0
T15700	Caspase-8	Autoimmune diabetes		E08-E13
T15739	Cellular tumor antigenp53	Acute myeloid leukemia	205	C92.0
T15739	Cellular tumor antigenp53	Cancer	140-229	C00-C96
T15739	Cellular tumor antigenp53	Colorectal cancer	153, 154	C18-C21
T15739	Cellular tumor antigenp53	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T15739	Cellular tumor antigenp53	Hematological malignancies	200-209	C81-C86
T15739	Cellular tumor antigenp53	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T15739	Cellular tumor antigenp53	Oral cavity cancer		C00-C08
T15739	Cellular tumor antigenp53	Renal artery disease		I70.1
T15739	Cellular tumor antigenp53	Solid tumours	140-199, 210-229	C00-D48
T15739	Cellular tumor antigenp53	Toxicity		T36-T50, T51-T65
T15739	Cellular tumor antigenp53	Unspecified		
T15783	NKG2A	Rheumatoid arthritis	710-719, 714	M05-M06
T15784	Lipid peroxidation in the substantia nigra and striatum	Mild to moderate alzheimer disease	331	G30
T15803	mRNA of Factor XI	Alzheimer disease	331	G30
T15803	mRNA of Factor XI	Clotting disorders	286	D65-D69
T15803	mRNA of Factor XI	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T16016	C-C chemokine receptor type 1	Autoimmune diabetes		E08-E13
T16016	C-C chemokine receptor type 1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T16016	C-C chemokine receptor type 1	Rheumatoid arthritis	710-719, 714	M05-M06
T16038	Hepatitis C virus non-structural protein 5A	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T16047	Glutamate-gated chloride channel	Intestinal strongyloidiasis due to nematode parasite	127.2	B78
T16117	Nitric-oxide synthase, brain	Headache	339, 784.0	G43-G44, R51
T16128	Gastrin	Gastric cancer	151	C16
T16144	B7RP1	Systemic lupus erythematosus	710	M32
T16156	Thrombopoietin Receptor	Acute myeloid leukemia	205	C92.0
T16156	Thrombopoietin Receptor	Bone marrow transplantation	279.5, 996	D89.8, T86
T16156	Thrombopoietin Receptor	Chemotherapy-induced thrombocytopenia; Myelodysplastic syndromes	238.7, 287.3, 287.4, 287.5	D46, D69.6, P61.0
T16156	Thrombopoietin Receptor	Chronic liver disease; HCV induced thrombocytopaenia	287.3, 287.4, 287.5	D69.6, P61.0
T16156	Thrombopoietin Receptor	Idiopathic thrombocytopenic purpura	287.31	D69.3
T16156	Thrombopoietin Receptor	Immune thrombocytopenic purpura; Idiopathic thrombocytopenic purpura	287.31	D69.3
T16156	Thrombopoietin Receptor	Liver disease	570-574	K70-K77
T16156	Thrombopoietin Receptor	Myocardial infarction; Thrombotic stroke	410, 434.91	I21, I22, I61-I63
T16156	Thrombopoietin Receptor	Oncology-related thrombocytopaenia	287.3, 287.4, 287.5	D69.6, P61.0
T16156	Thrombopoietin Receptor	Sarcoma; Idiopathic thrombocytopenic purpura	287.31	D69.3
T16156	Thrombopoietin Receptor	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T16156	Thrombopoietin Receptor	Thrombocytopenic purpura		D69
T16156	Thrombopoietin Receptor	Unspecified		
T16263	RANTES ligand	Autoimmune diabetes		E08-E13
T16340	Interleukin-1 alpha ligand	Atherosclerosis	414.0, 440	I70
T16340	Interleukin-1 alpha ligand	Rheumatoid arthritis	710-719, 714	M05-M06
T16340	Interleukin-1 alpha ligand	Unspecified		
T16347	Protein tyrosine phosphatase-1B	Diabetes	253.5, 588.1	E23.2, N25.1
T16347	Protein tyrosine phosphatase-1B	Obesity	278	E66
T16347	Protein tyrosine phosphatase-1B	Type 2 diabetes	250	E11
T16353	Gap junction alpha-8 protein	Cancer	140-229	C00-C96
T16422	Multidrug resistance protein	Acute myeloid leukemia	205	C92.0
T16422	Multidrug resistance protein	Cancer	140-229	C00-C96
T16422	Multidrug resistance protein	Nausea; Vomiting; Emesis	787, 787.0	R11
T16514	Fatty acid synthase	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T16514	Fatty acid synthase	Cancer	140-229	C00-C96
T16514	Fatty acid synthase	Dramatic weight loss	783.21	R63.4
T16514	Fatty acid synthase	Fungal infections	110-118	B35-B49
T16514	Fatty acid synthase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T16514	Fatty acid synthase	Mycobacterium tuberculosis infection		A15-A19
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Breast cancer	174, 175	C50
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Cancer	140-229	C00-C96
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Colorectal cancer	153, 154	C18-C21
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Glioblastoma multiforme	191	C71
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Metastatic medullary thyroid cancer	193	C73
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Small-cell lung cancer	162.9	C33-C34
T16601	Carcinoembryonic antigen-related cell adhesion molecule 5	Solid tumours	140-199, 210-229	C00-D48
T16605	mRNA of marburg virusnucleoprotein NP	Marburg virus infection		A98.3
T16633	Somatostatin receptor 1	Alzheimer disease	331	G30
T16633	Somatostatin receptor 1	Cushing's disease	255	E24.0
T16633	Somatostatin receptor 1	Neuroendocrine cancer		C7A
T16688	Diglyceride acyltransferase	Diabetes	253.5, 588.1	E23.2, N25.1
T16688	Diglyceride acyltransferase	Familial chylomicronemia syndrome; HCV infection	070.4, 070.5, 070.70	J10, J11, B17.1, B18.2
T16688	Diglyceride acyltransferase	High cholesterol level	272	E78.0
T16688	Diglyceride acyltransferase	Obesity	278	E66
T16688	Diglyceride acyltransferase	Obesity; Diabetes	250, 278	E08-E13, E66
T16688	Diglyceride acyltransferase	Type 2 diabetes	250	E11
T16691	5-hydroxytryptamine 6 receptor	Alzheimer disease	331	G30
T16691	5-hydroxytryptamine 6 receptor	Alzheimer disease; Anxiety disorder	331, 300, 311	G30, F32, F40-F42
T16691	5-hydroxytryptamine 6 receptor	Alzheimer disease; Dementia	290-294, 331.0	F01-F07, G30
T16691	5-hydroxytryptamine 6 receptor	Anxiety disorder	300, 311	F32, F40-F42
T16691	5-hydroxytryptamine 6 receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T16691	5-hydroxytryptamine 6 receptor	Emesis	787	R11
T16691	5-hydroxytryptamine 6 receptor	Neurodegenerative disease	330-337	G30-G32
T16691	5-hydroxytryptamine 6 receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T16691	5-hydroxytryptamine 6 receptor	Obesity	278	E66
T16691	5-hydroxytryptamine 6 receptor	Schizophrenia	295	F20
T16691	5-hydroxytryptamine 6 receptor	Unspecified		
T16731	Vacuolar ATP synthase catalytic subunit A	Fungal infections	110-118	B35-B49
T16739	Lysine specific histone demethylase 1	Cancer	140-229	C00-C96
T16739	Lysine specific histone demethylase 1	Small-cell lung cancer	162.9	C33-C34
T16761	Pneumocystis carinii dihydropteroate synthase	Pneumocystis carinii pneumonia	136.3	B20.6
T16769	X-linked inhibitor of apoptosis protein	Hematological malignancies	200-209	C81-C86
T16769	X-linked inhibitor of apoptosis protein	Obesity	278	E66
T16868	Neural-cadherin	Solid tumours	140-199, 210-229	C00-D48
T16888	Eotaxin ligand	Ocular allergy	360-379	H00-H59
T16942	IFN-gamma production	Inflammatory bowel disease	555, 556	K50, K51
T17003	DNA-dependent RNA polymerase	Tuberculosis	010-018	A15-A19
T17003	DNA-dependent RNA polymerase	Tuberculosis; Mycobacterium avium complex disease	010-018, 031	A15-A19, A31
T17048	DNA topoisomerase II alpha	Solid tumours	140-199, 210-229	C00-D48
T17140	P2X purinoceptor 3	Overactive bladder disorder	188, 596.51	C67, N32.81
T17140	P2X purinoceptor 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T17163	Leptin receptor	Alzheimer disease	331	G30
T17163	Leptin receptor	Cachexia	799.4	R64
T17163	Leptin receptor	Cancer	140-229	C00-C96
T17163	Leptin receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T17163	Leptin receptor	Diabetes; Hypertriglyceridemia	250, 272.1, 272.6	E08-E13, E78.1, E78.2, E78.3, E88.1
T17163	Leptin receptor	Obesity	278	E66
T17234	Ganciclovir kinase	Cytomegalovirus infection		B25
T17248	Fusion glycoprotein	Diabetes	253.5, 588.1	E23.2, N25.1
T17248	Fusion glycoprotein	Respiratory syncytial virus infection	79.6	B97.4
T17248	Fusion glycoprotein	Type 2 diabetes	250	E11
T17345	DHFR	Bladder cancer	188	C67
T17345	DHFR	Cancer	140-229	C00-C96
T17345	DHFR	Pulmonary and extrapulmonary tuberculosis		A15-A19
T17345	DHFR	Rheumatoid arthritis	710-719, 714	M05-M06
T17345	DHFR	Solid tumours	140-199, 210-229	C00-D48
T17345	DHFR	Urinary tract infections	599	N39.0
T17367	Sequestosome-1 p62	Mucositis		K92.81
T17423	IV iron	Iron deficiency anaemia in chronic kidney disease	280	D50, N00-N29
T17427	CD42b	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T17448	Histamine N-methyltransferase	Malaria		B54
T17502	Retinal pigment epithelium protein	Blindness		H53.6
T17502	Retinal pigment epithelium protein	Ocular disease		H00-H59
T17502	Retinal pigment epithelium protein	Visual disturbances		H53
T17569	Potassium voltage-gated channel subfamily A member 5	Angina pectoris	413	I20
T17569	Potassium voltage-gated channel subfamily A member 5	Arrhythmia	427	I47-I49
T17569	Potassium voltage-gated channel subfamily A member 5	Atrial fibrillation	272, 427.31	E78, I48
T17569	Potassium voltage-gated channel subfamily A member 5	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T17687	Fibroblast growth factor receptor	Cancer	140-229	C00-C96
T17687	Fibroblast growth factor receptor	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T17687	Fibroblast growth factor receptor	Multiple myeloma	203	C90
T17710	Zonulin	Autoimmune diabetes		E08-E13
T17758	Urokinase-type plasminogen activator	Breast cancer	174, 175	C50
T17758	Urokinase-type plasminogen activator	Cancer	140-229	C00-C96
T17758	Urokinase-type plasminogen activator	Cerebrovascular ischaemia	434.91	I61-I63
T17758	Urokinase-type plasminogen activator	Deep venous thrombosis; Pulmonary embolism; Myocardial infarction	410, 415.1, 437.6, 444.9, 453, 453.40, 671.5, 671.9	I21, I22, I26, I74, I80-I82, I80.2, I82, O88, T79.0-T79.1
T17758	Urokinase-type plasminogen activator	Myocardial hypertrophy		I51.7
T17758	Urokinase-type plasminogen activator	Myocardial infarction	410	I21, I22
T17758	Urokinase-type plasminogen activator	Myocardial infarction; Thrombolysis	410, 415.1, 434.91, 459.9	I21, I22, I21-I22, I26, I61-I63, I99.9
T17758	Urokinase-type plasminogen activator	Myocardial ischemia; Reperfusion injury	459.89	I99.8
T17758	Urokinase-type plasminogen activator	Solid tumours	140-199, 210-229	C00-D48
T17758	Urokinase-type plasminogen activator	Thrombin deficiency	437.6, 444.9, 453, 671.5, 671.9	I74, I80-I82, I82, O88, T79.0-T79.1
T17758	Urokinase-type plasminogen activator	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T17758	Urokinase-type plasminogen activator	Unspecified		
T17852	Phosphodiesterase (PDE) 9	Alzheimer disease	331	G30
T17852	Phosphodiesterase (PDE) 9	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T17852	Phosphodiesterase (PDE) 9	Genitourinary disease		N00-N99
T17852	Phosphodiesterase (PDE) 9	Psychiatric disorder	290-319	F01-F99
T17873	Fatty acid synthesis	Dyslipidaemias	272	E78
T17967	Pyruvate dehydrogenase kinase isoform 2 (PDHK2)	Diabetes	253.5, 588.1	E23.2, N25.1
T18170	mRNA of protein kinase A1	Solid tumours	140-199, 210-229	C00-D48
T18299	CaM kinase II	Anxiety disorder	300, 311	F32, F40-F42
T18299	CaM kinase II	Rheumatoid arthritis	710-719, 714	M05-M06
T18468	BCR/ABL protein	Acute lymphoblastic leukemia	204.0, 556	C91.0
T18477	Heat shock protein HSP 90	Breast cancer; Melanoma	140-229, 172, 174, 175	C00-C96, C43, C50
T18477	Heat shock protein HSP 90	Cancer	140-229	C00-C96
T18477	Heat shock protein HSP 90	Hematological malignancies	200-209	C81-C86
T18477	Heat shock protein HSP 90	Melanoma	172	C43
T18477	Heat shock protein HSP 90	Multiple myeloma	203	C90
T18477	Heat shock protein HSP 90	Ovarian cancer; Refractory hematological malignancies	140-229, 140-239, 183, 200-209	C56, C81-C86
T18639	Heparin-binding growth factor1	Coronary artery disease	410-414, 429.2	I20-I25
T18639	Heparin-binding growth factor1	Critical limb ischemia	459.89	I99.8
T18779	Mucin 1	Acute myeloid leukemia	205	C92.0
T18779	Mucin 1	Breast cancer	174, 175	C50
T18779	Mucin 1	Cancer	140-229	C00-C96
T18779	Mucin 1	Colorectal cancer	153, 154	C18-C21
T18779	Mucin 1	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T18779	Mucin 1	Multiple myeloma	203	C90
T18779	Mucin 1	Non-small cell lung cancer		C33-C34
T18779	Mucin 1	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T18779	Mucin 1	Solid tumours	140-199, 210-229	C00-D48
T18779	Mucin 1	Unspecified		
T18872	Malignant melanoma metastasis-suppressor KiSS-1	Prostate cancer	185	C61
T18876	Prostaglandin E2 receptor, EP4 subtype	Acute heart failure	428	I50
T18876	Prostaglandin E2 receptor, EP4 subtype	Asthma		J45
T18876	Prostaglandin E2 receptor, EP4 subtype	Fracture		M48.5
T18876	Prostaglandin E2 receptor, EP4 subtype	Glaucoma	365	H40-H42
T18876	Prostaglandin E2 receptor, EP4 subtype	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T18876	Prostaglandin E2 receptor, EP4 subtype	Migraine	346	G43
T18876	Prostaglandin E2 receptor, EP4 subtype	Osteoarthritis	715	M15-M19, M47
T18876	Prostaglandin E2 receptor, EP4 subtype	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
T18876	Prostaglandin E2 receptor, EP4 subtype	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T18876	Prostaglandin E2 receptor, EP4 subtype	Ulcerative colitis	556	K51
T18950	Leutinizing-hormone-releasing hormone	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
T18950	Leutinizing-hormone-releasing hormone	Prostate cancer	185	C61
T18972	CD3	Gastrointestinal adenocarcinoma		C15-C26
T19011	M-phase inducer phosphatase 3	Cancer	140-229	C00-C96
T19160	Phospholipase A2, membrane associated	Breast cancer	174, 175	C50
T19244	Cytochrome P450 2C9	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T19250	Inhibiting vascular cell adhesion molecule expression	Atherosclerosis	414.0, 440	I70
T19334	Interleukin-21 receptor	Crohn's disease	555	K50
T19334	Interleukin-21 receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T19368	lipase, endothelial	Coagulation		I80-I82
T19414	Fibrin	Bleeding	444, 453	I74, I80-I82
T19414	Fibrin	Blood forming organ disorders		D75.9
T19414	Fibrin	Cardiovascular disorder		I00-I99
T19414	Fibrin	Dengue fever	61	A90
T19414	Fibrin	Injury		S00-T88
T19414	Fibrin	Occlusion		I66.9
T19414	Fibrin	Ulcer	531-534	K25-K27
T19414	Fibrin	Wound healing		T14.0-T14.1
T19433	Glutathione S-transferase	Allergy	995.3	T78.4
T19433	Glutathione S-transferase	Alzheimer disease	331	G30
T19433	Glutathione S-transferase	Flatworms infection	120-129	B65-B83
T19556	Oncostatin M	Rheumatoid arthritis	710-719, 714	M05-M06
T19579	Interleukin-2 receptor subunit beta	Head and neck cancer; Human immunodeficiency virus infection	140-149, 140-229, 279.3	C07-C14, C32-C33, B20-B26
T19579	Interleukin-2 receptor subunit beta	Unspecified		
T19615	Granulocyte colony-stimulating factor	Aplastic anemia	284	D60-D61
T19615	Granulocyte colony-stimulating factor	Neutropenia	288	D70
T19615	Granulocyte colony-stimulating factor	Neutropenia; Breast cancer	174, 175	C50
T19625	mRNA of influenza virus neuraminidase	Influenza virus		J11.1
T19693	Soluble guanylyl cyclase 	Angina pectoris	413	I20
T19693	Soluble guanylyl cyclase 	Heart failure	428	I50
T19693	Soluble guanylyl cyclase 	Pulmonary arterial hypertension	416	I27.0, I27.2
T19760	Mitogen-activated protein kinase kinase kinase 9	Asthma		J45
T19784	Somatotropin	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
T19829	AE-H	Human immunodeficiency virus infection	279.3	B20-B26
T19852	Keratinocyte growth factor	Solid tumours	140-199, 210-229	C00-D48
T20059	TGF beta receptor	Idiopathic pulmonary fibrosis	516.3	J84.1
T20103	Vacuolar-type (H+)-ATPase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T20178	Tumor necrosis factor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T20178	Tumor necrosis factor	Asthma		J45
T20178	Tumor necrosis factor	Atopic dermatitis; Psoriatic disorder	691.8, 692.9, 696	L00-L99, L40
T20178	Tumor necrosis factor	Autoimmune diabetes		E08-E13
T20178	Tumor necrosis factor	Colitis	556.9	K50-K52
T20178	Tumor necrosis factor	Crohn's disease	555	K50
T20178	Tumor necrosis factor	Crohn's disease; Ulcerative colitis; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; Plaque psoriasis		K50.0, K51.90, M05.9, M45.3, L40.52, L40
T20178	Tumor necrosis factor	Diarrhea	787.91	A09, K59.1
T20178	Tumor necrosis factor	Esophageal cancer	150	C15
T20178	Tumor necrosis factor	Heart transplant rejection	996	T86
T20178	Tumor necrosis factor	Inflammatory bowel disease	555, 556	K50, K51
T20178	Tumor necrosis factor	Intermittent claudication	440.21	I73.9
T20178	Tumor necrosis factor	Multiple myeloma	203	C90
T20178	Tumor necrosis factor	Multiple myeloma; Anaemia	203, 280-285, 585.9585.1-585.5403	C90, D50-D64, N18
T20178	Tumor necrosis factor	Neuropathic pain	356.0, 356.8	G64, G90.0
T20178	Tumor necrosis factor	Ocular disease		H00-H59
T20178	Tumor necrosis factor	Osteoarthritis	715	M15-M19, M47
T20178	Tumor necrosis factor	Pneumonia		J12-J18
T20178	Tumor necrosis factor	Psoriasis	696	L40
T20178	Tumor necrosis factor	Rheumatoid arthritis	710-719, 714	M05-M06
T20178	Tumor necrosis factor	Rheumatoid arthritis; Dermatomyositis; Polymyositis; Juvenile rheumatoid arthritis; Graft-versus-host disease; Esophagitis		K20, L40, M05-M06, M08.0, T86.0
T20178	Tumor necrosis factor	Rheumatoid arthritis; Psoriasis	696, 710-719, 714	L40, M00-M25, M05-M06
T20178	Tumor necrosis factor	Rheumatold arthritis; Psoriatic arthritis; Ankylosing spondylitis	696.0, 710-719, 714, 720.0	L40.5, M00-M25, M05-M06, M07, M08.1, M45
T20178	Tumor necrosis factor	Sepsis	995.91	A40, A41
T20178	Tumor necrosis factor	Solid tumours	140-199, 210-229	C00-D48
T20178	Tumor necrosis factor	Unspecified		
T20210	Feto-acinar pancreatic protein (FAPP)	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T20251	Potassium voltage-gated channel subfamily H member 2	Angina pectoris	413	I20
T20251	Potassium voltage-gated channel subfamily H member 2	Cardiac arrhythmias	427	I47-I49
T20251	Potassium voltage-gated channel subfamily H member 2	Cardiac failure		I50
T20251	Potassium voltage-gated channel subfamily H member 2	Heart arrhythmia		I47-I49
T20251	Potassium voltage-gated channel subfamily H member 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T20278	Major histocompatibility complex	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T20297	Serine protease	Acute coronary syndrome	444	I74
T20297	Serine protease	Bleeding	444, 453	I74, I80-I82
T20297	Serine protease	Cancer	140-229	C00-C96
T20297	Serine protease	Community-acquired pneumonia; Acute lung injury	480-486, 518, 770.0	J12-J18, J80, P23
T20297	Serine protease	Cystic fibrosis	277	E84
T20297	Serine protease	Graft rejection in heart transplantation	996	T86
T20297	Serine protease	Pancreatitis	577.0-577.1	K85, K86.0K86.1
T20297	Serine protease	Restenosis		I51.89
T20297	Serine protease	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T20331	Neuropeptide Y receptor 5	Eating disorder; Obesity	278, 307.5	E66, F50
T20331	Neuropeptide Y receptor 5	Eating disorder; Obesity; Diabetes	250, 278, 307.5	E08-E13, E66, F50
T20331	Neuropeptide Y receptor 5	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T20331	Neuropeptide Y receptor 5	Obesity	278	E66
T20401	Carbonic anhydrase II	Duodenal ulcers		K25-K27
T20401	Carbonic anhydrase II	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
T20401	Carbonic anhydrase II	High blood pressure; Edema	401	I10-I16, R60.9
T20401	Carbonic anhydrase II	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T20401	Carbonic anhydrase II	Open-angle glaucoma	365	H40-H42
T20426	Profibrinolytic	Diabetic nephropathy	250.4	E11.21
T20426	Profibrinolytic	Hepatic veno-occlusive disease		K00-K95
T20514	Delta-aminolevulinic acid dehydratase	Photodynamic therapy	706.1	L70.0
T20575	C-C chemokine receptor type 8	Psoriasis	696	L40
T20709	Muscarinic acetylcholine receptor M4	Mydriasis diagnosis	379.43	H57.0
T20709	Muscarinic acetylcholine receptor M4	Nausea; Vomiting; Emesis	787, 787.0	R11
T20710	Interleukin-2 receptor	Advanced non-small cell lung cancer	162	C33-C34
T20710	Interleukin-2 receptor	Leukemia; Lymphoma	202.8, 204-208	C81-C86, C91-C95
T20761	Vascular endothelial growth factor A	Adult primary hepatocellular carcinoma		C22
T20761	Vascular endothelial growth factor A	Breast cancer	174, 175	C50
T20761	Vascular endothelial growth factor A	Cancer	140-229	C00-C96
T20761	Vascular endothelial growth factor A	Colorectal cancer	153, 154	C18-C21
T20761	Vascular endothelial growth factor A	Exudative age-related macular degeneration	362.5	H35.3
T20761	Vascular endothelial growth factor A	Lateral sclerosis		G12.2
T20761	Vascular endothelial growth factor A	Lymphoma; Non-hodgkin's lymphoma	200, 202, 202.8	C81-C86, C82-C85
T20761	Vascular endothelial growth factor A	Macular degeneration	362.5	H35.3
T20761	Vascular endothelial growth factor A	Metastatic breast cancer		C50
T20761	Vascular endothelial growth factor A	Non-small cell lung cancer		C33-C34
T20761	Vascular endothelial growth factor A	Non-small cell lung cancer; Metastatic colorectal cancer	153, 154	C33-C34, C18-C21
T20761	Vascular endothelial growth factor A	Recurrent squamous cell carcinoma of the hypopharynx		D37
T20761	Vascular endothelial growth factor A	Solid tumours	140-199, 210-229	C00-D48
T20796	Reactive oxygen species	Amyotrophic lateral sclerosis	335.2	G12.2
T20796	Reactive oxygen species	Asthma		J45
T20808	Isocitrate dehydrogenase (IDH2)	Acute myeloid leukemia	205	C92.0
T20891	3-phosphoinositide dependent protein kinase-1	Cancer	140-229	C00-C96
T20891	3-phosphoinositide dependent protein kinase-1	Lymphoma	202.8, 208.9	C81-C86
T20958	Neuropeptide S receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T20978	T-cell surface glycoprotein CD8	Cancer	140-229	C00-C96
T20978	T-cell surface glycoprotein CD8	Human immunodeficiency virus infection	279.3	B20-B26
T20978	T-cell surface glycoprotein CD8	Influenza virus		J11.1
T21291	Plasmodium apical membrane protein	Malaria		B54
T21307	MAPKAP kinase 2	Autoimmune diabetes		E08-E13
T21307	MAPKAP kinase 2	Fibrosis	709.2	L90.5
T21307	MAPKAP kinase 2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T21312	Immune checkpoint	Solid tumours	140-199, 210-229	C00-D48
T21324	Isomerase	Angina pectoris	413	I20
T21324	Isomerase	Bronchodilator	493	J45
T21334	Tumor necrosis factor ligand superfamily member 11	Bone metastases	198.5	C79.51
T21334	Tumor necrosis factor ligand superfamily member 11	Bone metastases in prostate cancer	185, 198.5	C61, C79.51
T21334	Tumor necrosis factor ligand superfamily member 11	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T21334	Tumor necrosis factor ligand superfamily member 11	Postmenopausal osteoporosis	733	M80-M81
T21334	Tumor necrosis factor ligand superfamily member 11	Rheumatoid arthritis	710-719, 714	M05-M06
T21351	Nuclear receptor	Arthritis	710-719	M00-M25
T21396	Bacterial 30S ribosome subunit	Advanced gum disease; Chronic periodontitis	523.4, 523.5	K05.3, K05.4
T21396	Bacterial 30S ribosome subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T21396	Bacterial 30S ribosome subunit	Diabetic foot ulcer	707	L88-L89
T21434	Neuronal acetylcholine receptor subunit alpha-10	Neuropathic pain	356.0, 356.8	G64, G90.0
T21447	Glutamine receptor	Mucositis		K92.81
T21532	Fungal cell membrane	Fungal infections	110-118	B35-B49
T21617	signal transduction pathway	Cancer	140-229	C00-C96
T21669	Glutathione S-transferase P	Myelodysplastic syndrome	238.7	D46
T21669	Glutathione S-transferase P	Solid tumours	140-199, 210-229	C00-D48
T21678	Alpha-galactosidase A	Fabry's disease	272.7	E75.2
T21679	mRNA of Huntingtin protein	Huntington's disease	294.1, 333.4	F02.2, G10
T21689	Apolipoprotein E	Glaucoma	365	H40-H42
T21689	Apolipoprotein E	Hyperlipidaemia	272.0-272.4	E78
T21782	Proliferating cell nuclear antigen	Retinal disorders		H30-H36
T21782	Proliferating cell nuclear antigen	Submental fat removal		C00-C75, C7A, C7B, D10-D36, D3A
T21865	P-selectin glycoprotein ligand 1	Acute coronary syndrome	444	I74
T21865	P-selectin glycoprotein ligand 1	Allergy	995.3	T78.4
T21890	Carcinoembryonic antigen	Breast cancer	174, 175	C50
T21945	Sodium-dependent noradrenaline transporter	Attention deficit hyperactivity disorder	314	F90
T21945	Sodium-dependent noradrenaline transporter	Cancer pain	140-229, 338,780	R52, G89
T21945	Sodium-dependent noradrenaline transporter	Depression	311	F30-F39
T21945	Sodium-dependent noradrenaline transporter	Depression; Anxiety disorder	311, 300	F30-F39, F32, F40-F42
T21945	Sodium-dependent noradrenaline transporter	Depression; Attention deficit hyperactivity disorder	311, 314	F30-F39, F90
T21945	Sodium-dependent noradrenaline transporter	Depression; Bipolar disorder	311, 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F30-F39, F31, F40-F42
T21945	Sodium-dependent noradrenaline transporter	Fatigue		R53
T21945	Sodium-dependent noradrenaline transporter	Fibromyalgia	729.1	M79.7
T21945	Sodium-dependent noradrenaline transporter	Heart failure	428	I50
T21945	Sodium-dependent noradrenaline transporter	Heart failure diagnosis	428	I50
T21945	Sodium-dependent noradrenaline transporter	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T21945	Sodium-dependent noradrenaline transporter	Neuroblastoma	194.0, 194.5, 194.6, 227.0, 227.5, 227.6, 237.3, 255.6	C74.1, C74.9, C75.4, C75.5, D35.0, D35.5, D35.6, D44.6, D44.7
T21945	Sodium-dependent noradrenaline transporter	Neuroendocrine cancer		C7A
T21945	Sodium-dependent noradrenaline transporter	Obesity	278	E66
T21945	Sodium-dependent noradrenaline transporter	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T21945	Sodium-dependent noradrenaline transporter	Unspecified		
T21960	Angiopoietin-2	Cancer	140-229	C00-C96
T21960	Angiopoietin-2	Colorectal cancer	153, 154	C18-C21
T21960	Angiopoietin-2	Solid tumours	140-199, 210-229	C00-D48
T22032	Parathyroid hormone receptor	Alopecia	704.09	L65.9
T22032	Parathyroid hormone receptor	Endocrine disease		E00-E35
T22032	Parathyroid hormone receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T22032	Parathyroid hormone receptor	Psoriatic disorder	696	L40
T22032	Parathyroid hormone receptor	Unspecified		
T22050	Prostaglandin receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T22050	Prostaglandin receptor	Skin infections	680-709	L00-L99
T22095	Interleukin-17	Arthritis	710-719	M00-M25
T22095	Interleukin-17	Asthma		J45
T22095	Interleukin-17	Plaque psoriasis		L00-L99
T22095	Interleukin-17	Psoriasis	696	L40
T22095	Interleukin-17	Psoriatic arthritis	696	L40.5, M07
T22095	Interleukin-17	Rheumatoid arthritis	710-719, 714	M05-M06
T22095	Interleukin-17	Severe plaque psoriasis		L40
T22118	Dopamine D1 receptor	Cocaine addiction	304.2	F14.2
T22118	Dopamine D1 receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T22118	Dopamine D1 receptor	Dementia	290-294	F01-F07
T22118	Dopamine D1 receptor	Excessive bleeding following childbirth and spontaneous or elective abortion		O04
T22118	Dopamine D1 receptor	Hypertension	401	I10-I16
T22118	Dopamine D1 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T22118	Dopamine D1 receptor	Parkinson's disease	332	G20
T22118	Dopamine D1 receptor	Psychiatric disorder	290-319	F01-F99
T22118	Dopamine D1 receptor	Psychotic disorders	290-299	F20-F29
T22118	Dopamine D1 receptor	Schizophrenia	295	F20
T22118	Dopamine D1 receptor	Substance dependence		F10-F19
T22118	Dopamine D1 receptor	Type 2 diabetes	250	E11
T22118	Dopamine D1 receptor	Unspecified		
T22128	Glutamate decarboxylase 2	Type 1 diabetes	250	E10
T22158	Folate binding protein-E39	Endometrial cancer	182	C54.1
T22212	Lowaffinity immunoglobulin gamma Fc region receptor II-A	Idiopathic thrombocytopenic purpura	287.31	D69.3
T22274	Histone deacetylase 6	Cancer	140-229	C00-C96
T22274	Histone deacetylase 6	Multiple myeloma	203	C90
T22285	Glutamate [NMDA] receptor subunit epsilon 1	Dietary shortage	260-269	E40-E46
T22295	Staphylococus aureus 4 antigen	Major depressive disorder; Staphylococcal infection	296.2, 296.3, 710.0, 001-139	F32, F33, M32, A00-B99
T22302	Solute carrier family 12A5	Epilepsy		G40
T22348	Bacterial DNA gyrase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T22348	Bacterial DNA gyrase	Chronic bronchitis		J42
T22348	Bacterial DNA gyrase	Fungal infections	110-118	B35-B49
T22348	Bacterial DNA gyrase	Infections	001-139	A00-B99
T22348	Bacterial DNA gyrase	Infections disease		A00-B99
T22348	Bacterial DNA gyrase	Otitis media		H65-H67
T22348	Bacterial DNA gyrase	Pneumonia		J12-J18
T22348	Bacterial DNA gyrase	Staphylococcus aureus infection		B95.6
T22348	Bacterial DNA gyrase	Unspecified		
T22350	Endoglin	Fallopian tube cancer; Peritoneal cancer; Macular degeneration; Ovarian cancer	140-229, 183.2, 221.0, 362.5, 183	C57, D28, H35.3, C56
T22415	Pseudomonas PcrV protein type III	Infections disease		A00-B99
T22484	LPS receptor	Septic shock	785.52	A41.9
T22583	Sodium/glucose cotransporter 2	Diabetes	253.5, 588.1	E23.2, N25.1
T22583	Sodium/glucose cotransporter 2	Type 1/2 diabetes	250, 278	E08-E13
T22583	Sodium/glucose cotransporter 2	Type 2 diabetes	250	E11
T22608	TNF alpha production	Peripheral vascular disease	443.9	I73.9
T22655	Mucosal addressin cell adhesion molecule 1	Ulcerative colitis; Inflammatory bowel disease	555, 556, 556.9	K50, K50-K52, K51
T22658	Interleukin-8	Autoimmune diabetes		E08-E13
T22658	Interleukin-8	Melanoma	172	C43
T22778	Intracellular reductase	Diagnostic imaging	331	G30, I73.9
T22839	Elastase 1	Alpha-1 antitrypsin deficiency	273.4	E88.0
T22839	Elastase 1	Bronchitis		J20-J21, J42
T22839	Elastase 1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T22839	Elastase 1	Cystic fibrosis	277	E84
T22839	Elastase 1	Emphysema	492	J43
T22839	Elastase 1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T22939	Progesterone receptor	Advanced breast carcinoma; Advanced endometrium carcinoma	174, 175, 182.0	C50, C54.1
T22939	Progesterone receptor	Cancer	140-229	C00-C96
T22939	Progesterone receptor	Contraception		Z30
T22939	Progesterone receptor	Endometrial cancer	182	C54.1
T22939	Progesterone receptor	Endometriosis	617	N80
T22939	Progesterone receptor	Estrogen deficiency		E28.39
T22939	Progesterone receptor	Female contraception		Z30
T22939	Progesterone receptor	Gynecological disorder		N70-N98
T22939	Progesterone receptor	Hormonal contraceptives		Z30
T22939	Progesterone receptor	Menstrual disorders	626	N91-N95
T22939	Progesterone receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T22939	Progesterone receptor	Premature labour	644, 765	O60.1, P07.3
T22939	Progesterone receptor	Unspecified		
T22939	Progesterone receptor	Uterine fibroids		D25
T22939	Progesterone receptor	Uterine leiomyoma	218.9	D25
T22977	Superoxide dismutase [Cu-Zn]	Dermatitis	692.9	L20-L30
T22977	Superoxide dismutase [Cu-Zn]	Motor neurone disease	335.2	G12.2
T22977	Superoxide dismutase [Cu-Zn]	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T22977	Superoxide dismutase [Cu-Zn]	Solid tumours	140-199, 210-229	C00-D48
T22978	TGF beta-3 ligand	Scar tissue		L00-L99
T22995	Hepcidin	Anemia	280-285	D50-D64
T23003	MEK protein kinase	Breast cancer; Colon tumor; NSCLC		C50
T23003	MEK protein kinase	Cancer	140-229	C00-C96
T23003	MEK protein kinase	Colorectal cancer	153, 154	C18-C21
T23003	MEK protein kinase	Melanoma	172	C43
T23003	MEK protein kinase	Non-small-cell lung cancer; Melanoma	162, 172	C33-C34, C43
T23003	MEK protein kinase	Psoriasis	696	L40
T23003	MEK protein kinase	Solid tumours	140-199, 210-229	C00-D48
T23036	Staphylococcus aureus Enoyl ACP reductase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T23036	Staphylococcus aureus Enoyl ACP reductase	Staphylococcus aureus infection		B95.6
T23145	Cytochrome P450 11A1, mitochondrial	Cushing's disease; Metastatic breast cancer	174, 175, 255.0	C50, E24
T23172	Tyrosine-protein kinase JAK3	Autoimmune diabetes		E08-E13
T23172	Tyrosine-protein kinase JAK3	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T23172	Tyrosine-protein kinase JAK3	Psoriasis	696	L40
T23172	Tyrosine-protein kinase JAK3	Renal transplantation	279.5	D89.8
T23172	Tyrosine-protein kinase JAK3	Rheumatoid arthritis	710-719, 714	M05-M06
T23212	Monocyte differentiation antigen CD14	Sepsis	995.91	A40, A41
T23292	N-acetylgalactosamine 6 sulfatase	Morquio syndrome		E76.2
T23292	N-acetylgalactosamine 6 sulfatase	Mucopolysaccharidosis		E76
T23343	HIV p24 capsid protein	HIV-1 infection	001-139, 042	B20-B24
T23347	Interleukin-1 receptor, type II	Arthritis	710-719	M00-M25
T23347	Interleukin-1 receptor, type II	Immune disorder		D80-D89
T23347	Interleukin-1 receptor, type II	Rheumatoid arthritis	710-719, 714	M05-M06
T23348	Von Willebrand factor	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T23348	Von Willebrand factor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T23348	Von Willebrand factor	Von willebrand disease		D68.0
T23355	mRNA of integrin beta 3	Peripheral vascular disease	443.9	I73.9
T23389	mRNA of transthyretin	Amyloidosis	277.3	E85
T23459	Epstein-Barr virus envelope glycoprotein gp340	Herpes simplex virus infection	54	B00
T23471	Myeloperoxidase	Chronic obstructive pulmonary disease; Multiple scierosis	490-492, 494-496, 340	J40-J44, J47, G35
T23471	Myeloperoxidase	Infections disease		A00-B99
T23471	Myeloperoxidase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T23471	Myeloperoxidase	Parkinson's disease	332	G20
T23499	Endothelin-1 receptor	Cerebrovascular disorders		I60-I69
T23499	Endothelin-1 receptor	Diabetic nephropathy	250.4	E11.21
T23499	Endothelin-1 receptor	Heart disease	390-429	I00-I52
T23499	Endothelin-1 receptor	Hormone refractory prostate cancer	140-229, 185	C61
T23499	Endothelin-1 receptor	Hormone resistant prostate cancer	185	C61
T23499	Endothelin-1 receptor	Hypertension	401	I10-I16
T23499	Endothelin-1 receptor	Hypotension	458, 796.3	I95
T23499	Endothelin-1 receptor	Nerve injury		T14.4
T23499	Endothelin-1 receptor	Premature labour	644, 765	O60.1, P07.3
T23499	Endothelin-1 receptor	Prostate cancer	185	C61
T23499	Endothelin-1 receptor	Pulmonary arterial hypertension	416	I27.0, I27.2
T23499	Endothelin-1 receptor	Pulmonary hypertension	416	I27.0, I27.2
T23499	Endothelin-1 receptor	Solid tumours	140-199, 210-229	C00-D48
T23499	Endothelin-1 receptor	Unspecified		
T23499	Endothelin-1 receptor	Vasospasm following subarachnoid hemorrhage	430, 728.85, 852.0, 852.1	I60, P10.3, R25.2, S06.6
T23547	Opioid receptor	Alcohol dependence		F10
T23547	Opioid receptor	Alcohol use disorders	303	F10.2
T23547	Opioid receptor	Analgesia	338	R52, G89
T23547	Opioid receptor	Anxiety disorder	300, 311	F32, F40-F42
T23547	Opioid receptor	Cancer pain	140-229, 338,780	R52, G89
T23547	Opioid receptor	Constipation	564	K59.0
T23547	Opioid receptor	Dry cough; Drug withdrawal syndrome; Ppioid type drug dependence		R05
T23547	Opioid receptor	Hepatitis virus infection	573.3	K75.9
T23547	Opioid receptor	Human immunodeficiency virus infection	279.3	B20-B26
T23547	Opioid receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T23547	Opioid receptor	Influenza A infection		J10, J11
T23547	Opioid receptor	Moderate to severe pain		R52, G89
T23547	Opioid receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T23547	Opioid receptor	Opioid addication		F11
T23547	Opioid receptor	Opioid induced adverse effect	304	F11
T23547	Opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T23547	Opioid receptor	Parkinson's disease	332	G20
T23547	Opioid receptor	Psychotic disorders	290-299	F20-F29
T23666	Aryl hydrocarbon receptor	Multiple myeloma; HIV infections	001-139, 042, 203.0	B20-B24, C90
T23673	Proto-oncogene c-RAF	Autoimmune diabetes		E08-E13
T23673	Proto-oncogene c-RAF	Colorectal cancer	153, 154	C18-C21
T23714	B2 bradykinin receptor	Asthma		J45
T23714	B2 bradykinin receptor	Brain cancer	191, 225.0	C71, D33
T23714	B2 bradykinin receptor	Cancer	140-229	C00-C96
T23714	B2 bradykinin receptor	Hereditary angioedema	277.6	D84.1
T23714	B2 bradykinin receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T23714	B2 bradykinin receptor	Osteoarthritis	715	M15-M19, M47
T23714	B2 bradykinin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T23714	B2 bradykinin receptor	Rhinitis	472.0, 477	J00, J30, J31.0
T23714	B2 bradykinin receptor	Septic shock	785.52	A41.9
T23714	B2 bradykinin receptor	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
T23714	B2 bradykinin receptor	Unspecified		
T23761	Sarcoplasmic/endoplasmic reticulum calcium ATPase	Malaria		B54
T23787	PFKFB3 kinase	Solid tumours	140-199, 210-229	C00-D48
T23797	Interleukin-33	Asthma		J45
T23953	Prostate stem cell antigen	Metastatic pancreatic cancer	185	C61
T23995	Protein kinase C, theta type	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T24127	Peptide YY	Obesity	278	E66
T24211	C1 esterase inhibitor	Hereditary angioedema	277.6	D84.1
T24373	Lysosomal acid lipase	Enzyme deficiency		E70-E90
T24555	mRNA of Beta 2 adrenoceptor	Ocular hypertension	365.04	H40.0
T24587	Methylated-DNA--protein-cysteine methyltransferase	Sarcoma	202.8	C81-C86
T24626	Haemophilus influenzae acetylglucosamine deacetylase (LpxC)	Pseudomonas infection		B96.5
T24634	UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T24634	UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T24836	Vitamin K-dependent protein C	Blood forming organ disorders		D75.9
T24836	Vitamin K-dependent protein C	Cardiovascular disorder		I00-I99
T24836	Vitamin K-dependent protein C	Cerebrovascular ischaemia	434.91	I61-I63
T24836	Vitamin K-dependent protein C	Varicose and spider veins of leg; Hemangioma	454-456, 671	I83, I85, I86, D18.00
T24982	Ileal bile acid transfer	Hyperlipidaemia	272.0-272.4	E78
T24982	Ileal bile acid transfer	Lipid metabolism disorder		E75-E78
T24982	Ileal bile acid transfer	Primary biliary cirrhosis	571.6	K74.3
T24982	Ileal bile acid transfer	Type 2 diabetes	250	E11
T24982	Ileal bile acid transfer	Unspecified		
T24983	D(4) dopamine receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T24983	D(4) dopamine receptor	Psychotic disorders	290-299	F20-F29
T24983	D(4) dopamine receptor	Schizophrenia	295	F20
T25005	Tyrosine-protein kinase BTK	Autoimmune diabetes		E08-E13
T25005	Tyrosine-protein kinase BTK	B-cell lymphoma	202.8	C85.1
T25005	Tyrosine-protein kinase BTK	Chronic lymphocytic leukaemia		C91
T25005	Tyrosine-protein kinase BTK	Chronic lymphocytic leukaemia; Refractory or relapsed mantle cell lymphoma	200.4	C91, C85.7
T25005	Tyrosine-protein kinase BTK	Rheumatoid arthritis	710-719, 714	M05-M06
T25163	Carbamoyl-phosphate synthetase I	Acute hyperammonaemia	270.6	E72.2
T25163	Carbamoyl-phosphate synthetase I	Varicose veins		I83.10
T25258	Multidrug resistance protein 1	Adrenocortical carcinoma	194	C74.0
T25258	Multidrug resistance protein 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T25258	Multidrug resistance protein 1	Cancer	140-229	C00-C96
T25258	Multidrug resistance protein 1	Non-small cell lung cancer		C33-C34
T25258	Multidrug resistance protein 1	Ovarian cancer	183	C56
T25258	Multidrug resistance protein 1	Solid tumours	140-199, 210-229	C00-D48
T25265	Enhancer of zeste homolog 2	Cancer	140-229	C00-C96
T25265	Enhancer of zeste homolog 2	Solid tumours	140-199, 210-229	C00-D48
T25315	C-X-C chemokine receptor type 3	Autoimmune diabetes		E08-E13
T25315	C-X-C chemokine receptor type 3	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T25315	C-X-C chemokine receptor type 3	Inflammatory disorder		
T25315	C-X-C chemokine receptor type 3	Psoriatic disorder	696	L40
T25315	C-X-C chemokine receptor type 3	Rheumatoid arthritis	710-719, 714	M05-M06
T25317	Cholestenol delta-isomerase	Rheumatoid arthritis	710-719, 714	M05-M06
T25417	Humanized IgG2	Sickle-cell disease	282.6	D57
T25464	Calcineurin	Atopic dermatitis	691.8, 692.9	L00-L99
T25464	Calcineurin	Kidney diseases; Heart transplantation	996	T86
T25464	Calcineurin	Ocular allergy	360-379	H00-H59
T25464	Calcineurin	Organ transplant rejection	279.5, 996	D89.8, T86
T25464	Calcineurin	Psoriasis	696	L40
T25464	Calcineurin	Xerophthalmia		E50.6-E50.7
T25537	MAP kinase	Keratosis		L57.0
T25608	GPR40	Diabetes	253.5, 588.1	E23.2, N25.1
T25608	GPR40	Non-insulin dependent diabetes		E11.9
T25608	GPR40	Type 2 diabetes	250	E11
T25637	Lysyl oxidase homolog 2	Colorectal cancer; Pancreatic cancer	153, 154, 140-199, 140-229, 157, 210-229	C18-C21, C25
T25663	Adenosine receptor	Cardiac arrhythmias	427	I47-I49
T25663	Adenosine receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T25663	Adenosine receptor	Cystic fibrosis	277	E84
T25663	Adenosine receptor	Hypertension	401	I10-I16
T25698	Pseudomonas aeruginosa lipopolysaccharide	Hospital-acquired pneumonia; Ventilator-associated pneumonia		J18.9, J95
T25698	Pseudomonas aeruginosa lipopolysaccharide	Pseudomonas aeruginosa infection	001-139	B96.5
T25703	Heme oxygenase	Neonatal hyperbilirubinemia; Jaundice	773, 774, 782.4	P58, P59, R17
T25726	Glypican-3	Hepatocellular carcinoma	155	C22.0
T25739	Zinc transporter ZIP6	Breast cancer	174, 175	C50
T25847	Peptidyl-prolyl cis-trans isomerase B	Dietary shortage	260-269	E40-E46
T25889	Adenylate cyclase	Cardiac failure		I50
T25950	Bone metabolism	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T26125	Peptidyl transferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T26203	ICAM-1	Hormone refractory prostate cancer	140-229, 185	C61
T26203	ICAM-1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T26203	ICAM-1	Multiple myeloma	203	C90
T26203	ICAM-1	Psoriasis	696	L40
T26203	ICAM-1	Unspecified		
T26220	Somatostatin receptor	Acromegaly	253	E22.0
T26220	Somatostatin receptor	Alzheimer disease	331	G30
T26220	Somatostatin receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T26220	Somatostatin receptor	Duodenal ulcers		K25-K27
T26220	Somatostatin receptor	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T26220	Somatostatin receptor	Melanoma	172	C43
T26220	Somatostatin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T26226	Prolactin receptor	Cancer	140-229	C00-C96
T26240	Estramustine binding protein	Prostate cancer	185	C61
T26327	Superoxide anion	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T26368	Gamma-aminobutyric-acid receptor alpha-5 subunit	Alzheimer disease	331	G30
T26368	Gamma-aminobutyric-acid receptor alpha-5 subunit	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T26428	Melanin-concentrating hormone receptor	Obesity	278	E66
T26463	DNA polymerase alpha catalytic subunit GenePOLA1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T26500	Histamine H4 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T26500	Histamine H4 receptor	Asthma		J45
T26500	Histamine H4 receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T26500	Histamine H4 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T26623	Aldose reductase	Diabetes	253.5, 588.1	E23.2, N25.1
T26623	Aldose reductase	Diabetic cataract		E10.36, E11.36
T26623	Aldose reductase	Diabetic complication		E08-E13
T26623	Aldose reductase	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T26623	Aldose reductase	Glaucoma	365	H40-H42
T26623	Aldose reductase	Gout	274.00274.1274.8274.9	M10
T26623	Aldose reductase	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T26623	Aldose reductase	Rheumatoid arthritis	710-719, 714	M05-M06
T26851	Complement C3	Advanced indolent non-hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C86, C82-C85, C91-C95
T26851	Complement C3	Macular degeneration	362.5	H35.3
T26945	Immunoglobulin Fc receptor	Ischemic heart diseases	410-414	I20-I25
T27021	Transferase	Arthritis	710-719	M00-M25
T27021	Transferase	Cancer	140-229	C00-C96
T27021	Transferase	Cerebrovascular ischaemia	434.91	I61-I63
T27106	Potentiating dexamethasone-induced GR transcriptional activity	Cancer	140-229	C00-C96
T27137	Metabotropicglutamate receptor 1	Alzheimer disease; Huntington's disease	331, 294.1, 333.4	G30, F02.2, G10
T27137	Metabotropicglutamate receptor 1	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T27137	Metabotropicglutamate receptor 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T27137	Metabotropicglutamate receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T27137	Metabotropicglutamate receptor 1	Schizophrenia	295	F20
T27186	Placenta growth factor	Macular degeneration	362.5	H35.3
T27186	Placenta growth factor	Solid tumours	140-199, 210-229	C00-D48
T27198	Methionyl-tRNA synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T27265	5-alpha reductase	Acne vulgaris	706.1	L70.0
T27265	5-alpha reductase	Alopecia	704.09	L65.9
T27265	5-alpha reductase	Benign prostatic hyperplasia	600	N40
T27265	5-alpha reductase	Hirsutism	704.1	L68.0
T27265	5-alpha reductase	Prostate cancer	185	C61
T27265	5-alpha reductase	Prostate disease		N42.9
T27288	Gastric emptying	Obesity	278	E66
T27325	DNA topoisomerase I	Cancer	140-229	C00-C96
T27325	DNA topoisomerase I	Colorectal cancer	153, 154	C18-C21
T27325	DNA topoisomerase I	Lung cancer	162	C33-C34
T27325	DNA topoisomerase I	Ovarian cancer	183	C56
T27325	DNA topoisomerase I	Small-cell lung cancer	162.9	C33-C34
T27325	DNA topoisomerase I	Solid tumours	140-199, 210-229	C00-D48
T27376	GABA A receptor delta subunit	Anesthesia	338	R20.0
T27376	GABA A receptor delta subunit	Anxiety disorder	300, 311	F32, F40-F42
T27376	GABA A receptor delta subunit	Epilepsy		G40
T27376	GABA A receptor delta subunit	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T27376	GABA A receptor delta subunit	Neuropathic pain	356.0, 356.8	G64, G90.0
T27376	GABA A receptor delta subunit	Unspecified		
T27445	Isoleucyl-tRNA synthetase (bacterial)	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T27602	Trypsin	Asthma		J45
T27602	Trypsin	Blood coagulation disorders		D65-D68
T27602	Trypsin	Hypotension	458, 796.3	I95
T27602	Trypsin	Premature labour	644, 765	O60.1, P07.3
T27602	Trypsin	Unspecified		
T27611	Bone morphogenetic protein-9 ligand	Advanced cancers; Age-related macular degeneration	140-229, 362.50	H35.3
T27736	Programmed cell death ligand 2	Cancer	140-229	C00-C96
T27770	Late sodium current	Ischemic heart diseases	410-414	I20-I25
T27792	Signal transduction	Systemic lupus erythematosus	710	M32
T27812	Sodium-dependent serotonin transporter	Appetite suppressant		
T27812	Sodium-dependent serotonin transporter	Cancer	140-229	C00-C96
T27812	Sodium-dependent serotonin transporter	Chronic low back pain; Neuropathic pain	338, 356.0, 356.8, 724.2, 724.5,780	G64, G90.0, M54, M54.5, R52, G89
T27812	Sodium-dependent serotonin transporter	Depression	311	F30-F39
T27812	Sodium-dependent serotonin transporter	Depression; Attention deficit hyperactivity disorder	311, 314.00, 314.01	F30-F39, F90
T27812	Sodium-dependent serotonin transporter	Depression; Chronic pain	311, 338,780	F30-F39, R52, G89
T27812	Sodium-dependent serotonin transporter	Depressive disorders; Neuropathic pain	296, 710.0, 356.0, 356.8	F30-F39, M32, G64, G90.0
T27812	Sodium-dependent serotonin transporter	Fibromyalgia	729.1	M79.7
T27812	Sodium-dependent serotonin transporter	Fibromyalgia; Myalgia; Chemotherapyinduced emesis	729.1, 787	M79.1, M79.7, R11
T27812	Sodium-dependent serotonin transporter	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T27812	Sodium-dependent serotonin transporter	Major depression	296.2, 296.3	F32, F33
T27812	Sodium-dependent serotonin transporter	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T27812	Sodium-dependent serotonin transporter	Major depressive disorder; Menopausal staging; Vasomotor symptoms	296, 296.2, 296.3, 627.2	F30-F39, F32, F33, N95.0, N95.1
T27812	Sodium-dependent serotonin transporter	Migraine; Obisity	278, 346	E66, G43
T27812	Sodium-dependent serotonin transporter	Mood disorder		F30-F39
T27812	Sodium-dependent serotonin transporter	Obesity	278	E66
T27812	Sodium-dependent serotonin transporter	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T27812	Sodium-dependent serotonin transporter	Parkinson's disease	332	G20
T27812	Sodium-dependent serotonin transporter	Premature ejaculation	302.75	F52.4
T27812	Sodium-dependent serotonin transporter	Schizophrenia	295	F20
T27812	Sodium-dependent serotonin transporter	Smoking cessation	292	F17.2
T27826	SPTBN1	Cancer	140-229	C00-C96
T27861	Pleiotropic pathway	Solid tumours	140-199, 210-229	C00-D48
T27889	Recombinant human angiotensin converting enzyme 2	Acute lung injury	518	J80
T27889	Recombinant human angiotensin converting enzyme 2	Diabetes	253.5, 588.1	E23.2, N25.1
T27889	Recombinant human angiotensin converting enzyme 2	Type 2 diabetes	250	E11
T27918	Probable ATP-dependent RNA helicase DDX5	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T27944	Neuropeptide Y receptor type 4	Diabetes	253.5, 588.1	E23.2, N25.1
T27944	Neuropeptide Y receptor type 4	Obesity	278	E66
T27944	Neuropeptide Y receptor type 4	Schizophrenia	295	F20
T27999	Protective antigen	Anthrax	22	A00-B99
T27999	Protective antigen	Bacillus anthracis infection		A22
T27999	Protective antigen	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T28076	Fibroblast growth factor-4	Angina pectoris	413	I20
T28076	Fibroblast growth factor-4	Heart disease	390-429	I00-I52
T28076	Fibroblast growth factor-4	Interstitial cystitis; Painful bladder syndrome	595.1,338,780	N30.1, G89, R52
T28140	Phospholipids in bacterial cell membrane	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T28213	Free fatty acid receptor 2	Abortion	779.6	O04
T28213	Free fatty acid receptor 2	Diabetes	253.5, 588.1	E23.2, N25.1
T28265	Alpha-1-antitrypsin	Alpha-1 antitrypsin deficiency	273.4	E88.0
T28265	Alpha-1-antitrypsin	Chronic obstructive pulmonary disease; Cystic fibrosis	277.0, 460-519, 490-492, 494-496, 709.2	E84, J00-J99, J40-J44, J47, L90.5
T28265	Alpha-1-antitrypsin	Emphysema	492	J43
T28265	Alpha-1-antitrypsin	Unspecified		
T28330	Cholecystokinin receptor type A	Bladder disease		N30-N32
T28330	Cholecystokinin receptor type A	Dyspepsia	536.8	K30
T28330	Cholecystokinin receptor type A	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10-I16, I50
T28330	Cholecystokinin receptor type A	Gallstone prophylaxis; Obesity	278	E66
T28330	Cholecystokinin receptor type A	Gastrointestinal disease		K00-K93
T28330	Cholecystokinin receptor type A	Obesity	278	E66
T28330	Cholecystokinin receptor type A	Obesity; Eating disorders	278, 307.5	E66, F50
T28330	Cholecystokinin receptor type A	Pancreatic cancer; Obesity	140-229, 157, 278	C25, E66
T28330	Cholecystokinin receptor type A	Pancreatic disease		K85-K86
T28413	Epha3 tyrosine kinase receptor	Hematological malignancies	200-209	C81-C86
T28484	Kinesin-like protein KIF11	Acute myeloid leukemia	205	C92.0
T28484	Kinesin-like protein KIF11	Cancer	140-229	C00-C96
T28484	Kinesin-like protein KIF11	Head and neck cancer; Renal cell carcinoma; Ovarian cancer; Solid tumors	140-149, 140-199, 140-229, 183, 189, 210-229	C07-C14, C32-C33, C56, C64, D10-D36, D3A
T28484	Kinesin-like protein KIF11	Hematological malignancies	200-209	C81-C86
T28484	Kinesin-like protein KIF11	Lymphoma	202.8, 208.9	C81-C86
T28484	Kinesin-like protein KIF11	Solid tumours	140-199, 210-229	C00-D48
T28532	Ribonuclease P	Psoriasis	696	L40
T28658	Food vacuoles	Malaria		B54
T28661	Tubulin beta-2 chain	Cancer	140-229	C00-C96
T28692	Lipoprotein lipase	Blood forming organ disorders		D75.9
T28692	Lipoprotein lipase	Dysbetalipoproteinemia	272.2	E78.2
T28692	Lipoprotein lipase	Hyperlipidaemia	272.0-272.4	E78
T28713	Serine/threonine-protein kinase Chk2	Cancer	140-229	C00-C96
T28713	Serine/threonine-protein kinase Chk2	Solid tumours	140-199, 210-229	C00-D48
T28717	TNF superfamily receptor 12A	Solid tumours	140-199, 210-229	C00-D48
T28722	GABA A receptor	Alzheimer disease	331	G30
T28722	GABA A receptor	Anesthesia	338	R20.0
T28722	GABA A receptor	Anxiety disorder	300, 311	F32, F40-F42
T28722	GABA A receptor	Anxiolytic and sedative		F40-F42
T28722	GABA A receptor	Epilepsy		G40
T28722	GABA A receptor	Epileptic seizures	345.9, 780.3	G40, P90, R56
T28722	GABA A receptor	General anesthesia	338	R20.0
T28722	GABA A receptor	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
T28722	GABA A receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T28722	GABA A receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T28722	GABA A receptor	Neurodegenerative disease	330-337	G30-G32
T28722	GABA A receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T28722	GABA A receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T28722	GABA A receptor	Panic disorder	300.01, 300.21	F41.0
T28722	GABA A receptor	Premenstrual syndrome		N94.3
T28722	GABA A receptor	Sedation	338	R52, G89
T28722	GABA A receptor	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T28722	GABA A receptor	Unspecified		
T28869	Urease	Urinary tract infections	599	N39.0
T28887	Histone Deacetylase 8	Cancer	140-229	C00-C96
T28893	Muscarinic acetylcholine receptor M1	Abdominal stomach pain; Irritable bowel syndrome	789.0, 338, 780, 564.1, 787.91	R10, G89, R52, A09, K58, K59.1
T28893	Muscarinic acetylcholine receptor M1	Alzheimer disease	331	G30
T28893	Muscarinic acetylcholine receptor M1	Anesthesia	338	R20.0
T28893	Muscarinic acetylcholine receptor M1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T28893	Muscarinic acetylcholine receptor M1	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T28893	Muscarinic acetylcholine receptor M1	Excessive sweating; Stomach ulcer	780.8	R61, K25-K27
T28893	Muscarinic acetylcholine receptor M1	Functional bowel syndrome; Irritable bowel syndrome		K58
T28893	Muscarinic acetylcholine receptor M1	Glaucoma	365	H40-H42
T28893	Muscarinic acetylcholine receptor M1	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T28893	Muscarinic acetylcholine receptor M1	Neuropathic pain	356.0, 356.8	G64, G90.0
T28893	Muscarinic acetylcholine receptor M1	Overactive bladder disorder	188, 596.51	C67, N32.81
T28893	Muscarinic acetylcholine receptor M1	Parkinson's disease	332	G20
T28893	Muscarinic acetylcholine receptor M1	Parkinson's disease; Dystonia	332	G20, G24
T28893	Muscarinic acetylcholine receptor M1	Parkinsonism; Extrapyramidal disorders secondary to neuroleptic drug therapy		F06
T28893	Muscarinic acetylcholine receptor M1	Peptic ulcer	531-534	K25-K27
T28893	Muscarinic acetylcholine receptor M1	Schizophrenia	295	F20
T28893	Muscarinic acetylcholine receptor M1	Schizophrenia; Dementia	290-294, 295	F01-F07, F20
T28893	Muscarinic acetylcholine receptor M1	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
T28893	Muscarinic acetylcholine receptor M1	Unspecified		
T28893	Muscarinic acetylcholine receptor M1	Urinary incontinence	788.3	N39.3, N39.4, R32
T28893	Muscarinic acetylcholine receptor M1	Visceral spasms		R25.2
T28916	AP endonuclease APE1	Melanoma; Glioma	172, 191	C43, C71
T28925	Inosine monophosphate dehydrogenase	Cancer	140-229	C00-C96
T28925	Inosine monophosphate dehydrogenase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T28925	Inosine monophosphate dehydrogenase	Inflammatory bowel disease	555, 556	K50, K51
T28925	Inosine monophosphate dehydrogenase	Transplant rejection	279.5, 996	D89.8, T86
T28993	Iduronate 2-sulfatase	Hunter syndrome		E76.1
T28993	Iduronate 2-sulfatase	Hunter syndrome; Infertility	628	E76.1, N97.0
T28998	Gonadotropin-releasing hormone	Prostate cancer	185	C61
T28998	Gonadotropin-releasing hormone	Solid tumours	140-199, 210-229	C00-D48
T29024	mRNA of copper zinc superoxide dismutase 1	Amyotrophic lateral sclerosis	335.2	G12.2
T29024	mRNA of copper zinc superoxide dismutase 1	Motor neurone disease	335.2	G12.2
T29064	Angiogenesis and myeloma cell growth	Systemic sclerosis	710.1	M34
T29075	HIV DNA polymerase	Human immunodeficiency virus infection	279.3	B20-B26
T29130	Signal transducer and activator of transcription 3	Hepatocellular carcinoma	155	C22.0
T29130	Signal transducer and activator of transcription 3	Multiple myeloma	203	C90
T29130	Signal transducer and activator of transcription 3	Psoriasis	696	L40
T29130	Signal transducer and activator of transcription 3	Solid tumours	140-199, 210-229	C00-D48
T29143	Interleukin-13	Allergic asthma	493, 995.3	J45, T78.4
T29143	Interleukin-13	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T29143	Interleukin-13	Allergy	995.3	T78.4
T29143	Interleukin-13	Asthma; Atopic eczema		J45, L20-L30
T29143	Interleukin-13	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T29143	Interleukin-13	Asthma; Ulcerative colitis		J45, K51
T29143	Interleukin-13	Idiopathic pulmonary fibrosis	516.3	J84.1
T29143	Interleukin-13	Severe asthma	493	J45
T29144	Arginase	Cancer	140-229	C00-C96
T29303	Sodium channel	Anesthesia	338	R20.0
T29303	Sodium channel	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T29303	Sodium channel	Cardiac arrhythmias	427	I47-I49
T29303	Sodium channel	Cardiac failure		I50
T29303	Sodium channel	Cardiovascular disorder		I00-I99
T29303	Sodium channel	Cerebral infarction		I63
T29303	Sodium channel	Cerebrovascular ischaemia	434.91	I61-I63
T29303	Sodium channel	Cough	786.2	R05
T29303	Sodium channel	Cystic fibrosis	277	E84
T29303	Sodium channel	Diabetes	253.5, 588.1	E23.2, N25.1
T29303	Sodium channel	Epilepsy		G40
T29303	Sodium channel	Epilepsy; Focal; Seizure disorder	345, 345.4, 345.5, 345.9, 780.3	G40, G40.2, P90, R56
T29303	Sodium channel	Epileptic seizures	345.9, 780.3	G40, P90, R56
T29303	Sodium channel	Gastric cancer	151	C16
T29303	Sodium channel	Heart arrhythmia		I47-I49
T29303	Sodium channel	Infections with sarcoptes scabiei	133	B86
T29303	Sodium channel	Ischemia	459.89	I99.8
T29303	Sodium channel	Local or regional analgesia and anesthesia		R20.0
T29303	Sodium channel	Migraine	346	G43
T29303	Sodium channel	Nerve injury		T14.4
T29303	Sodium channel	Neuropathic pain	356.0, 356.8	G64, G90.0
T29303	Sodium channel	Osteoarthritis	715	M15-M19, M47
T29303	Sodium channel	Overactive bladder disorder	188, 596.51	C67, N32.81
T29303	Sodium channel	Oxytocic		O00-O99
T29303	Sodium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T29303	Sodium channel	Parkinson's disease	332	G20
T29303	Sodium channel	Peripheral neuropathy		G64
T29303	Sodium channel	Schizophrenia	295	F20
T29303	Sodium channel	Seizures	345.9, 780.3	G40, P90, R56
T29303	Sodium channel	Seizures associated with lennox-Gastaut syndrome		R56.9
T29303	Sodium channel	Seizures occurring during or following neurosurgery		G40
T29303	Sodium channel	Spasm	728.85	R25.2
T29303	Sodium channel	Type 1 diabetes	250	E10
T29500	Alpha-1B adrenergic receptor	Attention deficit hyperactivity disorder	314	F90
T29500	Alpha-1B adrenergic receptor	Exogenous obesity		E66
T29500	Alpha-1B adrenergic receptor	Hypertension	401	I10-I16
T29500	Alpha-1B adrenergic receptor	Psychiatric disorder	290-319	F01-F99
T29525	HIV replication earlyphase	Acquired immune deficiency syndrome	42	B20
T29592	50S ribosomal subunit	Acne vulgaris	706.1	L70.0
T29592	50S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T29592	50S ribosomal subunit	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T29592	50S ribosomal subunit	Impetigo	684	L01
T29649	Leukotriene receptor	Allergy	995.3	T78.4
T29649	Leukotriene receptor	Asthma		J45
T29649	Leukotriene receptor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T29649	Leukotriene receptor	Cardiotonic		I50
T29649	Leukotriene receptor	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T29683	Nigral tachykinin NK(3) receptor	Asthma		J45
T29683	Nigral tachykinin NK(3) receptor	Central nervous system disease		G00-G99
T29683	Nigral tachykinin NK(3) receptor	Depression	311	F30-F39
T29683	Nigral tachykinin NK(3) receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T29683	Nigral tachykinin NK(3) receptor	Psychiatric disorder	290-319	F01-F99
T29683	Nigral tachykinin NK(3) receptor	Psychotic disorders	290-299	F20-F29
T29683	Nigral tachykinin NK(3) receptor	Schizophrenia	295	F20
T29683	Nigral tachykinin NK(3) receptor	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
T29736	Laminin beta-3 chain	Epidermolysis bullosa		Q81
T29754	MAPKAPK5	Rheumatoid arthritis	710-719, 714	M05-M06
T29815	Neoplasm antigen	Colorectal cancer	153, 154	C18-C21
T29879	Integrin alpha-5	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T29879	Integrin alpha-5	Allergy	995.3	T78.4
T29879	Integrin alpha-5	Asthma		J45
T29879	Integrin alpha-5	Macular degeneration	362.5	H35.3
T29879	Integrin alpha-5	Multiple scierosis	340	G35
T29960	Wilms' tumor protein	Acute myeloid leukemia	205	C92.0
T29960	Wilms' tumor protein	Acute myeloid leukemia; Lung cancer	205, 162	C92.0, C33-C34
T29960	Wilms' tumor protein	Leukemia	208.9	C90-C95
T29960	Wilms' tumor protein	Myeloid leukemia	208.9	C92
T29999	Vasopressin V1 receptor	Amnesia		F04
T30014	Immunoglobulin	Bacillus anthracis infection		A22
T30014	Immunoglobulin	Bone marrow transplantation	279.5, 996	D89.8, T86
T30014	Immunoglobulin	Vaccination		
T30028	Vesicle-associated membrane protein	Parkinson's disease	332	G20
T30081	Thymidine kinase	Acute myeloid leukemia	205	C92.0
T30081	Thymidine kinase	Adult varicella zoster virus infection		B02
T30081	Thymidine kinase	Brain cancer	191, 225.0	C71, D33
T30081	Thymidine kinase	Cancer	140-229	C00-C96
T30081	Thymidine kinase	Graft-versus-host disease	279.5	T86.0
T30081	Thymidine kinase	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T30081	Thymidine kinase	Prostate cancer	185	C61
T30081	Thymidine kinase	Solid tumours	140-199, 210-229	C00-D48
T30082	Acetylcholinesterase	Alzheimer disease	331	G30
T30082	Acetylcholinesterase	Alzheimer disease; Mild cognitive impairment	331.0, 331.83	F06.7, G30, G31.84
T30082	Acetylcholinesterase	Cancer	140-229	C00-C96
T30082	Acetylcholinesterase	Chronic glaucoma	365	H40-H42
T30082	Acetylcholinesterase	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T30082	Acetylcholinesterase	Epileptic seizures; Alzheimer disease	345.9, 780.3, 331	G40, P90, R56, G30
T30082	Acetylcholinesterase	Glaucoma	365	H40-H42
T30082	Acetylcholinesterase	Helminth infection	001-139	A00-B99
T30082	Acetylcholinesterase	Myasthenia gravis	358	G70.0
T30082	Acetylcholinesterase	Myasthenia gravis diagnosis	358	G70.0
T30082	Acetylcholinesterase	Neurodegenerative disease	330-337	G30-G32
T30082	Acetylcholinesterase	Open-angle glaucoma; Anxiety disorder	365, 300, 311	H40-H42, F32, F40-F42
T30082	Acetylcholinesterase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T30082	Acetylcholinesterase	Parkinson's disease	332	G20
T30082	Acetylcholinesterase	Pediculus humanus capitis	132	B85.0
T30082	Acetylcholinesterase	Poison intoxication		T36-T50
T30082	Acetylcholinesterase	Poisoning due to pesticides and chemicals		T36-T50
T30082	Acetylcholinesterase	Unspecified		
T30082	Acetylcholinesterase	Upper abdominal bloating; Early satiation associated with functional dyspepsia	536.8	K30
T30082	Acetylcholinesterase	Urinary dysfunction		N39.3-N39.4
T30082	Acetylcholinesterase	Xerostomia	527.7	K11.7, R68.2
T30085	SLGT2	Diabetes	253.5, 588.1	E23.2, N25.1
T30085	SLGT2	Liver disease	570-574	K70-K77
T30085	SLGT2	Type 1 diabetes	250	E10
T30085	SLGT2	Type 2 diabetes	250	E11
T30208	Secretion of growth hormone	Cerebrovascular ischaemia	434.91	I61-I63
T30284	Interferon-gamma receptor	Chronic granulomatous disease	288.1	D71
T30355	Cellular immunotherapy	Renal cancer	140-229, 189	C64
T30356	Blood group Rh(D) polypeptide	Anemia	280-285	D50-D64
T30372	Cruzipain	Helminth infection	001-139	A00-B99
T30374	Gamma-aminobutyric acid uptake	Anxiety disorder; Insomnia	300, 307.4, 327.0	F40-F42, F51.0, G47.0
T30374	Gamma-aminobutyric acid uptake	Panic disorder; Epilepsy	300.01, 300.21, 345	F41.0, G40
T30383	Endogenous gut peptide	Obesity	278	E66
T30418	DNA synthesis	Cancer	140-229	C00-C96
T30418	DNA synthesis	Solid tumours	140-199, 210-229	C00-D48
T30455	Atypical antipsychotic	Parkinson disease psychosis		G00-G99
T30455	Atypical antipsychotic	Parkinson's disease; Psychosis; Schizophrenia	290-299, 332, 295	F02.3, F20-F29, G20, F20
T30520	bacterial RNA polymerase switch region	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T30520	bacterial RNA polymerase switch region	Clostridium difficile associated diarrhea	008.45, 787.91	A04.7, A09, K59.1
T30520	bacterial RNA polymerase switch region	Tuberculosis	010-018	A15-A19
T30563	Leukotriene B4 receptor 2	Inflammatory bowel disease	555, 556	K50, K51
T30578	Probable arabinosyltransferase	Pulmonary tuberculosis		A15-A19
T30635	Small inducible cytokine B10	Autoimmune diabetes		E08-E13
T30635	Small inducible cytokine B10	Crohn's disease	555	K50
T30635	Small inducible cytokine B10	Crohn's disease; Ulcerative colitis	555, 556, 556.9	K50, K50-K52, K51
T30635	Small inducible cytokine B10	Immune disorder		D80-D89
T30653	Lyso-PAF: acetyl-CoA acetyltransferase 	Obesity	278	E66
T30687	mRNA of glucocorticoid receptor	Type 2 diabetes	250	E11
T30784	Thrombospondin-1 ligand	Solid tumours	140-199, 210-229	C00-D48
T30803	Glutathione reductase	Asthma		J45
T30803	Glutathione reductase	Inflammatory bowel disease	555, 556	K50, K51
T30803	Glutathione reductase	Vascular disease	325, 430-459	G45-G46, I60-I95
T30817	Serine palmitoyltransferase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T30834	Amylin receptor	Hypertension	401	I10-I16
T30834	Amylin receptor	Obesity	278	E66
T30834	Amylin receptor	Type 2 diabetes	250	E11
T30834	Amylin receptor	Unspecified		
T30926	mRNA of GRB2	Acute lymphoblastic leukemia; Acute myeloid leukemia; Chronic myelogenous leukemia; Hematological malignancies; Myelodysplastic syndrome	204.0, 205.0, 205.1, 238.7, 200-209	C91.0, C92.0, C92.1, D46, C81-C86
T30938	RNA polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T30938	RNA polymerase	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T30938	RNA polymerase	Influenza virus		J11.1
T30940	Mitochondrial 10 kDa heat shock protein	Autoimmune diabetes		E08-E13
T30956	Anthrax toxin	Anthrax	22	A00-B99
T30956	Anthrax toxin	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T30985	Histamine H2 receptor	Acid-reflux disorders	530.81	K21
T30985	Histamine H2 receptor	Duodenal ulcers		K25-K27
T30985	Histamine H2 receptor	Gastric secretory disorders	536.8	K30
T30985	Histamine H2 receptor	Gastric ulcer	531	K25
T30985	Histamine H2 receptor	Gastroesophageal reflux disease	140-229, 530	K21
T30985	Histamine H2 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T30985	Histamine H2 receptor	Peptic ulcer	531-534	K25-K27
T30985	Histamine H2 receptor	Stomach ulcer		K25-K27
T30985	Histamine H2 receptor	Ulcerative colitis	556	K51
T31133	Potassium	Hyperkalemia		E87.5
T31204	5-hydroxytryptamine 2B receptor	Congestive heart failure	428	I50
T31204	5-hydroxytryptamine 2B receptor	Coronary heart disease	414	I25.1
T31204	5-hydroxytryptamine 2B receptor	Depression; Cerebral infarction	311	F30-F39, I63
T31204	5-hydroxytryptamine 2B receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T31204	5-hydroxytryptamine 2B receptor	Migraine	346	G43
T31204	5-hydroxytryptamine 2B receptor	Psychoses	290-299	F20-F29
T31204	5-hydroxytryptamine 2B receptor	Pulmonary arterial hypertension	416	I27.0, I27.2
T31230	Fumarate reductase flavoprotein subunit	Dutch elm disease; Helminth infection	001-139	B81-B83, A00-B99
T31230	Fumarate reductase flavoprotein subunit	Mature gastrointestinal nematode infections	127	B77-B81
T31230	Fumarate reductase flavoprotein subunit	Trichuris trichiura infection	127.3	B79
T31309	Apoptosis regulator Bcl-2	Advanced melanoma; Multiple myeloma	172, 203.0	C43, C90
T31309	Apoptosis regulator Bcl-2	Amyotrophic lateral sclerosis	335.2	G12.2
T31309	Apoptosis regulator Bcl-2	Breast cancer	174, 175	C50
T31309	Apoptosis regulator Bcl-2	Cancer	140-229	C00-C96
T31309	Apoptosis regulator Bcl-2	Chronic lymphocytic leukaemia		C91
T31309	Apoptosis regulator Bcl-2	Prostate cancer	185	C61
T31309	Apoptosis regulator Bcl-2	Psoriasis	696	L40
T31309	Apoptosis regulator Bcl-2	Unspecified		
T31329	Leishmania donovani DNA topoisomerase I	Solid tumours	140-199, 210-229	C00-D48
T31391	Dipeptidyl peptidase IV	Autism	299	F84.0
T31391	Dipeptidyl peptidase IV	Autoimmune diabetes		E08-E13
T31391	Dipeptidyl peptidase IV	Bone marrow transplantation	279.5, 996	D89.8, T86
T31391	Dipeptidyl peptidase IV	Diabetes	253.5, 588.1	E23.2, N25.1
T31391	Dipeptidyl peptidase IV	Hematological malignancies	200-209	C81-C86
T31391	Dipeptidyl peptidase IV	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
T31391	Dipeptidyl peptidase IV	Metabolic disorders	270-279	E70-E89
T31391	Dipeptidyl peptidase IV	Non-insulin dependent diabetes		E11.9
T31391	Dipeptidyl peptidase IV	Type 2 diabetes	250	E11
T31391	Dipeptidyl peptidase IV	Unspecified		
T31424	Alpha-2 adrenergic receptor	Acute myeloid leukemia	205	C92.0
T31424	Alpha-2 adrenergic receptor	Additional intra ocular pressure reduction		H40-H42
T31424	Alpha-2 adrenergic receptor	Angina pectoris	413	I20
T31424	Alpha-2 adrenergic receptor	Attention deficit hyperactivity disorder	314	F90
T31424	Alpha-2 adrenergic receptor	Glaucoma	365	H40-H42
T31424	Alpha-2 adrenergic receptor	Heroin and opiate withdrawal	304	F10-F19
T31424	Alpha-2 adrenergic receptor	High blood pressure	401	I10-I16
T31424	Alpha-2 adrenergic receptor	Hypertension	401	I10-I16
T31424	Alpha-2 adrenergic receptor	Male impotence	302.72, 607.84	F52.2, N48.4
T31424	Alpha-2 adrenergic receptor	Male sexual disorders		F52
T31424	Alpha-2 adrenergic receptor	Moderate-to-severe pain		R52, G89
T31424	Alpha-2 adrenergic receptor	Muscle weakness; Easy fatigability		M62.8
T31424	Alpha-2 adrenergic receptor	Nasal congestion; Eye irritations		R09.81
T31424	Alpha-2 adrenergic receptor	Sedation	338	R52, G89
T31424	Alpha-2 adrenergic receptor	Senile dementia; Brain ischaemia	290-294, 435, 437	F01-F07, G45.9, I67.8
T31424	Alpha-2 adrenergic receptor	Spasms; Pain	338,780	R52, G89
T31458	PK modulator	Hereditary angioedema	277.6	D84.1
T31479	Phospholipase A2	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T31479	Phospholipase A2	Allergy	995.3	T78.4
T31479	Phospholipase A2	Arteriosclerosis	440	I70
T31479	Phospholipase A2	Arthritis	710-719	M00-M25
T31479	Phospholipase A2	Asthma		J45
T31479	Phospholipase A2	Contact dermatitis	692	L23, L24, L25
T31479	Phospholipase A2	Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses		L20-L30
T31479	Phospholipase A2	Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp		L20-L30
T31479	Phospholipase A2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T31479	Phospholipase A2	Leishmaniasis		B55.0
T31479	Phospholipase A2	Nerve injury		T14.4
T31479	Phospholipase A2	Pruritus	698	L29
T31479	Phospholipase A2	Rheumatoid arthritis	710-719, 714	M05-M06
T31479	Phospholipase A2	Unspecified		
T31479	Phospholipase A2	Visceral leishmaniasis	85	B55.0
T31514	Lysosomal alpha-glucosidase	Pompe's disease		E74.02
T31518	ApoCIII	Severe hypertriglyceridemia		I20-I25
T31595	Neuraminidase	Influenza virus		J11.1
T31600	protein kinase N3	Solid tumours	140-199, 210-229	C00-D48
T31621	Heparin-binding growth factor 2	Acne vulgaris	706.1	L70.0
T31621	Heparin-binding growth factor 2	Arteriosclerosis	440	I70
T31621	Heparin-binding growth factor 2	Neurodegenerative disease	330-337	G30-G32
T31751	1-deoxy-D-xylulose-5-phosphate reductoisomerase	Malaria		B54
T31825	Hemoglobin subunit beta	Beta thalassemia		D56.1
T31902	ADAM 10	Cancer	140-229	C00-C96
T31956	Glutamyl aminopeptidase	Hypertension	401	I10-I16
T31989	Sphingosine kinase	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T31992	Carbonic anhydrase XIV	Inborn error of metabolism		E88.9
T32060	5-hydroxytryptamine 2A receptor	Addiction		
T32060	5-hydroxytryptamine 2A receptor	Alcohol use disorders	303	F10.2
T32060	5-hydroxytryptamine 2A receptor	Anxiety disorder	300, 311	F32, F40-F42
T32060	5-hydroxytryptamine 2A receptor	Cardiovascular disorder		I00-I99
T32060	5-hydroxytryptamine 2A receptor	Central nervous system disease		G00-G99
T32060	5-hydroxytryptamine 2A receptor	Depression	311	F30-F39
T32060	5-hydroxytryptamine 2A receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T32060	5-hydroxytryptamine 2A receptor	Erythropoietic porphyria		E80.0
T32060	5-hydroxytryptamine 2A receptor	Fibromyalgia	729.1	M79.7
T32060	5-hydroxytryptamine 2A receptor	Glaucoma	365	H40-H42
T32060	5-hydroxytryptamine 2A receptor	Hemorrhoids		I84
T32060	5-hydroxytryptamine 2A receptor	Migraine	346	G43
T32060	5-hydroxytryptamine 2A receptor	Mood disorder		F30-F39
T32060	5-hydroxytryptamine 2A receptor	Pancreatitis	577.0-577.1	K85, K86.0K86.1
T32060	5-hydroxytryptamine 2A receptor	Psychiatric disorder	290-319	F01-F99
T32060	5-hydroxytryptamine 2A receptor	Schizophrenia	295	F20
T32060	5-hydroxytryptamine 2A receptor	Schizophrenia; Sleep maintenance insomnia	295, 307.41, 307.42, 327.0, 780.51, 780.52	F20, F51.0, G47.0
T32060	5-hydroxytryptamine 2A receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
T32060	5-hydroxytryptamine 2A receptor	Unspecified		
T32137	NADH oxidase	Fibrosis	709.2	L90.5
T32240	Interleukin-15	Rheumatoid arthritis	710-719, 714	M05-M06
T32247	Calcitonin receptor	Hypertension	401	I10-I16
T32247	Calcitonin receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T32247	Calcitonin receptor	Paget's disease	731	M88
T32247	Calcitonin receptor	Pain; Postmenopausal osteoporosis	338, 356.0, 356.8, 780, 733	G64, G90.0, R52, G89, M80-M81
T32262	Calcitoningene-related peptide type 1 receptor	Migraine	346	G43
T32262	Calcitoningene-related peptide type 1 receptor	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
T32282	Prolactin	Multiple scierosis	340	G35
T32326	HBV immunoglobulin	HBV infection	070.2-070.3	B16, B18.0, B18.1
T32335	Inhibitor of nuclear factor kappa-B kinase	Arthritis	710-719	M00-M25
T32369	Endonuclease	Alzheimer disease	331	G30
T32369	Endonuclease	Heart disease	390-429	I00-I52
T32369	Endonuclease	Hypertension	401	I10-I16
T32387	endothelium of blood vessels	Uncomplicated spider veins; Uncomplicated reticular veins		I80-I89
T32418	Expression of STAT-3	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
T32456	Second phase insulin secretion	Restenosis		I51.89
T32578	Interleukin-6	Anemia	280-285	D50-D64
T32578	Interleukin-6	Crohn's disease	555	K50
T32578	Interleukin-6	Hematological malignancies	200-209	C81-C86
T32578	Interleukin-6	Psoriatic arthritis; Rheumatoid arthritis	696.0, 710-719, 714	L40.5, M00-M25, M05-M06, M07
T32578	Interleukin-6	Rheumatoid arthritis	710-719, 714	M05-M06
T32612	Cyclin-dependent kinase	Cancer	140-229	C00-C96
T32628	Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)	Malaria		B54
T32720	Killer cell immunoglobulin-like receptor 2DL1/2DL2/2DL3/2DS1/2DS2	Multiple myeloma	203	C90
T32855	Neurotrophin-3	Central nervous system disease		G00-G99
T32855	Neurotrophin-3	Constipation	564	K59.0
T32862	Fungal ergosterol on cell membrane	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T32862	Fungal ergosterol on cell membrane	Fungal infections	110-118	B35-B49
T32880	HIF prolyl hydroxylase-2	Cancer	140-229	C00-C96
T32973	Legumain	Solid tumours	140-199, 210-229	C00-D48
T33124	D-amino acid oxidase	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T33193	Penicillin binding protein 3	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T33193	Penicillin binding protein 3	Bacterial respiratory tract infection		J13, J15
T33193	Penicillin binding protein 3	Urinary tract infections	599	N39.0
T33275	Tuftsin receptor	Diagnostic imaging	331	G30, I73.9
T33425	Epidermal growth factor ligand	Oral mucositis	528	K12.3
T33425	Epidermal growth factor ligand	Wound healing		T14.0-T14.1
T33489	Steryl-sulfatase	Endometriosis	617	N80
T33489	Steryl-sulfatase	Prostate cancer	185	C61
T33491	Histidine kinase KinA	Fungal infections	110-118	B35-B49
T33584	Glutamate receptor 1	Convulsions	780.3	R56.0
T33584	Glutamate receptor 1	Major depressive disorder; Schizophrenia	296.2, 296.3, 710.0, 295	F32, F33, M32, F20
T33629	Apoptosis in prostate tumor	Breast cancer	174, 175	C50
T33641	Cholesterol 24-hydroxylase	Glutamate excitotoxiity		T36-T65
T33754	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Congestive heart failure	428	I50
T33754	CGMP-inhibited 3',5'-cyclic phosphodiesterase	Heart failure	428	I50
T33765	mRNA of MCL-1	Systemic mastocytosis	202.6, 757.33	C96.2
T33846	Interleukin-17 receptor	Autoimmune diabetes		E08-E13
T33846	Interleukin-17 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T33887	PDGF receptor	Cancer	140-229	C00-C96
T33901	Niemann-Pick C1-like protein 1	Hypercholesterolemia		E78
T33917	Hydroxy radical	Renal disease		N00-N29
T34071	mRNA of TNF alpha	Crohn's disease; Rheumatoid arthritis	555, 710-719, 714	K50, M05-M06
T34234	Vitamin D receptor	Acne vulgaris	706.1	L70.0
T34234	Vitamin D receptor	Acute myeloid leukemia	205	C92.0
T34234	Vitamin D receptor	Cancer	140-229	C00-C96
T34234	Vitamin D receptor	Chronic kidney disease; Kidney transplantation	403, 580-589, 585.1-585.5, 585.9, 996	N00-N29, N18, T86
T34234	Vitamin D receptor	Hyperparathyroidism	252.02, 588.81	E21.1
T34234	Vitamin D receptor	Hypocalcemia; Hypoparathyroidism	252.0, 275.41	E21, E83.51
T34234	Vitamin D receptor	Hypoparathyroidism	252.1	E20, E89.2, P71.4
T34234	Vitamin D receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T34234	Vitamin D receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T34234	Vitamin D receptor	Prostate cancer	185	C61
T34234	Vitamin D receptor	Prostate disease		N42.9
T34234	Vitamin D receptor	Psoriasis	696	L40
T34234	Vitamin D receptor	Rickets		E55
T34234	Vitamin D receptor	Unspecified		
T34234	Vitamin D receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T34234	Vitamin D receptor	Vitamin D deficiency	268	E55
T34239	Protoporphyrinogen oxidase	Actinic keratosis	702	L57.0
T34287	Mannose-6-phosphate isomerase	Acne vulgaris	706.1	L70.0
T34287	Mannose-6-phosphate isomerase	Leprosy and dermatitis herpetiformis		L13.0
T34296	Collagenase 3	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T34296	Collagenase 3	Osteoarthritis	715	M15-M19, M47
T34296	Collagenase 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T34318	Cathelicidin antimicrobial peptide	Asthma		J45
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Alzheimer disease	331	G30
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Alzheimer disease; Schizophrenia	295, 331.0	F20, G30
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Anesthesia	338	R20.0
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Asthma		J45
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Attention deficit hyperactivity disorder	314	F90
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Central nervous system disease		G00-G99
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Mild to moderate alzheimer disease; Schizophrenia	331, 295	G30, F20
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Parkinson's disease	332	G20
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Psychiatric disorder	290-319	F01-F99
T34429	Neuronal acetylcholine receptor protein, alpha-7 chain	Schizophrenia	295	F20
T34596	DNA gyraseA subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T34596	DNA gyraseA subunit	Cystic fibrosis	277	E84
T34596	DNA gyraseA subunit	Otitis externa		H60
T34599	Bacterial penicillin binding protein	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T34599	Bacterial penicillin binding protein	Bacterial respiratory tract infection		J13, J15
T34599	Bacterial penicillin binding protein	Intensive care unit; Bacterial infections	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T34599	Bacterial penicillin binding protein	Unspecified		
T34610	IgE-mediated histamine release	Asthma		J45
T34624	Stress kinase p38	Asthma		J45
T34624	Stress kinase p38	Atherosclerosis; Psoriasis	414.0, 440, 696	I70, L40
T34624	Stress kinase p38	Cancer	140-229	C00-C96
T34624	Stress kinase p38	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T34624	Stress kinase p38	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J47, J45
T34624	Stress kinase p38	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T34624	Stress kinase p38	Rheumatoid arthritis	710-719, 714	M05-M06
T34743	DNA	Acute bronchitis		J20-J21, J42
T34743	DNA	Acute myeloid leukemia	205	C92.0
T34743	DNA	Arthritis	710-719	M00-M25
T34743	DNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T34743	DNA	Brain cancer	191, 225.0	C71, D33
T34743	DNA	Brain cancer; Glioma	191, 225.0	C71, D33
T34743	DNA	Breast cancer	174, 175	C50
T34743	DNA	Cancer	140-229	C00-C96
T34743	DNA	Chronic bronchitis		J42
T34743	DNA	Chronic lymphocytic leukaemia		C91
T34743	DNA	Cystic fibrosis	277	E84
T34743	DNA	Dietary shortage	260-269	E40-E46
T34743	DNA	Fungal infections	110-118	B35-B49
T34743	DNA	Gastrointestinal cancers; Breast cancers	150-159, 174, 175	C15-C26, C50
T34743	DNA	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T34743	DNA	Herpes simplex virus infection	54	B00
T34743	DNA	Hodgkin's lymphoma		C81
T34743	DNA	Infections by susceptible microorganisms		A00-B99
T34743	DNA	Infections of the upper and lower urinary tract		A00-B99
T34743	DNA	Leukemia	208.9	C90-C95
T34743	DNA	Lupus nephritis	583.81	M32.1, N08.5
T34743	DNA	Malaria		B54
T34743	DNA	Melanoma	172	C43
T34743	DNA	Metastatic islet cell carcinoma	157.4	C25.4
T34743	DNA	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T34743	DNA	Ovarian cancer	183	C56
T34743	DNA	Pseudomonas aeruginosa infection; Haemophilus influenzae infection		B96.5
T34743	DNA	Psoriasis; Cutaneous T-cell lymphoma	696, 202.1, 202.2	L40, C84.0, C84.1
T34743	DNA	Refractory chronic myeloid leukaemia	205.1	C92.1
T34743	DNA	Sepsis	995.91	A40, A41
T34743	DNA	Stage IA/IB mycosisfungoides-type cutaneous T-cell lymphoma		C81-C86
T34743	DNA	Systemic lupus erythematosus	710	M32
T34743	DNA	Urinary tract infections	599	N39.0
T34772	Endopeptidase	Diarrhea	787.91	A09, K59.1
T34843	Glucagon-like peptide 2 receptor	Diarrhea	787.91	A09, K59.1
T34843	Glucagon-like peptide 2 receptor	Gastrointestinal disease		K00-K93
T34843	Glucagon-like peptide 2 receptor	Inflammatory bowel disease	555, 556	K50, K51
T34843	Glucagon-like peptide 2 receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T34843	Glucagon-like peptide 2 receptor	Short bowel syndrome	579.3	K91.8
T34867	Poly ADP ribose polymerase (PARP)	Acute ischemic stroke	434.91	I61-I63
T34867	Poly ADP ribose polymerase (PARP)	Brain cancer	191, 225.0	C71, D33
T34867	Poly ADP ribose polymerase (PARP)	BRCA-positive ovarian cancer		C56
T34867	Poly ADP ribose polymerase (PARP)	Breast cancer	174, 175	C50
T34867	Poly ADP ribose polymerase (PARP)	Breast cancer; Ovarian cancer	174, 175, 183	C50, C56
T34867	Poly ADP ribose polymerase (PARP)	Cerebrovascular ischaemia	434.91	I61-I63
T34867	Poly ADP ribose polymerase (PARP)	Cerebrovascular ischaemia; Non-small cell lung cancer	434.91	I61-I63, C33-C34
T34867	Poly ADP ribose polymerase (PARP)	Melanoma	172	C43
T34867	Poly ADP ribose polymerase (PARP)	Ovarian cancer	183	C56
T34867	Poly ADP ribose polymerase (PARP)	Psoriatic arthritis	696	L40.5, M07
T34867	Poly ADP ribose polymerase (PARP)	Solid tumours	140-199, 210-229	C00-D48
T34867	Poly ADP ribose polymerase (PARP)	Type 2 diabetes	250	E11
T34997	Hepatitis C virus serine protease NS4a	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T35040	Basigin	Graft-versus-host disease	279.5	T86.0
T35040	Basigin	Liver cancer	140-229, 155, 203.0	C22
T35063	KIR	Acute myeloid leukemia	205	C92.0
T35116	Synthetic peptide-based	Multiple scierosis	340	G35
T35135	Voltage-gated sodium channel	Amyotrophic lateral sclerosis	335.2	G12.2
T35135	Voltage-gated sodium channel	Anesthesia	338	R20.0
T35135	Voltage-gated sodium channel	Atrial fibrillation; Pain	338, 427.31,780	I48, R52, G89
T35135	Voltage-gated sodium channel	Dysmenorrhea	625.3	N94.4-N94.6
T35135	Voltage-gated sodium channel	Epilepsy		G40
T35135	Voltage-gated sodium channel	Epilepsy; Bipolar disorder	296, 345	F31, G40
T35135	Voltage-gated sodium channel	Multiple scierosis	340	G35
T35135	Voltage-gated sodium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T35232	Recombinant human interleukin-7	Multiple scierosis	340	G35
T35265	S100 calcium binding protein A4	Breast cancer	174, 175	C50
T35303	Pancreatic hormone ligand	Obesity	278	E66
T35474	mRNA of KRAS	Cancer	140-229	C00-C96
T35486	Ras GTPase	Cancer	140-229	C00-C96
T35486	Ras GTPase	Colorectal cancer; Pancreatic cancer	153, 154, 157	C18-C21, C25
T35486	Ras GTPase	Fallopian tube cancer; Metastatic head and neck cancer	140-149, 140-199, 140-229, 183, 210-229	C57.0, D28.2, C07-C14, C32-C33
T35486	Ras GTPase	Lung adenocarcinomas		C33-C34
T35486	Ras GTPase	Prostate cancer	185	C61
T35573	Various structural proteins including laminin and fibronectin	Symptomatic vitreomacular adhesion		H43
T35591	Nectin-4	Solid tumours	140-199, 210-229	C00-D48
T35640	Lymphocyte function-associated antigen 1	Allergic conjunctivitis	204.0, 372.0, 372.14, 995.3	C91.0, H10, H10.45, T78.4
T35640	Lymphocyte function-associated antigen 1	Autoimmune diabetes		E08-E13
T35640	Lymphocyte function-associated antigen 1	Dry eye disease	370.33	H16.229
T35640	Lymphocyte function-associated antigen 1	Human immunodeficiency virus infection	279.3	B20-B26
T35640	Lymphocyte function-associated antigen 1	Psoriasis	696	L40
T35640	Lymphocyte function-associated antigen 1	Renal transplantation	279.5	D89.8
T35734	Soluble epoxide hydrolase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T35734	Soluble epoxide hydrolase	Hypertension	401	I10-I16
T35842	Melanocyte stimulating hormone receptor	Atopic dermatitis	691.8, 692.9	L00-L99
T36049	Inducing anti-tumor immune responses by human lymphocyte	Breast cancer	174, 175	C50
T36059	Adenosine A3 receptor	Cancer	140-229	C00-C96
T36059	Adenosine A3 receptor	Cerebrovascular ischaemia	434.91	I61-I63
T36059	Adenosine A3 receptor	Glaucoma	365	H40-H42
T36059	Adenosine A3 receptor	Hepatocellular carcinoma; Hepatitis C virus infection	001-139, 070.4, 070.5, 070.70, 155, 573.3	A00-B99, B17.1, B18.2, C22.0, K75.9
T36059	Adenosine A3 receptor	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T36059	Adenosine A3 receptor	Ischemia	459.89	I99.8
T36059	Adenosine A3 receptor	Malaria		B54
T36075	Glucagon-like peptide 1 receptor	Brain injury		S09.90
T36075	Glucagon-like peptide 1 receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T36075	Glucagon-like peptide 1 receptor	Irritable bowel syndrome; Dyspepsia	536.8, 564.1	K30, K58
T36075	Glucagon-like peptide 1 receptor	Non-alcoholic steatohepatitis	571.8	K76.0
T36075	Glucagon-like peptide 1 receptor	Non-insulin dependent diabetes		E11.9
T36075	Glucagon-like peptide 1 receptor	Obesity	278	E66
T36075	Glucagon-like peptide 1 receptor	Type 1 diabetes	250	E10
T36075	Glucagon-like peptide 1 receptor	Type 1/2 diabetes	250, 278	E08-E13
T36075	Glucagon-like peptide 1 receptor	Type 2 diabetes	250	E11
T36075	Glucagon-like peptide 1 receptor	Unspecified		
T36098	Farnesyl pyrophosphatesynthetase	Bone disease		M00-M99
T36098	Farnesyl pyrophosphatesynthetase	Diabetes	253.5, 588.1	E23.2, N25.1
T36098	Farnesyl pyrophosphatesynthetase	Hypercalcemia	275.42	E83.5
T36098	Farnesyl pyrophosphatesynthetase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T36098	Farnesyl pyrophosphatesynthetase	Paget's disease	731	M88
T36467	Cytosine deaminase	Solid tumours	140-199, 210-229	C00-D48
T36483	Thrombin receptor	Acute coronary syndrome	444	I74
T36483	Thrombin receptor	Atherosclerosis	414.0, 440	I70
T36483	Thrombin receptor	Cancer	140-229	C00-C96
T36483	Thrombin receptor	Myocardial infarction	410	I21, I22
T36483	Thrombin receptor	Restenosis		I51.89
T36483	Thrombin receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T36557	Peroxisomeproliferator activated receptor delta	Atherosclerosis	414.0, 440	I70
T36557	Peroxisomeproliferator activated receptor delta	Central nervous system disease		G00-G99
T36557	Peroxisomeproliferator activated receptor delta	Dyslipidaemias	272	E78
T36557	Peroxisomeproliferator activated receptor delta	Dyslipidaemias; Hyperlipidaemia; Obesity	272, 272.0-272.4, 278	E78, E66
T36557	Peroxisomeproliferator activated receptor delta	Metabolic disease; Obesity	270-279, 278	E66, E70-E89
T36557	Peroxisomeproliferator activated receptor delta	Non-alcoholic fatty liver disease	571.8	K76.0
T36557	Peroxisomeproliferator activated receptor delta	Type 1 diabetes	250	E10
T36557	Peroxisomeproliferator activated receptor delta	Type 2 diabetes; Dyslipidemia	250, 250.00, 250.02, 272	E08-E13, E11, E78
T36658	Inhibiting sodium/calcium ion exchange	Cerebral infarction		I63
T36702	Recombinant tetravalent attenuated live dengue	Dengue fever	61	A90
T36806	Arginase II, mitochondrial	Trypanosoma brucei gambiense infection	86.5	B56
T36846	Improve mitochondrial function	Motor neurone disease	335.2	G12.2
T36909	Nicotinic ACh receptor	Alzheimer disease	331	G30
T36909	Nicotinic ACh receptor	Anesthesia	338	R20.0
T36909	Nicotinic ACh receptor	Asthma		J45
T36909	Nicotinic ACh receptor	Attention deficit hyperactivity disorder	314	F90
T36909	Nicotinic ACh receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T36909	Nicotinic ACh receptor	Multiple scierosis	340	G35
T36909	Nicotinic ACh receptor	Nicotine dependence	305.1	F17
T36909	Nicotinic ACh receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T36909	Nicotinic ACh receptor	Pollakiuria		R35
T36935	Prostate specific antigen	Prostate cancer	185	C61
T36935	Prostate specific antigen	Prostate hyperplasia		N40
T36935	Prostate specific antigen	Restenosis		I51.89
T36959	Activin receptor-like kinase-1	Cancer	140-229	C00-C96
T37046	Biliverdin reductase A	Primary biliary cirrhosis	571.6	K74.3
T37154	Cathepsin A	Diabetic complication		E08-E13
T37245	mRNA of HIF-1 responsive protein RTP801	Diabetic macular degeneration; Age-related macular degeneration	250, 362.01, 362.50, 362.53	E08-E13, H35.3, H35.8
T37298	mRNA of C-myc binding protein	Hepatocellular carcinoma	155	C22.0
T37308	Immunoglobulin E	Allergic diseases	995.3	T78.4
T37308	Immunoglobulin E	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T37308	Immunoglobulin E	Allergy	995.3	T78.4
T37308	Immunoglobulin E	Asthma		J45
T37308	Immunoglobulin E	Myasthenia gravis	358	G70.0
T37308	Immunoglobulin E	Rhinitis	472.0, 477	J00, J30, J31.0
T37405	Neuropeptide recptor	Type 1 diabetes	250	E10
T37434	Prominin 1	Cancer	140-229	C00-C96
T37510	Coagulation Factor Va	Severe sepsis; Cerebrovascular ischaemia	995.91, 434.91	A40-A41, I61-I63
T37539	B-cell receptor CD22	Acute lymphoblastic leukemia	204.0, 556	C91.0
T37539	B-cell receptor CD22	Aggressive non-hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C86, C82-C85, C91-C95
T37539	B-cell receptor CD22	Autoimmune diabetes		E08-E13
T37539	B-cell receptor CD22	Cancer	140-229	C00-C96
T37539	B-cell receptor CD22	Haematological malignancies	200-209	C81-C86
T37539	B-cell receptor CD22	Hematologic malignancies	200-209	C81-C86
T37539	B-cell receptor CD22	Hematological malignancies	200-209	C81-C86
T37539	B-cell receptor CD22	Lyme disease	88.81	A69.2
T37539	B-cell receptor CD22	Non-hodgkin's lymphoma; Diffuse large B-cell lymphoma	200, 200.0, 202	C82-C85, C83.3
T37539	B-cell receptor CD22	Systemic lupus erythematosus; Graft rejection in heart transplantation	695, 710.0, 996	L51-L54, M32, T86
T37693	Cannabinoid receptor 2	Atopic dermatitis	691.8, 692.9	L00-L99
T37693	Cannabinoid receptor 2	Immune disorder		D80-D89
T37693	Cannabinoid receptor 2	Inflammatory bowel disease	555, 556	K50, K51
T37693	Cannabinoid receptor 2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T37693	Cannabinoid receptor 2	Neuropathic pain	356.0, 356.8	G64, G90.0
T37693	Cannabinoid receptor 2	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T37693	Cannabinoid receptor 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T37693	Cannabinoid receptor 2	Rheumatoid arthritis	710-719, 714	M05-M06
T37735	Glutamate decarboxylase	Parkinson's disease	332	G20
T37742	Serum amyloid P-component	Amyloidosis	277.3	E85
T37742	Serum amyloid P-component	Parkinson's disease	332	G20
T37847	DNA polymerase	Acute lymphoblastic leukemia	204.0, 556	C91.0
T37847	DNA polymerase	Adult varicella zoster virus infection		B02
T37847	DNA polymerase	Cancer	140-229	C00-C96
T37847	DNA polymerase	Cytomegalovirus infection		B25
T37847	DNA polymerase	Cytomegalovirus retinitis	78.5	B25.8, H30.9
T37847	DNA polymerase	HBV infection	070.2-070.3	B16, B18.0, B18.1
T37847	DNA polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T37847	DNA polymerase	Herpes simplex virus infection	54	B00
T37847	DNA polymerase	Human immunodeficiency virus infection	279.3	B20-B26
T37847	DNA polymerase	Melanoma	172	C43
T37847	DNA polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T37876	Rhinovirus capsid	Rhinovirus infection		J20.6?
T37952	mRNA of SYK	Asthma		J45
T38052	Pyruvate:ferredoxin oxidoreductase	Diarrhea	787.91	A09, K59.1
T38159	Trefoil factor-1	Oral mucositis	528	K12.3
T38161	Induction of phospholipase A2 inhibitory proteins	Inflammation and pain associated with ocular surgery	338,780	R52, G89
T38179	Beta-lactamase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T38179	Beta-lactamase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T38179	Beta-lactamase	Infections	001-139	A00-B99
T38179	Beta-lactamase	Methicillin-resistant staphylococcus aureus infection		B95.62
T38179	Beta-lactamase	Multidrug resistant infection		A00-B99
T38179	Beta-lactamase	Otitis media		H65-H67
T38179	Beta-lactamase	Serious infections	001-139	A00-B99
T38179	Beta-lactamase	Streptococcus pneumoniae infection		J13
T38179	Beta-lactamase	Toxicity		T36-T50, T51-T65
T38179	Beta-lactamase	Unspecified		
T38301	Ribonucleoside-diphosphatereductase subunit M2	Cancer	140-229	C00-C96
T38301	Ribonucleoside-diphosphatereductase subunit M2	Chronic myelogenous leukaemia	205.1	C92.1
T38301	Ribonucleoside-diphosphatereductase subunit M2	Gastric cancer	151	C16
T38301	Ribonucleoside-diphosphatereductase subunit M2	Human immunodeficiency virus infection	279.3	B20-B26
T38301	Ribonucleoside-diphosphatereductase subunit M2	Nerve injury		T14.4
T38301	Ribonucleoside-diphosphatereductase subunit M2	Solid tumours	140-199, 210-229	C00-D48
T38338	Voltage-dependent N-type calcium channel	Neuropathic pain	356.0, 356.8	G64, G90.0
T38338	Voltage-dependent N-type calcium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T38338	Voltage-dependent N-type calcium channel	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
T38431	Calgranulin B	Lupus	710	M32
T38431	Calgranulin B	Metastatic prostate cancer	185	C61
T38449	meningococcal group B quadrivalent recombinant	Neisseria meningitidis infection	001-139, 041.5, 487, 488	A00-B99, A49.2, J10, J11
T38528	AdoHcy hydrolase	Arthritis	710-719	M00-M25
T38529	Prostaglandin E2receptor, EP2 subtype	Cancer	140-229	C00-C96
T38529	Prostaglandin E2receptor, EP2 subtype	Diabetic foot ulcer	707	L88-L89
T38529	Prostaglandin E2receptor, EP2 subtype	Endometriosis	617	N80
T38529	Prostaglandin E2receptor, EP2 subtype	Glaucoma	365	H40-H42
T38529	Prostaglandin E2receptor, EP2 subtype	Immune disorder		D80-D89
T38529	Prostaglandin E2receptor, EP2 subtype	Medical abortion	779.6	O04
T38529	Prostaglandin E2receptor, EP2 subtype	Miscarriage		O03
T38529	Prostaglandin E2receptor, EP2 subtype	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T38529	Prostaglandin E2receptor, EP2 subtype	Pulmonary arterial hypertension	416	I27.0, I27.2
T38529	Prostaglandin E2receptor, EP2 subtype	Solid tumours	140-199, 210-229	C00-D48
T38763	DNA RNA polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T38810	mRNA of Apolipoprotein A	Coronary artery disease	410-414, 429.2	I20-I25
T38875	AMP-activated protein kinase	Diabetes	253.5, 588.1	E23.2, N25.1
T38875	AMP-activated protein kinase	Fatty liver disease		K70, K76.0
T38875	AMP-activated protein kinase	Metabolic disorders	270-279	E70-E89
T38875	AMP-activated protein kinase	Non-insulin dependent diabetes		E11.9
T38875	AMP-activated protein kinase	Obesity	278	E66
T38875	AMP-activated protein kinase	Type 2 diabetes	250	E11
T38950	Myeloid cell surface antigen CD33	Acute myeloid leukemia	205	C92.0
T38950	Myeloid cell surface antigen CD33	Leukemia	208.9	C90-C95
T39031	Tumor antigen NGcGM3	Breast cancer	174, 175	C50
T39078	Calcium-activated potassium channel	Acute pain	338,780	R52, G89
T39078	Calcium-activated potassium channel	Scorpion envenoming syndrome	989.5	T63.2
T39087	HIV integrase	Human immunodeficiency virus infection	279.3	B20-B26
T39123	G-protein coupled receptor 54	Prostate cancer	185	C61
T39244	Inhibiting expression of interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor (TNF)	Ulcerative colitis	556	K51
T39321	Glyceraldehyde 3-phosphate dehydrogenase, muscle	Lateral sclerosis		G12.2
T39325	Lipid	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
T39523	Phosphodiesterase (PDE) 7A	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T39610	Calmodulin	Cardiac arrhythmias	427	I47-I49
T39610	Calmodulin	Malaria		B54
T39610	Calmodulin	Schizophrenia; Generalized non-psychotic anxiety		F20
T39644	Unspecified hormone	Cardiovascular disorder		I00-I99
T39664	17-beta-hydroxysteroid dehydrogenase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T39677	Bile-salt-activated lipase	Exocrine pancreatic insufficiency		K86.8
T39677	Bile-salt-activated lipase	Hypercholesterolemia		E78
T39677	Bile-salt-activated lipase	Pancreatic disease		K85-K86
T39677	Bile-salt-activated lipase	Type 2 diabetes	250	E11
T39716	Sodium channel protein type 5 subunit alpha	Anesthesia	338	R20.0
T39716	Sodium channel protein type 5 subunit alpha	Anesthesia; Hemorrhoids	338	R20.0, I84
T39716	Sodium channel protein type 5 subunit alpha	Angina pectoris	413	I20
T39716	Sodium channel protein type 5 subunit alpha	Arrhythmia	427	I47-I49
T39716	Sodium channel protein type 5 subunit alpha	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T39716	Sodium channel protein type 5 subunit alpha	Complex partial seizures	345.4	G40.2
T39716	Sodium channel protein type 5 subunit alpha	Cough	786.2	R05
T39716	Sodium channel protein type 5 subunit alpha	Dysrhythmias	427	I47-I49
T39716	Sodium channel protein type 5 subunit alpha	Epilepsy		G40
T39716	Sodium channel protein type 5 subunit alpha	Epilepsy; Convulsion		G40
T39716	Sodium channel protein type 5 subunit alpha	Heart arrhythmia		I47-I49
T39716	Sodium channel protein type 5 subunit alpha	Local anaesthetic		R20.0
T39716	Sodium channel protein type 5 subunit alpha	Migraine	346	G43
T39716	Sodium channel protein type 5 subunit alpha	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T39716	Sodium channel protein type 5 subunit alpha	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T39716	Sodium channel protein type 5 subunit alpha	Urinary incontinence	788.3	N39.3, N39.4, R32
T39716	Sodium channel protein type 5 subunit alpha	Ventricular arrhythmias	427.1	I47.2
T39716	Sodium channel protein type 5 subunit alpha	Ventricular tachycardia; Symptomatic premature ventricular beats; Ventricular fibrillation		I47.2
T39797	Frizzled-7 receptor	Solid tumours	140-199, 210-229	C00-D48
T39921	Heat shock protein 20	Asthma		J45
T39977	Macrophage migration inhibitory factor	Autoimmune diabetes		E08-E13
T39977	Macrophage migration inhibitory factor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T39977	Macrophage migration inhibitory factor	Refractory autoimmune diseases	279.4	D84.9, M35.9
T40000	Kallikrein 1	Respiratory disease		J00-J99
T40010	EGF-like domain-containing protein 7	Non-small-cell lung cancer; Metastatic colorectal cancer	140-199, 140-229, 153, 154, 162, 204.0, 210-229	C18-C21, C33, C33-C34, C34, C91.0, D10-D36, D3A
T40016	Glucocorticoid receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T40016	Glucocorticoid receptor	Anxiety disorder	300, 311	F32, F40-F42
T40016	Glucocorticoid receptor	Asthma		J45
T40016	Glucocorticoid receptor	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T40016	Glucocorticoid receptor	Asthma; Non-infectious rhinitis	472.0, 477, 493	J00, J30, J31.0, J45
T40016	Glucocorticoid receptor	Ataxia telangiectasia		G11.3
T40016	Glucocorticoid receptor	Atopic dermatitis	691.8, 692.9	L00-L99
T40016	Glucocorticoid receptor	Cancer	140-229	C00-C96
T40016	Glucocorticoid receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T40016	Glucocorticoid receptor	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J47, J45
T40016	Glucocorticoid receptor	Corticosteroid-responsive inflammation		
T40016	Glucocorticoid receptor	Cushing's disease	255	E24.0
T40016	Glucocorticoid receptor	Depression	311	F30-F39
T40016	Glucocorticoid receptor	Dermatitis	692.9	L20-L30
T40016	Glucocorticoid receptor	Dermatological disease		L00-L99
T40016	Glucocorticoid receptor	Duchenne muscular dystrophy		G71.0
T40016	Glucocorticoid receptor	Eczema		L20-L30
T40016	Glucocorticoid receptor	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T40016	Glucocorticoid receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T40016	Glucocorticoid receptor	Multiple scierosis	340	G35
T40016	Glucocorticoid receptor	Ocular disease		H00-H59
T40016	Glucocorticoid receptor	Otitis externa		H60
T40016	Glucocorticoid receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T40016	Glucocorticoid receptor	Rhinitis	472.0, 477	J00, J30, J31.0
T40016	Glucocorticoid receptor	Severe mood disorders	296	F30-F39
T40016	Glucocorticoid receptor	Skin allergies	995.3	T78.4
T40016	Glucocorticoid receptor	Spinal cord injury		S14, S24, S34
T40016	Glucocorticoid receptor	Xerophthalmia		E50.6-E50.7
T40045	mRNA of Ribonucleotide reductase R1 component	Solid tumours	140-199, 210-229	C00-D48
T40097	Mitogen-activated protein kinase 8	Brain injury		S09.90
T40097	Mitogen-activated protein kinase 8	Neurodegenerative disease	330-337	G30-G32
T40097	Mitogen-activated protein kinase 8	Solid tumours	140-199, 210-229	C00-D48
T40111	Inosine-5'-monophosphate dehydrogenase	Acute lymphoblastic leukemia	204.0, 556	C91.0
T40111	Inosine-5'-monophosphate dehydrogenase	Cancer	140-229	C00-C96
T40111	Inosine-5'-monophosphate dehydrogenase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T40111	Inosine-5'-monophosphate dehydrogenase	Hepatitis virus infection	573.3	K75.9
T40111	Inosine-5'-monophosphate dehydrogenase	Hyperuricemia; Transplant rejection	790.6, 279.5, 996	E79.0, D89.8, T86
T40111	Inosine-5'-monophosphate dehydrogenase	Psoriasis	696	L40
T40160	Phosphorylating and stabilizing p53 and increasing expression of the p53	Breast cancer	174, 175	C50
T40192	Nuclear factor kappa B p105 subunit	Cancer	140-229	C00-C96
T40192	Nuclear factor kappa B p105 subunit	Type 2 diabetes	250	E11
T40276	Protein kinase C, beta type	Brain cancer; Central nervous system tumors	191	C71
T40276	Protein kinase C, beta type	Cancer	140-229	C00-C96
T40276	Protein kinase C, beta type	Glioblastoma multiforme	191	C71
T40276	Protein kinase C, beta type	Lymphoma	202.8, 208.9	C81-C86
T40276	Protein kinase C, beta type	Non-hodgkin's lymphoma		C85
T40276	Protein kinase C, beta type	Renal transplantation	279.5	D89.8
T40332	Leukocyte elastase	Acute lung injury	518	J80
T40332	Leukocyte elastase	Acute lung injury; Acute respiratory distress syndrome	518.5, 518.82	J80
T40332	Leukocyte elastase	Acute lung injury; Acute respiratory distress syndrome; Cystic fibrosis	277.0, 518.5, 518.82, 709.2	E84, J80, L90.5
T40332	Leukocyte elastase	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T40332	Leukocyte elastase	Bronchiectasis	494, 748.61	J47, Q33.4
T40332	Leukocyte elastase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T40332	Leukocyte elastase	Cystic fibrosis	277	E84
T40332	Leukocyte elastase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T40332	Leukocyte elastase	Mucolytic		J00-J99
T40332	Leukocyte elastase	Myocardial infarction	410	I21, I22
T40332	Leukocyte elastase	Pulmonary disease	460-519	J00-J99
T40332	Leukocyte elastase	Pulmonary emphysema		J43
T40332	Leukocyte elastase	Rheumatoid arthritis	710-719, 714	M05-M06
T40332	Leukocyte elastase	Septic shock; Myocardial ischaemia-reperfusion injury; Acute respiratory distress syndrome	492, 518.5, 518.82, 785.52	A41.9, J43, J80
T40378	Coccidia schizogony and gametogony processes	Isosporiasis		A07.3
T40459	Interleukin-13 receptor alpha-2 chain	Asthma; Idiopathic pulmonary fibrosis; Alopecia areata; Ulcerative colitis; Atopic dermatitis		J45, J84.1, K51, L20
T40459	Interleukin-13 receptor alpha-2 chain	Brain cancer; Glioblastoma multiforme	191, 225.0	C71, D33
T40459	Interleukin-13 receptor alpha-2 chain	Ulcerative colitis	556	K51
T40474	Hepatocyte growth factor receptor	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T40474	Hepatocyte growth factor receptor	Cancer	140-229	C00-C96
T40474	Hepatocyte growth factor receptor	Chemotherapy-induced mucositis	528	K12.3
T40474	Hepatocyte growth factor receptor	Fibrosis	709.2	L90.5
T40474	Hepatocyte growth factor receptor	Heart disease	390-429	I00-I52
T40474	Hepatocyte growth factor receptor	Hepatocellular carcinoma	155	C22.0
T40474	Hepatocyte growth factor receptor	Liver disease	570-574	K70-K77
T40474	Hepatocyte growth factor receptor	Metastatic HER2-negative gastric cancer; Non-small cell lung cancer	140-229, 151	C16, C33-C34
T40474	Hepatocyte growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T40491	Protein phosphatase 2A	Cancer	140-229	C00-C96
T40492	Nonstructural protein NS3	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T40492	Nonstructural protein NS3	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T40492	Nonstructural protein NS3	Hepatitis virus infection	573.3	K75.9
T40492	Nonstructural protein NS3	Human immunodeficiency virus infection	279.3	B20-B26
T40492	Nonstructural protein NS3	Unspecified		
T40555	Hepatitis C virus NS5A protein	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T40556	Bromodomain-containing protein 4	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T40556	Bromodomain-containing protein 4	Alzheimer disease; Atherosclerosis	331, 414.0, 440	G30, I70
T40556	Bromodomain-containing protein 4	Cancer	140-229	C00-C96
T40556	Bromodomain-containing protein 4	Myelodysplastic syndrome	238.7	D46
T40663	Regulatory protein	Autoimmune diabetes		E08-E13
T40663	Regulatory protein	Bone marrow transplantation	279.5, 996	D89.8, T86
T40663	Regulatory protein	Graft-versus-host disease	279.5	T86.0
T40663	Regulatory protein	Melanoma; Type 1 diabetes	172, 250	C43, E10
T40694	Serine/threonine-protein kinase PLK1	Acute myeloid leukemia	205	C92.0
T40694	Serine/threonine-protein kinase PLK1	Advanced solid tumor; Non-hodgkin's lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C86, C82-C85, D10-D36, D3A
T40694	Serine/threonine-protein kinase PLK1	Cancer	140-229	C00-C96
T40694	Serine/threonine-protein kinase PLK1	Lymphoma	202.8, 208.9	C81-C86
T40694	Serine/threonine-protein kinase PLK1	Pancreatic cancer; Prostate cancer	157, 185	C25, C61
T40694	Serine/threonine-protein kinase PLK1	Solid tumours	140-199, 210-229	C00-D48
T40696	Topoisomerase IV	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T40696	Topoisomerase IV	Bacterial pneumonia		J13, J15
T40696	Topoisomerase IV	Methicillin-resistant staphylococcus aureus infection		B95.62
T40696	Topoisomerase IV	Mrsa infection	41.12	A49.02
T40696	Topoisomerase IV	Ocular inflammation	370.33	H16.229
T40696	Topoisomerase IV	Pneumonia		J12-J18
T40696	Topoisomerase IV	Respiratory tract infection	460-519	J00-J99
T40696	Topoisomerase IV	Respiratory tract inflammation		J00-J99
T40696	Topoisomerase IV	Unspecified		
T40696	Topoisomerase IV	Urinary tract infections	599	N39.0
T40785	1,3-Beta-Glucan synthase	Candidiasis infection	001-139, 112	B37
T40785	1,3-Beta-Glucan synthase	Fungal infections	110-118	B35-B49
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Anesthesia	338	R20.0
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Atrial fibrillation; Heart failure	427.31, 428.0	I48, I50
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Cancer	140-229	C00-C96
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Congestive cardiac insufficiency; Arrhythmias; Heart failure	427, 428	I47-I49, I50
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Congestive heart failure	428	I50
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Hyperhidrosis	780.8	R61
T40800	Sodium/potassium-transporting ATPase alpha-1 chain	Malaria		B54
T40870	Dystrophin pre-mRNA	Duchenne muscular dystrophy		G71.0
T40909	HRV 3C protease	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T40954	Xanthine dehydrogenase/oxidase	Encephalopathy		G93.4
T40954	Xanthine dehydrogenase/oxidase	Gout	274.00274.1274.8274.9	M10
T40954	Xanthine dehydrogenase/oxidase	Heart failure	428	I50
T40954	Xanthine dehydrogenase/oxidase	Hyperuricaemia in gout	274, 790.6	E79.0, M10
T40954	Xanthine dehydrogenase/oxidase	Hyperuricemia	790.6	E79.0
T41141	Cathepsin L	Coagulation		I80-I82
T41201	Dehydropeptidase I	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T41263	taste receptor	Cholera		A00
T41515	mRNA of FGFR4	Obesity	278	E66
T41560	mRNA of EGFR	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T41580	Alpha-2B adrenergic receptor	Alcohol use disorders	303	F10.2
T41580	Alpha-2B adrenergic receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T41750	Gastric inhibitory polypeptide receptor	Type 2 diabetes	250	E11
T41820	Fungi/Bacteria isoleucyl t-RNA synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T41820	Fungi/Bacteria isoleucyl t-RNA synthetase	Fungal infections	110-118	B35-B49
T41901	Bacterial 23S RNA of 50S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T41901	Bacterial 23S RNA of 50S ribosomal subunit	Human immunodeficiency virus infection	279.3	B20-B26
T41955	TRPM8 protein	Neuropathic pain	356.0, 356.8	G64, G90.0
T41955	TRPM8 protein	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T41955	TRPM8 protein	Solid tumours	140-199, 210-229	C00-D48
T41963	Toll-like receptor	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
T41963	Toll-like receptor	Non-small cell lung cancer		C33-C34
T42000	Interleukin-1 beta	Acute gout flare	274	M10
T42000	Interleukin-1 beta	Alzheimer disease	331	G30
T42000	Interleukin-1 beta	Arthritis	710-719	M00-M25
T42000	Interleukin-1 beta	Cancer	140-229	C00-C96
T42000	Interleukin-1 beta	Cardiovascular disorder		I00-I99
T42000	Interleukin-1 beta	Cryopyrin-associated periodic syndromes; Rheumatoid arthritis	277.31, 322.2, 339.8, 708.2, 708.8, 714.3, 710-719, 714	E85.0, G03.1, G44.8, L50.2, L50.8, M08.9, M05-M06
T42000	Interleukin-1 beta	Hypercalcemia	275.42	E83.5
T42000	Interleukin-1 beta	Immune disorder		D80-D89
T42000	Interleukin-1 beta	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T42000	Interleukin-1 beta	Motor neurone disease; Amyotropic lateral sclerosis	335.2	G12.2
T42000	Interleukin-1 beta	Opioid-related disorders; Diabetic neuropathy	250, 250.6, 292, 304.0, 305.50, 356.0, 356.8	E08-E13, E10.4, E11.4, E13.4, F11, G64, G90.0
T42000	Interleukin-1 beta	Osteoarthritis	715	M15-M19, M47
T42000	Interleukin-1 beta	Type 2 diabetes	250	E11
T42000	Interleukin-1 beta	Urticaria; Vasculitis	446, 447.6, 708	I77.6, I80, L50, L95, M30-M31
T42065	N-acetylmannosamine kinase	Myopathy		M60-M63
T42392	Glutamate receptor 2	Parkinson's disease	332	G20
T42446	Gamma-aminobutyric acid B receptor	Absence seizures		G40
T42446	Gamma-aminobutyric acid B receptor	Anxiety disorder	300, 311	F32, F40-F42
T42446	Gamma-aminobutyric acid B receptor	Cancer	140-229	C00-C96
T42446	Gamma-aminobutyric acid B receptor	Depression	311	F30-F39
T42446	Gamma-aminobutyric acid B receptor	Drug abuse	303-304	F10-F19
T42446	Gamma-aminobutyric acid B receptor	Fragile X syndrome	332, 759.83	F02.3, G20, Q99.2
T42446	Gamma-aminobutyric acid B receptor	Nicotine dependence	305.1	F17
T42446	Gamma-aminobutyric acid B receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T42446	Gamma-aminobutyric acid B receptor	Partial seizures	345.4, 345.5	G40.0, G40.2
T42446	Gamma-aminobutyric acid B receptor	Schizophrenia	295	F20
T42521	Shiga toxin 2 subunit B	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T42521	Shiga toxin 2 subunit B	Shiga toxin escherichia coli-induced haemolytic uraemic syndrome		D59.3
T42724	KCa3.1	Hematopoietic		D50-D89
T42748	The activation of 3 monoaminergic neural systems (serotonin, norepinephrine, and dopamine)	Depression	311	F30-F39
T42822	Ferrochelatase	Acne vulgaris	706.1	L70.0
T42867	NF-kB pathway	Fungal infections	110-118	B35-B49
T42867	NF-kB pathway	Lupus nephritis	583.81	M32.1, N08.5
T42882	Pseudomonas aeruginosa Psl exopolysaccharide	Pseudomonas infection		B96.5
T42882	Pseudomonas aeruginosa Psl exopolysaccharide	Ventilator-associated pneumonia		J95
T42928	FGF-21 ligand	Type 2 diabetes	250	E11
T43115	Leukocyte common antigen	Acute myeloid leukemia	205	C92.0
T43115	Leukocyte common antigen	Leukemia	208.9	C90-C95
T43115	Leukocyte common antigen	Lymphoma	202.8, 208.9	C81-C86
T43115	Leukocyte common antigen	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T43115	Leukocyte common antigen	Transplant rejection	279.5, 996	D89.8, T86
T43189	Tubulin	Actinic keratosis	702	L57.0
T43189	Tubulin	Acute gouty arthritis	274	M10
T43189	Tubulin	Advanced breast cancer	174, 175	C50
T43189	Tubulin	Advanced sarcomar		C96.4
T43189	Tubulin	Breast cancer	174, 175	C50
T43189	Tubulin	Breast cancer; Ovarian cancer	174, 175, 183	C50, C56
T43189	Tubulin	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
T43189	Tubulin	Cancer	140-229	C00-C96
T43189	Tubulin	Central nervous system disease		G00-G99
T43189	Tubulin	Immuno-suppressant		T86.0
T43189	Tubulin	Ovarian cancer	183	C56
T43189	Tubulin	Pancreatic cancer; Bladder cancer	188	C25, C67
T43189	Tubulin	Solid tumours	140-199, 210-229	C00-D48
T43332	Coagulation factor VII	Alzheimer disease	331	G30
T43332	Coagulation factor VII	Bleeding	444, 453	I74, I80-I82
T43332	Coagulation factor VII	Colorectal cancer	153, 154	C18-C21
T43332	Coagulation factor VII	Factor IX deficiency		D67
T43332	Coagulation factor VII	Factor VII deficiency		D68
T43332	Coagulation factor VII	Hemophilia	286	D66-D68
T43718	Toll-like receptor 5	Acute radiation syndrome	990	T66
T43721	Corticosteroid 11-beta-dehydrogenase, isozyme 2	Type 2 diabetes	250	E11
T43739	Voltage-gated sodium channel subunit alpha Nav1.8	Anesthesia	338	R20.0
T43739	Voltage-gated sodium channel subunit alpha Nav1.8	Asthma		J45
T43739	Voltage-gated sodium channel subunit alpha Nav1.8	Neuropathic pain	356.0, 356.8	G64, G90.0
T43739	Voltage-gated sodium channel subunit alpha Nav1.8	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T43739	Voltage-gated sodium channel subunit alpha Nav1.8	Spinal anesthesia	338	R20.0
T43760	Thyroid hormone receptor	Cardiovascular disorder		I00-I99
T43760	Thyroid hormone receptor	Dyslipidaemias	272	E78
T43760	Thyroid hormone receptor	Hypercholesterolemia		E78
T43760	Thyroid hormone receptor	Lipid metabolism disorder		E75-E78
T43830	5-hydroxytryptamine 2 receptor	Depression	311	F30-F39
T43830	5-hydroxytryptamine 2 receptor	Hypertension	401	I10-I16
T43881	Beta defensin 2	Unspecified		
T43902	Histamine release	Asthma		J45
T43920	Carbonic anhydrase	Hypertension; Congestive heart failure	401, 428	I10-I16, I50
T44008	Inducing a significant increase in cyclic AMP level	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T44068	Beta-1 adrenergic receptor	Acute supraventricular tachycardia	427.0, 427.89	I47.1
T44068	Beta-1 adrenergic receptor	Allergy; Sepsis	995.3, 995.91	T78.4, A40, A41
T44068	Beta-1 adrenergic receptor	Angina pectoris	413	I20
T44068	Beta-1 adrenergic receptor	Angina pectoris; Hypertension	413, 401	I20, I10-I16
T44068	Beta-1 adrenergic receptor	Bronchodilator	493	J45
T44068	Beta-1 adrenergic receptor	Cardiac arrhythmias	427	I47-I49
T44068	Beta-1 adrenergic receptor	Central and peripheral nervous diseases		G96.9
T44068	Beta-1 adrenergic receptor	Chronic open-angle glaucoma		H40
T44068	Beta-1 adrenergic receptor	Chronic open-angle glaucoma; Ocular hypertension		H40
T44068	Beta-1 adrenergic receptor	Circulatory disorders		I00-I99
T44068	Beta-1 adrenergic receptor	Coronary artery disease	410-414, 429.2	I20-I25
T44068	Beta-1 adrenergic receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T44068	Beta-1 adrenergic receptor	Glaucoma	365	H40-H42
T44068	Beta-1 adrenergic receptor	Heart failure	428	I50
T44068	Beta-1 adrenergic receptor	Heart failure; Cardiogenic shock	428.0, 785.51	I50, R57.0
T44068	Beta-1 adrenergic receptor	High blood pressure	401	I10-I16
T44068	Beta-1 adrenergic receptor	High blood pressure; Angina	401, 413	I10, I11, I12, I13, I15, I20
T44068	Beta-1 adrenergic receptor	Hypertension	401	I10-I16
T44068	Beta-1 adrenergic receptor	Hypertension; Angina	401, 413	I10-I16, I20
T44068	Beta-1 adrenergic receptor	Hypertension; Angina pectoris	401, 413	I10-I16, I20
T44068	Beta-1 adrenergic receptor	Hypertension; Heart arrhythmia	401	I10-I16, I47-I49
T44068	Beta-1 adrenergic receptor	Hypertension; Ventricular premature beats		I10-I16
T44068	Beta-1 adrenergic receptor	Maintenance of normal sinus rhythm	427	I46-I49
T44068	Beta-1 adrenergic receptor	Migraine	346	G43
T44068	Beta-1 adrenergic receptor	Open-angle glaucoma	365	H40-H42
T44068	Beta-1 adrenergic receptor	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
T44068	Beta-1 adrenergic receptor	Septic shock; Neurogenic shock	785, 785.52	R57.8, R65.21
T44068	Beta-1 adrenergic receptor	Ventricular fibrillation		I49.01
T44141	Angiopoietin-1	Breast cancer	174, 175	C50
T44141	Angiopoietin-1	Cancer	140-229	C00-C96
T44282	Aldehyde dehydrogenase, mitochondrial	Alcohol use disorders	303	F10.2
T44282	Aldehyde dehydrogenase, mitochondrial	Cerebrovascular ischaemia	434.91	I61-I63
T44282	Aldehyde dehydrogenase, mitochondrial	Substance dependence		F10-F19
T44351	Cannabinoid receptor	Autoimmune diabetes		E08-E13
T44479	Gap junction alpha-1 protein	Wound healing		T14.0-T14.1
T44589	Interleukin-3 receptor	Acute myeloid leukemia	205	C92.0
T44589	Interleukin-3 receptor	Acute myeloid leukemia; Blastic plasmacytoid dendritic cell neoplasm	205	C92.0, Q93.88
T44589	Interleukin-3 receptor	Asthma		J45
T44589	Interleukin-3 receptor	Immune disorder		D80-D89
T44614	Cysteine protease falcipain-2	Infection of P. falciparum 	84	B50-B54
T44682	Interleukin-22 ligand	Psoriasis	696	L40
T44771	mRNA of TGF beta-2 ligand	Brain cancer	191, 225.0	C71, D33
T44771	mRNA of TGF beta-2 ligand	Non-small cell lung cancer; Small-cell lung cancer	162.9	C33-C34
T44791	VEGF ligand	Age related macular degeneration	362.5	H35.3
T44791	VEGF ligand	Cancer	140-229	C00-C96
T44791	VEGF ligand	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
T44791	VEGF ligand	Macular degeneration	362.5	H35.3
T44861	Protein kinase C, delta type	Reperfusion injury and heart attacks; Acute myocardial infarction	410	I21, I21-I22, I22
T44862	CMV 65kDa lowermatrix phosphoprotein	Cytomegalovirus infection		B25
T45074	Carnitine acyltransferase	Diabetes	253.5, 588.1	E23.2, N25.1
T45074	Carnitine acyltransferase	Ischemia	459.89	I99.8
T45083	Tryptophan 5-hydroxylase	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T45151	Plasminogen activator inhibitor	Alzheimer disease	331	G30
T45151	Plasminogen activator inhibitor	Atherosclerosis	414.0, 440	I70
T45151	Plasminogen activator inhibitor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T45151	Plasminogen activator inhibitor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T45262	Corticotropin releasing factor receptor 1	Alcohol use disorders; Major depressive disorder	303, 296.2, 296.3, 710.0	F10.2, F32, F33, M32
T45262	Corticotropin releasing factor receptor 1	Anxiety disorder	300, 311	F32, F40-F42
T45262	Corticotropin releasing factor receptor 1	Anxiety disorder; Depression	300, 311	F30-F39, F40-F42
T45262	Corticotropin releasing factor receptor 1	Depression	311	F30-F39
T45262	Corticotropin releasing factor receptor 1	Depression; Anxiety	300, 311	F30-F39, F40-F42
T45262	Corticotropin releasing factor receptor 1	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T45262	Corticotropin releasing factor receptor 1	Major depressive disorder; Severe mood disorder	296, 296.2, 296.3	F30-F39, F32, F33
T45262	Corticotropin releasing factor receptor 1	Staphylococcus aureus infection		B95.6
T45457	Melanocortin receptor	Ulcerative colitis	556	K51
T45516	Cyclin D1 synthesis	Hematopoietic		D50-D89
T45518	Herpes simplex virus DNA polymerase	Unspecified		
T45591	Nucleophosmin	Cancer	140-229	C00-C96
T45593	Microtubule-associated protein tau	Alzheimer disease	331	G30
T45593	Microtubule-associated protein tau	Central nervous system disease		G00-G99
T45593	Microtubule-associated protein tau	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T45593	Microtubule-associated protein tau	Neurodegenerative disease	330-337	G30-G32
T45596	JNK pathway	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T45597	S6K kinase	Cancer	140-229	C00-C96
T45598	Interferon alpha ligand	Behcet's disease; Chronic obstructive pulmonary disease; Fibromyalgia	136.1, 490-492, 494-496, 729.1	M35.2, J40-J44, J47, M79.7
T45598	Interferon alpha ligand	Bladder cancer	188	C67
T45598	Interferon alpha ligand	Hairy cell leukemia	202.4	C91.4
T45598	Interferon alpha ligand	HBV infection	070.2-070.3	B16, B18.0, B18.1
T45598	Interferon alpha ligand	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T45598	Interferon alpha ligand	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T45598	Interferon alpha ligand	Hepatitis virus infection	573.3	K75.9
T45598	Interferon alpha ligand	Human immunodeficiency virus infection	279.3	B20-B26
T45598	Interferon alpha ligand	Systemic lupus erythematosus	710	M32
T45612	B7-H3	Glioblastoma multiforme	191	C71
T45612	B7-H3	Refractory metastatic solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T45737	Immunoglobulin alpha Fc receptor	Autoimmune diabetes		E08-E13
T45758	Tumor necrosisfactor receptor superfamily member 5	Autoimmune diabetes		E08-E13
T45758	Tumor necrosisfactor receptor superfamily member 5	Chronic lymphocytic leukaemia		C91
T45758	Tumor necrosisfactor receptor superfamily member 5	Rheumatoid arthritis	710-719, 714	M05-M06
T45758	Tumor necrosisfactor receptor superfamily member 5	Solid tumours	140-199, 210-229	C00-D48
T45758	Tumor necrosisfactor receptor superfamily member 5	Transplant rejection	279.5, 996	D89.8, T86
T45968	RING finger protein 43	Colorectal cancer	153, 154	C18-C21
T45993	Calcium channel	Allergy	995.3	T78.4
T45993	Calcium channel	Alzheimer disease	331	G30
T45993	Calcium channel	Angina pectoris	413	I20
T45993	Calcium channel	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T45993	Calcium channel	Cardiac arrhythmias	427	I47-I49
T45993	Calcium channel	Cardiovascular disorder		I00-I99
T45993	Calcium channel	Cerebral vasospasm	443.9	I73.9
T45993	Calcium channel	Cerebrovascular ischaemia	434.91	I61-I63
T45993	Calcium channel	Chronic stable angina	413	I20
T45993	Calcium channel	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T45993	Calcium channel	Colorectal cancer	153, 154	C18-C21
T45993	Calcium channel	Epilepsy		G40
T45993	Calcium channel	Glaucoma	365	H40-H42
T45993	Calcium channel	Heart arrhythmia		I47-I49
T45993	Calcium channel	Heart failure	428	I50
T45993	Calcium channel	High blood pressure; Angina	401, 413	I10, I11, I12, I13, I15, I20
T45993	Calcium channel	Hyperinsulinemia		E16.1
T45993	Calcium channel	Hypertension	401	I10-I16
T45993	Calcium channel	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T45993	Calcium channel	Nerve injury		T14.4
T45993	Calcium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T45993	Calcium channel	Psoriasis	696	L40
T45993	Calcium channel	Unspecified		
T46062	HCV replication enzyme	Hepatitis virus infection	573.3	K75.9
T46084	TNF related apoptosis inducing ligand	Brain cancer	191, 225.0	C71, D33
T46084	TNF related apoptosis inducing ligand	Indolent relapsed non-hodgkin's lymphoma; Metastatic non-small cell lung cancer; Metastatic colorectal cancer	140-229, 162, 200, 202, 202.8, 204.0, 153, 154	C33, C33-C34, C34, C81-C86, C82-C85, C91.0, C18-C21
T46084	TNF related apoptosis inducing ligand	Prostate cancer	185	C61
T46128	Melanocytes lineage-specific antigen GP100	Melanoma	172	C43
T46185	Muscarinic acetylcholine receptor M2	Alzheimer disease	331	G30
T46185	Muscarinic acetylcholine receptor M2	Asthma		J45
T46185	Muscarinic acetylcholine receptor M2	Cardiovascular disorder		I00-I99
T46185	Muscarinic acetylcholine receptor M2	Heart failure	428	I50
T46185	Muscarinic acetylcholine receptor M2	Nausea; Addiction	303-305, 787.0	F10-F19, R11
T46185	Muscarinic acetylcholine receptor M2	Parkinson's disease	332	G20
T46185	Muscarinic acetylcholine receptor M2	Peptic ulcer	531-534	K25-K27
T46185	Muscarinic acetylcholine receptor M2	Stabilize muscle contractions		M00-M99
T46185	Muscarinic acetylcholine receptor M2	Unspecified		
T46185	Muscarinic acetylcholine receptor M2	Urinary incontinence	788.3	N39.3, N39.4, R32
T46245	Glutaminyl cyclase	Dementia	290-294	F01-F07
T46263	Solute carrier family 3 member2	Acute myeloid leukemia	205	C92.0
T46360	Sigma(1)-type opioid receptor	Aging skin		L00-L99
T46360	Sigma(1)-type opioid receptor	Alzheimer disease	331	G30
T46360	Sigma(1)-type opioid receptor	Anxiety disorder	300, 311	F32, F40-F42
T46360	Sigma(1)-type opioid receptor	Brain injury		S09.90
T46360	Sigma(1)-type opioid receptor	Breast cancer	174, 175	C50
T46360	Sigma(1)-type opioid receptor	Central nervous system disease		G00-G99
T46360	Sigma(1)-type opioid receptor	Cough; Pain	338, 786.2,780	R05, R52, G89
T46360	Sigma(1)-type opioid receptor	Drug abuse	303-304	F10-F19
T46360	Sigma(1)-type opioid receptor	Dry cough		R05
T46360	Sigma(1)-type opioid receptor	Excessive daytime sleepiness	291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54	F51.1, G47.1
T46360	Sigma(1)-type opioid receptor	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
T46360	Sigma(1)-type opioid receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T46360	Sigma(1)-type opioid receptor	Melanoma; Prostate cancer; Pancreatic cancer	140-229, 157, 172, 185	C25, C43, C61
T46360	Sigma(1)-type opioid receptor	Mood disorder		F30-F39
T46360	Sigma(1)-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T46360	Sigma(1)-type opioid receptor	Peptic ulcer	531-534	K25-K27
T46360	Sigma(1)-type opioid receptor	Pollakiuria		R35
T46360	Sigma(1)-type opioid receptor	Psychotic disorders	290-299	F20-F29
T46360	Sigma(1)-type opioid receptor	Schizophrenia	295	F20
T46365	M-phase inducer phosphatase 2	Cancer	140-229	C00-C96
T46456	Retinoic acid receptor RXR-gamma	Cancer	140-229	C00-C96
T46456	Retinoic acid receptor RXR-gamma	Diabetes	253.5, 588.1	E23.2, N25.1
T46456	Retinoic acid receptor RXR-gamma	Night blindness	368.6	H53.6
T46456	Retinoic acid receptor RXR-gamma	Prostate cancer	185	C61
T46479	Bacteria corynebacterium diphtheriae	Clostridium infection	001-139	A00-B99
T46482	Toll-like receptor 7	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T46482	Toll-like receptor 7	Asthma		J45
T46482	Toll-like receptor 7	Autoimmune diabetes		E08-E13
T46482	Toll-like receptor 7	Bladder cancer	188	C67
T46482	Toll-like receptor 7	Cancer	140-229	C00-C96
T46482	Toll-like receptor 7	HBV infection	070.2-070.3	B16, B18.0, B18.1
T46482	Toll-like receptor 7	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T46482	Toll-like receptor 7	Immuno-modulator	135, 691.8, 692.9, 710-719, 714	D86, L20, L20-L30, M00-M25, M05-M06
T46482	Toll-like receptor 7	Immuno-stimulant		C00-C97
T46482	Toll-like receptor 7	Malaria		B54
T46482	Toll-like receptor 7	Skin cancers	172, 173	C43, C44
T46482	Toll-like receptor 7	Systemic lupus erythematosus	710	M32
T46521	mRNA of androgen receptor	Acne vulgaris	706.1	L70.0
T46521	mRNA of androgen receptor	Prostate cancer	185	C61
T46524	TWEAK ligand	Rheumatoid arthritis	710-719, 714	M05-M06
T46524	TWEAK ligand	Solid tumours	140-199, 210-229	C00-D48
T46616	Botulinum toxin A	Acne vulgaris	706.1	L70.0
T46616	Botulinum toxin A	Clostridium infection	001-139	A00-B99
T46628	Microsomal triglyceride transfer protein, large subunit	Arteriosclerosis	440	I70
T46628	Microsomal triglyceride transfer protein, large subunit	Diabetes; Dyslipidaemias; Hyperlipidaemia	253.5, 588.1, 272, 272.0-272.4	E23.2, N25.1, E78
T46628	Microsomal triglyceride transfer protein, large subunit	Familial hypercholesterolemia	272	E78.0
T46628	Microsomal triglyceride transfer protein, large subunit	Hyperlipidaemia	272.0-272.4	E78
T46628	Microsomal triglyceride transfer protein, large subunit	Kidney disorders		N00-N39
T46628	Microsomal triglyceride transfer protein, large subunit	Type 2 diabetes	250	E11
T46642	Arachidonate 5-lipoxygenaseactivating protein	Allergy	995.3	T78.4
T46642	Arachidonate 5-lipoxygenaseactivating protein	Asthma		J45
T46642	Arachidonate 5-lipoxygenaseactivating protein	Cardiovascular disorder		I00-I99
T46658	Mediator release	Asthma		J45
T46743	HV MAG pDNA	Human immunodeficiency virus infection	279.3	B20-B26
T46781	Aurora kinase B	Acute myeloid leukemia	205	C92.0
T46781	Aurora kinase B	Hematological malignancies	200-209	C81-C86
T46781	Aurora kinase B	Solid tumours	140-199, 210-229	C00-D48
T46828	D(1B) dopamine receptor	Schizophrenia	295	F20
T46828	D(1B) dopamine receptor	Solid tumours	140-199, 210-229	C00-D48
T46871	SH2 domain inositol phosphatase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T46904	Secretin receptor	Gastrinoma; Pancreatic exocrine dysfunction diagnosis	157.4, 577.8	D37.9, C25.4, K86.8
T46937	P2Y purinoceptor 12	Acute coronary syndrome	444	I74
T46937	P2Y purinoceptor 12	Arterial thrombosis; Myocardial infarction	437.6, 453, 671.5, 671.9, 410	I80-I82, I21, I22
T46937	P2Y purinoceptor 12	Cardiovascular disorder		I00-I99
T46937	P2Y purinoceptor 12	Myocardial infarction	410	I21, I22
T46937	P2Y purinoceptor 12	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T46937	P2Y purinoceptor 12	Unspecified		
T47077	Prostanoid receptor	Alopecia	704.09	L65.9
T47077	Prostanoid receptor	Cancer	140-229	C00-C96
T47077	Prostanoid receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T47077	Prostanoid receptor	Glaucoma	365	H40-H42
T47077	Prostanoid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T47077	Prostanoid receptor	Pneumonia		J12-J18
T47077	Prostanoid receptor	Psoriasis	696	L40
T47077	Prostanoid receptor	Scar tissue		L00-L99
T47077	Prostanoid receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T47087	mRNA of E1 region of human papillomavirus	Cancer	140-229	C00-C96
T47094	Substance-P receptor	Alcohol use disorders	303	F10.2
T47094	Substance-P receptor	Asthma		J45
T47094	Substance-P receptor	Brain injury		S09.90
T47094	Substance-P receptor	Cancer pain	140-229, 338,780	R52, G89
T47094	Substance-P receptor	Chemotherapy-induced nausea	787, 787.0	R11
T47094	Substance-P receptor	Cough	786.2	R05
T47094	Substance-P receptor	Depression	311	F30-F39
T47094	Substance-P receptor	Depression; Anxiety	300, 311	F30-F39, F40-F42
T47094	Substance-P receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T47094	Substance-P receptor	Eczema		L20-L30
T47094	Substance-P receptor	Emesis	787	R11
T47094	Substance-P receptor	Emesis; Irritable bowel syndrome	564.1, 787	K58, R11
T47094	Substance-P receptor	Incontinence; Anxiety disorder; Chemotherapyinduced emesis; Major depressive disorder	296.2, 296.3, 300, 787, 787.6, 788.3	F32, F33, F40-F42, N39.3-N39.4
T47094	Substance-P receptor	Influenza virus		J11.1
T47094	Substance-P receptor	Irritable bowel syndrome; Chemo therapy induced emesis; Gastric motility disorder	536.8, 564.1, 787	K30, K58, R11
T47094	Substance-P receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T47094	Substance-P receptor	Migraine	346	G43
T47094	Substance-P receptor	Mood disorder		F30-F39
T47094	Substance-P receptor	Nausea; Vomiting	787, 787.0	R11
T47094	Substance-P receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
T47094	Substance-P receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T47094	Substance-P receptor	Respiratory tract inflammation		J00-J99
T47094	Substance-P receptor	Schizophrenia	295	F20
T47094	Substance-P receptor	Severe mood disorders; Depression	296, 311	F30-F39, F32
T47094	Substance-P receptor	Unspecified		
T47094	Substance-P receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T47101	Basic fibroblast growth factor receptor 1	Cancer	140-229	C00-C96
T47101	Basic fibroblast growth factor receptor 1	Dermatological disease		L00-L99
T47101	Basic fibroblast growth factor receptor 1	Endometrial cancer	182	C54.1
T47101	Basic fibroblast growth factor receptor 1	Lymphoma	202.8, 208.9	C81-C86
T47101	Basic fibroblast growth factor receptor 1	Peripheral arterial occlusive disease		I73.9
T47101	Basic fibroblast growth factor receptor 1	Severe coronary heart disease	414	I25.1
T47101	Basic fibroblast growth factor receptor 1	Solid tumours	140-199, 210-229	C00-D48
T47101	Basic fibroblast growth factor receptor 1	Unspecified		
T47164	MST-1 protein kinase	Ischemic heart diseases	410-414	I20-I25
T47165	Neural cell adhesion molecule	Alzheimer disease	331	G30
T47165	Neural cell adhesion molecule	Cancer	140-229	C00-C96
T47165	Neural cell adhesion molecule	Solid tumours	140-199, 210-229	C00-D48
T47215	CCK receptor	Obesity	278	E66
T47387	mRNA of BCL-2	Cancer	140-229	C00-C96
T47387	mRNA of BCL-2	Leukemia	208.9	C90-C95
T47387	mRNA of BCL-2	Lymphoma	202.8, 208.9	C81-C86
T47415	HLA class I antigen B-7	Melanoma	172	C43
T47466	Porphobilinogen deaminase	Porphyria	277.1	E80.0-E80.2
T47610	Interleukin-11 receptor alpha chain	Prostate cancer	185	C61
T47610	Interleukin-11 receptor alpha chain	Severe thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T47610	Interleukin-11 receptor alpha chain	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T47623	Heparanase	Angiogenesis disorder		I00-I99
T47623	Heparanase	Ocular disease		H00-H59
T47768	Mu-type opioid receptor	Analgesia	338	R52, G89
T47768	Mu-type opioid receptor	Anesthesia	338	R20.0
T47768	Mu-type opioid receptor	Asthma		J45
T47768	Mu-type opioid receptor	Cancer pain	140-229, 338,780	R52, G89
T47768	Mu-type opioid receptor	Chronic pain	338.2,780	R52.1-R52.2, G89
T47768	Mu-type opioid receptor	Constipation	564	K59.0
T47768	Mu-type opioid receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T47768	Mu-type opioid receptor	Diarrhea	787.91	A09, K59.1
T47768	Mu-type opioid receptor	Gastrointestinal disease		K00-K93
T47768	Mu-type opioid receptor	Gastrointestinal disease; Pain	338, 356.0, 356.8, 780	K00-K93, G64, G90.0, R52, G89
T47768	Mu-type opioid receptor	General anesthesia	338	R20.0
T47768	Mu-type opioid receptor	Headache	339, 784.0	G43-G44, R51
T47768	Mu-type opioid receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T47768	Mu-type opioid receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T47768	Mu-type opioid receptor	Migraine	346	G43
T47768	Mu-type opioid receptor	Mild pain		R52, G89
T47768	Mu-type opioid receptor	Moderate-to-severe acute pain	338,780	R52, G89
T47768	Mu-type opioid receptor	Movement disorder		R25
T47768	Mu-type opioid receptor	Narcotic depression	304.9, 311	F19.20, F32
T47768	Mu-type opioid receptor	Non-small cell lung cancer		C33-C34
T47768	Mu-type opioid receptor	Obesity	278	E66
T47768	Mu-type opioid receptor	Opiate dependence	304	F11
T47768	Mu-type opioid receptor	Opioid-induced constipation	564	K59.0
T47768	Mu-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T47768	Mu-type opioid receptor	Systemic pain		R52, G89
T47768	Mu-type opioid receptor	Unspecified		
T47768	Mu-type opioid receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T47863	Tumor-associated calcium signal transducer 1	Cancer	140-229	C00-C96
T47863	Tumor-associated calcium signal transducer 1	Colorectal cancer	153, 154	C18-C21
T47863	Tumor-associated calcium signal transducer 1	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T47864	Teratocarcinoma-derived growth factor 1	Solid tumours	140-199, 210-229	C00-D48
T47885	Protein kinase D	Cancer	140-229	C00-C96
T47885	Protein kinase D	Renal disease		N00-N29
T47888	Sphingosine-1-phosphate receptor-2	Hypertension	401	I10-I16
T47941	PDE4	Asthma		J45
T47941	PDE4	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T47941	PDE4	Atopic dermatitis	691.8, 692.9	L00-L99
T47941	PDE4	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T47941	PDE4	Emphysema; Bronchitis; Chronic obstructive pulmonary disease	460-519, 466, 490, 490-492, 491, 492, 494-496	J00-J99, J20-J21, J40-J44, J42, J43, J47
T47941	PDE4	Psoriasis	696	L40
T47941	PDE4	Unspecified		
T48069	Insulin-like growth factor I receptor	Breast cancer	174, 175	C50
T48069	Insulin-like growth factor I receptor	Cancer	140-229	C00-C96
T48069	Insulin-like growth factor I receptor	Colorectal cancer	153, 154	C18-C21
T48069	Insulin-like growth factor I receptor	Graves' ophthalmopathy		H06.2
T48069	Insulin-like growth factor I receptor	Growth failure		R62.8
T48069	Insulin-like growth factor I receptor	Hepatocellular carcinoma; Non-small cell lung cancer	155	C22.0, C33-C34
T48069	Insulin-like growth factor I receptor	Hormone deficiency		E00-E90
T48069	Insulin-like growth factor I receptor	Liver cancer; Non-small cell lung cancer	140-229, 155, 203.0	C22, C33-C34
T48069	Insulin-like growth factor I receptor	Malignant adrenal gland cancer		C74.0
T48069	Insulin-like growth factor I receptor	Motor neurone disease	335.2	G12.2
T48069	Insulin-like growth factor I receptor	Multiple myeloma	203	C90
T48069	Insulin-like growth factor I receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T48069	Insulin-like growth factor I receptor	Solid tumours	140-199, 210-229	C00-D48
T48195	Interleukin-8 receptor	Unspecified		
T48268	Melatonin receptor type 1B	Epilepsy		G40
T48429	Interleukin-15 receptor subunit alpha	Cancer	140-229	C00-C96
T48457	Complement receptor type 1	Macular degeneration	362.5	H35.3
T48470	Hormone	Inflammatory bowel disease	555, 556	K50, K51
T48470	Hormone	Multiple scierosis	340	G35
T48472	70S prokaryotic ribosome	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T48472	70S prokaryotic ribosome	Mycobacterium tuberculosis infection		A15-A19
T48703	Toll-like receptor 8	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T48703	Toll-like receptor 8	Allergy	995.3	T78.4
T48703	Toll-like receptor 8	Autoimmune diabetes		E08-E13
T48703	Toll-like receptor 8	Diffuse large B-cell lymphoma	200	C83.3
T48703	Toll-like receptor 8	Herpes simplex virus infection	54	B00
T48703	Toll-like receptor 8	Systemic lupus erythematosus	710	M32
T48873	Synaptic vesicle amine transporter	Alzheimer disease	331	G30
T48873	Synaptic vesicle amine transporter	Chorea associated with huntington's disease		G10
T48873	Synaptic vesicle amine transporter	High blood pressure	401	I10-I16
T48873	Synaptic vesicle amine transporter	Huntington's disease; Hyperkinetic movement disorder	294.1, 333.4, 333	F02.2, G10, G20-G26
T48873	Synaptic vesicle amine transporter	Hypertension	401	I10-I16
T48873	Synaptic vesicle amine transporter	Movement disorder		R25
T48873	Synaptic vesicle amine transporter	Substance dependence		F10-F19
T48873	Synaptic vesicle amine transporter	Tardive dyskinesia		G24
T48940	HIF prolyl hydroxylase	Anemia	280-285	D50-D64
T48940	HIF prolyl hydroxylase	Anemia; Kidney disease	280-285, 580-589	D50-D64, N00-N29
T48940	HIF prolyl hydroxylase	Fungal infections	110-118	B35-B49
T48945	mRNA of Telomerase reverse transcriptase	Tumors	140-199, 210-229	C00-D48
T49040	Activating key enzymes to regulate glucose metabolism	Metabolic disorders	270-279	E70-E89
T49064	Gastric triacylglycerol lipase	Diabetes; Obesity	250, 278	E08-E13, E66
T49072	Urotensin II receptor	Asthma		J45
T49072	Urotensin II receptor	Diabetic nephropathy	250.4	E11.21
T49072	Urotensin II receptor	Renal failure	584, 585	N17, N18, N19
T49146	HLA class II antigen	Influenza virus		J11.1
T49146	HLA class II antigen	Leukemia	208.9	C90-C95
T49327	ATP-binding cassette sub-family A member 4 (ABCA4)	Retinitis pigmentosa		H35.5
T49453	Notch receptor	Lymphoma	202.8, 208.9	C81-C86
T49493	Hemoglobin	Alopecia	704.09	L65.9
T49493	Hemoglobin	Anemia	280-285	D50-D64
T49493	Hemoglobin	Beta thalassemia		D56.1
T49493	Hemoglobin	Blood forming organ disorders		D75.9
T49493	Hemoglobin	Blood transfusion		D50-D89
T49493	Hemoglobin	Cardiovascular disorder		I00-I99
T49493	Hemoglobin	Cerebrovascular ischaemia	434.91	I61-I63
T49493	Hemoglobin	Chronic myelogenous leukaemia	205.1	C92.1
T49493	Hemoglobin	Hematopoietic		D50-D89
T49493	Hemoglobin	Hypotension	458, 796.3	I95
T49493	Hemoglobin	Iron deficiency anaemia		D50
T49493	Hemoglobin	Iron overload		R79.0
T49493	Hemoglobin	Iron-deficiency anemia	280	D50
T49493	Hemoglobin	Liver cancer	140-229, 155, 203.0	C22
T49493	Hemoglobin	Lung cancer	162	C33-C34
T49493	Hemoglobin	Reperfusion injury		I00-I99
T49507	Ephrin type-B receptor 4	Cancer	140-229	C00-C96
T49507	Ephrin type-B receptor 4	Late-stage non-small cell lung cancer	162, 203.0, 208.9	C33-C34
T49520	Typhoid	Mycobacterium tuberculosis infection		A15-A19
T49526	Potassium voltage-gated channel subfamily KQT member 1	Hypertension	401	I10-I16
T49571	Aminotransferase	Liver disease	570-574	K70-K77
T49578	Transient receptor potential channel	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T49630	Lectin-like oxidized ldl receptor	Arteriosclerosis	440	I70
T49639	Heat shock protein 70	Amyotrophic lateral sclerosis	335.2	G12.2
T49639	Heat shock protein 70	Cancer	140-229	C00-C96
T49639	Heat shock protein 70	Diabetes	253.5, 588.1	E23.2, N25.1
T49639	Heat shock protein 70	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T49639	Heat shock protein 70	Gastrointestinal cancers	150-159	C15-C26
T49639	Heat shock protein 70	Herpes simplex virus infection	54	B00
T49639	Heat shock protein 70	Leukemia	208.9	C90-C95
T49639	Heat shock protein 70	Metastasis		C00-C97
T49689	rhIgG1k	Sickle-cell disease	282.6	D57
T49736	CD6	Type 1 diabetes	250	E10
T49814	Bacterial DNA	Amebiasis	6	A06
T49814	Bacterial DNA	Blastomycosis	116	B40
T49814	Bacterial DNA	Crohn's disease	555	K50
T49814	Bacterial DNA	Diarrhea	787.91	A09, K59.1
T49833	Increasing unstimulated AM release of both TNF and IL-10	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T49882	HIV maturation	HIV-1 infection	001-139, 042	B20-B24
T49898	Cell division control protein 2 homolog	Breast cancer	174, 175	C50
T49898	Cell division control protein 2 homolog	Cancer	140-229	C00-C96
T49898	Cell division control protein 2 homolog	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T49989	TGF-beta type II receptor	Cancer	140-229	C00-C96
T49989	TGF-beta type II receptor	Wound healing		T14.0-T14.1
T50066	Chloride channel protein 2	Alopecia	704.09	L65.9
T50066	Chloride channel protein 2	Chronic idiopathic constipation	564	K59
T50089	Sphingosine 1-phosphate receptor 5	Multiple scierosis	340	G35
T50444	Connective tissue growth factor	Diabetic nephropathy	250.4	E11.21
T50444	Connective tissue growth factor	Fibrosis	709.2	L90.5
T50444	Connective tissue growth factor	Type 2 diabetes; Idiopathic pulmonary fibrosis	250, 250.00, 250.02, 515, 516.3, 709.2	E08-E13, E11, J84.1, L90.5
T50461	Ribonuclease	Acute promyelocytic leukemia	205	C92.4
T50461	Ribonuclease	Cancer	140-229	C00-C96
T50461	Ribonuclease	Cervical cancer	180	C53
T50461	Ribonuclease	HIV-1 infection	001-139, 042	B20-B24
T50461	Ribonuclease	Lung cancer	162	C33-C34
T50584	Bactericidal permeability-increasing protein	Acne vulgaris	706.1	L70.0
T50594	Proto-oncogene pim-1	Cancer	140-229	C00-C96
T50688	Glycoprotein IIb/IIIa receptor	Acute cardiac ischemic events	410	I21, I22
T50688	Glycoprotein IIb/IIIa receptor	Acute coronary syndrome	444	I74
T50688	Glycoprotein IIb/IIIa receptor	Angina pectoris	413	I20
T50688	Glycoprotein IIb/IIIa receptor	Angiogenesis disorder		I00-I99
T50688	Glycoprotein IIb/IIIa receptor	Arterial thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T50688	Glycoprotein IIb/IIIa receptor	Arteriosclerosis	440	I70
T50688	Glycoprotein IIb/IIIa receptor	Cardiovascular disorder		I00-I99
T50688	Glycoprotein IIb/IIIa receptor	Coronary artery disease	410-414, 429.2	I20-I25
T50688	Glycoprotein IIb/IIIa receptor	Embolism		I74, I82
T50688	Glycoprotein IIb/IIIa receptor	Restenosis		I51.89
T50688	Glycoprotein IIb/IIIa receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T50688	Glycoprotein IIb/IIIa receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T50688	Glycoprotein IIb/IIIa receptor	Unspecified		
T50699	Lymphotoxin beta receptor	Cancer	140-229	C00-C96
T50699	Lymphotoxin beta receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T50823	Semaphorin-4D	Multiple scierosis	340	G35
T50918	Muscarinic acetylcholine receptor M5	Acquired nystagmus	379.5	H55
T50918	Muscarinic acetylcholine receptor M5	Alzheimer disease	331	G30
T50918	Muscarinic acetylcholine receptor M5	Bronchodilator	493	J45
T50918	Muscarinic acetylcholine receptor M5	Central and peripheral nervous diseases		G96.9
T50918	Muscarinic acetylcholine receptor M5	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T50918	Muscarinic acetylcholine receptor M5	Cough	786.2	R05
T50918	Muscarinic acetylcholine receptor M5	Depression	311	F30-F39
T50918	Muscarinic acetylcholine receptor M5	Dysuria; Urgency; Nocturia; Suprapubic pain		R300, R35
T50918	Muscarinic acetylcholine receptor M5	Gastric motility disorder; Spasm	728.85	K22.4, R25.2
T50918	Muscarinic acetylcholine receptor M5	Gastrointestinal disease		K00-K93
T50918	Muscarinic acetylcholine receptor M5	Glaucoma	365	H40-H42
T50918	Muscarinic acetylcholine receptor M5	Hypertension	401	I10-I16
T50918	Muscarinic acetylcholine receptor M5	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T50918	Muscarinic acetylcholine receptor M5	Moderate and severe psychomotor agitation		
T50918	Muscarinic acetylcholine receptor M5	Organophosphate poisoning	989.3	T60.0
T50918	Muscarinic acetylcholine receptor M5	Overactive bladder disorder; Spasm	188, 596.51, 728.85	C67, N32.81, R25.2
T50918	Muscarinic acetylcholine receptor M5	Parkinson's disease	332	G20
T50918	Muscarinic acetylcholine receptor M5	Peptic ulcer	531-534	K25-K27
T50918	Muscarinic acetylcholine receptor M5	Peptic ulcer disease; Irritable bowel syndrome; Pancreatitis; Gastritis		K58, K85, K86, K29.0-K29.7
T50918	Muscarinic acetylcholine receptor M5	Peptic ulcer; Gastrointestinal disease	531-534	K25-K27, K00-K93
T50918	Muscarinic acetylcholine receptor M5	Peptic ulcer; Uveitis	531-534, 364	K25-K27, H20
T50918	Muscarinic acetylcholine receptor M5	Poison intoxication		T36-T50
T50918	Muscarinic acetylcholine receptor M5	Produce mydriasis and cycloplegia for diagnostic purposes		H57.04
T50918	Muscarinic acetylcholine receptor M5	Solid tumours	140-199, 210-229	C00-D48
T50918	Muscarinic acetylcholine receptor M5	Urinary retention	788.2	R33
T50942	Tumor necrosis factor receptor superfamily member 16	Alzheimer disease	331	G30
T50942	Tumor necrosis factor receptor superfamily member 16	Arthralgia; Back pain; Cancer pain	724.5, 338, 780, 140-229	M25.5, M54, G89, R52
T50942	Tumor necrosis factor receptor superfamily member 16	Cerebrovascular ischaemia	434.91	I61-I63
T50942	Tumor necrosis factor receptor superfamily member 16	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T50942	Tumor necrosis factor receptor superfamily member 16	Cystitis		N30
T50942	Tumor necrosis factor receptor superfamily member 16	Motor neurone disease	335.2	G12.2
T50942	Tumor necrosis factor receptor superfamily member 16	Neurodegenerative disease	330-337	G30-G32
T50942	Tumor necrosis factor receptor superfamily member 16	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T50942	Tumor necrosis factor receptor superfamily member 16	Parkinson's disease	332	G20
T50942	Tumor necrosis factor receptor superfamily member 16	Unspecified		
T51038	Subcutaneous fluid administration for achieving hydration	Cancer	140-229	C00-C96
T51038	Subcutaneous fluid administration for achieving hydration	Resorption of radiopaque agents		W88
T51076	Trk receptor	Solid tumours	140-199, 210-229	C00-D48
T51115	Voltage-dependent L-type calcium channel subunit alpha-1C	Angina pectoris	413	I20
T51115	Voltage-dependent L-type calcium channel subunit alpha-1C	Cardiac failure		I50
T51115	Voltage-dependent L-type calcium channel subunit alpha-1C	Heart arrhythmia		I47-I49
T51120	Thyroid peroxidase	Hyperthyroidism	242	E05
T51120	Thyroid peroxidase	Hyperthyroidism; Alcoholic hepatitis	242, 571.1	E05, K70.1
T51120	Thyroid peroxidase	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T51146	CD15	Appendicitis		K35
T51171	Peptidylprolyl isomerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T51191	Histone deacetylase 2	Dermatitis	692.9	L20-L30
T51209	Clostridium difficile toxoid	Traveler's diarrhea	001-139, 787.91	A00-B99, A09, K59.1
T51223	IL-21	Autoimmune diabetes		E08-E13
T51223	IL-21	Colorectal cancer	153, 154	C18-C21
T51407	Exportin-1	Cancer	140-229	C00-C96
T51407	Exportin-1	Solid tumours	140-199, 210-229	C00-D48
T51408	Beta-3 adrenergic receptor	Angina pectoris	413	I20
T51408	Beta-3 adrenergic receptor	Asthma		J45
T51408	Beta-3 adrenergic receptor	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T51408	Beta-3 adrenergic receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T51408	Beta-3 adrenergic receptor	Gastrointestinal disease		K00-K93
T51408	Beta-3 adrenergic receptor	Glaucoma	365	H40-H42
T51408	Beta-3 adrenergic receptor	Hypertension	401	I10-I16
T51408	Beta-3 adrenergic receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T51408	Beta-3 adrenergic receptor	Major depressive disorder; Obesity; Type 2 diabetes	250, 250.00, 250.02, 278, 296, 296.2, 296.3	E08-E13, E11, E66, F30-F39, F32, F33
T51408	Beta-3 adrenergic receptor	Major depressive disorder; Severe mood disorders	296, 296.2, 296.3	F30-F39, F32, F33
T51408	Beta-3 adrenergic receptor	Obesity	278	E66
T51408	Beta-3 adrenergic receptor	Obesity; Type 2 diabetes	250, 250.00, 250.02, 278	E08-E13, E11, E66
T51408	Beta-3 adrenergic receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
T51408	Beta-3 adrenergic receptor	Type 2 diabetes	250	E11
T51408	Beta-3 adrenergic receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T51425	VEGF-C	Solid tumours	140-199, 210-229	C00-D48
T51426	Bile acid receptor	Anticholelithogenic		K80
T51426	Bile acid receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T51426	Bile acid receptor	Hyperlipidaemia	272.0-272.4	E78
T51426	Bile acid receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T51426	Bile acid receptor	Osteoarthritis	715	M15-M19, M47
T51426	Bile acid receptor	Primary biliary cholangitis		K00-K95
T51426	Bile acid receptor	Type 2 diabetes	250	E11
T51426	Bile acid receptor	Unspecified		
T51452	Gamma-aminobutyric-acid receptor alpha-2 subunit	Neuropathic pain	356.0, 356.8	G64, G90.0
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Anesthesia	338	R20.0
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Anxiety disorder	300, 311	F32, F40-F42
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Depression	311	F30-F39
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Epilepsy		G40
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Epilepsy; Anxiety disorder	300, 345	F40-F42, G40
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Headache; Anxiety disorder	339, 784.0, 300, 311	G43-G44, R51, F32, F40-F42
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Insomnia; Anxiety disorder	307.41, 307.42, 327.0, 780.51, 780.52, 300, 311	F51.0, G47.0, F32, F40-F42
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Insomnia; Epilepsy	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0, G40
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Intractable chronic pain; Cystitis	338, 780	R52, G89, N30
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Intractable insomnia		G47
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Respiratory distress syndrome	518.5, 518.82	J80
T51487	Gamma-aminobutyric acid receptor subunit alpha-1	Sleep maintenance insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T51489	Mite allergen	Asthma		J45
T51499	Ganglioside GM2 activator	Multiple myeloma	203	C90
T51565	Casein kinase II, alpha chain	Cancer	140-229	C00-C96
T51593	Tryptophan hydroxylase	Carcinoid syndrome		E34.0
T51593	Tryptophan hydroxylase	Carcinoid syndrome diarrhea		A09, K59
T51666	Potassium-transporting ATPase alpha chain 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T51666	Potassium-transporting ATPase alpha chain 1	Cancer	140-229	C00-C96
T51666	Potassium-transporting ATPase alpha chain 1	Cardiovascular disorder		I00-I99
T51666	Potassium-transporting ATPase alpha chain 1	Colorectal cancer	153, 154	C18-C21
T51666	Potassium-transporting ATPase alpha chain 1	Erosive esophagitis; Non-erosive gastro-esophageal reflux disease	530	K20, K21
T51666	Potassium-transporting ATPase alpha chain 1	Gastroesophageal reflux disease	140-229, 530	K21
T51666	Potassium-transporting ATPase alpha chain 1	Helicobacter pylori infection	41.86	B96.81
T51666	Potassium-transporting ATPase alpha chain 1	Peptic ulcer	531-534	K25-K27
T51666	Potassium-transporting ATPase alpha chain 1	Stomach ulcer		K25-K27
T51666	Potassium-transporting ATPase alpha chain 1	Ulcerative colitis	556	K51
T51693	Melanoma-associated antigen 3	Adjuvant non-small-cell lung carcinoma; Melanoma	162, 172	C33, C34, C43
T51693	Melanoma-associated antigen 3	Colorectal cancer	153, 154	C18-C21
T51694	Histone synthesis	Cancer	140-229	C00-C96
T51803	miR-34	Liver cancer	140-229, 155, 203.0	C22
T51843	RNA-dependentRNA polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T51883	Raf protein kinase	Cancer	140-229	C00-C96
T52007	Peripheral carotid chemoreceptor	Respiratory disease		J00-J99
T52173	Amiloride-sensitive sodium channel alpha-subunit	Hypertension; Edema; Congestive heart failure	401, 782.3, 428	I10-I16, R60.9, I50
T52227	Thymidylate synthase	Advanced gastric cancer	151	C16
T52227	Thymidylate synthase	Biliary cancer		C22, C24
T52227	Thymidylate synthase	Breast cancer	174, 175	C50
T52227	Thymidylate synthase	Cancer	140-229	C00-C96
T52227	Thymidylate synthase	Colon cancer	153, 154	C50
T52227	Thymidylate synthase	Colon cancer; Rectal cancer	153, 154	C50
T52227	Thymidylate synthase	Colorectal cancer	153, 154	C18-C21
T52227	Thymidylate synthase	Endocarditis	421	I33
T52227	Thymidylate synthase	Keratosis		L57.0
T52227	Thymidylate synthase	Malignant pleural mesothelioma	163	C45
T52227	Thymidylate synthase	Solid tumours	140-199, 210-229	C00-D48
T52227	Thymidylate synthase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T52258	mRNA of HBV	HBV infection	070.2-070.3	B16, B18.0, B18.1
T52373	Farnesyl pyrophosphate synthase	Bone resorption		M80
T52373	Farnesyl pyrophosphate synthase	Hypercalcemia	275.42	E83.5
T52373	Farnesyl pyrophosphate synthase	Osteoporosis in post-menopausal women	733	M80-M81
T52373	Farnesyl pyrophosphate synthase	Osteoporosis; Paget's disease	731.0, 733.0	M80-M81, M88
T52389	NAD(P)H dehydrogenase [quinone] 1	Huntington's disease	294.1, 333.4	F02.2, G10
T52450	Interstitial collagenase	Arthritis	710-719	M00-M25
T52450	Interstitial collagenase	Diabetic nephropathy	250.4	E11.21
T52450	Interstitial collagenase	Rheumatoid arthritis	710-719, 714	M05-M06
T52477	Gram-positive bacteria	Mycobacterium tuberculosis infection		A15-A19
T52522	Beta-2 adrenergic receptor	Acute asthma	493	J45
T52522	Beta-2 adrenergic receptor	Aging skin; Exacerbations of acute asthma	493	L00-L99, J45
T52522	Beta-2 adrenergic receptor	Asthma		J45
T52522	Beta-2 adrenergic receptor	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T52522	Beta-2 adrenergic receptor	Asthma; Chronic obstructive pulmonary disease	490-492, 494-496	J45, J40-J44, J47
T52522	Beta-2 adrenergic receptor	Bradycardia; Heart block	116.0, 426.9	B40, I44-I45
T52522	Beta-2 adrenergic receptor	Bronchodilator	493	J45
T52522	Beta-2 adrenergic receptor	Cachexia	799.4	R64
T52522	Beta-2 adrenergic receptor	Chronic breathing disorders	490-496	J44-J47
T52522	Beta-2 adrenergic receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T52522	Beta-2 adrenergic receptor	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J47, J45
T52522	Beta-2 adrenergic receptor	Hypertension	401	I10-I16
T52522	Beta-2 adrenergic receptor	Neurogenic bladder dysfunction		N31.9
T52522	Beta-2 adrenergic receptor	Obesity	278	E66
T52522	Beta-2 adrenergic receptor	Premature ejaculation	302.75	F52.4
T52522	Beta-2 adrenergic receptor	Premature labour	644, 765	O60.1, P07.3
T52522	Beta-2 adrenergic receptor	Skin infections	680-709	L00-L99
T52522	Beta-2 adrenergic receptor	Unspecified		
T52534	Bacterial protein synthesis	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T52534	Bacterial protein synthesis	Pneumonia		J12-J18
T52534	Bacterial protein synthesis	Tuberculosis	010-018	A15-A19
T52624	Platelet-derived growth factor receptor	Diabetic foot ulcer	707	L88-L89
T52671	Apolipoprotein(a)	Cancer	140-229	C00-C96
T52771	mycobacteria proton pump	Multi-drug resistant tuberculosis	010-018	A15-A19
T52790	NK-2 receptor	Anxiety disorder	300, 311	F32, F40-F42
T52790	NK-2 receptor	Asthma		J45
T52790	NK-2 receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T52790	NK-2 receptor	Depression; Acute or chronic pain; Anxiety disorders; Urinary incontinence	300, 311, 338, 338.2, 787.6, 788.3,780	F30-F42, N39.3-N39.4, G89
T52790	NK-2 receptor	Depression; Anxiety	300, 311	F30-F39, F40-F42
T52790	NK-2 receptor	Infantile colics; Postoperative ileus	537.2, 560.1, 560.31, 777.1, 777.4, 789.7	K31.5, K56.0, K56.3, K56.7, P76.1, R10.4
T52790	NK-2 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T52790	NK-2 receptor	Irritable bowel syndrome with diarrhoea	493, 564.1, 787.91	A09, J45, K58, K59.1
T52790	NK-2 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T52790	NK-2 receptor	Unspecified		
T52790	NK-2 receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T52921	Nociceptin receptor	Anxiety disorder	300, 311	F32, F40-F42
T52921	Nociceptin receptor	Central nervous system disease		G00-G99
T52921	Nociceptin receptor	Heart failure	428	I50
T52921	Nociceptin receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T52921	Nociceptin receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T52921	Nociceptin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T52921	Nociceptin receptor	Pain; Stress	300, 338,780	F40-F42, R52, G89
T52921	Nociceptin receptor	Psychiatric disorder	290-319	F01-F99
T52937	Agouti-related protein	Obesity	278	E66
T52953	mRNA of human C-reactive protein	Cardiovascular disease; Inflammatory disorders	390-459	I00-I99
T52953	mRNA of human C-reactive protein	Coronary artery disease	410-414, 429.2	I20-I25
T53024	Somatostatin receptor type 2	Acromegaly	253	E22.0
T53024	Somatostatin receptor type 2	Lung cancer	162	C33-C34
T53024	Somatostatin receptor type 2	Neuroendocrine cancer		C7A
T53103	Alpha-N-acetylglucosaminidase	Autoimmune diabetes		E08-E13
T53378	Carbonic anhydrase IV	Ocular hypertension	365.04	H40.0
T53378	Carbonic anhydrase IV	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
T53381	Alpha-1D adrenergic receptor	Benign prostatic hyperplasia	600	N40
T53381	Alpha-1D adrenergic receptor	Congestive heart failure	428	I50
T53381	Alpha-1D adrenergic receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T53381	Alpha-1D adrenergic receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T53381	Alpha-1D adrenergic receptor	Fecal incontinence		R15
T53381	Alpha-1D adrenergic receptor	Glaucoma	365	H40-H42
T53381	Alpha-1D adrenergic receptor	Hypertension	401	I10-I16
T53381	Alpha-1D adrenergic receptor	Pediatric cancer	140-229	C00-C96
T53381	Alpha-1D adrenergic receptor	Peripheral vascular disease	443.9	I73.9
T53381	Alpha-1D adrenergic receptor	Prostate disease		N42.9
T53381	Alpha-1D adrenergic receptor	Prostate hyperplasia		N40
T53381	Alpha-1D adrenergic receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T53389	TGF-beta receptor type I	Arteriosclerosis	440	I70
T53389	TGF-beta receptor type I	Cachexia	799.4	R64
T53389	TGF-beta receptor type I	Cancer	140-229	C00-C96
T53389	TGF-beta receptor type I	Chronic myelogenous leukaemia	205.1	C92.1
T53389	TGF-beta receptor type I	Diabetic nephropathy	250.4	E11.21
T53389	TGF-beta receptor type I	Fibrosis	709.2	L90.5
T53389	TGF-beta receptor type I	Pulmonary disease	460-519	J00-J99
T53389	TGF-beta receptor type I	Pulmonary fibrosis	515, 516.3	J84.1
T53389	TGF-beta receptor type I	Scar tissue		L00-L99
T53389	TGF-beta receptor type I	Scleroderma	701.0710.1	L94.0-L94.1, M34
T53389	TGF-beta receptor type I	Solid tumours	140-199, 210-229	C00-D48
T53524	Alpha platelet-derived growth factor receptor	Gastrointestinal cancers	150-159	C15-C26
T53524	Alpha platelet-derived growth factor receptor	Glioblastoma multiforme	191	C71
T53524	Alpha platelet-derived growth factor receptor	Non-small cell lung cancer; Ovarian cancer	183	C33-C34, C56
T53524	Alpha platelet-derived growth factor receptor	Soft tissue sarcoma	171	C00-D49
T53524	Alpha platelet-derived growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T53549	Thiol group of protein	Inflammatory bowel disease	555, 556	K50, K51
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Arteriosclerosis	440	I70
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Atherosclerosis	414.0, 440	I70
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Cardiovascular disease; Hyperlipidemia; Dyslipidemia		I00-I99, E78
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Cardiovascular disorder		I00-I99
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Chemotherapy or radiotherapy-induced mucositis	338, 528.0,780	K12.3, R52, G89
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Dyslipidaemias	272	E78
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Elevated CRP		E78.0
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	HBV infection	070.2-070.3	B16, B18.0, B18.1
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Hypercholesterolemia		E78
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Hyperlipidaemia	272.0-272.4	E78
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Multiple myeloma	203	C90
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Myocardial infarction; Cerebrovascular ischaemia	410, 434.91	I21, I22, I61-I63
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T53585	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Unspecified		
T53588	Escherichia coli NADH-dependent enoyl-ACP reductase	Methicillin-resistant staphylococcus aureus infection		B95.62
T53601	Bacteria 50S ribosomal subunit	Bacillus anthracis infection		A22
T53601	Bacteria 50S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T53601	Bacteria 50S ribosomal subunit	Bacterial respiratory tract infection		J13, J15
T53601	Bacteria 50S ribosomal subunit	Inflammatory bowel disease	555, 556	K50, K51
T53601	Bacteria 50S ribosomal subunit	Skin infections	680-709	L00-L99
T53601	Bacteria 50S ribosomal subunit	Unspecified		
T53640	Hepatitis B large envelope protein	HBV infection	070.2-070.3	B16, B18.0, B18.1
T53684	Expression of inflammation cytokines including TNF-alpha, IL-1beta and IL-6	Inflammatory bowel disease	555, 556	K50, K51
T53748	Enoyl-ACP reductase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T53748	Enoyl-ACP reductase	Infection of P. falciparum; Trypanosoma	084, 086	B50-B54, B56
T53764	Seprase	Cancer	140-229	C00-C96
T53764	Seprase	Hematopoietic		D50-D89
T53764	Seprase	Inflammatory bowel disease	555, 556	K50, K51
T53865	Immunoglobulin G1 (IgG1)	Influenza virus		J11.1
T53903	HCV genome conserved portion (unspecified)	Hepatitis virus infection	573.3	K75.9
T53904	Hypoxia-inducible factor-prolyl hydroxylase	Anemia	280-285	D50-D64
T53904	Hypoxia-inducible factor-prolyl hydroxylase	Anemia; Kidney disease	280-285, 580-589	D50-D64, N00-N29
T53904	Hypoxia-inducible factor-prolyl hydroxylase	Autism	299	F84.0
T54007	Vascular endothelial growth factor 165 isoform	Neovascular age-related macular degeneration	362.5	H35.3
T54055	Hyaluronic acid receptor	Hematological malignancies	200-209	C81-C86
T54055	Hyaluronic acid receptor	Pancytopenia		D61.81
T54093	Brachyury protein	Solid tumours	140-199, 210-229	C00-D48
T54128	Glutamate receptor AMPA subtype	Alcohol use disorders	303	F10.2
T54128	Glutamate receptor AMPA subtype	Alzheimer disease	331	G30
T54128	Glutamate receptor AMPA subtype	Anaesthesia	338	R52, G89
T54128	Glutamate receptor AMPA subtype	Anesthesia	338	R20.0
T54128	Glutamate receptor AMPA subtype	Anxiety disorder	300, 311	F32, F40-F42
T54128	Glutamate receptor AMPA subtype	Anxiety disorder; Panic attacks	300	F40-F42
T54128	Glutamate receptor AMPA subtype	Attention deficit hyperactivity disorder	314	F90
T54128	Glutamate receptor AMPA subtype	Cerebrovascular ischaemia	434.91	I61-I63
T54128	Glutamate receptor AMPA subtype	Chemotherapy-induced peripheral neuropathy	356.0, 356.8	G64, G90.0
T54128	Glutamate receptor AMPA subtype	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T54128	Glutamate receptor AMPA subtype	Coronary artery disease	410-414, 429.2	I20-I25
T54128	Glutamate receptor AMPA subtype	Epilepsy		G40
T54128	Glutamate receptor AMPA subtype	Epilepsy; Parkinson's disease	332, 345	F02.3, G20, G40
T54128	Glutamate receptor AMPA subtype	Infestations of lice and scabies	132.0, 133.0	B85.0, B86
T54128	Glutamate receptor AMPA subtype	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T54128	Glutamate receptor AMPA subtype	Insomnia; Anesthesia	307.41, 307.42, 327.0, 780.51, 780.52, 338	F51.0, G47.0, R20.0
T54128	Glutamate receptor AMPA subtype	Monitored anaesthesia care sedation	338	R52, G89
T54128	Glutamate receptor AMPA subtype	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T54128	Glutamate receptor AMPA subtype	Parkinson's disease	332	G20
T54128	Glutamate receptor AMPA subtype	Psychiatric disorder	290-319	F01-F99
T54128	Glutamate receptor AMPA subtype	Schizophrenia	295	F20
T54128	Glutamate receptor AMPA subtype	Schizophrenia; Pervasive developmental disorder	295, 299	F20, F84
T54132	Potassium voltage-gated channel subfamily KQT member 3	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T54132	Potassium voltage-gated channel subfamily KQT member 3	Epilepsy		G40
T54156	MMP-9	Cancer	140-229	C00-C96
T54156	MMP-9	Colorectal cancer	153, 154	C18-C21
T54156	MMP-9	Solid tumours; Ulcerative colitis	140-199, 210-229, 556	C00-D48, K51
T54156	MMP-9	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T54347	Candida albicans chitinsynthase 3	Candidiasis infection	001-139, 112	B37
T54387	Antigens on activated T-cells	Transplant rejection	279.5, 996	D89.8, T86
T54447	Pigment epithelium-derived factor	Exudative age-related macular degeneration	362.5	H35.3
T54447	Pigment epithelium-derived factor	Macular degeneration	362.5	H35.3
T54519	Schistosoma mansoni purine nucleoside phosphorylase	Prostate cancer	185	C61
T54582	Nicotinamide phosphoribosyltransferase	Leukemia	208.9	C90-C95
T54582	Nicotinamide phosphoribosyltransferase	Solid tumours	140-199, 210-229	C00-D48
T54606	five leukocidin toxins	Hospital-acquired pneumonia; Ventilator-associated pneumonia		J18.9, J95
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Angina pectoris	413	I20
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Cancer	140-229	C00-C96
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Migraine	346	G43
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Ovarian cancer	183	C56
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T54644	Voltage-dependent T-type calcium channel subunit alpha-1H	Unspecified		
T54761	Myelin basic protein	Multiple scierosis	340	G35
T54771	Sodium/glucose cotransporter 1	Diabetes	253.5, 588.1	E23.2, N25.1
T54771	Sodium/glucose cotransporter 1	Type 2 diabetes	250	E11
T54931	Nicotinic acetylcholine receptoralpha2 / alpha3	Drug abuse	303-304	F10-F19
T55012	Ion channel	Atrial fibrillation	272, 427.31	E78, I48
T55012	Ion channel	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T55012	Ion channel	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
T55012	Ion channel	Influenza virus		J11.1
T55012	Ion channel	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T55094	Acid-sensing ion channel ASIC1a/ASIC1b	Congestive heart failure; Hypertension	428	I50
T55094	Acid-sensing ion channel ASIC1a/ASIC1b	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T55269	Nucleoside transporter	Cardiac arrhythmias	427	I47-I49
T55273	Delta-like 4	Solid tumours	140-199, 210-229	C00-D48
T55285	Glycine receptor	Cerebrovascular ischaemia	434.91	I61-I63
T55285	Glycine receptor	Epilepsy		G40
T55285	Glycine receptor	Migraine	346	G43
T55285	Glycine receptor	Nerve injury		T14.4
T55285	Glycine receptor	Tobacco dependence	305.1	F17
T55293	Integrin alpha-2	Solid tumours	140-199, 210-229	C00-D48
T55302	B-type natriuretic peptide (BNP)	Hypertension	401	I10-I16
T55398	Interleukin-1receptor-associated kinase-4	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T55435	Mycobacterium tuberculosis serine/threonine-protein kinase PknB	Mycobacterium tuberculosis infection		A15-A19
T55610	Hypoxia-inducible factor 1 alpha	Cancer	140-229	C00-C96
T55610	Hypoxia-inducible factor 1 alpha	Lymphoma	202.8, 208.9	C81-C86
T55610	Hypoxia-inducible factor 1 alpha	Pulmonary arterial hypertension	416	I27.0, I27.2
T55610	Hypoxia-inducible factor 1 alpha	Solid tumours	140-199, 210-229	C00-D48
T55643	Heat shock protein	Meningococcal infection	36.9	A39
T55654	cystic fibrosis transmembrane conductance regulator	Cystic fibrosis	277	E84
T55654	cystic fibrosis transmembrane conductance regulator	Diarrhea	787.91	A09, K59.1
T55654	cystic fibrosis transmembrane conductance regulator	HIV-associated diarrhoea		A09
T55689	Hormone sensitive lipase	Obesity	278	E66
T55689	Hormone sensitive lipase	Pancreatitis	577.0-577.1	K85, K86.0K86.1
T55709	Choline kinase	Solid tumours	140-199, 210-229	C00-D48
T55815	Neuronal acetylcholinereceptor subunit alpha-2	General anesthesia	338	R20.0
T55815	Neuronal acetylcholinereceptor subunit alpha-2	Glaucoma	365	H40-H42
T55815	Neuronal acetylcholinereceptor subunit alpha-2	Muscle relaxant		N39.3, N39.4, R32
T55815	Neuronal acetylcholinereceptor subunit alpha-2	Narcotic depression	304.9, 311	F19.20, F32
T55815	Neuronal acetylcholinereceptor subunit alpha-2	Smoking withdrawl syndrom; Anesthesia	292, 338	F17.2, R20.0
T55815	Neuronal acetylcholinereceptor subunit alpha-2	Spasms; Pain	338,780	R52, G89
T55860	OX40 ligand	Asthma		J45
T55860	OX40 ligand	Solid tumours	140-199, 210-229	C00-D48
T55922	S-adenosylmethioninedecarboxylase proenzyme	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T55922	S-adenosylmethioninedecarboxylase proenzyme	Pneumocystis carinii infection		B59
T55922	S-adenosylmethioninedecarboxylase proenzyme	Solid tumours	140-199, 210-229	C00-D48
T55959	Sodium-dependent dopamine transporter	Attention deficit hyperactivity disorder	314	F90
T55959	Sodium-dependent dopamine transporter	Cocaine addiction	304.2	F14.2
T55959	Sodium-dependent dopamine transporter	Dementia	290-294	F01-F07
T55959	Sodium-dependent dopamine transporter	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T55959	Sodium-dependent dopamine transporter	Mood disorder		F30-F39
T55959	Sodium-dependent dopamine transporter	Narcolepsy	347	G47.4
T55959	Sodium-dependent dopamine transporter	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T55959	Sodium-dependent dopamine transporter	Parkinson's disease	332	G20
T55959	Sodium-dependent dopamine transporter	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
T56175	Lanosterol synthase	Arteriosclerosis	440	I70
T56259	Brain concentrations of gamma-aminobutyric acid (GABA)	Epilepsy		G40
T56262	Tripeptidyl peptidase-1	Late infantile neuronal ceroid lipofuscinosis type 2		E75.4
T56308	Interleukin-11	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T56315	Targeting multiple components of the immune system	Acute myeloid leukemia; Head and neck cancer	205, 140-149, 140-229	C92.0, C07-C14, C32-C33
T56362	Choline transporter-like protein 4	Pancreatic cancer; Prostate cancer	157, 185	C25, C61
T56365	B-lymphocyte antigen CD19	Acute lymphoblastic leukemia	204.0, 556	C91.0
T56365	B-lymphocyte antigen CD19	Autoimmune diabetes		E08-E13
T56365	B-lymphocyte antigen CD19	B-cell lymphoma	202.8	C85.1
T56365	B-lymphocyte antigen CD19	Chronic lymphocytic leukaemia		C91
T56365	B-lymphocyte antigen CD19	Diffuse large B-cell lymphoma	200	C83.3
T56365	B-lymphocyte antigen CD19	Hematologic malignancies	200-209	C81-C86
T56365	B-lymphocyte antigen CD19	Leukemia	208.9	C90-C95
T56365	B-lymphocyte antigen CD19	Lymphoma; Chronic lymphocytic leukemia; Multiple myeloma	202.8, 203.0, 204.1, 208.9	C81-C86, C90, C91-C95, C91.1
T56365	B-lymphocyte antigen CD19	Non-hodgkin's lymphoma		C85
T56365	B-lymphocyte antigen CD19	Rheumatoid arthritis	710-719, 714	M05-M06
T56365	B-lymphocyte antigen CD19	Scleroderma	701.0710.1	L94.0-L94.1, M34
T56367	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1	Acute ischemic stroke	434.91	I61-I63
T56418	ALK tyrosine kinase receptor	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T56418	ALK tyrosine kinase receptor	Cancer	140-229	C00-C96
T56418	ALK tyrosine kinase receptor	Late-stage B-cell lymphoma	140-199, 202.8, 210-229	C00-C75, C7A, C7B, C81-C86, C85.1, D10-D36, D3A
T56418	ALK tyrosine kinase receptor	Lymphoma	202.8, 208.9	C81-C86
T56418	ALK tyrosine kinase receptor	Non-small cell lung cancer		C33-C34
T56510	Antiapoptotic protein BCL-XL	Advanced small cell lung cancer; Relapsed or refractory chronic lymphocytic leukemia; Lymphoid malignancies	140-229, 140-239, 162, 162.9, 202, 204.0, 204.1, 208.9	C33-C34, C34.90, C81-C86, C91-C95, C91.0, C91.1
T56510	Antiapoptotic protein BCL-XL	Cancer	140-229	C00-C96
T56510	Antiapoptotic protein BCL-XL	Solid tumours	140-199, 210-229	C00-D48
T56518	DNA polymerase/reverse transcriptase	HBV infection	070.2-070.3	B16, B18.0, B18.1
T56518	DNA polymerase/reverse transcriptase	Hepatitis virus infection	573.3	K75.9
T56545	Apolipoprotein A-I	Acute coronary syndrome	444	I74
T56545	Apolipoprotein A-I	Aortic valve stenosis		I35.0, I06.0
T56545	Apolipoprotein A-I	Atherosclerosis	414.0, 440	I70
T56545	Apolipoprotein A-I	Cardiovascular disorder		I00-I99
T56545	Apolipoprotein A-I	Cholesterol metabolism disorder		E70-E88
T56545	Apolipoprotein A-I	Hyperlipidaemia	272.0-272.4	E78
T56556	5-aminoimidazole-4-carboxamidoribonucleotide (AICAR) transformylase	Inflammatory bowel dieasea; Rheumatoid arthritis	555, 556, 714	K50, K51, M05-M06
T56625	Tripeptidyl-peptidase II	Obesity	278	E66
T56697	DKK1 protein	Multiple myeloma	203	C90
T56697	DKK1 protein	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T56915	HIV protease	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T56915	HIV protease	HIV-1 infection	001-139, 042	B20-B24
T56915	HIV protease	Human immunodeficiency virus infection	279.3	B20-B26
T56915	HIV protease	Unspecified		
T56915	HIV protease	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T56923	High affinity interleukin-8 receptor B	Asthma		J45
T56923	High affinity interleukin-8 receptor B	Cancer	140-229	C00-C96
T56923	High affinity interleukin-8 receptor B	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T56923	High affinity interleukin-8 receptor B	Cystic fibrosis; Chronic obstructive pulmonary disease	277.0, 490-492, 494-496	E84, J40-J44, J47
T56923	High affinity interleukin-8 receptor B	Fungal infections	110-118	B35-B49
T56923	High affinity interleukin-8 receptor B	Ischemia-reperfusion injury; Lung transplantation; Graft rejection in heart transplantation	996, 996.84	T86, T86.81
T57001	Cell surface A33 antigen	Colorectal cancer	153, 154	C18-C21
T57011	mRNA of Intercellularadhesion molecule-1	Crohn's disease; Ulcerative colitis	555, 556, 556.9	K50, K50-K52, K51
T57011	mRNA of Intercellularadhesion molecule-1	Pouchitis		K91.8
T57011	mRNA of Intercellularadhesion molecule-1	Transplant rejection	279.5, 996	D89.8, T86
T57034	Protein tyrosine phosphatase beta	Peripheral arterial disease	443	I73
T57047	DNA topical patch	Human immunodeficiency virus infection	279.3	B20-B26
T57059	E2F transcription factor 1	Solid tumours	140-199, 210-229	C00-D48
T57211	mRNA of HCMV DNA polymerase	Cytomegalovirus infection		B25
T57278	Ephrin type-A receptor 2	Cancer	140-229	C00-C96
T57278	Ephrin type-A receptor 2	Solid tumours	140-199, 210-229	C00-D48
T57361	Kallikrein	Peptic ulcer	531-534	K25-K27
T57392	Cytochrome P450 2D6	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T57392	Cytochrome P450 2D6	Malaria		B54
T57392	Cytochrome P450 2D6	Migraine	346	G43
T57585	Chloride channel	Cancer	140-229	C00-C96
T57585	Chloride channel	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T57585	Chloride channel	Cystic fibrosis	277	E84
T57585	Chloride channel	Glioma	191	C71
T57585	Chloride channel	Onchocerciasis		B73
T57654	Viral protein	Influenza A infection		J10, J11
T57680	Soluble guanylate cyclase	Angina pectoris	413	I20
T57699	Omega 1 Benzodiazepine receptor	Fibromyalgia; Insomnia	307.4, 327.0, 729.1	F51.0, G47.0, M79.7
T57700	Mast/stem cell growth factor receptor	Cancer	140-229	C00-C96
T57700	Mast/stem cell growth factor receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T57700	Mast/stem cell growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T57862	human papillomaviru 9-valent	Human papillomavirus infections	078.1079.4	B97.7
T57943	Apopain	Cancer	140-229	C00-C96
T58093	Peptide deformylase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T58093	Peptide deformylase	Infection of P. falciparum 	84	B50-B54
T58184	Ribosome	Solid tumours	140-199, 210-229	C00-D48
T58203	Glutamatergc system	Schizophrenia	295	F20
T58238	T-lymphocyte activation antigen CD80	Autoimmune diabetes		E08-E13
T58238	T-lymphocyte activation antigen CD80	Lymphoma	202.8, 208.9	C81-C86
T58238	T-lymphocyte activation antigen CD80	Rheumatoid arthritis	710-719, 714	M05-M06
T58238	T-lymphocyte activation antigen CD80	Transplant rejection	279.5, 996	D89.8, T86
T58454	Fibroblast growth factor receptor 2	Cancer	140-229	C00-C96
T58454	Fibroblast growth factor receptor 2	Chronic HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T58454	Fibroblast growth factor receptor 2	Oral mucositis	528	K12.3
T58454	Fibroblast growth factor receptor 2	Periodontitis	523.5	K05.4
T58479	mRNA of VEGF	Macular degeneration	362.5	H35.3
T58496	Transient receptor potential cation channel subfamily V member 3	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T58496	Transient receptor potential cation channel subfamily V member 3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T58589	B1 bradykinin receptor	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
T58589	B1 bradykinin receptor	Osteoarthritis	715	M15-M19, M47
T58589	B1 bradykinin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T58589	B1 bradykinin receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T58716	Sphingomyelin phosphodiesterase 4	Depression	311	F30-F39
T58902	Tau aggregation	Acute myeloid leukemia	205	C92.0
T58920	Thyrotropin releasing hormone	Dementia	290-294	F01-F07
T58920	Thyrotropin releasing hormone	Parkinson's disease	332	G20
T58921	Peroxisome proliferator activated receptor gamma	Alzheimer disease	331	G30
T58921	Peroxisome proliferator activated receptor gamma	Alzheimer disease; Type 2 diabetes	331, 250	G30, E11
T58921	Peroxisome proliferator activated receptor gamma	Diabetes	253.5, 588.1	E23.2, N25.1
T58921	Peroxisome proliferator activated receptor gamma	Drug abuse	303-304	F10-F19
T58921	Peroxisome proliferator activated receptor gamma	Endometriosis	617	N80
T58921	Peroxisome proliferator activated receptor gamma	Gout	274.00274.1274.8274.9	M10
T58921	Peroxisome proliferator activated receptor gamma	Inflammatory bowel disease	555, 556	K50, K51
T58921	Peroxisome proliferator activated receptor gamma	Nicotine dependence	305.1	F17
T58921	Peroxisome proliferator activated receptor gamma	Non-alcoholic fatty liver disease	571.8	K76.0
T58921	Peroxisome proliferator activated receptor gamma	Obesity	278	E66
T58921	Peroxisome proliferator activated receptor gamma	Ocular inflammation	370.33	H16.229
T58921	Peroxisome proliferator activated receptor gamma	Type 1 diabetes	250	E10
T58921	Peroxisome proliferator activated receptor gamma	Type 2 diabetes	250	E11
T58970	Mitogen-activated protein kinase 1	Cancer	140-229	C00-C96
T58970	Mitogen-activated protein kinase 1	Restenosis		I51.89
T58970	Mitogen-activated protein kinase 1	Solid tumours	140-199, 210-229	C00-D48
T58992	Delta-type opioid receptor	Acute migraine	346	G43
T58992	Delta-type opioid receptor	Acute nonspecific diarrhea; Chronic diarrhea associated with inflammatory bowel disease		K50, K60
T58992	Delta-type opioid receptor	Alcohol use disorders	303	F10.2
T58992	Delta-type opioid receptor	Anxiety disorder	300, 311	F32, F40-F42
T58992	Delta-type opioid receptor	Bladder disease		N30-N32
T58992	Delta-type opioid receptor	Cough	786.2	R05
T58992	Delta-type opioid receptor	Diarrhea-predominant IBS	564.1	K58.0
T58992	Delta-type opioid receptor	Ischemic heart diseases	410-414	I20-I25
T58992	Delta-type opioid receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T58992	Delta-type opioid receptor	Moderate-to-severe pain		R52, G89
T58992	Delta-type opioid receptor	Overactive bladder disorder	188, 596.51	C67, N32.81
T58992	Delta-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T58992	Delta-type opioid receptor	Premature ejaculation	302.75	F52.4
T58992	Delta-type opioid receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T58992	Delta-type opioid receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T59045	4-aminobutyrate aminotransferase, mitochondrial	Dementia	290-294	F01-F07
T59045	4-aminobutyrate aminotransferase, mitochondrial	Dietary shortage	260-269	E40-E46
T59045	4-aminobutyrate aminotransferase, mitochondrial	Dietary shortage; Glioma	260-269, 191	E40-E46, C71
T59045	4-aminobutyrate aminotransferase, mitochondrial	Epilepsy; Infantile spasms; Complex partial seizures	345, 345.4, 345.5, 345.9, 728.85, 780.3	G40, G40.2, P90, R25.2, R56
T59045	4-aminobutyrate aminotransferase, mitochondrial	Infantile spasms		G40.4
T59045	4-aminobutyrate aminotransferase, mitochondrial	Seizures	345.9, 780.3	G40, P90, R56
T59045	4-aminobutyrate aminotransferase, mitochondrial	Substance dependence		F10-F19
T59056	Aldosterone synthase	Cushing's disease	255	E24.0
T59102	Beta platelet-derived growth factor receptor	Brain injury		S09.90
T59102	Beta platelet-derived growth factor receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T59102	Beta platelet-derived growth factor receptor	Non-small cell lung cancer		C33-C34
T59102	Beta platelet-derived growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T59122	CD58	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T59156	Nuclear factor kappa B	Acute liver failure		K72
T59156	Nuclear factor kappa B	Gynecological disorder		N70-N98
T59156	Nuclear factor kappa B	Inflammatory bowel disease	555, 556	K50, K51
T59156	Nuclear factor kappa B	Skin infections	680-709	L00-L99
T59156	Nuclear factor kappa B	Solid tumours	140-199, 210-229	C00-D48
T59156	Nuclear factor kappa B	Unspecified		
T59174	Sodium hydrogen exchanger	Hypertension	401	I10-I16
T59174	Sodium hydrogen exchanger	Myocardial infarction	410	I21, I22
T59273	mRNA of PLK1	Solid tumours	140-199, 210-229	C00-D48
T59328	Epidermal growth factor receptor	Advanced cancers	140-229	C00-C96
T59328	Epidermal growth factor receptor	Brain cancer	191, 225.0	C71, D33
T59328	Epidermal growth factor receptor	Brain cancer; Glioblastoma multiforme	191, 225.0	C71, D33
T59328	Epidermal growth factor receptor	Breast cancer	174, 175	C50
T59328	Epidermal growth factor receptor	Cancer	140-229	C00-C96
T59328	Epidermal growth factor receptor	Cerebrovascular ischaemia	434.91	I61-I63
T59328	Epidermal growth factor receptor	Chronic lymphocytic leukaemia		C91
T59328	Epidermal growth factor receptor	Colon cancer; Glioma; Breast cancer; Head and neck cancer	140-149, 140-229, 183, 191	C00-C96, C07-C14, C32, C33, C56, C71
T59328	Epidermal growth factor receptor	Colorectal cancer	153, 154	C18-C21
T59328	Epidermal growth factor receptor	Colorectal cancer; Squamous Non-small-cell lung cancer	153, 154, 140-229, 162, 204.0	C18-C21, C33, C33-C34, C34, C91.0
T59328	Epidermal growth factor receptor	Cryptosporidium infection		A07.2
T59328	Epidermal growth factor receptor	Diabetic foot ulcer	707	L88-L89
T59328	Epidermal growth factor receptor	Esophageal cancer	150	C15
T59328	Epidermal growth factor receptor	Gastric cancer	151	C16
T59328	Epidermal growth factor receptor	Gastric cancer; Non-small cell lung cancer	151	C16, C33-C34
T59328	Epidermal growth factor receptor	Gastrointestinal disease		K00-K93
T59328	Epidermal growth factor receptor	Glioblastoma multiforme	191	C71
T59328	Epidermal growth factor receptor	Glioma	191	C71
T59328	Epidermal growth factor receptor	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T59328	Epidermal growth factor receptor	Head and neck squamous cell carcinoma	199	C44
T59328	Epidermal growth factor receptor	Inflammatory breast cancer	174, 175	C50
T59328	Epidermal growth factor receptor	Locally advanced head and neck cancer	140-149	C07-C14, C32, C33
T59328	Epidermal growth factor receptor	Lung cancer	162	C33-C34
T59328	Epidermal growth factor receptor	Lymphoma	202.8, 208.9	C81-C86
T59328	Epidermal growth factor receptor	Malignant tumor	140-199	C00-C75, C7A, C7B
T59328	Epidermal growth factor receptor	Melanoma	172	C43
T59328	Epidermal growth factor receptor	Metastatic colorectal cancer	153, 154	C18-C21
T59328	Epidermal growth factor receptor	Non-small cell lung cancer		C33-C34
T59328	Epidermal growth factor receptor	Ovarian cancer	183	C56
T59328	Epidermal growth factor receptor	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T59328	Epidermal growth factor receptor	Psoriasis	696	L40
T59328	Epidermal growth factor receptor	Refractory breast cancer	174, 175	C50
T59328	Epidermal growth factor receptor	Solid tumours	140-199, 210-229	C00-D48
T59328	Epidermal growth factor receptor	Unspecified		
T59328	Epidermal growth factor receptor	Urethral cancer; Bladder cancer; Ovarian cancer; Prostate cancer; Breast cancer	140-229, 174, 175, 183, 188	C50, C56, C67
T59328	Epidermal growth factor receptor	Vulnerary		S00-T98
T59550	CI Man-6-P receptor	Cancer	140-229	C00-C96
T59550	CI Man-6-P receptor	Fibrosis	709.2	L90.5
T59550	CI Man-6-P receptor	Scar tissue		L00-L99
T59563	G-protein-coupled receptor	Depression	311	F30-F39
T59604	Growth hormone secretagogue receptor type 1	Alcohol use disorders	303	F10.2
T59604	Growth hormone secretagogue receptor type 1	Anorexia nervosa cachexia	307.1, 799.4	F50.0-F50.1
T59604	Growth hormone secretagogue receptor type 1	Cachexia	799.4	R64
T59604	Growth hormone secretagogue receptor type 1	Cancer	140-229	C00-C96
T59604	Growth hormone secretagogue receptor type 1	Carbohydrate metabolism disorder		E73-E74
T59604	Growth hormone secretagogue receptor type 1	Fibromyalgia	729.1	M79.7
T59604	Growth hormone secretagogue receptor type 1	Frailty		R54
T59604	Growth hormone secretagogue receptor type 1	Functional bowel disorder		K00-K93
T59604	Growth hormone secretagogue receptor type 1	Gastric motility disorder		K22.4
T59604	Growth hormone secretagogue receptor type 1	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
T59604	Growth hormone secretagogue receptor type 1	Ileus; Gastroparesis; Miscellaneous gastrointestinal disorders	530-558, 536.3, 537.2, 560.1, 560.31, 777.1, 777.4	K20-K64, K31.5, K31.8, K56.0, K56.3, K56.7, P76.1
T59604	Growth hormone secretagogue receptor type 1	Metabolic disorders	270-279	E70-E89
T59604	Growth hormone secretagogue receptor type 1	Obesity	278	E66
T59604	Growth hormone secretagogue receptor type 1	Postoperative ileus	537.2, 560.1, 560.31, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, P76.1
T59604	Growth hormone secretagogue receptor type 1	Type 2 diabetes	250	E11
T59626	Leukotriene B4 receptor 1	Allergy	995.3	T78.4
T59626	Leukotriene B4 receptor 1	Asthma		J45
T59626	Leukotriene B4 receptor 1	Cystic fibrosis	277	E84
T59626	Leukotriene B4 receptor 1	Human immunodeficiency virus infection	279.3	B20-B26
T59626	Leukotriene B4 receptor 1	Inflammatory bowel disease	555, 556	K50, K51
T59626	Leukotriene B4 receptor 1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T59626	Leukotriene B4 receptor 1	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T59626	Leukotriene B4 receptor 1	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T59626	Leukotriene B4 receptor 1	Psoriasis	696	L40
T59626	Leukotriene B4 receptor 1	Renal cancer	140-229, 189	C64
T59626	Leukotriene B4 receptor 1	Rheumatoid arthritis	710-719, 714	M05-M06
T59631	PD-1	Hematological malignancies	200-209	C81-C86
T59631	PD-1	Melanoma	172	C43
T59631	PD-1	Solid tumours	140-199, 210-229	C00-D48
T59654	Polo-like kinase 2	Cancer	140-229	C00-C96
T59679	5-hydroxytryptamine 4 receptor	Alzheimer disease	331	G30
T59679	5-hydroxytryptamine 4 receptor	Alzheimer disease; Post-traumatic stress disorder	331, 309.81	G30, F43.1
T59679	5-hydroxytryptamine 4 receptor	Atrial fibrillation	272, 427.31	E78, I48
T59679	5-hydroxytryptamine 4 receptor	Congestive heart failure	428	I50
T59679	5-hydroxytryptamine 4 receptor	Constipation	564	K59.0
T59679	5-hydroxytryptamine 4 receptor	Diabetic gastroparesis	250, 536.3	E08-E13, K31.8
T59679	5-hydroxytryptamine 4 receptor	Dyspepsia; Gastro-oesophageal reflux; Irritable bowel syndrome	536.8, 530, 564.1, 787.91	K30, K21, A09, K58, K59.1
T59679	5-hydroxytryptamine 4 receptor	Emesis	787	R11
T59679	5-hydroxytryptamine 4 receptor	Gastric motility disorder		K22.4
T59679	5-hydroxytryptamine 4 receptor	Gastroesophageal reflux disease	140-229, 530	K21
T59679	5-hydroxytryptamine 4 receptor	Gastrointestinal disease		K00-K93
T59679	5-hydroxytryptamine 4 receptor	Gastroparesis	536.3	K31.8
T59679	5-hydroxytryptamine 4 receptor	Inflammatory bowel disease	555, 556	K50, K51
T59679	5-hydroxytryptamine 4 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T59679	5-hydroxytryptamine 4 receptor	Neurodegenerative disease	330-337	G30-G32
T59679	5-hydroxytryptamine 4 receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T59679	5-hydroxytryptamine 4 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T59679	5-hydroxytryptamine 4 receptor	Parkinson's disease	332	G20
T59679	5-hydroxytryptamine 4 receptor	Schizophrenia	295	F20
T59679	5-hydroxytryptamine 4 receptor	Unspecified		
T59679	5-hydroxytryptamine 4 receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T59720	Bis(5'-adenosyl)-triphosphatase	Emesis	787	R11
T59735	Interferon receptor	Cancer	140-229	C00-C96
T59735	Interferon receptor	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T59735	Interferon receptor	Human immunodeficiency virus infection	279.3	B20-B26
T59735	Interferon receptor	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T59845	Serine/threonine protein phosphatase PP1-alpha 1 catalytic subunit	Molluscum contagiosum infection		B08.1
T59870	Cholesterol absorption	Hypercholesterolemia		E78
T59870	Cholesterol absorption	Hyperlipidaemia	272.0-272.4	E78
T59881	Vasopressin V1b receptor	Anxiety disorder	300, 311	F32, F40-F42
T59881	Vasopressin V1b receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T59881	Vasopressin V1b receptor	Major depressive disorder; Anxiety	300	F40-F42
T59909	Protein prenyltransferase	Cancer	140-229	C00-C96
T59929	Thymidine phosphorylase	Depression	311	F30-F39
T59955	Progesterone	Contraception		Z30
T59955	Progesterone	Metastatic breast cancer		C50
T59974	Chaperonin	Cerebrovascular ischaemia	434.91	I61-I63
T60136	Brain membranes	Epileptic seizures	345.9, 780.3	G40, P90, R56
T60182	Glucagon receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T60182	Glucagon receptor	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
T60182	Glucagon receptor	Non-insulin dependent diabetes		E11.9
T60182	Glucagon receptor	Obesity; Diabetes	250, 278	E08-E13, E66
T60182	Glucagon receptor	Type 1 diabetes	250	E10
T60182	Glucagon receptor	Type 2 diabetes	250	E11
T60213	Bone morphogenetic protein receptor	Articular cartilage disorders		M24.10
T60213	Bone morphogenetic protein receptor	Prostate cancer	185	C61
T60213	Bone morphogenetic protein receptor	Renal disease		N00-N29
T60213	Bone morphogenetic protein receptor	Renal injury		N17.9
T60345	T-cell surface glycoprotein CD3	Acute lymphoblastic leukemia	204.0, 556	C91.0
T60345	T-cell surface glycoprotein CD3	Acute lymphoblastic leukemia; Acute myeloid lymphoma	204.0, 556	C91.0, C92.0
T60345	T-cell surface glycoprotein CD3	Type 1 diabetes	250	E10
T60366	Ornithine decarboxylase	African trypanosomiasis	86.5	B56
T60366	Ornithine decarboxylase	Burns and burn infection	001-139	A00-B99
T60366	Ornithine decarboxylase	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T60405	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Autoimmune diabetes		E08-E13
T60405	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Cancer	140-229	C00-C96
T60405	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Diabetic macular edema; Diabetic retinopathy	250, 250.5, 362.0-362.2, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35-H35.2, H35.8, H36
T60405	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Melanoma	172	C43
T60405	mRNA of RAF proto-oncogene serine/threonine-protein kinase	Solid tumours	140-199, 210-229	C00-D48
T60433	T-cell surfaceglycoprotein CD1a	Aplastic anemia	284	D60-D61
T60514	Platelet glycoprotein VI	Arteriosclerosis	440	I70
T60526	L-selectin	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T60526	L-selectin	Psoriasis	696	L40
T60529	Prostaglandin G/H synthase 1	Acne vulgaris; Dermatitis	706.1, 692.9	L70.0, L20-L30
T60529	Prostaglandin G/H synthase 1	Colorectal cancer	153, 154	C18-C21
T60529	Prostaglandin G/H synthase 1	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T60529	Prostaglandin G/H synthase 1	Dietary shortage	260-269	E40-E46
T60529	Prostaglandin G/H synthase 1	Inflammatory bowel disease	555, 556	K50, K51
T60529	Prostaglandin G/H synthase 1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T60529	Prostaglandin G/H synthase 1	Miosis during ocular surgery; Dysmenorrhea	379.42, 625.3	H57.03, N94.4-N94.6
T60529	Prostaglandin G/H synthase 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T60529	Prostaglandin G/H synthase 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T60529	Prostaglandin G/H synthase 1	Postoperative inflammation	998	T81
T60529	Prostaglandin G/H synthase 1	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
T60529	Prostaglandin G/H synthase 1	Ulcerative colitis	556	K51
T60606	Thyrotropin receptor	Diagnostic test to differentiate primary and secondary hypothyroidism		W88
T60606	Thyrotropin receptor	Thyroid cancer	140-229, 193	C73
T60606	Thyrotropin receptor	Thyroid cancer diagnosis	193	C73
T60628	Kappa myeloma antigen (KMA)	Hematological malignancies	200-209	C81-C86
T60631	Proto-oncogene tyrosine-protein kinase receptor ret	Cancer	140-229	C00-C96
T60631	Proto-oncogene tyrosine-protein kinase receptor ret	Neurodegenerative disease	330-337	G30-G32
T60631	Proto-oncogene tyrosine-protein kinase receptor ret	Solid tumours	140-199, 210-229	C00-D48
T60631	Proto-oncogene tyrosine-protein kinase receptor ret	Thyroid cancer	140-229, 193	C73
T60636	Alpha-ketoglutarate dehydrogenase	Hematological malignancies	200-209	C81-C86
T60693	Kappa-type opioid receptor	Alcohol use disorders	303	F10.2
T60693	Kappa-type opioid receptor	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T60693	Kappa-type opioid receptor	Diarrhea-predominant IBS	564.1	K58.0
T60693	Kappa-type opioid receptor	Erythema	695	L51-L54
T60693	Kappa-type opioid receptor	Inflammatory bowel disease	555, 556	K50, K51
T60693	Kappa-type opioid receptor	Neurodegenerative disease	330-337	G30-G32
T60693	Kappa-type opioid receptor	Obesity	278	E66
T60693	Kappa-type opioid receptor	Opiate dependence	304	F11
T60693	Kappa-type opioid receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T60693	Kappa-type opioid receptor	Substance dependence		F10-F19
T60693	Kappa-type opioid receptor	Unspecified		
T60724	Sclerostin	Metabolic bone disease		E50-E64, E70-E90
T60724	Sclerostin	Osteopenia	733.9	M85.8
T60724	Sclerostin	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T60724	Sclerostin	Postmenopausal osteoporosis	733	M80-M81
T60810	Cell mediated immunity response	Bordetella pertussis infection		A37.0
T60810	Cell mediated immunity response	HBV infection	070.2-070.3	B16, B18.0, B18.1
T60810	Cell mediated immunity response	Hepatitis E virus infection		B17.2
T60810	Cell mediated immunity response	HIV-1 infection	001-139, 042	B20-B24
T60810	Cell mediated immunity response	Human immunodeficiency virus infection	279.3	B20-B26
T60810	Cell mediated immunity response	Infections	001-139	A00-B99
T60810	Cell mediated immunity response	Influenza A virus H5N1	487, 488	J10, J11
T60810	Cell mediated immunity response	Influenza virus		J11.1
T60810	Cell mediated immunity response	Leishmania infection		B55.0
T60810	Cell mediated immunity response	Malaria		B54
T60810	Cell mediated immunity response	Vaccination		
T60857	Aldo-keto reductase family 1 member C3	Prostate cancer	185	C61
T60873	FK506 binding protein	Cancer	140-229	C00-C96
T60873	FK506 binding protein	Hyperuricosuria		E79
T60873	FK506 binding protein	Psoriasis	696	L40
T60930	Insulin-like growth factor-1 ligand	Solid tumours	140-199, 210-229	C00-D48
T61033	Ciliary neurotrophic factor receptor alpha	Obesity	278	E66
T61033	Ciliary neurotrophic factor receptor alpha	Ocular inflammation	370.33	H16.229
T61052	Binding to a specific neuroepithelial receptor	Premenstrual syndrome		N94.3
T61142	Neutrophil adhesion	Asthma		J45
T61339	Alpha-glucosidase	Unspecified		
T61400	Dihydroorotate dehydrogenase	Kidney transplant rejection; Heart transplant rejection	996	T86
T61400	Dihydroorotate dehydrogenase	Multiple scierosis	340	G35
T61400	Dihydroorotate dehydrogenase	Rheumatoid arthritis	710-719, 714	M05-M06
T61400	Dihydroorotate dehydrogenase	Rheumatold arthritis; Inflammatory bowel disease	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
T61484	Chymotrypsin	Attention deficit hyperactivity disorder; Autism	314, 299	F90, F84.0
T61484	Chymotrypsin	Cancer	140-229	C00-C96
T61484	Chymotrypsin	Pancreatic disease		K85-K86
T61518	Tyrosine-protein kinase MELK	Solid tumours	140-199, 210-229	C00-D48
T61544	Transcription factor Sp1	Solid tumours	140-199, 210-229	C00-D48
T61581	Guanylate cyclase soluble subunit beta-1	Acute decompensated heart failure	428	I50
T61581	Guanylate cyclase soluble subunit beta-1	Heart failure	428	I50
T61581	Guanylate cyclase soluble subunit beta-1	Hypertension	401	I10-I16
T61622	Renin, renal	Cardiovascular disorder		I00-I99
T61622	Renin, renal	Glaucoma	365	H40-H42
T61622	Renin, renal	Hypertension	401	I10-I16
T61622	Renin, renal	Type 2 diabetes	250	E11
T61622	Renin, renal	Unspecified		
T61683	Inhibitor of apoptosis (IAP)	Cancer	140-229	C00-C96
T61698	Interleukin-2	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T61698	Interleukin-2	Cancer	140-229	C00-C96
T61698	Interleukin-2	Chronic lymphocytic leukaemia		C91
T61698	Interleukin-2	Diabetes	253.5, 588.1	E23.2, N25.1
T61698	Interleukin-2	Immuno-stimulant		C00-C97
T61698	Interleukin-2	Lung cancer	162	C33-C34
T61698	Interleukin-2	Lymphoma	202.8, 208.9	C81-C86
T61698	Interleukin-2	Melanoma	172	C43
T61698	Interleukin-2	Metastatic renal cell carcer	189	C64
T61698	Interleukin-2	Multiple scierosis	340	G35
T61698	Interleukin-2	Non-hodgkin's lymphoma		C85
T61698	Interleukin-2	Ovarian cancer	183	C56
T61698	Interleukin-2	Renal cancer	140-229, 189	C64
T61698	Interleukin-2	Rheumatoid arthritis	710-719, 714	M05-M06
T61698	Interleukin-2	Solid tumours	140-199, 210-229	C00-D48
T61698	Interleukin-2	Unspecified		
T61722	Putative G-protein coupled receptor 44	Allergic asthma	493, 995.3	J45, T78.4
T61722	Putative G-protein coupled receptor 44	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T61722	Putative G-protein coupled receptor 44	Allergy	995.3	T78.4
T61722	Putative G-protein coupled receptor 44	Asthma		J45
T61722	Putative G-protein coupled receptor 44	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T61722	Putative G-protein coupled receptor 44	Respiratory disease		J00-J99
T61729	Prolyl 4-hydroxylasesubunit alpha-1	Liver cirrhosis		K70.3, K71.7, K74
T61729	Prolyl 4-hydroxylasesubunit alpha-1	Transplant rejection	279.5, 996	D89.8, T86
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Acute bronchial asthma	493	J45
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Allergy	995.3	T78.4
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Asthma		J45
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Atopic dermatitis	691.8, 692.9	L00-L99
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Chronic lymphocytic leukaemia		C91
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Chronic obstructive pulmonary disease; Asthma	490-492, 493, 494-496	J40-J44, J47, J45
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Crohn's disease	555	K50
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Glomerulonephritis	580-582	N00, N01, N03, N18
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Huntington's disease	294.1, 333.4	F02.2, G10
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Lung inflammation		D86
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Mood disorder		F30-F39
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Multiple scierosis	340	G35
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Parkinson's disease	332	G20
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Peripheral vascular disease	443.9	I73.9
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Psoriasis	696	L40
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Respiratory tract inflammation		J00-J99
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Rheumatoid arthritis	710-719, 714	M05-M06
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Rhinitis	472.0, 477	J00, J30, J31.0
T61744	CAMP-specific 3',5'-cyclic phosphodiesterase 4A	Xerophthalmia		E50.6-E50.7
T61801	Fatty acid binding protein	Obesity	278	E66
T61896	Multi-IAP	Acute myeloid leukemia	205	C92.0
T61997	20S proteasome	Mantle cell lymphoma	200.4, 202.8, 203.0, 208.9	C81-C86, C85.7, C90.0, C91-C95
T62005	Integrin alpha-V/beta-3	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T62005	Integrin alpha-V/beta-3	Prostate cancer	185	C61
T62005	Integrin alpha-V/beta-3	Rheumatoid arthritis	710-719, 714	M05-M06
T62005	Integrin alpha-V/beta-3	Solid tumours	140-199, 210-229	C00-D48
T62094	Bacterial 30S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T62094	Bacterial 30S ribosomal subunit	Bacterial pneumonia		J13, J15
T62094	Bacterial 30S ribosomal subunit	Infections	001-139	A00-B99
T62151	Monoamine oxidase	Alzheimer disease	331	G30
T62166	Adenine biosynthesis	Brain cancer	191, 225.0	C71, D33
T62184	Sodium- and chloride-dependent GABA transporter 1	Convulsions	780.3	R56.0
T62184	Sodium- and chloride-dependent GABA transporter 1	Myeloma	203	C90
T62187	Herpes simplex virus helicase-primase	Herpes simplex virus infection	54	B00
T62193	Aromatic-L-amino-acid decarboxylase	Parkinson's disease	332	G20
T62193	Aromatic-L-amino-acid decarboxylase	Vitamin B6 deficiency	266.1	E53.1
T62206	Proprotein convertase subtilisin/kexin type 9	Cardiovascular disorder		I00-I99
T62206	Proprotein convertase subtilisin/kexin type 9	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T62206	Proprotein convertase subtilisin/kexin type 9	Coronary artery disease	410-414, 429.2	I20-I25
T62206	Proprotein convertase subtilisin/kexin type 9	Hypercholesterolemia		E78
T62206	Proprotein convertase subtilisin/kexin type 9	Hyperlipidaemia	272.0-272.4	E78
T62206	Proprotein convertase subtilisin/kexin type 9	Type 1 diabetes	250	E10
T62241	Interleukin-17 ligand	Psoriasis	696	L40
T62263	Protofibrillar AB	Alzheimer disease	331	G30
T62292	Gamma-aminobutyric-acid receptor alpha-3 subunit	Anxiety disorder	300, 311	F32, F40-F42
T62292	Gamma-aminobutyric-acid receptor alpha-3 subunit	Anxiety disorder; Schizophrenia	295, 300	F20, F40-F42
T62292	Gamma-aminobutyric-acid receptor alpha-3 subunit	Sleep disorders	307.4, 327, 780.5	F51, G47
T62292	Gamma-aminobutyric-acid receptor alpha-3 subunit	Unspecified		
T62306	Motilin receptor	Constipation	564	K59.0
T62306	Motilin receptor	Delayed gastric emptying; Gastroparesis	536.3	K31.8
T62306	Motilin receptor	Diarrhea	787.91	A09, K59.1
T62306	Motilin receptor	Dyspepsia	536.8	K30
T62306	Motilin receptor	Gastric motility disorder		K22.4
T62306	Motilin receptor	Gastroesophageal reflux disease	140-229, 530	K21
T62306	Motilin receptor	Gastrointestinal disease		K00-K93
T62306	Motilin receptor	Gastrointestinal disorders; Gastroesophageal reflux disease	530, 530-558	K20-K64, K21
T62306	Motilin receptor	Gastroparesis	536.3	K31.8
T62306	Motilin receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T62306	Motilin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T62390	Tyrosine 3-monooxygenase	Dietary shortage	260-269	E40-E46
T62390	Tyrosine 3-monooxygenase	Parkinson's disease	332	G20
T62390	Tyrosine 3-monooxygenase	Pheochromocytoma	194.0, 227.0, 255.6	C74.1, D35.0
T62431	Tyrosine-protein kinase SYK	Allergy	995.3	T78.4
T62431	Tyrosine-protein kinase SYK	Asthma		J45
T62431	Tyrosine-protein kinase SYK	Autoimmune diabetes		E08-E13
T62431	Tyrosine-protein kinase SYK	B-cell lymphoma	202.8	C85.1
T62431	Tyrosine-protein kinase SYK	Cancer	140-229	C00-C96
T62431	Tyrosine-protein kinase SYK	Chronic lymphocytic leukaemia		C91
T62431	Tyrosine-protein kinase SYK	Hematological malignancies	200-209	C81-C86
T62431	Tyrosine-protein kinase SYK	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T62431	Tyrosine-protein kinase SYK	Non-hodgkin's lymphoma		C85
T62431	Tyrosine-protein kinase SYK	Rheumatoid arthritis	710-719, 714	M05-M06
T62431	Tyrosine-protein kinase SYK	Solid tumours	140-199, 210-229	C00-D48
T62431	Tyrosine-protein kinase SYK	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T62449	Serine/threonine-protein kinase Chk1	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T62449	Serine/threonine-protein kinase Chk1	Cancer	140-229	C00-C96
T62449	Serine/threonine-protein kinase Chk1	Lymphoma	202.8, 208.9	C81-C86
T62449	Serine/threonine-protein kinase Chk1	Non-small cell lung cancer		C33-C34
T62449	Serine/threonine-protein kinase Chk1	Non-small cell lung cancer; Pancreatic cancer	140-199, 140-229, 157, 210-229	C33-C34, C25
T62449	Serine/threonine-protein kinase Chk1	Solid tumours	140-199, 210-229	C00-D48
T62460	JAK1	Essential thrombocythemia	238.71, 289.9	D47.3, D75.2, D75.8
T62460	JAK1	Malignancies	140-239	C00-C96
T62460	JAK1	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T62460	JAK1	Polycythemia vera	238.4	D45
T62460	JAK1	Psoriasis	696	L40
T62460	JAK1	Rheumatoid arthritis	710-719, 714	M05-M06
T62460	JAK1	Rheumatold arthritis; Psoriasis; Diabetic nephropathy	250, 250.4, 580-599, 696, 710-719, 714	E08-E13, E10.2, E11.2, E13.2, L40, M00-M25, M05-M06, N00-N29
T62460	JAK1	Systemic lupus erythematosus	710	M32
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Advanced or metastatic urothelial carcinoma		C67
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Bladder cancer	188	C67
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Cancer	140-229	C00-C96
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Diffuse large B-cell lymphoma	200	C83.3
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	HIV-1 infection; Solid tumours	001-139, 042, 140-199, 210-229	B20-B24, C00-D48
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Merkel cell carcinoma		C4A
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Metastatic melanoma	172	C43
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Solid tumours	140-199, 210-229	C00-D48
T99948	Programmed cell deathe?Y? ligand 1 (PD-L1)	Urothelial carcinoma		C00-D49
T62501	Toxic effects of methotrexate	Delayed methotrexate clearance		
T62553	Ribonucleoside-diphosphate reductase	Cancer	140-229	C00-C96
T62553	Ribonucleoside-diphosphate reductase	Glioma	191	C71
T62553	Ribonucleoside-diphosphate reductase	Herpes simplex virus infection	54	B00
T62553	Ribonucleoside-diphosphate reductase	Myelodysplastic syndrome; Acute lymphoblastic leukemia	238.7, 204.0, 556	D46, C91.0
T62704	3-beta-HSD	Termination of early pregnancy	779.6	O04
T62705	Activation-inducible lymphocyte IMMUNOMEDIATORY molecule AILIM	Systemic lupus erythematosus	710	M32
T62739	mRNA of STMN1	Solid tumours	140-199, 210-229	C00-D48
T62753	Activity of important signaling molecules (pAKT) involved in chemoresistance	Cancer	140-229	C00-C96
T62763	Keratinocyte growth factor 2	Oral mucositis	528	K12.3
T62820	Metabotropic glutamate receptor 2	Alzheimer disease; Major depressive disorder	331, 296.2, 296.3, 710.0	G30, F32, F33, M32
T62820	Metabotropic glutamate receptor 2	Anxiety disorder	300, 311	F32, F40-F42
T62820	Metabotropic glutamate receptor 2	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T62820	Metabotropic glutamate receptor 2	Central nervous system disease		G00-G99
T62820	Metabotropic glutamate receptor 2	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T62820	Metabotropic glutamate receptor 2	Mood disorder		F30-F39
T62820	Metabotropic glutamate receptor 2	Psychiatric disorder	290-319	F01-F99
T62820	Metabotropic glutamate receptor 2	Schizophrenia	295	F20
T62905	Sodium-dependent multivitamin transporter	Unspecified		
T62945	Voltage-dependent calcium channel	Muscle spasm		M62.838
T63068	Serum albumin	Arthritis; Bursitis		M00-M25
T63068	Serum albumin	Cholecystography; Gallbladder disease	574, 575	K81, K82, K80-K82
T63068	Serum albumin	Constipation	564	K59.0
T63068	Serum albumin	Diarrhea	787.91	A09, K59.1
T63068	Serum albumin	Hemophilia	286	D66-D68
T63068	Serum albumin	Hypovolemic shock; hypoalbuminemia		E88.09
T63068	Serum albumin	Imaging		W88
T63068	Serum albumin	Reperfusion injury and stroke	410, 434.91	I21, I22, I61-I63
T63068	Serum albumin	Visualizing lesions with abnormal blood brain barrier	437.9	I67.9
T63068	Serum albumin	Xerophthalmia		E50.6-E50.7
T63140	Integral membrane protein LmrP	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T63220	Activated CDC42 kinase 1	Cancer	140-229	C00-C96
T63414	P2X purinoceptor 7	Alzheimer disease	331	G30
T63414	P2X purinoceptor 7	Arthralgia		M25.5
T63414	P2X purinoceptor 7	Autoimmune diabetes		E08-E13
T63414	P2X purinoceptor 7	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T63414	P2X purinoceptor 7	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T63414	P2X purinoceptor 7	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T63414	P2X purinoceptor 7	Rheumatoid arthritis	710-719, 714	M05-M06
T63484	Glucose-6-phosphate dehydrogenase	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T63484	Glucose-6-phosphate dehydrogenase	Rheumatoid arthritis	710-719, 714	M05-M06
T63505	Proto-oncogene c-Abl	Acute lymphoblastic leukemia	204.0, 556	C91.0
T63505	Proto-oncogene c-Abl	Cancer	140-229	C00-C96
T63505	Proto-oncogene c-Abl	Chronic myelogenous leukaemia	205.1	C92.1
T63505	Proto-oncogene c-Abl	Dietary shortage	260-269	E40-E46
T63505	Proto-oncogene c-Abl	Glioma; Lung cancer; Prostate cancer; Solid tumours	140-199, 191, 210-229	C00-C75, C71, C7A, C7B, D10-D36, D3A
T63505	Proto-oncogene c-Abl	Intestinal cancer; Myeloid leukemia	152, 153, 205	C17, C18, C92
T63505	Proto-oncogene c-Abl	Leukemia	208.9	C90-C95
T63598	Neuronal excitation	Head lice	132	B85.0
T63609	Adenylate cyclase type 1	Dietary shortage	260-269	E40-E46
T63803	Vascular endothelial growth factor D	Angina pectoris	413	I20
T63803	Vascular endothelial growth factor D	Peripheral vascular disease	443.9	I73.9
T63816	Histone deacetylase 4	Huntington's disease	294.1, 333.4	F02.2, G10
T63934	Interferon alpha 2 ligand	Bladder cancer	188	C67
T63934	Interferon alpha 2 ligand	Colorectal cancer	153, 154	C18-C21
T63934	Interferon alpha 2 ligand	Hairy cell leukemia	202.4	C91.4
T63934	Interferon alpha 2 ligand	HBV infection	070.2-070.3	B16, B18.0, B18.1
T63934	Interferon alpha 2 ligand	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T63934	Interferon alpha 2 ligand	Melanoma	172	C43
T63934	Interferon alpha 2 ligand	Mesothelioma	163	C45
T63934	Interferon alpha 2 ligand	Unspecified		
T63934	Interferon alpha 2 ligand	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T63966	Vascular endothelial growth factor receptor 1	Advanced solid tumor; Macular degeneration	140-199, 362.5	C00-C75, C7A, C7B, H35.3
T63966	Vascular endothelial growth factor receptor 1	Arteriosclerosis; Bladder cancer	440, 188	I70, C67
T63966	Vascular endothelial growth factor receptor 1	Cancer	140-229	C00-C96
T63966	Vascular endothelial growth factor receptor 1	Diabetic foot ulcer	707	L88-L89
T63966	Vascular endothelial growth factor receptor 1	Hereditary hemorrhagic telangiectasia		I78.0
T63966	Vascular endothelial growth factor receptor 1	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T63966	Vascular endothelial growth factor receptor 1	Peripheral vascular disease	443.9	I73.9
T63966	Vascular endothelial growth factor receptor 1	Renal cancer	140-229, 189	C64
T63967	Nicotinic ACh receptor alpha 4/beta 2	Alzheimer disease	331	G30
T63967	Nicotinic ACh receptor alpha 4/beta 2	Anesthesia	338	R20.0
T63967	Nicotinic ACh receptor alpha 4/beta 2	Attention deficit hyperactivity disorder	314	F90
T63967	Nicotinic ACh receptor alpha 4/beta 2	Attention deficit hyperactivity disorder; Schizophrenia; Anxiety; Dementia	290-294, 295, 300, 314.0	F01-F07, F20, F40-F42, F90
T63967	Nicotinic ACh receptor alpha 4/beta 2	Gastrointestinal disease		K00-K93
T63967	Nicotinic ACh receptor alpha 4/beta 2	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T63967	Nicotinic ACh receptor alpha 4/beta 2	Mood disorder		F30-F39
T63967	Nicotinic ACh receptor alpha 4/beta 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T63967	Nicotinic ACh receptor alpha 4/beta 2	Parkinson's disease	332	G20
T63967	Nicotinic ACh receptor alpha 4/beta 2	Schizophrenia; Alzheimer disease	295, 331.0	F20, G30
T63967	Nicotinic ACh receptor alpha 4/beta 2	Smoking cessation	292	F17.2
T63967	Nicotinic ACh receptor alpha 4/beta 2	Tobacco dependence	305.1	F17
T63986	mRNA of kinesin spindle protein	Hematological malignancies	200-209	C81-C86
T63986	mRNA of kinesin spindle protein	Liver cancer	140-229, 155, 203.0	C22
T64074	Scavenger decapping enzyme DcpS	Spinal muscular atrophy	335.0-335.1	G00-G99
T64081	Farnesyltransferase	Non-small cell lung cancer		C33-C34
T64081	Farnesyltransferase	Solid tumours	140-199, 210-229	C00-D48
T64205	STAT-1 transcription factor	Skin infections	680-709	L00-L99
T64242	24-hydroxylase	Cancer	140-229	C00-C96
T64258	Microtubular protein	Cancer	140-229	C00-C96
T64376	Fibroblast growth factor	Cancer	140-229	C00-C96
T64376	Fibroblast growth factor	Skin burns	940-949	T20-T31
T64382	Gamma-aminobutyric acid receptor	Alcohol use disorders	303	F10.2
T64382	Gamma-aminobutyric acid receptor	Anxiety disorder	300, 311	F32, F40-F42
T64382	Gamma-aminobutyric acid receptor	Ascariasis; Enterobiasis	127.0, 127.4	B77, B80
T64382	Gamma-aminobutyric acid receptor	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T64382	Gamma-aminobutyric acid receptor	Epilepsy		G40
T64382	Gamma-aminobutyric acid receptor	Epileptic seizures	345.9, 780.3	G40, P90, R56
T64382	Gamma-aminobutyric acid receptor	Obesity	278	E66
T64382	Gamma-aminobutyric acid receptor	Seizures	345.9, 780.3	G40, P90, R56
T64410	D-alanyl-D-alanine carboxypeptidase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T64410	D-alanyl-D-alanine carboxypeptidase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T64567	Carbonic anhydrase IX	Breast cancer	174, 175	C50
T64567	Carbonic anhydrase IX	Cancer	140-229	C00-C96
T64567	Carbonic anhydrase IX	Clear cell renal cell carcinoma	189	C64
T64567	Carbonic anhydrase IX	Lymphoma	202.8, 208.9	C81-C86
T64567	Carbonic anhydrase IX	Renal cancer	140-229, 189	C64
T64567	Carbonic anhydrase IX	Solid tumours	140-199, 210-229	C00-D48
T64591	5-hydroxytryptamine receptor 3A	Emesis	787	R11
T64591	5-hydroxytryptamine receptor 3A	Fibromyalgia	729.1	M79.7
T64591	5-hydroxytryptamine receptor 3A	Gastroesophageal reflux disease	140-229, 530	K21
T64591	5-hydroxytryptamine receptor 3A	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T64591	5-hydroxytryptamine receptor 3A	Local anaesthetic		R20.0
T64591	5-hydroxytryptamine receptor 3A	Nausea		R11
T64591	5-hydroxytryptamine receptor 3A	Nausea; Vomiting	787, 787.0	R11
T64645	N-sulphoglucosamine sulphohydrolase	Sanfilippo syndrome		E76.2
T64676	Immunoglobulin G	Autoimmune diabetes		E08-E13
T64682	Serine/threonine-protein kinase Sgk1	Prostate cancer	185	C61
T64765	Histamine H3 receptor	Alcohol use disorders	303	F10.2
T64765	Histamine H3 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T64765	Histamine H3 receptor	Alzheimer disease	331	G30
T64765	Histamine H3 receptor	Alzheimer disease; Schizophrenia	331, 295	G30, F20
T64765	Histamine H3 receptor	Anxiety disorder	300, 311	F32, F40-F42
T64765	Histamine H3 receptor	Attention deficit hyperactivity disorder	314	F90
T64765	Histamine H3 receptor	Central nervous system disease		G00-G99
T64765	Histamine H3 receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T64765	Histamine H3 receptor	Dementia	290-294	F01-F07
T64765	Histamine H3 receptor	Diabetic neuropathy; Musculoskeletal pain	250, 250.6, 356.0, 356.8, 338, 780	E11.40, R52, G89
T64765	Histamine H3 receptor	Eating disorder; Epilepsy; Pain	307.5, 338,780	F50, R52, G89
T64765	Histamine H3 receptor	Excessive daytime sleepiness	291.82, 292.85, 307.43-307.44, 327.1, 780.53-780.54	F51.1, G47.1
T64765	Histamine H3 receptor	Metabolic disorders	270-279	E70-E89
T64765	Histamine H3 receptor	Mild to moderate alzheimer disease; Dementia	290-294, 331.0	F01-F07, G30
T64765	Histamine H3 receptor	Narcolepsy	347	G47.4
T64765	Histamine H3 receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T64765	Histamine H3 receptor	Obese insulin-resistant disorders	250	E11
T64765	Histamine H3 receptor	Obesity	278	E66
T64765	Histamine H3 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T64765	Histamine H3 receptor	Schizophrenia	295	F20
T64765	Histamine H3 receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
T64774	Voltage-dependent anion-selective channel protein 3	Solid tumours	140-199, 210-229	C00-D48
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Cancer	140-229	C00-C96
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Epilepsy		G40
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Epileptic conditions; Pancreatic cancer	345, 140-199, 140-229, 157, 210-229	G40, C25
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Epileptic seizures	345.9, 780.3	G40, P90, R56
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Hypertension; Angina	401, 413	I10-I16, I20
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Paramethadione syndrome; Seizures	741, 744, 745, 746, 751, 753, 345.9, 780.3	Q05, Q17, Q20-Q28, Q60, Q79, G40, P90, R56
T64795	Voltage-dependent T-type calcium channel alpha-1G subunit	Schizophrenia	295	F20
T64969	Epidermal growth factor receptor variant III	Glioblastoma multiforme	191	C71
T64977	mRNA of Insulin-like growth factor 1 receptor	Psoriatic disorder	696	L40
T64987	Latent membrane protein 1	Lymphoma	202.8, 208.9	C81-C86
T64987	Latent membrane protein 1	Nasopharyngeal carcinoma	147	C11
T65019	Matrix metalloproteinase-14	Solid tumours	140-199, 210-229	C00-D48
T65054	Actin	Vaginal yeast infection		B37.3
T65128	Fibrolase	Peripheral vascular disease	443.9	I73.9
T65182	Peptidyl-transferase domain of the bacterial ribosome	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T65197	Erythropoietin Receptor	Anemia	280-285	D50-D64
T65197	Erythropoietin Receptor	Cancer	140-229	C00-C96
T65197	Erythropoietin Receptor	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
T65197	Erythropoietin Receptor	Emesis; Kidney transplant rejection	787, 996.81	R11, T86.1
T65197	Erythropoietin Receptor	Hematological disease		D50-D89
T65198	Pro-neuregulin-1	Congestive heart failure	428	I50
T65198	Pro-neuregulin-1	Heart failure	428	I50
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Atherosclerosis	414.0, 440	I70
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Diabetes	253.5, 588.1	E23.2, N25.1
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Diabetes; Obesity	250, 278	E08-E13, E66
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Hypercholesterolemia		E78
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Influenza virus		J11.1
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Lipid metabolism disorder		E75-E78
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Metabolic disorders	270-279	E70-E89
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Metabolic syndrome x	277.7	E88.81
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Non-insulin dependent diabetes		E11.9
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Ocular hypertension	365.04	H40.0
T65200	Corticosteroid 11-beta-dehydrogenase, isozyme 1	Type 2 diabetes	250	E11
T65291	Aldehyde dehydrogenase	Alcohol use disorders	303	F10.2
T65291	Aldehyde dehydrogenase	Epilepsy		G40
T65351	Superoxide dismutase	Cerebral infarction		I63
T65351	Superoxide dismutase	Cerebrovascular ischaemia	434.91	I61-I63
T65351	Superoxide dismutase	Head injury	800-879	S00.0S09
T65351	Superoxide dismutase	Interstitial lung disease		J84.9
T65351	Superoxide dismutase	Multiple scierosis	340	G35
T65351	Superoxide dismutase	Myocardial infarction	410	I21, I22
T65351	Superoxide dismutase	Neurodegenerative disease	330-337	G30-G32
T65351	Superoxide dismutase	Skin burns	940-949	T20-T31
T65351	Superoxide dismutase	Spinal cord injury		S14, S24, S34
T65351	Superoxide dismutase	Unspecified		
T65414	mRNA of HIV-1 envelope protein	Acquired immune deficiency syndrome	42	B20
T65570	Alcohol dehydrogenase 1A	Athylene glycol or methanol poisoning	980.1, 982	T51.1, T52.3
T65667	Neutrophil	Rhinitis	472.0, 477	J00, J30, J31.0
T65731	Nitric oxide	Type 2 diabetes	250	E11
T65755	Histone deacetylase	Autoimmune diabetes		E08-E13
T65755	Histone deacetylase	Cancer	140-229	C00-C96
T65755	Histone deacetylase	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
T65755	Histone deacetylase	Epilepsy		G40
T65755	Histone deacetylase	Keratosis		L57.0
T65755	Histone deacetylase	Lymphoma	202.8, 208.9	C81-C86
T65755	Histone deacetylase	Multiple myeloma	203	C90
T65755	Histone deacetylase	Myelodysplastic syndrome; Myelofibrosis	238.7, 208.9, 289.83, 709.2	D46, C94.4, D47.4
T65755	Histone deacetylase	Rheumatoid arthritis	710-719, 714	M05-M06
T65755	Histone deacetylase	Rhinovirus infection		J20.6?
T65755	Histone deacetylase	Spinal muscular atrophy	335.0-335.1	G00-G99
T65864	Mitogen-activated protein kinase 14	Acute coronary syndrome	444	I74
T65864	Mitogen-activated protein kinase 14	Acute lung injury; Acute respiratory distress syndrome	518.5, 518.82	J80
T65864	Mitogen-activated protein kinase 14	Arthritis	710-719	M00-M25
T65864	Mitogen-activated protein kinase 14	Cancer	140-229	C00-C96
T65864	Mitogen-activated protein kinase 14	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T65864	Mitogen-activated protein kinase 14	Coronary artery disease	410-414, 429.2	I20-I25
T65864	Mitogen-activated protein kinase 14	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
T65864	Mitogen-activated protein kinase 14	Inflammatory bowel disease	555, 556	K50, K51
T65864	Mitogen-activated protein kinase 14	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T65864	Mitogen-activated protein kinase 14	Inflammatory disorder		
T65864	Mitogen-activated protein kinase 14	Psoriasis	696	L40
T65864	Mitogen-activated protein kinase 14	Rheumatoid arthritis	710-719, 714	M05-M06
T65864	Mitogen-activated protein kinase 14	Rheumatold arthritis; Coronary artery disease	410-414, 429.2, 710-719, 714	I20-I25, M00-M25, M05-M06
T65868	RNA synthesis	Hypercalcemia; Testicular cancer	275.42, 186	E83.5, C62
T65879	Inhibitor of nuclear factor kappa-B kinase alpha subunit	Autoimmune diabetes		E08-E13
T65879	Inhibitor of nuclear factor kappa-B kinase alpha subunit	Cancer	140-229	C00-C96
T65883	Claudin 18	Esophageal cancer	150	C15
T65889	Pyruvate kinase M2	Pain; Solid tumours	338, 356.0, 356.8, 780, 140-199, 210-229	G64, G90.0, R52, G89, C00-D48
T65889	Pyruvate kinase M2	Refractory renal cell carcinoma	189	C64
T66011	Complement Factor B	Age related macular degeneration	362.5	H35.3
T66011	Complement Factor B	Asthma		J45
T66011	Complement Factor B	Coronary artery disease	410-414, 429.2	I20-I25
T66023	Parasitic DNA	Schistosomiasis	120	B65
T66030	Activating NK cells through induction of IL-12 expression	Breast cancer	174, 175	C50
T66040	Penicillin binding protein 2	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T66093	HCV MicroRNA-122 (miR-122)	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T66237	Vasopressin V2 receptor	Acute and chronic heart failure	428	I50
T66237	Vasopressin V2 receptor	Congestive heart failure	428	I50
T66237	Vasopressin V2 receptor	Enuresis; Polyuria; Diabetes insipidus	250, 253.5, 307.6, 588.1, 788.30, 788.42	E08-E13, E23.2, F98.0, N25.1
T66237	Vasopressin V2 receptor	Euvolemic hyponatremia; Hypervolemic hyponatremia	276.1	E87.1
T66237	Vasopressin V2 receptor	Heart failure	428	I50
T66237	Vasopressin V2 receptor	Hypervolaemic hyponatraemia; Euvolaemic hyponatraemia	276.1	E87.1
T66237	Vasopressin V2 receptor	Nocturia		R35
T66237	Vasopressin V2 receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T66290	L-type calcium channel	Angina pectoris	413	I20
T66290	L-type calcium channel	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T66290	L-type calcium channel	Cardiovascular disorder		I00-I99
T66290	L-type calcium channel	Dementia	290-294	F01-F07
T66290	L-type calcium channel	Hypertension	401	I10-I16
T66290	L-type calcium channel	Nerve injury		T14.4
T66350	Ras-related protein Rab-9A	Fungal infections	110-118	B35-B49
T66383	Complement factor D	Autoimmune diabetes		E08-E13
T66383	Complement factor D	Geographic atrophy associated with AMD	362.5	H35.3
T66426	CD34	Heart failure	428	I50
T66505	smoothened receptor	Cancer	140-229	C00-C96
T66505	smoothened receptor	Metastatic or locally advanced basal cell carcinoma	173	C44
T66505	smoothened receptor	Skin cancers	172, 173	C43, C44
T66505	smoothened receptor	Solid tumours	140-199, 210-229	C00-D48
T66514	Carbohydrate antigen Lewis Y	Cancer	140-229	C00-C96
T66719	Heat shock protein HSP90	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T66719	Heat shock protein HSP90	Autoimmune diabetes		E08-E13
T66719	Heat shock protein HSP90	Breast cancer	174, 175	C50
T66719	Heat shock protein HSP90	Cancer	140-229	C00-C96
T66719	Heat shock protein HSP90	Gastric cancer	151	C16
T66719	Heat shock protein HSP90	Kidney cancer; Peripheral nerve damage	140-229, 356.0, 356.8	G64, G90.0
T66719	Heat shock protein HSP90	Myeloma	203	C90
T66719	Heat shock protein HSP90	Respiratory tract inflammation		J00-J99
T66719	Heat shock protein HSP90	Solid tumours	140-199, 210-229	C00-D48
T67022	Caspase	Cancer	140-229	C00-C96
T67022	Caspase	Cardiovascular disorder		I00-I99
T67054	5-hydroxytryptamine 1 receptor	Anxiety disorder	300, 311	F32, F40-F42
T67054	5-hydroxytryptamine 1 receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T67054	5-hydroxytryptamine 1 receptor	Migraine	346	G43
T67063	Maxi K potassium channel	Asthma		J45
T67063	Maxi K potassium channel	Cerebrovascular ischaemia	434.91	I61-I63
T67063	Maxi K potassium channel	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T67079	Interleukin-9	Asthma		J45
T67084	Glucosidase	Diabetes	253.5, 588.1	E23.2, N25.1
T67102	Cathepsin D	Hypertension	401	I10-I16
T67102	Cathepsin D	Multiple scierosis	340	G35
T67103	Integrin alpha-V	Colorectal cancer	153, 154	C18-C21
T67103	Integrin alpha-V	Solid tumours	140-199, 210-229	C00-D48
T67162	D(2) dopamine receptor	Advanced stage Parkinson's disease	332	F02.3, G20
T67162	D(2) dopamine receptor	Alcohol use disorders	303	F10.2
T67162	D(2) dopamine receptor	Allergy	995.3	T78.4
T67162	D(2) dopamine receptor	Alzheimer disease	331	G30
T67162	D(2) dopamine receptor	Anxiety disorder	300, 311	F32, F40-F42
T67162	D(2) dopamine receptor	Asthma; Bronchitis	466, 490, 491, 493	J20-J21, J42, J45
T67162	D(2) dopamine receptor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T67162	D(2) dopamine receptor	Bipolar disorder	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F31, F40-F42
T67162	D(2) dopamine receptor	Bipolar disorder; Schizophrenia	296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300, 295	F31, F40-F42, F20
T67162	D(2) dopamine receptor	Breast cancer	174, 175	C50
T67162	D(2) dopamine receptor	Carcinoid syndrome; Acromegaly	253	E34.0, E22.0
T67162	D(2) dopamine receptor	Cardiac failure		I50
T67162	D(2) dopamine receptor	Cardiotonic		I50
T67162	D(2) dopamine receptor	Cerebrovascular ischaemia	434.91	I61-I63
T67162	D(2) dopamine receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T67162	D(2) dopamine receptor	Corneal vascularity; Hyperaemia; Itching		L29
T67162	D(2) dopamine receptor	Depressive fatigue	780.71	R53.82
T67162	D(2) dopamine receptor	Dermal necrosis		K05
T67162	D(2) dopamine receptor	Emesis	787	R11
T67162	D(2) dopamine receptor	False perceptions; Bipolar disorder	297, 780.1, 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300	F22, R44, F31, F40-F42
T67162	D(2) dopamine receptor	Fibrosis	709.2	L90.5
T67162	D(2) dopamine receptor	Gastrointestinal problems	536, 750	K30-K31, Q40-Q41
T67162	D(2) dopamine receptor	Glaucoma	365	H40-H42
T67162	D(2) dopamine receptor	Huntington's disease	294.1, 333.4	F02.2, G10
T67162	D(2) dopamine receptor	Hyperprolactinemia	253.1	E22.1
T67162	D(2) dopamine receptor	Hypertension	401	I10-I16
T67162	D(2) dopamine receptor	Hypertension; Angina pectoris	401, 413	I10-I16, I20
T67162	D(2) dopamine receptor	Hypotension	458, 796.3	I95
T67162	D(2) dopamine receptor	Idiopathic thrombocytopenic purpura	287.31	D69.3
T67162	D(2) dopamine receptor	Inflammatory bowel disease	555, 556	K50, K51
T67162	D(2) dopamine receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T67162	D(2) dopamine receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T67162	D(2) dopamine receptor	Maintain blood pressure in hypotensive states		I10
T67162	D(2) dopamine receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T67162	D(2) dopamine receptor	Malignant phaeochromocytoma; Benign prostatic hypertrophy; Malignant essential hypertension		N40, C61
T67162	D(2) dopamine receptor	Migraine headaches	346	G43
T67162	D(2) dopamine receptor	Nasal congestion	478.19	J34.89
T67162	D(2) dopamine receptor	Nausea; Vomiting	787, 787.0	R11
T67162	D(2) dopamine receptor	Non-small cell lung cancer		C33-C34
T67162	D(2) dopamine receptor	Ophthalmic disease		H00-H59
T67162	D(2) dopamine receptor	Pain; Inflammatory diseases	338,780	R52, G89
T67162	D(2) dopamine receptor	Parkinson's disease	332	G20
T67162	D(2) dopamine receptor	Peripheral vasoconstriction; Pulmonary hypertension	443, 416	I73, I27.0, I27.2
T67162	D(2) dopamine receptor	Postpartum haemorrhage	666	O72
T67162	D(2) dopamine receptor	Psychosis		F20-F29
T67162	D(2) dopamine receptor	Psychotic disorders	290-299	F20-F29
T67162	D(2) dopamine receptor	Schizophrenia	295	F20
T67162	D(2) dopamine receptor	Schizophrenia; Bipolar disorder	295, 296	F20, F31
T67162	D(2) dopamine receptor	Schizophrenia; Schizoaffective disorders	295, 295.70	F20, F25
T67162	D(2) dopamine receptor	Sexual dysfunction	302.7	F52
T67162	D(2) dopamine receptor	Substance dependence		F10-F19
T67207	Fc-epsilon-RII (CD23)	Leukemia	208.9	C90-C95
T67233	Cholesterol transporter	Hyperlipidaemia	272.0-272.4	E78
T67272	Aminopeptidase N	Psoriasis	696	L40
T67282	Fungal aureus leucyl-tRNA synthetase	Fungal infections	110-118	B35-B49
T67282	Fungal aureus leucyl-tRNA synthetase	Onychomycosis		B35.1
T67282	Fungal aureus leucyl-tRNA synthetase	Urinary tract infections	599	N39.0
T67310	Ionotropic glutamate receptor	Cerebrovascular ischaemia	434.91	I61-I63
T67310	Ionotropic glutamate receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T67364	Streptokinase	Hemorrhoids		I84
T67364	Streptokinase	Unspecified		
T67416	Bifunctional aminoacyl tRNA synthetase	Duchenne muscular dystrophy		G71.0
T67619	RAC serine/threonine-protein kinase	Cancer	140-229	C00-C96
T67619	RAC serine/threonine-protein kinase	Hematologic malignancies	200-209	C81-C86
T67619	RAC serine/threonine-protein kinase	Leukemia	208.9	C90-C95
T67619	RAC serine/threonine-protein kinase	Lymphoma	202.8, 208.9	C81-C86
T67619	RAC serine/threonine-protein kinase	Myocardial reperfusion injury		T86.4
T67619	RAC serine/threonine-protein kinase	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T67619	RAC serine/threonine-protein kinase	Solid tumours	140-199, 210-229	C00-D48
T67658	Solute carrier family 2, facilitated glucose transporter, member 4	Type 2 diabetes	250	E11
T67684	Muscarinic acetylcholine receptor M3	Alzheimer disease	331	G30
T67684	Muscarinic acetylcholine receptor M3	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T67684	Muscarinic acetylcholine receptor M3	Diagnosing bronchial hyperreactivity		W88
T67684	Muscarinic acetylcholine receptor M3	Glaucoma	365	H40-H42
T67684	Muscarinic acetylcholine receptor M3	Obstructive lung diseases	490-492, 494-496	J40-J44, J47
T67684	Muscarinic acetylcholine receptor M3	Overactive bladder	596.51	N32.81
T67684	Muscarinic acetylcholine receptor M3	Overactive bladder disorder	188, 596.51	C67, N32.81
T67684	Muscarinic acetylcholine receptor M3	Postoperative nausea and vomiting		R11
T67684	Muscarinic acetylcholine receptor M3	Respiratory disease		J00-J99
T67684	Muscarinic acetylcholine receptor M3	Seborrhea		L21
T67684	Muscarinic acetylcholine receptor M3	Sjogren's syndrome	710.2	M35.0
T67684	Muscarinic acetylcholine receptor M3	Spasms; Pain	338,780	R52, G89
T67684	Muscarinic acetylcholine receptor M3	Unspecified		
T67684	Muscarinic acetylcholine receptor M3	Urinary incontinence	788.3	N39.3, N39.4, R32
T67710	Parathyroid hormone/parathyroid hormone-related peptide receptor	Postmenopausal osteoporosis at high risk for fracture		M80-M81
T67747	mRNA of NFkappaB	Atopic dermatitis	691.8, 692.9	L00-L99
T67801	Lactotransferrin	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T67801	Lactotransferrin	Diabetic foot ulcer	707	L88-L89
T67805	CD70	Autoimmune diabetes		E08-E13
T67805	CD70	Cancer	140-229	C00-C96
T67805	CD70	Hematological malignancies	200-209	C81-C86
T67805	CD70	Non-hodgkin's lymphoma		C85
T67805	CD70	Renal cancer	140-229, 189	C64
T67818	P2Y purinoceptor 1	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T67849	PI3K delta	Cancer	140-229	C00-C96
T67849	PI3K delta	Chronic lymphocytic leukaemia		C91
T67849	PI3K delta	Chronic lymphocytic leukaemia; Lymphoma	202.8, 208.9	C91, C81-C86
T67849	PI3K delta	Hematologic malignancies; Myeloid leukemia	200-209, 208.9	C81-C86, C92
T67849	PI3K delta	Hematological malignancies	200-209	C81-C86
T67849	PI3K delta	Lymphoma	202.8, 208.9	C81-C86
T67894	Toll-like receptor 3	Anal intraepithelial neoplasia; Human papillomavirus infections	154, 078.1079.4	C21, B97.7
T67894	Toll-like receptor 3	Autoimmune diabetes		E08-E13
T67894	Toll-like receptor 3	Cancer	140-229	C00-C96
T67894	Toll-like receptor 3	Glioblastoma multiforme	191	C71
T67894	Toll-like receptor 3	Human immunodeficiency virus infection	279.3	B20-B26
T67894	Toll-like receptor 3	Keratosis		L57.0
T67952	Potassium channel	Alopecia	704.09	L65.9
T67952	Potassium channel	Angina pectoris	413	I20
T67952	Potassium channel	Arrhythmia	427	I47-I49
T67952	Potassium channel	Arteriosclerosis	440	I70
T67952	Potassium channel	Asthma		J45
T67952	Potassium channel	Atrial fibrillation	272, 427.31	E78, I48
T67952	Potassium channel	Atrial fibrillation; Atrial flutter	427.31, 487, 488	I48, J10, J11
T67952	Potassium channel	Cardiac arrhythmias	427	I47-I49
T67952	Potassium channel	Cerebrovascular ischaemia	434.91	I61-I63
T67952	Potassium channel	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T67952	Potassium channel	Diabetes	253.5, 588.1	E23.2, N25.1
T67952	Potassium channel	Heart arrhythmia		I47-I49
T67952	Potassium channel	High blood pressure	401	I10-I16
T67952	Potassium channel	Hypertension	401	I10-I16
T67952	Potassium channel	Maintenance of normal sinus rhythm	427	I46-I49
T67952	Potassium channel	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T67952	Potassium channel	Multiple scierosis	340	G35
T67952	Potassium channel	Nerve injury		T14.4
T67952	Potassium channel	Obstructive sleep apnea	327.23, 780.57	G47.3
T67952	Potassium channel	Ocular hypertension	365.04	H40.0
T67952	Potassium channel	Overactive bladder disorder	188, 596.51	C67, N32.81
T67952	Potassium channel	Rhinitis	472.0, 477	J00, J30, J31.0
T67952	Potassium channel	Solid tumours	140-199, 210-229	C00-D48
T67952	Potassium channel	Tachyarrhythmias	427, 785.0	I47-I49, R00.0
T67952	Potassium channel	Unspecified		
T67952	Potassium channel	Urinary incontinence	788.3	N39.3, N39.4, R32
T67977	Cytochrome P450 3A	Human immunodeficiency virus infection	279.3	B20-B26
T68039	Cell adhesion molecule	Cerebrovascular disorders		I60-I69
T68039	Cell adhesion molecule	Deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
T68039	Cell adhesion molecule	Graft-versus-host disease	279.5	T86.0
T68039	Cell adhesion molecule	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T68039	Cell adhesion molecule	Melanoma	172	C43
T68039	Cell adhesion molecule	Neurodegenerative disease	330-337	G30-G32
T68039	Cell adhesion molecule	Rheumatoid arthritis	710-719, 714	M05-M06
T68066	Steroid hormone receptor	Asthma; Allergic rhinitis	477, 493	J30, J45
T68066	Steroid hormone receptor	Atopic dermatitis	691.8, 692.9	L00-L99
T68066	Steroid hormone receptor	Cancer	140-229	C00-C96
T68066	Steroid hormone receptor	Certain skin conditions		
T68066	Steroid hormone receptor	Contact dermatitis	692	L23, L24, L25
T68066	Steroid hormone receptor	Eye inflammation	360-379	H00-H59
T68066	Steroid hormone receptor	Inflammatory arthritis	710-719	M00-M25
T68066	Steroid hormone receptor	Inflammatory bowel disease	555, 556	K50, K51
T68066	Steroid hormone receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T68163	Lyn tyrosine kinase	Bone disease; Chronic lymphocytic leukaemia; Metastatic hormone refractory prostate cancer	185	M00-M99, C91, C61
T68230	Clostridium difficile toxin	Clostridium infection; Malaria	001-139	A00-B99, B54
T68251	72 kDa type IV collagenase	Acne vulgaris	706.1	L70.0
T68251	72 kDa type IV collagenase	Cancer	140-229	C00-C96
T68251	72 kDa type IV collagenase	Non-small-cell lung cancer; Renal cell carcinoma	140-229, 162, 162.9, 189, 204.0	C33, C33-C34, C34, C34.90, C64, C91.0
T68251	72 kDa type IV collagenase	Pancreatic cancer; Lung cancer; Ovarian cancer; Osteoarthritis	140-229, 157, 162, 183, 715	C25, C33-C34, C56, M15-M19, M47
T68251	72 kDa type IV collagenase	Solid tumours	140-199, 210-229	C00-D48
T68253	D-alanine--D-alanine ligase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T68290	Cathepsin S	Asthma		J45
T68290	Cathepsin S	Autoimmune diabetes		E08-E13
T68290	Cathepsin S	Cancer	140-229	C00-C96
T68290	Cathepsin S	Cardiovascular disorder		I00-I99
T68290	Cathepsin S	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T68290	Cathepsin S	Neuropathic pain	356.0, 356.8	G64, G90.0
T68290	Cathepsin S	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T68290	Cathepsin S	Psoriatic disorder	696	L40
T68315	Endothelin receptor	Hypertension	401	I10-I16
T68315	Endothelin receptor	Renal failure	584, 585	N17, N18, N19
T68334	Follicle stimulating hormone receptor	African trypanosomiasis	86.5	B56
T68334	Follicle stimulating hormone receptor	Contraception		Z30
T68334	Follicle stimulating hormone receptor	Female infertility	628	N97.0
T68334	Follicle stimulating hormone receptor	Ovarian cancer	183	C56
T68383	Bone morphogenetic protein-2 ligand	Bone development disorder		M89
T68461	Adenine nucleotide translocator 1	Hypercalcemia	275.42	E83.5
T68517	Heat shock protein 27 	Atrial fibrillation	272, 427.31	E78, I48
T68517	Heat shock protein 27 	Breast cancer; Ovarian cancer; Bladder cancer; Prostate cancer; Lung cancer	140-229, 162, 183, 188	C00-C96, C33-C34, C56, C67
T68536	Tubulin beta	Acute lymphoblastic leukemia	204.0, 556	C91.0
T68536	Tubulin beta	Breast cancer	174, 175	C50
T68536	Tubulin beta	Cancer	140-229	C00-C96
T68536	Tubulin beta	Glioblastoma multiforme	191	C71
T68536	Tubulin beta	Mesothelioma	163	C45
T68536	Tubulin beta	Non-small cell lung cancer		C33-C34
T68536	Tubulin beta	Solid tumours	140-199, 210-229	C00-D48
T68536	Tubulin beta	Worm infections	120-129	B65-B83
T68547	Histone deacetylase 1	Acute myeloid leukemia; Refractory sickle cell ulcers	205, 282.5, 282.6	C92.0, D57
T68547	Histone deacetylase 1	Cancer	140-229	C00-C96
T68547	Histone deacetylase 1	Cerebrovascular ischaemia	434.91	I61-I63
T68547	Histone deacetylase 1	Cutaneous T-cell lymphoma	202.1, 202.2	C84.0, C84.1
T68547	Histone deacetylase 1	Friedreich's ataxia	334	G11.1
T68547	Histone deacetylase 1	General leukaemia cancer	204-208	C91-C95
T68547	Histone deacetylase 1	Hepatocellular carcinoma	155	C22.0
T68547	Histone deacetylase 1	Hodgkin's lymphoma; Multiple myeloma	201, 202.8, 203.0	C81, C81-C86, C90
T68547	Histone deacetylase 1	Melanoma	172	C43
T68547	Histone deacetylase 1	Myelofibrosis; Essential thrombocythemia; Polycythemia vera	238.71, 289.0, 289.83, 289.9, 776.4	C94.4, D47.1, D47.3, D75.1, D75.2, D75.8, P61.1
T68547	Histone deacetylase 1	Peripheral T-cell lymphoma	202.7	C84.4
T68547	Histone deacetylase 1	Primary myelofibrosis; Post-polycythemia vera; Post-essential thrombocytopenia; Cutaneous T cell-lymphomas	203.0, 287.3, 287.4, 287.5, 289.0, 289.83, 776.4	C90.0, C94.4, D47.1, D69.6, D75.1, P61.0, P61.1
T68547	Histone deacetylase 1	Renal cell carcinoma; Hormone refractory prostate cancer	140-229, 185, 189, 203.0, 205.0	C61, C64, C90.0, C92.0
T68547	Histone deacetylase 1	Severe mood disorders	296	F30-F39
T68547	Histone deacetylase 1	Solid tumours	140-199, 210-229	C00-D48
T68547	Histone deacetylase 1	Type 2 diabetes	250	E11
T68547	Histone deacetylase 1	Unspecified		
T68547	Histone deacetylase 1	Urea cycle disorders	270.6	E72.2
T68668	Golgi alpha-mannosidase II	Cancer	140-229	C00-C96
T68766	mRNA of DMPK	Myotonic dystrophy		G71.1
T68782	Prostaglandin D2 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T68782	Prostaglandin D2 receptor	Allergy	995.3	T78.4
T68782	Prostaglandin D2 receptor	Asthma		J45
T68782	Prostaglandin D2 receptor	Atopic dermatitis	691.8, 692.9	L00-L99
T68782	Prostaglandin D2 receptor	Dyslipidaemias	272	E78
T68782	Prostaglandin D2 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T68782	Prostaglandin D2 receptor	Rhinitis	472.0, 477	J00, J30, J31.0
T68782	Prostaglandin D2 receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T68782	Prostaglandin D2 receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T68816	VEGF receptor	Age related macular degeneration	362.5	H35.3
T68816	VEGF receptor	Angina pectoris	413	I20
T68816	VEGF receptor	Cancer	140-229	C00-C96
T68816	VEGF receptor	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
T68816	VEGF receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T68816	VEGF receptor	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
T68816	VEGF receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T68816	VEGF receptor	Psoriasis	696	L40
T68816	VEGF receptor	Solid tumours	140-199, 210-229	C00-D48
T68887	Bombesin receptor	Breast cancer	174, 175	C50
T68887	Bombesin receptor	Cancer	140-229	C00-C96
T68934	Collagen	Dermal ulcers; Skin burns	707.00, 940-949	L88, L89, T20-T31
T68934	Collagen	Urinary tract infections	599	N39.0
T68934	Collagen	Vitamin C deficiency	267	E54
T68967	Sphingomyelin synthase	Hypertension	401	I10-I16
T69067	T-cell receptor	Graft-versus-host disease	279.5	T86.0
T69067	T-cell receptor	Psoriatic disorder	696	L40
T69085	Transcription factor AP-1	Rheumatoid arthritis	710-719, 714	M05-M06
T69128	ROS1	ALK-positive advanced or metastatic NSCLC	162	C33, C34
T69128	ROS1	Solid tumours	140-199, 210-229	C00-D48
T69485	Orexin receptor type 2	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T69494	NMDA receptor	Acute ischemic stroke	434.91	I61-I63
T69494	NMDA receptor	Acute pain	338,780	R52, G89
T69494	NMDA receptor	Alzheimer disease	331	G30
T69494	NMDA receptor	Anaesthesia; Anxiety disorder	338, 300, 311	R52, G89, F32, F40-F42
T69494	NMDA receptor	Anesthesia	338	R20.0
T69494	NMDA receptor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T69494	NMDA receptor	Cancer pain	140-229, 338,780	R52, G89
T69494	NMDA receptor	Cerebral infarction		I63
T69494	NMDA receptor	Cerebrovascular ischaemia	434.91	I61-I63
T69494	NMDA receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T69494	NMDA receptor	Dementia	290-294	F01-F07
T69494	NMDA receptor	Depression	311	F30-F39
T69494	NMDA receptor	Epilepsy		G40
T69494	NMDA receptor	Epileptic seizures	345.9, 780.3	G40, P90, R56
T69494	NMDA receptor	Exogenous obesity		E66
T69494	NMDA receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T69494	NMDA receptor	Neurodegenerative disease	330-337	G30-G32
T69494	NMDA receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T69494	NMDA receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T69494	NMDA receptor	Neuropathy	356.0, 356.8	G64, G90.0
T69494	NMDA receptor	Obsessive compulsive disorder	300.3	F42
T69494	NMDA receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T69494	NMDA receptor	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
T69494	NMDA receptor	Parkinson's disease	332	G20
T69494	NMDA receptor	Schizophrenia	295	F20
T69494	NMDA receptor	Schizophrenia; Indigestion	295	F20, K30
T69494	NMDA receptor	Suicidal ideation		R45.8
T69494	NMDA receptor	Traumatic brain injury	800.0-801.9, 803.0-804.9, 850.0-854.1	S06
T69506	Orphan nuclear receptor NR1I3	Nausea; Vomiting; Dizziness		R11
T69563	Isocitrate dehydrogenase [NADP] cytoplasmic	Hematological malignancies	200-209	C81-C86
T69619	Membrane copper amine oxidase	Asthma		J45
T69619	Membrane copper amine oxidase	Atopic dermatitis	691.8, 692.9	L00-L99
T69619	Membrane copper amine oxidase	Central nervous system disease		G00-G99
T69619	Membrane copper amine oxidase	Cerebrovascular ischaemia	434.91	I61-I63
T69619	Membrane copper amine oxidase	Diabetes	253.5, 588.1	E23.2, N25.1
T69619	Membrane copper amine oxidase	Hypertension	401	I10-I16
T69619	Membrane copper amine oxidase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T69619	Membrane copper amine oxidase	Psoriasis	696	L40
T69619	Membrane copper amine oxidase	Pulmonary disease	460-519	J00-J99
T69619	Membrane copper amine oxidase	Vascular disease	325, 430-459	G45-G46, I60-I95
T69685	Sodium- and chloride-dependent glycine transporter 1	Dementia	290-294	F01-F07
T69685	Sodium- and chloride-dependent glycine transporter 1	Psychotic disorders	290-299	F20-F29
T69685	Sodium- and chloride-dependent glycine transporter 1	Schizophrenia	295	F20
T69707	Proteasome	Ischemia-reperfusion injury		I00-I99
T69707	Proteasome	Multiple myeloma	203	C90
T69707	Proteasome	Multiple myeloma; Relapsed or refractory primary amyloidosis	203, 277.3	C90, E85
T69707	Proteasome	Myeloma	203	C90
T69707	Proteasome	Non-hodgkin's lymphoma; Mantle cell lymphoma		C859, C85
T69707	Proteasome	Solid tumours	140-199, 210-229	C00-D48
T69707	Proteasome	Unspecified		
T69762	Fructose	Constipation	564	K59.0
T69912	Lipoprotein-associated phospholipase A2	Alzheimer disease	331	G30
T69912	Lipoprotein-associated phospholipase A2	Arteriosclerosis	440	I70
T69912	Lipoprotein-associated phospholipase A2	Atherosclerosis	414.0, 440	I70
T69912	Lipoprotein-associated phospholipase A2	Cardiovascular disorder		I00-I99
T69912	Lipoprotein-associated phospholipase A2	Sepsis	995.91	A40, A41
T69991	Wee1-like protein kinase	Ovarian cancer	183	C56
T70062	Reticulon 4	Nerve injury		T14.4
T70067	Tumor necrosis factor receptor superfamily member 10B	Cancer	140-229	C00-C96
T70067	Tumor necrosis factor receptor superfamily member 10B	Colorectal cancer	153, 154	C18-C21
T70067	Tumor necrosis factor receptor superfamily member 10B	Solid tumours	140-199, 210-229	C00-D48
T70071	Endothelin converting enzyme	Acute decompensated heart failure; Renal dysfunction	428, 428.0, 584, 585	I50, N17-N19
T70071	Endothelin converting enzyme	Brain injury		S09.90
T70071	Endothelin converting enzyme	Cardiovascular disorder		I00-I99
T70071	Endothelin converting enzyme	Hypertension	401	I10-I16
T70101	CTP synthase	Solid tumours	140-199, 210-229	C00-D48
T70176	Cell division protein kinase 2	Acute lymphoblastic leukemia	204.0, 556	C91.0
T70176	Cell division protein kinase 2	Cancer	140-229	C00-C96
T70176	Cell division protein kinase 2	Non-small cell lung cancer		C33-C34
T70176	Cell division protein kinase 2	Solid tumours	140-199, 210-229	C00-D48
T70176	Cell division protein kinase 2	Thymoma	164.0, 212.6	C37, D15.0
T70201	Glioma pathogenesis-related protein 1	Prostate cancer	185	C61
T70234	Epha4 tyrosine kinase receptor	Solid tumours	140-199, 210-229	C00-D48
T70309	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Acne vulgaris	706.1	L70.0
T70309	3-oxo-5-alpha-steroid 4-dehydrogenase 1	Prostate disease		N42.9
T70449	Growth hormone-releasing hormone receptor	Acromegaly	253	E22.0
T70449	Growth hormone-releasing hormone receptor	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
T70449	Growth hormone-releasing hormone receptor	HIV lipodystrophy	272.6	E88.1
T70449	Growth hormone-releasing hormone receptor	Lipodystrophy	272.6	E88.1
T70449	Growth hormone-releasing hormone receptor	Pediatric growth disorders		R62.51
T70490	Dipeptidyl-peptidase I	Bronchiectasis	494, 748.61	J47, Q33.4
T70490	Dipeptidyl-peptidase I	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T70518	S-nitrosoglutathione reductase	Asthma		J45
T70680	Organic anion transporter 1	Gout; Hyperuricemia	274, 790.6	E79.0, M10
T70680	Organic anion transporter 1	Obesity	278	E66
T70680	Organic anion transporter 1	Ocular disease		H00-H59
T70792	Placental growth factor	Metastatic colorectal cancer	153, 154	C18-C21
T70888	TNF receptor	Asthma		J45
T70888	TNF receptor	Human immunodeficiency virus infection	279.3	B20-B26
T70888	TNF receptor	Inflammatory disorder		
T70888	TNF receptor	Pemphigus vulgaris; Vasculitis; Wegener's granulomatosis		C91-C95, J45, J84.1, L80, M081, M45, M35.0, M40-M54, T86.0
T70888	TNF receptor	Sciatica		M54.3-M54.4
T70967	Neuronal acetylcholine receptor protein, alpha-4 chain	Hypertensive emergencies; Aneurysm	401-405	I10, I72
T70967	Neuronal acetylcholine receptor protein, alpha-4 chain	Hypotension	458, 796.3	I95
T70977	Glycogen synthase kinase-3 beta	Alzheimer disease	331	G30
T70977	Glycogen synthase kinase-3 beta	Cancer	140-229	C00-C96
T70977	Glycogen synthase kinase-3 beta	Diabetes	253.5, 588.1	E23.2, N25.1
T70977	Glycogen synthase kinase-3 beta	Osteosarcoma	170	C40-C41
T71011	Enterobacteria phage shiga like toxin II B subunit	Escherichia coli infections		B96.2
T71023	Synaptosomal-associated protein 25	Strabismus; Blepharospasm	333.81, 378	G24.5, H49-H50
T71046	Na+ K+ ATPase	Cancer	140-229	C00-C96
T71046	Na+ K+ ATPase	Cardiotonic		I50
T71046	Na+ K+ ATPase	Heart arrhythmia		I47-I49
T71046	Na+ K+ ATPase	Hypertension	401	I10-I16
T71054	CC chemokine receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T71086	Complement Factor H	Autoimmune diabetes		E08-E13
T71141	Integrin alpha-V/beta-6	Idiopathic pulmonary fibrosis	516.3	J84.1
T71167	Liver X receptor	Atherosclerosis	414.0, 440	I70
T71192	Cysteinyl leukotriene receptor 1	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T71192	Cysteinyl leukotriene receptor 1	Allergy	995.3	T78.4
T71192	Cysteinyl leukotriene receptor 1	Asthma		J45
T71192	Cysteinyl leukotriene receptor 1	Asthma; Prophylaxis	493	J45
T71192	Cysteinyl leukotriene receptor 1	Migraine	346	G43
T71192	Cysteinyl leukotriene receptor 1	Unspecified		
T71230	Atrial natriuretic peptide receptor A	Acutely decompensated congestive heart failure		I50
T71230	Atrial natriuretic peptide receptor A	Asthma; Congestive heart failure; Hypertension	428, 401	J45, I50, I10-I16
T71230	Atrial natriuretic peptide receptor A	Heart disease	390-429	I00-I52
T71230	Atrial natriuretic peptide receptor A	Heart failure	428	I50
T71230	Atrial natriuretic peptide receptor A	Neuropathic pain	356.0, 356.8	G64, G90.0
T71266	AKT3 protein kinase	Acute myeloid leukemia	205	C92.0
T71266	AKT3 protein kinase	Cancer	140-229	C00-C96
T71266	AKT3 protein kinase	Colon cancer; Rectal cancer	153, 154	C50
T71266	AKT3 protein kinase	Colorectal cancer; Lymphoma	153, 154, 202.8, 208.9	C18-C21, C81-C86
T71266	AKT3 protein kinase	Hematologic malignancies	200-209	C81-C86
T71266	AKT3 protein kinase	Inoperable and unresectable late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T71266	AKT3 protein kinase	Multiple myeloma	203	C90
T71266	AKT3 protein kinase	Solid tumours	140-199, 210-229	C00-D48
T71377	Interleukin 3 receptor	Leukemia	208.9	C90-C95
T71377	Interleukin 3 receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T71398	Guanylate cyclase	Angina pectoris	413	I20
T71398	Guanylate cyclase	Angina pectoris; Anal fissure	413, 565.0	I20, K60.0-K60.2
T71398	Guanylate cyclase	Cancer	140-229	C00-C96
T71398	Guanylate cyclase	Hydrocephalus; Glaucoma		H40-H42
T71398	Guanylate cyclase	Respiratory failure	518.81	J96
T71479	JAK-STAT pathway	Cancer	140-229	C00-C96
T71484	Human keratin	Ringworm infections	110	B35, B36
T71501	HBV polymerase	HBV infection	070.2-070.3	B16, B18.0, B18.1
T71501	HBV polymerase	Hepatitis virus infection	573.3	K75.9
T71536	DNA minor groove	Breast cancer	174, 175	C50
T71556	Lymphoid cell	Atopic dermatitis	691.8, 692.9	L00-L99
T71690	Pyruvate decarboxylase	Vitamin B1 deficiency	265.0, 265.1	E51
T71905	16S rRNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T71907	Survival motor neuron protein	Spinal muscular atrophy	335.0-335.1	G00-G99
T71928	CD158a	Acute myeloid leukemia	205	C92.0
T71928	CD158a	Multiple myeloma	203	C90
T72038	Galectin-3	Melanoma	172	C43
T72042	GAR transformylase	Solid tumours	140-199, 210-229	C00-D48
T72120	Utrophin	Duchenne muscular dystrophy		G71.0
T72168	Mineralocorticoid receptor	Addison's disease	255.4	E27.1-E27.2
T72168	Mineralocorticoid receptor	Cancer	140-229	C00-C96
T72168	Mineralocorticoid receptor	Cardiovascular disorder		I00-I99
T72168	Mineralocorticoid receptor	Cerebral salt-wasting syndrome		E87.1
T72168	Mineralocorticoid receptor	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
T72168	Mineralocorticoid receptor	Congestive heart failure	428	I50
T72168	Mineralocorticoid receptor	Diabetic nephropathy	250.4	E11.21
T72168	Mineralocorticoid receptor	Heart failure	428	I50
T72168	Mineralocorticoid receptor	Human immunodeficiency virus infection	279.3	B20-B26
T72168	Mineralocorticoid receptor	Oral contraceptive		Z30
T72168	Mineralocorticoid receptor	Type 2 diabetes	250	E11
T72168	Mineralocorticoid receptor	Unspecified		
T72171	mRNA of CCR5	Human immunodeficiency virus infection	279.3	B20-B26
T72182	Inhibiting both TNF-alpha and IL-1 beta production	Arthritis	710-719	M00-M25
T72195	Annexin A5	Myocardial reperfusion injury		T86.4
T72245	Alpha v beta 3 integrin receptor	Cancer	140-229	C00-C96
T72245	Alpha v beta 3 integrin receptor	Peripheral vascular disease	443.9	I73.9
T72269	Elongation factor 1A 	Melanoma	172	C43
T72335	Lethal factor	Bacillus anthracis infection		A22
T72437	von Willebrand Factor-dependent platelet adhesion to collagen	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T72458	Melanocortin-4 receptor	Anorexia nervosa cachexia	307.1, 799.4	F50.0-F50.1
T72458	Melanocortin-4 receptor	Cachexia	799.4	R64
T72458	Melanocortin-4 receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T72458	Melanocortin-4 receptor	Female sexual dysfunction	302.7	F52
T72458	Melanocortin-4 receptor	Metabolic disorders	270-279	E70-E89
T72458	Melanocortin-4 receptor	Obesity	278	E66
T72458	Melanocortin-4 receptor	Obesity; Diabetes	250, 278	E08-E13, E66
T72458	Melanocortin-4 receptor	Obesity; Sexual dysfunction	278, 302.7	E66, F52
T72458	Melanocortin-4 receptor	Sexual dysfunction	302.7	F52
T72458	Melanocortin-4 receptor	Sexual dysfunction; Obesity	278, 302.7	E66, F52
T72478	Sodium/calcium exchanger	Cardiovascular disorder		I00-I99
T72478	Sodium/calcium exchanger	Cerebrovascular ischaemia	434.91	I61-I63
T72511	Ubiquitin-activating enzyme E1	Leukemia	208.9	C90-C95
T72515	Interleukin 1 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T72657	30S ribosomal subunit	Acne vulgaris	706.1	L70.0
T72657	30S ribosomal subunit	Acute and chronic intestinal amebiasis	6	A06
T72657	30S ribosomal subunit	Acute hepatic failure; Alcoholic cirrhosis of liver	570, 571.1	K71, K72
T72657	30S ribosomal subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T72657	30S ribosomal subunit	Lyme disease; Acne; Bronchitis		L70, J20-J21, J42
T72657	30S ribosomal subunit	Skin infections	680-709	L00-L99
T72702	Tissue factor	Adult respiratory distress syndrome	518.5, 518.82	J80
T72702	Tissue factor	Bleeding	444, 453	I74, I80-I82
T72702	Tissue factor	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T72737	Cytomegalovirus DNA	Cytomegalovirus reactivation in hematopoietic cell transplant recipients	78.5	B25
T72835	E-selectin	Acute myeloid leukemia	205	C92.0
T72835	E-selectin	Asthma		J45
T72835	E-selectin	Chronic obstructive pulmonary disease; Psoriatic disorder; Atopic dermatitis	490-492, 494-496, 691.8, 692.9, 696	J40-J44, J47, L20, L20-L30, L40
T72835	E-selectin	Hypertension	401	I10-I16
T72835	E-selectin	Inflammatory bowel disease	555, 556	K50, K51
T72841	Steroid hormone receptor ERR1	Acne vulgaris	706.1	L70.0
T72841	Steroid hormone receptor ERR1	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T72841	Steroid hormone receptor ERR1	Arthritis	710-719	M00-M25
T72841	Steroid hormone receptor ERR1	Asthma		J45
T72841	Steroid hormone receptor ERR1	Cachexia	799.4	R64
T72841	Steroid hormone receptor ERR1	Choroidal neovascularisation		H35
T72841	Steroid hormone receptor ERR1	Dermatitis	692.9	L20-L30
T72841	Steroid hormone receptor ERR1	Dermatological disease		L00-L99
T72841	Steroid hormone receptor ERR1	Gastrointestinal disease		K00-K93
T72841	Steroid hormone receptor ERR1	Non-insulin dependent diabetes		E11.9
T72841	Steroid hormone receptor ERR1	Rheumatoid arthritis	710-719, 714	M05-M06
T72841	Steroid hormone receptor ERR1	Schizophrenia	295	F20
T72850	Forkhead box protein O1A	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
T72957	Chemokine receptor	Asthma		J45
T72957	Chemokine receptor	Chronic obstructive pulmonary disease; Rheumatoid arthritis	460-519, 490-492, 494-496, 710-719, 714	J00-J99, J40-J44, J47, M00-M25, M05-M06
T72957	Chemokine receptor	Multiple scierosis	340	G35
T73075	Perlecan	Atherosclerosis	414.0, 440	I70
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Acute myeloid leukemia; Chronic myeloid leukemia	205.0, 205.1, 238.7	C92.0, C92.1, D46
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Bone marrow transplantation	279.5, 996	D89.8, T86
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Cancer	140-229	C00-C96
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Glioblastoma multiforme	191	C71
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Human immunodeficiency virus infection	279.3	B20-B26
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Indolent follicular lymphoma	202.0, 202.8	C81-C86, C82
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Multiple myeloma	203	C90
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Multiple scierosis	340	G35
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Neutropenia	288	D70
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Rheumatoid arthritis	710-719, 714	M05-M06
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Solid tumours	140-199, 210-229	C00-D48
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Stage III colorectal cancer	140-229, 153, 154	C18-C21, C20
T73097	Granulocyte-macrophage colony-stimulating factor receptor alpha chain	Wound healing		T14.0-T14.1
T73189	Fungal 1,3-beta-glucan synthase	Aspergillosis		B44
T73189	Fungal 1,3-beta-glucan synthase	Candidiasis infection	001-139, 112	B37
T73189	Fungal 1,3-beta-glucan synthase	Convulsions	780.3	R56.0
T73189	Fungal 1,3-beta-glucan synthase	Fungal infections	110-118	B35-B49
T73215	B-lymphocyte antigen CD20	Autoimmune diabetes		E08-E13
T73215	B-lymphocyte antigen CD20	B-cell lymphoma	202.8	C85.1
T73215	B-lymphocyte antigen CD20	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T73215	B-lymphocyte antigen CD20	Cancer	140-229	C00-C96
T73215	B-lymphocyte antigen CD20	Chronic lymphocytic leukaemia		C91
T73215	B-lymphocyte antigen CD20	Chronic lymphocytic leukaemia; Non-hodgkin's lymphoma; Systemic lupus erythematosus	710	C91, C85, M32
T73215	B-lymphocyte antigen CD20	Cluster headache		G44.0
T73215	B-lymphocyte antigen CD20	Diffuse large B-cell lymphoma; Multiple sclerosis	202.8, 340	C85.1, G35
T73215	B-lymphocyte antigen CD20	Hematologic malignancies	200-209	C81-C86
T73215	B-lymphocyte antigen CD20	Late-stage follicular lymphoma	202.0, 202.8	C81-C86, C82
T73215	B-lymphocyte antigen CD20	Lymphoma	202.8, 208.9	C81-C86
T73215	B-lymphocyte antigen CD20	Mantle cell lymphoma	200.4, 202.8, 203.0, 208.9	C81-C86, C85.7, C90.0, C91-C95
T73215	B-lymphocyte antigen CD20	Multiple scierosis	340	G35
T73215	B-lymphocyte antigen CD20	Multiple scierosis; Rheumatoid arthritis	340, 710-719, 714	G35, M05-M06
T73215	B-lymphocyte antigen CD20	Multiple sclerosis; Primary progressive	340	G35
T73215	B-lymphocyte antigen CD20	Non-hodgkin's lymphoma		C85
T73215	B-lymphocyte antigen CD20	Non-hodgkin's lymphoma; Follicular lymphoma	200, 202, 202.0, 202.8	C81-C86, C82, C82-C85
T73215	B-lymphocyte antigen CD20	Pemphigus disease	694.4	L10
T73215	B-lymphocyte antigen CD20	Relapsing or primary progressive forms of multiple sclerosis		G35
T73215	B-lymphocyte antigen CD20	Rheumatoid arthritis	710-719, 714	M05-M06
T73215	B-lymphocyte antigen CD20	Rheumatold arthritis; Follicular lymphoma	202.0, 714	C82, M05-M06
T73215	B-lymphocyte antigen CD20	Unspecified		
T73475	Matrilysin	Brain cancer	191, 225.0	C71, D33
T73475	Matrilysin	Cancer	140-229	C00-C96
T73475	Matrilysin	Lung cancer; Prostate cancer	140-229, 162, 185	C33-C34, C61
T73475	Matrilysin	Non-small-cell lung cancer; Hormone-refractory prostate cancer; Kaposi's sarcoma	140-229, 162, 176, 185, 204.0	C33, C33-C34, C34, C46, C61, C91.0
T73475	Matrilysin	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T73475	Matrilysin	Pancreatic cancer; Lung cancer	140-229, 157, 162	C25, C33-C34
T73476	Antithrombin-III	Acute coronary syndrome	444	I74
T73476	Antithrombin-III	Asthma		J45
T73476	Antithrombin-III	Blood coagulation disorders		D65-D68
T73476	Antithrombin-III	Cancer	140-229	C00-C96
T73476	Antithrombin-III	Central or sensorineural tinnitus	388.3	H93.1
T73476	Antithrombin-III	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T73476	Antithrombin-III	Coagulation		I80-I82
T73476	Antithrombin-III	Deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
T73476	Antithrombin-III	Phlebothrombosis		I80-I82
T73476	Antithrombin-III	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T73476	Antithrombin-III	Ulcerative colitis	556	K51
T73476	Antithrombin-III	Unspecified		
T73476	Antithrombin-III	Venous thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T73482	Orexin receptor type 1	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T73482	Orexin receptor type 1	Sleep disorders; Insomnia	307.4, 307.41, 307.42, 327, 327.0, 780.5, 780.51, 780.52	F51, F51.0, G47, G47.0
T73482	Orexin receptor type 1	Sleep disorders; Insomnia; Substance dependence	307.4, 307.41, 307.42, 327, 327.0, 780.5, 780.51, 780.52	F51, F51.0, G47, G47.0, F10-F19
T73495	Glutamate receptor, ionotropic kainate 1	Epilepsy; Alcohol use disorders	303	G40, F10.2
T73495	Glutamate receptor, ionotropic kainate 1	Epilepsy; Neuropathic pain	356.0, 356.8	G40, G64, G90.0
T73495	Glutamate receptor, ionotropic kainate 1	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T73495	Glutamate receptor, ionotropic kainate 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T73633	Ricin toxin pre-exposure	Ricin poisoning		T36-T50
T73671	Interferon ligand	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T73676	Synaptic vesicle glycoprotein 2A	Epilepsy		G40
T73676	Synaptic vesicle glycoprotein 2A	Pain; Epilepsy	338, 356.0, 356.8, 780	G64, G90.0, R52, G89, G40
T73676	Synaptic vesicle glycoprotein 2A	Partial-onset seizures		G00-G99
T73696	Relaxin receptor 1	Acute heart failure	428	I50
T73724	Neuronal acetylcholine receptor protein, beta-4 chain	Alzheimer disease	331	G30
T73726	Fungal Cytochrome P450 51	Aspergillosis		B44
T73726	Fungal Cytochrome P450 51	Candidiasis infection	001-139, 112	B37
T73726	Fungal Cytochrome P450 51	Chronic pain	338.2,780	R52.1-R52.2, G89
T73726	Fungal Cytochrome P450 51	Dermatological disease		L00-L99
T73726	Fungal Cytochrome P450 51	Dry eye disease	370.33	H16.229
T73726	Fungal Cytochrome P450 51	Fungal infections	110-118	B35-B49
T73726	Fungal Cytochrome P450 51	Hyperlipidaemia	272.0-272.4	E78
T73726	Fungal Cytochrome P450 51	Invasive aspergillosis	117.3	B44
T73726	Fungal Cytochrome P450 51	Onychomycosis		B35.1
T73726	Fungal Cytochrome P450 51	Solid tumours	140-199, 210-229	C00-D48
T73726	Fungal Cytochrome P450 51	Tinea pedis		B35.6
T73726	Fungal Cytochrome P450 51	Tinea pedis; Tinea cruris; Tinea corporis; Cutaneous candidiasis; Tinea versicolor		B353
T73760	Synthesis of T(H2) cytokines	Allergy	995.3	T78.4
T73928	HPV antigens	Cervical cancer	180	C53
T73977	Voltage-dependent R-type calcium channel alpha-1E subunit	Reperfusion injury		I00-I99
T73992	Beta-secretase	Alzheimer disease	331	G30
T73992	Beta-secretase	Cardiovascular disorder		I00-I99
T73992	Beta-secretase	Diabetes	253.5, 588.1	E23.2, N25.1
T73992	Beta-secretase	Diabetic nephropathy	250.4	E11.21
T73992	Beta-secretase	Rheumatoid arthritis	710-719, 714	M05-M06
T73992	Beta-secretase	Solid tumours	140-199, 210-229	C00-D48
T74002	Granulocyte-macrophage colony-stimulating factor	Autoimmune diabetes		E08-E13
T74002	Granulocyte-macrophage colony-stimulating factor	Bladder cancer	188	C67
T74002	Granulocyte-macrophage colony-stimulating factor	Cancer	140-229	C00-C96
T74002	Granulocyte-macrophage colony-stimulating factor	Colorectal cancer; Liver cancer	153, 154, 140-229, 155, 203.0	C18-C21, C22
T74002	Granulocyte-macrophage colony-stimulating factor	Melanoma	172	C43
T74002	Granulocyte-macrophage colony-stimulating factor	Ovarian cancer	183	C56
T74002	Granulocyte-macrophage colony-stimulating factor	Plaque psoriasis		L00-L99
T74002	Granulocyte-macrophage colony-stimulating factor	Prostate cancer	185	C61
T74002	Granulocyte-macrophage colony-stimulating factor	Rheumatoid arthritis	710-719, 714	M05-M06
T74002	Granulocyte-macrophage colony-stimulating factor	Severe asthma	493	J45
T74002	Granulocyte-macrophage colony-stimulating factor	Solid tumours	140-199, 210-229	C00-D48
T74002	Granulocyte-macrophage colony-stimulating factor	Unspecified		
T74034	Hepatitis C DNA	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T74166	Nicotinic acetylcholine receptor alpha3/beta4	Cough	786.2	R05
T74181	Growth hormone ligand	Growth disorder		E23.0
T74181	Growth hormone ligand	Growth hormone deficiency	253.0, 253.3	E22.0, E23.0
T74203	Mycobacterium tuberculosis antigen complex 85A	Mycobacterium tuberculosis infection		A15-A19
T74225	Class B GPCR	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T74238	Leukotriene CysLT2 receptor	Asthma		J45
T74238	Leukotriene CysLT2 receptor	Unspecified		
T74312	FL cytokine receptor	Acute lymphoblastic leukemia	204.0, 556	C91.0
T74312	FL cytokine receptor	Acute myeloid leukemia	205	C92.0
T74312	FL cytokine receptor	Acute myeloid leukemia; Prostate cancer; Pancreatic cancer	140-199, 140-229, 157, 205.0, 210-229	C25, C92.0, D10-D36, D3A
T74312	FL cytokine receptor	Airway inflammation	460-519	J00-J99
T74312	FL cytokine receptor	Breast cancer; Colorectal cancer	153, 154, 174, 175	C18-C21, C50
T74312	FL cytokine receptor	Cancer	140-229	C00-C96
T74312	FL cytokine receptor	Cancer; Hematopoietic stem cell transplantation	140-229	C00-C96, Z00-Z99
T74312	FL cytokine receptor	Colon cancer; Breast cancer; CLL; AML; GIST	140-199, 150-159, 200, 202, 202.8, 204.1, 205.0, 210-229	C00-C75, C15-C26, C7A, C7B, C81-C86, C82-C85, C91.1, C92.0, D10-D36, D3A
T74312	FL cytokine receptor	Glioblatoma; Gliosarcoma; Anaplastic mixed oligoastrocytoma	191	C71
T74312	FL cytokine receptor	Human immunodeficiency virus infection	279.3	B20-B26
T74312	FL cytokine receptor	Leukemia	208.9	C90-C95
T74312	FL cytokine receptor	Myelofibrosis	208.9, 289.83, 709.2	C94.4, D47.4
T74312	FL cytokine receptor	Myeloid leukemia	208.9	C92
T74312	FL cytokine receptor	Psoriasis	696	L40
T74312	FL cytokine receptor	Solid tumours	140-199, 210-229	C00-D48
T74402	Inhibiting NF-kappa B and p38 MAP kinase signalling pathway	Rheumatoid arthritis	710-719, 714	M05-M06
T74429	Calcium	Hypercalciuria		E83.5
T74429	Calcium	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T74437	Actin polymerization	Restenosis		I51.89
T74456	Type-1 angiotensin II receptor	Alzheimer disease	331	G30
T74456	Type-1 angiotensin II receptor	Heart failure	428	I50
T74456	Type-1 angiotensin II receptor	High blood pressure	401	I10-I16
T74456	Type-1 angiotensin II receptor	Hypertension	401	I10-I16
T74456	Type-1 angiotensin II receptor	Hypotension	458, 796.3	I95
T74456	Type-1 angiotensin II receptor	Metabolic syndrome x	277.7	E88.81
T74456	Type-1 angiotensin II receptor	Myocardial infarction	410	I21, I22
T74456	Type-1 angiotensin II receptor	Restenosis		I51.89
T74456	Type-1 angiotensin II receptor	Unspecified		
T74483	Potassium voltage-gated channel subfamily KQT member 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T74500	Potassiumvoltage-gated channel subfamily D member 3	Heart arrhythmia		I47-I49
T74500	Potassiumvoltage-gated channel subfamily D member 3	Metabolic acidosis	276.2	E87.2
T74654	Adrenergic neuron	Hypertension	401	I10-I16
T74654	Adrenergic neuron	Moderate and severe hypertension		I10-I16
T74891	Entamoebahistolytica cysteine proteinase EhCP4	Amebiasis	6	A06
T74937	Dopamine beta hydroxylase	Heart failure	428	I50
T74937	Dopamine beta hydroxylase	Post-traumatic stress disorder; Cocaine addiction	309.81, 304.2	F43.1, F14.2
T74977	Dual specificity protein kinase TTK	Cancer	140-229	C00-C96
T75041	TAG-72 antigen	Breast cancer	174, 175	C50
T75243	Serine/threonine-protein kinase mTOR	Advanced kidney cancer	189	C64
T75243	Serine/threonine-protein kinase mTOR	Bladder cancer	188	C67
T75243	Serine/threonine-protein kinase mTOR	Cancer	140-229	C00-C96
T75243	Serine/threonine-protein kinase mTOR	Coronary artery restenosis; Multiple myeloma	203	I51.89, C90
T75243	Serine/threonine-protein kinase mTOR	Dutch elm disease		B81-B83
T75243	Serine/threonine-protein kinase mTOR	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T75243	Serine/threonine-protein kinase mTOR	Multiple myeloma	203	C90
T75243	Serine/threonine-protein kinase mTOR	Non-hodgkin's lymphoma		C85
T75243	Serine/threonine-protein kinase mTOR	Non-small cell lung cancer		C33-C34
T75243	Serine/threonine-protein kinase mTOR	Organ rejection	279.5, 996	D89.8, T86
T75243	Serine/threonine-protein kinase mTOR	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T75243	Serine/threonine-protein kinase mTOR	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T75243	Serine/threonine-protein kinase mTOR	Renal cancer	140-229, 189	C64
T75243	Serine/threonine-protein kinase mTOR	Restenosis		I51.89
T75243	Serine/threonine-protein kinase mTOR	Sarcoma	202.8	C81-C86
T75243	Serine/threonine-protein kinase mTOR	Solid cancer; Lymphoma	140-199, 140-229, 202.8	C81-C86
T75243	Serine/threonine-protein kinase mTOR	Solid tumours	140-199, 210-229	C00-D48
T75243	Serine/threonine-protein kinase mTOR	Transplant rejection	279.5, 996	D89.8, T86
T75243	Serine/threonine-protein kinase mTOR	Ulcerative colitis	556	K51
T75251	Tubulin receptor	Macular degeneration	362.5	H35.3
T75354	JAK-2/STAT-1 pathway	Cancer	140-229	C00-C96
T75440	Peripheral-type benzodiazepine receptor	Alzheimer disease	331	G30
T75440	Peripheral-type benzodiazepine receptor	Anxiety disorder	300, 311	F32, F40-F42
T75440	Peripheral-type benzodiazepine receptor	Anxiety disorder; Insomnia	300, 307.4, 327.0	F40-F42, F51.0, G47.0
T75440	Peripheral-type benzodiazepine receptor	Anxiety disorder; Status epilepticus	300, 345.3	F40-F42, G40
T75440	Peripheral-type benzodiazepine receptor	Brain diseases		G00-G99
T75440	Peripheral-type benzodiazepine receptor	Cancer	140-229	C00-C96
T75440	Peripheral-type benzodiazepine receptor	Convulsions	780.3	R56.0
T75440	Peripheral-type benzodiazepine receptor	Epilepsy		G40
T75440	Peripheral-type benzodiazepine receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T75440	Peripheral-type benzodiazepine receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T75440	Peripheral-type benzodiazepine receptor	Lateral sclerosis		G12.2
T75440	Peripheral-type benzodiazepine receptor	Muscle relaxant		N39.3, N39.4, R32
T75440	Peripheral-type benzodiazepine receptor	Nootropic		F00-F99
T75440	Peripheral-type benzodiazepine receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T75440	Peripheral-type benzodiazepine receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T75440	Peripheral-type benzodiazepine receptor	Sedation	338	R52, G89
T75440	Peripheral-type benzodiazepine receptor	Spasms; Pain; Anxiety disorder	338, 780, 300, 311	R52, G89, F32, F40-F42
T75498	NRH dehydrogenase [quinone] 2	Breast cancer	174, 175	C50
T75498	NRH dehydrogenase [quinone] 2	Cancer	140-229	C00-C96
T75499	DNA intercalative bis-alkylating agents	Cancer	140-229	C00-C96
T75596	Methionine aminopeptidase 2	Autoimmune diabetes		E08-E13
T75596	Methionine aminopeptidase 2	Obesity	278	E66
T75596	Methionine aminopeptidase 2	Solid tumours	140-199, 210-229	C00-D48
T75613	Laminin gamma-2 subunit	Cancer	140-229	C00-C96
T75643	Pattern recognition receptor NOD2	Autoimmune diabetes		E08-E13
T75643	Pattern recognition receptor NOD2	Bacillus anthracis infection		A22
T75643	Pattern recognition receptor NOD2	HBV infection	070.2-070.3	B16, B18.0, B18.1
T75685	Hepatitis C Virus RNA-dependent RNA Polymerase	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T75788	Endostatin	Unspecified		
T75797	Prostaglandin F2-alpha receptor	Aborting pregnancy	779.6	O04
T75797	Prostaglandin F2-alpha receptor	Alzheimer disease	331	G30
T75797	Prostaglandin F2-alpha receptor	Dysmenorrhea	625.3	N94.4-N94.6
T75797	Prostaglandin F2-alpha receptor	Glaucoma	365	H40-H42
T75797	Prostaglandin F2-alpha receptor	Ocular disease		H00-H59
T75797	Prostaglandin F2-alpha receptor	Open-angle glaucoma; Ocular hypertension	365, 365.04	H40-H42, H40.0
T75797	Prostaglandin F2-alpha receptor	Renal cancer	140-229, 189	C64
T75888	Carnitine O-palmitoyltransferase I	Angina pectoris	413	I20
T75888	Carnitine O-palmitoyltransferase I	Diabetes	253.5, 588.1	E23.2, N25.1
T75888	Carnitine O-palmitoyltransferase I	Heart failure	428	I50
T75888	Carnitine O-palmitoyltransferase I	Nutritional deficiency	260-269	E40-E64
T75888	Carnitine O-palmitoyltransferase I	Obesity	278	E66
T75888	Carnitine O-palmitoyltransferase I	Psoriasis	696	L40
T75890	Dihydropyrimidine dehydrogenase [NADP+]	Cancer	140-229	C00-C96
T75890	Dihydropyrimidine dehydrogenase [NADP+]	Hyperlipidaemia	272.0-272.4	E78
T75890	Dihydropyrimidine dehydrogenase [NADP+]	Unspecified		
T75984	5-HT 2 receptor	Alcohol use disorders	303	F10.2
T75984	5-HT 2 receptor	Anxiety disorder	300, 311	F32, F40-F42
T75984	5-HT 2 receptor	Arthritis	710-719	M00-M25
T75984	5-HT 2 receptor	Cerebrovascular ischaemia	434.91	I61-I63
T75984	5-HT 2 receptor	Depression	311	F30-F39
T75984	5-HT 2 receptor	Hypertension	401	I10-I16
T75984	5-HT 2 receptor	Migraine	346	G43
T75984	5-HT 2 receptor	Peripheral vascular disease	443.9	I73.9
T75984	5-HT 2 receptor	Psychotic disorders	290-299	F20-F29
T75984	5-HT 2 receptor	Schizophrenia	295	F20
T75984	5-HT 2 receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T76024	C1 esterase	Hereditary angioedema	277.6	D84.1
T76024	C1 esterase	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T76034	Intracellular signaling, damage sensing, and DNA repair pathways responsible for DNA damage	Radiation sickness	990	T66
T76059	FK506-binding protein 1A	Parkinson's disease	332	G20
T76059	FK506-binding protein 1A	Pruritus	698	L29
T76059	FK506-binding protein 1A	Transplant rejection	279.5, 996	D89.8, T86
T76093	HB-EGF	Ovarian cancer	183	C56
T76093	HB-EGF	Solid tumours	140-199, 210-229	C00-D48
T76121	Radioactive diagnostic	Neuroendocrine cancer		C7A
T76121	Radioactive diagnostic	Suspected prostate cancer recurrence		C00-D49
T76198	Thromboxane A2 receptor	Acute myocardial infarction	410	I21-I22
T76198	Thromboxane A2 receptor	Allergic asthma	493, 995.3	J45, T78.4
T76198	Thromboxane A2 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T76198	Thromboxane A2 receptor	Angina pectoris	413	I20
T76198	Thromboxane A2 receptor	Asthma		J45
T76198	Thromboxane A2 receptor	Cardiovascular disorder		I00-I99
T76198	Thromboxane A2 receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T76198	Thromboxane A2 receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T76198	Thromboxane A2 receptor	Perennial allergic rhinitis	204.0, 472.0, 477, 995.3	C91.0, J00, J30, J31.0, T78.4
T76198	Thromboxane A2 receptor	Peripheral vascular disease	443.9	I73.9
T76198	Thromboxane A2 receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T76198	Thromboxane A2 receptor	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T76198	Thromboxane A2 receptor	Unspecified		
T76213	Phenylalanine hydroxylase	Autoimmune diabetes		E08-E13
T76213	Phenylalanine hydroxylase	Genetic disease		Q00-Q99
T76213	Phenylalanine hydroxylase	Hyperphenylalaninemia		E70.1
T76213	Phenylalanine hydroxylase	Liver failure		K72.9
T76213	Phenylalanine hydroxylase	Phenylketonuria		E70.0
T76285	Phosphodiesterase I beta	Renal cancer	140-229, 189	C64
T76310	Calcium flux	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T76369	Liver carboxylesterase	Acute lymphoblastic leukemia	204.0, 556	C91.0
T76369	Liver carboxylesterase	Arteriosclerosis	440	I70
T76369	Liver carboxylesterase	Atherosclerosis	414.0, 440	I70
T76369	Liver carboxylesterase	Hypercholesterolemia		E78
T76369	Liver carboxylesterase	Hyperlipidaemia	272.0-272.4	E78
T76369	Liver carboxylesterase	Peripheral vascular disease	443.9	I73.9
T76396	Geranylgeranyltransferase I	Lymphoma	202.8, 208.9	C81-C86
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Brain injury		S09.90
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Cancer pain	140-229, 338,780	R52, G89
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Cardiac arrest		I46
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Cerebrovascular ischaemia	434.91	I61-I63
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Convulsions	780.3	R56.0
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Diabetic peripheral neuropathic pain	250.6, 338,780	E10.4, E11.4, E13.4, R52, G89
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Multiple scierosis	340	G35
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Neuropathic pain	356.0, 356.8	G64, G90.0
T76414	Glutamate [NMDA] receptor subunit epsilon 2	Parkinson's disease	332	G20
T76581	Cytochrome P450 3A	Human immunodeficiency virus infection	279.3	B20-B26
T76630	CAMPATH-1 antigen	Multiple scierosis	340	G35
T76630	CAMPATH-1 antigen	Multiple scierosis; Chronic lymphocytic leukaemia	340	G35, C91
T76685	Cannabinoid receptor 1	Anorexia	307.1	F50.0-F50.1
T76685	Cannabinoid receptor 1	Central nervous system disease		G00-G99
T76685	Cannabinoid receptor 1	Cerebrovascular ischaemia	434.91	I61-I63
T76685	Cannabinoid receptor 1	Chemotherapy-induced nausea	787, 787.0	R11
T76685	Cannabinoid receptor 1	Diabetes; Obesity	250, 278	E08-E13, E66
T76685	Cannabinoid receptor 1	Drug abuse	303-304	F10-F19
T76685	Cannabinoid receptor 1	Endocrine disease		E00-E35
T76685	Cannabinoid receptor 1	Hypertension; Diabetes; Obesity	250, 278, 401	E08-E13, E66, I10-I16
T76685	Cannabinoid receptor 1	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T76685	Cannabinoid receptor 1	Ischemia	459.89	I99.8
T76685	Cannabinoid receptor 1	Lipid metabolism disorder		E75-E78
T76685	Cannabinoid receptor 1	Metabolic disorders	270-279	E70-E89
T76685	Cannabinoid receptor 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T76685	Cannabinoid receptor 1	Nicotine dependence; Obesity	278, 305.1	E66, F17
T76685	Cannabinoid receptor 1	Obesity	278	E66
T76685	Cannabinoid receptor 1	Obesity; Diabetes	250, 278	E08-E13, E66
T76685	Cannabinoid receptor 1	Obesity; Metabolic disorders	270-279, 278	E66, E70-E89
T76685	Cannabinoid receptor 1	Ovarian cancer	183	C56
T76685	Cannabinoid receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T76685	Cannabinoid receptor 1	Postherpetic neuralgia	53.19	B02.2, G44.847, G53.0
T76685	Cannabinoid receptor 1	Psychotic disorders	290-299	F20-F29
T76685	Cannabinoid receptor 1	Schizophrenia	295	F20
T76685	Cannabinoid receptor 1	Type 2 diabetes	250	E11
T76701	Cyclin D1/E2F pathway	Platelet aggregatory		D69.1
T76818	Cyclosporine receptor	Allergy	995.3	T78.4
T76846	Melanocortin-3 receptor	Sexual dysfunction; Obesity; Type 2 diabetes	250, 250.00, 250.02, 278, 302.7	E08-E13, E11, E66, F52
T76855	Bacterial elongation factor Tu	Acne vulgaris	706.1	L70.0
T76855	Bacterial elongation factor Tu	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T76904	Catechol-O-methyl-transferase	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T76904	Catechol-O-methyl-transferase	Non-insulin dependent diabetes		E11.9
T76904	Catechol-O-methyl-transferase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T76904	Catechol-O-methyl-transferase	Parkinson's disease	332	G20
T76904	Catechol-O-methyl-transferase	Parkinson's disease; Restless legs syndrome	332, 333.94	F02.3, G20, G25.8
T76904	Catechol-O-methyl-transferase	Schizophrenia	295	F20
T76910	Glycogen synthase kinase-3	Acute myeloid leukemia; Acute promyelocytic leukemia	205.0, 208.9	C91-C95, C92.0, C92.4
T76910	Glycogen synthase kinase-3	Alcohol use disorders	303	F10.2
T76910	Glycogen synthase kinase-3	Epilepsy		G40
T76914	Potassium voltage-gated channel subfamily A member 3	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T76914	Potassium voltage-gated channel subfamily A member 3	Psoriatic arthritis	696	L40.5, M07
T76937	Voltage-gated sodium channel subunit alpha Nav1.3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T77009	Thioredoxin reductase	Brain cancer	191, 225.0	C71, D33
T77009	Thioredoxin reductase	Human immunodeficiency virus infection	279.3	B20-B26
T77158	Protein synthesis	Cancer	140-229	C00-C96
T77190	SLIT and NTRK-like family member 6 (SLITRK6)	Bladder cancer	188	C67
T77195	NADH dehydrogenase	Parkinson's disease	332	G20
T77365	Adenosine A2a receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T77365	Adenosine A2a receptor	Arteriosclerosis	440	I70
T77365	Adenosine A2a receptor	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T77365	Adenosine A2a receptor	Coronary disorder diagnosis	410-414, 429.2	I20-I25
T77365	Adenosine A2a receptor	Diabetic foot ulcer	707	L88-L89
T77365	Adenosine A2a receptor	Glaucoma	365	H40-H42
T77365	Adenosine A2a receptor	Hypertension	401	I10-I16
T77365	Adenosine A2a receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T77365	Adenosine A2a receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T77365	Adenosine A2a receptor	Parkinson's disease	332	G20
T77365	Adenosine A2a receptor	Radionuclide imaging		W88
T77400	CGMP-dependent3',5'-cyclic phosphodiesterase	Inflammatory bowel disease	555, 556	K50, K51
T77400	CGMP-dependent3',5'-cyclic phosphodiesterase	Mood disorder		F30-F39
T77428	AMPA receptor	Diabetic neuropathy	250, 250.6, 356.0, 356.8	E11.40
T77428	AMPA receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T77428	AMPA receptor	Parkinson's disease	332	G20
T77428	AMPA receptor	Unspecified		
T77431	5-HT 3 receptor	Anxiety disorder	300, 311	F32, F40-F42
T77431	5-HT 3 receptor	Chronic functional vomiting	536.2	R11.10
T77431	5-HT 3 receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T77431	5-HT 3 receptor	Gastric motility disorder		K22.4
T77431	5-HT 3 receptor	Gastro-oesophageal reflux	530	K21
T77431	5-HT 3 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T77431	5-HT 3 receptor	Mood disorder		F30-F39
T77431	5-HT 3 receptor	Nausea		R11
T77431	5-HT 3 receptor	Substance dependence		F10-F19
T77431	5-HT 3 receptor	Unspecified		
T77473	Translationally controlled tumor protein	Acute myeloid leukemia	205	C92.0
T77534	Phospholipase C	Cancer	140-229	C00-C96
T77534	Phospholipase C	Leukemia	208.9	C90-C95
T77594	78 kDa glucose-regulated protein	Melanoma	172	C43
T77594	78 kDa glucose-regulated protein	Solid tumours	140-199, 210-229	C00-D48
T77613	Phosphodiesterase (PDE) 1B	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T77645	Tumor necrosis factor receptor superfamily member 10A	Advanced hepatocellular carcinoma; Non-small cell lung cancer	155	C22.0, C33-C34
T77645	Tumor necrosis factor receptor superfamily member 10A	Cancer	140-229	C00-C96
T77664	Interferon gamma	B-cell lymphoma	202.8	C85.1
T77664	Interferon gamma	Basal cell cancer	140-229, 173	C44
T77664	Interferon gamma	Discoid lupus erythematosus; Systemic lupus erythematosus	695.4, 710	L93.0, M32
T77664	Interferon gamma	Human immunodeficiency virus infection	279.3	B20-B26
T77664	Interferon gamma	Inflammatory bowel disease; Rheumatoid arthritis	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
T77664	Interferon gamma	Prostate cancer	185	C61
T77664	Interferon gamma	Psoriatic disorder	696	L40
T77664	Interferon gamma	Pustular palmoplantar psoriasis; Multiple sclerosis	340, 696, 696.1	G35, L40, L40.3
T77796	Thyrotropin-releasing hormone receptor	CNS stimulant		
T77796	Thyrotropin-releasing hormone receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T77796	Thyrotropin-releasing hormone receptor	Endocrine disease		E00-E35
T77796	Thyrotropin-releasing hormone receptor	Neurodegenerative disease	330-337	G30-G32
T77796	Thyrotropin-releasing hormone receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T77796	Thyrotropin-releasing hormone receptor	Unspecified		
T77896	Inhibiting the expression of inducible nitric oxide synthase (iNOS)	Diarrhea	787.91	A09, K59.1
T77913	Histamine H1 receptor	Allergic conjunctivitis	204.0, 372.0, 372.14, 995.3	C91.0, H10, H10.45, T78.4
T77913	Histamine H1 receptor	Allergic disorders; Itching; Nausea	698, 787, 787.0, 995.3	L29, R11, T78.4
T77913	Histamine H1 receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T77913	Histamine H1 receptor	Allergic rhinitis; Urticaria	477, 708	J30, L50
T77913	Histamine H1 receptor	Allergic rhinitis; Urticaria; Pruritus	477, 708	J30, L50
T77913	Histamine H1 receptor	Allergic skin disorders		L00-L99
T77913	Histamine H1 receptor	Allergy	995.3	T78.4
T77913	Histamine H1 receptor	Anesthesia	338	R20.0
T77913	Histamine H1 receptor	Anxiety disorder	300, 311	F32, F40-F42
T77913	Histamine H1 receptor	Anxiety disorder; Morning sickness	300, 643.0	F40-F42, O21.0
T77913	Histamine H1 receptor	Asthma		J45
T77913	Histamine H1 receptor	Common cold; Allergies	460, 995.3	J00, T78.4
T77913	Histamine H1 receptor	Depression	311	F30-F39
T77913	Histamine H1 receptor	Dry cough		R05
T77913	Histamine H1 receptor	Hay fever	477	J30
T77913	Histamine H1 receptor	Hay fever; Allergic rhinitis	477, 472.0, 995.3	J30, J00, J31.0, T78.4
T77913	Histamine H1 receptor	Hay fever; Cough	477, 786.2	J30, R05
T77913	Histamine H1 receptor	Hypersensitivity reactions; Coughs; Common colds		R05
T77913	Histamine H1 receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T77913	Histamine H1 receptor	Insomnia; Anxiety disorder	307.41, 307.42, 327.0, 780.51, 780.52, 300, 311	F51.0, G47.0, F32, F40-F42
T77913	Histamine H1 receptor	Nasal congestion	478.19	J34.89
T77913	Histamine H1 receptor	Nausea; Vomiting	787, 787.0	R11
T77913	Histamine H1 receptor	Obesity	278	E66
T77913	Histamine H1 receptor	Ocular allergy	360-379	H00-H59
T77913	Histamine H1 receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T77913	Histamine H1 receptor	Parkinson's disease	332	G20
T77913	Histamine H1 receptor	Perennial and seasonal allergic rhinitis; Vasomotor rhinitis; Allergic conjunctivitis		H10
T77913	Histamine H1 receptor	Pruritus	698	L29
T77913	Histamine H1 receptor	Respiratory allergies; Allergic rhinitis	460-519, 472.0, 477, 995.3	J00-J99, J00, J30, J31.0, T78.4
T77913	Histamine H1 receptor	Respiratory allergies; Cancer	460-519, 140-229	J00-J99, C00-C96
T77913	Histamine H1 receptor	Respiratory disease		J00-J99
T77913	Histamine H1 receptor	Rhinitis	472.0, 477	J00, J30, J31.0
T77913	Histamine H1 receptor	Rhinitis; Urticaria; Allergy		J00, J30, J31.0, L50, T78.4
T77913	Histamine H1 receptor	Seasonal and perennial allergic rhinitis and vasomotor rhinitis		J30
T77913	Histamine H1 receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
T77913	Histamine H1 receptor	Unspecified		
T77913	Histamine H1 receptor	Vertigo meniere's disease	386.0, 438.85, 780.4	H81, H81.0, R42
T77913	Histamine H1 receptor	Vertigo's disease; Meniere's disease		H81.09
T77990	Staphylococcus aureus iron-regulated surface determinant protein B	Staphylococcus aureus infection		B95.6
T78111	Nicotinic acetylcholine receptor	Alzheimer disease	331	G30
T78111	Nicotinic acetylcholine receptor	Anesthesia	338	R20.0
T78111	Nicotinic acetylcholine receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T78111	Nicotinic acetylcholine receptor	Diabetic foot ulcer	707	L88-L89
T78111	Nicotinic acetylcholine receptor	General anesthesia	338	R20.0
T78111	Nicotinic acetylcholine receptor	Insecticide		F19.20
T78111	Nicotinic acetylcholine receptor	Moderately severe to severe essential hypertension		I10
T78111	Nicotinic acetylcholine receptor	Nicotine dependence	305.1	F17
T78111	Nicotinic acetylcholine receptor	Paralysis		G72.3
T78111	Nicotinic acetylcholine receptor	Parkinson's disease	332	G20
T78111	Nicotinic acetylcholine receptor	Schizophrenia	295	F20
T78111	Nicotinic acetylcholine receptor	Severe mood disorders	296	F30-F39
T78111	Nicotinic acetylcholine receptor	Tobacco dependence	305.1	F17
T78114	CD55	Colorectal cancer	153, 154	C18-C21
T78114	CD55	Gastric cancer	151	C16
T78114	CD55	Glioblastoma multiforme	191	C71
T78156	Capsid-SP1 cleavage site in HIV Gag protein	Human immunodeficiency virus infection	279.3	B20-B26
T78173	Fungal squalene epoxidase	Dermatologic infections	680-686	L00-L08
T78173	Fungal squalene epoxidase	Fungal infections	110-118	B35-B49
T78198	Purine nucleoside phosphorylase	Autoimmune diabetes		E08-E13
T78198	Purine nucleoside phosphorylase	Gout; Moderate-to-severe plaque psoriasis	274.00274.1274.8274.9, 696	M10, L40
T78198	Purine nucleoside phosphorylase	Refractory cutaneous T-cell lymphoma; B-cell acute lymphoblastic leukemia	202.1, 202.2, 202.8, 204.0, 208.9	C81-C86, C84.0, C84.1, C91-C95, C91.0
T78198	Purine nucleoside phosphorylase	Rheumatoid arthritis	710-719, 714	M05-M06
T78244	Vasoactive intestinal polypeptide receptor	Asthma		J45
T78277	Asparaginase	Acute lymphoblastic leukemia	204.0, 556	C91.0
T78277	Asparaginase	Adolescents and children acute lymphoblastic leukemia	204	C91.0
T78319	CD44 antigen	Cancer	140-229	C00-C96
T78319	CD44 antigen	Macular degeneration	362.5	H35.3
T78356	Thromboxane-A synthase	Angina pectoris	413	I20
T78356	Thromboxane-A synthase	Asthma		J45
T78356	Thromboxane-A synthase	Cardiac arrhythmias	427	I47-I49
T78356	Thromboxane-A synthase	Inflammatory bowel disease	555, 556	K50, K51
T78356	Thromboxane-A synthase	Nephritis		N00-N19, N25-N29
T78356	Thromboxane-A synthase	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T78356	Thromboxane-A synthase	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T78356	Thromboxane-A synthase	Type 2 diabetes	250	E11
T78356	Thromboxane-A synthase	Unspecified		
T78366	Hydroxyl radicals and superoxide anions	Immuno-stimulant		C00-C97
T78381	Interleukin-29 ligand	Acute myeloid leukemia	205	C92.0
T78381	Interleukin-29 ligand	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T78429	Inhibitor of nuclear factor kappa B kinase beta subunit	Acne vulgaris	706.1	L70.0
T78429	Inhibitor of nuclear factor kappa B kinase beta subunit	Alzheimer disease	331	G30
T78429	Inhibitor of nuclear factor kappa B kinase beta subunit	Arthritis	710-719	M00-M25
T78429	Inhibitor of nuclear factor kappa B kinase beta subunit	Osteoarthritis	715	M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Alzheimer disease	331	G30
T78464	Prostaglandin G/H synthase 2	Arthritis	710-719	M00-M25
T78464	Prostaglandin G/H synthase 2	Asthma		J45
T78464	Prostaglandin G/H synthase 2	Cancer	140-229	C00-C96
T78464	Prostaglandin G/H synthase 2	Chronic pain; Ankylosing spondylitis	338.2, 780, 720	R52.1-R52.2, G89, M08.1, M45
T78464	Prostaglandin G/H synthase 2	Colon polyps		K63.5
T78464	Prostaglandin G/H synthase 2	Dysmenorrhea	625.3	N94.4-N94.6
T78464	Prostaglandin G/H synthase 2	Gout	274.00274.1274.8274.9	M10
T78464	Prostaglandin G/H synthase 2	Hyperthermia		T68
T78464	Prostaglandin G/H synthase 2	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T78464	Prostaglandin G/H synthase 2	Inflammatory bowel disease	555, 556	K50, K51
T78464	Prostaglandin G/H synthase 2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T78464	Prostaglandin G/H synthase 2	Joint and muscular pain; Arthritis; Dysmenorrhea		M00-M25, N94
T78464	Prostaglandin G/H synthase 2	Knee osteoarthritis	715	M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Moderate to severe rheumatoid arthritis		M05-M06
T78464	Prostaglandin G/H synthase 2	Neuropathic pain	356.0, 356.8	G64, G90.0
T78464	Prostaglandin G/H synthase 2	Non-small cell lung cancer; Pancreatic cancer; Rheumatoid arthritis	140-199, 140-229, 157, 210-229, 710-719, 714	C33-C34, C25, M05-M06
T78464	Prostaglandin G/H synthase 2	Osteoarthritis	715	M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Osteoarthritis; Neuropathic pain	338, 356.0, 356.8, 715,780	G64, G90.0, M15-M19, M47, R52, G89
T78464	Prostaglandin G/H synthase 2	Osteoarthritis; Rheumatoid arthritis	714, 715	M05-M06, M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T78464	Prostaglandin G/H synthase 2	Pain; Endometriosis	338, 617.0,780	N80, R52, G89
T78464	Prostaglandin G/H synthase 2	Pain; Osteoarthritis	338, 356.0, 356.8, 780, 715	G64, G90.0, R52, G89, M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Rheumatoid arthritis	710-719, 714	M05-M06
T78464	Prostaglandin G/H synthase 2	Rheumatoid arthritis; Dysmenorrhea	710-719, 714, 625.3	M05-M06, N94.4-N94.6
T78464	Prostaglandin G/H synthase 2	Rheumatold arthritis; Osteoarthritis	714, 715	M05-M06, M15-M19, M47
T78464	Prostaglandin G/H synthase 2	Rheumatold arthritis; Osteoarthritis; Dysmenorrhea	714, 715, 625.3	M05-M06, M15-M19, M47, N94.4-N94.6
T78464	Prostaglandin G/H synthase 2	Rheumatold arthritis; Pain	338, 714,780	M05-M06, R52, G89
T78464	Prostaglandin G/H synthase 2	Type 2 diabetes	250	E11
T78464	Prostaglandin G/H synthase 2	Unspecified		
T78581	Galanin receptor type 1	Epileptic seizures	345.9, 780.3	G40, P90, R56
T78585	Interleukin-5	Asthma; Eosinophilic esophagitis; Severe asthma; Loiasis		J45, K200
T78585	Interleukin-5	Asthma; Eosinophilic oesophagitis; Hypereosinophilia		D72.1, J40-J44, J47, J45, L20
T78585	Interleukin-5	Eosinophilic asthma	493	J45
T78585	Interleukin-5	Severe asthma	493	J45
T78585	Interleukin-5	Severe asthma; Nasal polyposis	471, 493	J33, J45
T78590	Polymorphonuclear neutrophil adhesion	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T78656	5-hydroxytryptamine 1F receptor	Migraine	346	G43
T78709	5-hydroxytryptamine 1A receptor	Alzheimer disease	331	G30
T78709	5-hydroxytryptamine 1A receptor	Alzheimer disease; Peripheral sensory neuropathies; Lateral sclerosis	331.0, 356.0, 356.8	G30, G64, G90.0, G12.2
T78709	5-hydroxytryptamine 1A receptor	Anxiety disorder	300, 311	F32, F40-F42
T78709	5-hydroxytryptamine 1A receptor	Bulimia nervosa; Severe mood disorders	296, 307.51	F30-F39, F50.2
T78709	5-hydroxytryptamine 1A receptor	Cervical dystonia; Spasm	333.83, 728.85	G24.3, R25.2
T78709	5-hydroxytryptamine 1A receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T78709	5-hydroxytryptamine 1A receptor	Coronary artery disease	410-414, 429.2	I20-I25
T78709	5-hydroxytryptamine 1A receptor	Depression	311	F30-F39
T78709	5-hydroxytryptamine 1A receptor	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10-I16, I50
T78709	5-hydroxytryptamine 1A receptor	Female sexual dysfunction	302.7	F52
T78709	5-hydroxytryptamine 1A receptor	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
T78709	5-hydroxytryptamine 1A receptor	Generalized anxiety disorder; Social phobia	300, 300.02, 300.23	F40-F42, F40.1, F41.1, F93.2
T78709	5-hydroxytryptamine 1A receptor	Hypertension	401	I10-I16
T78709	5-hydroxytryptamine 1A receptor	Hypoactive sexual desire disorder		F52.0
T78709	5-hydroxytryptamine 1A receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T78709	5-hydroxytryptamine 1A receptor	Major depressive disorder; Episode; Anxiety	296.2, 296.3, 300	F32, F32.2, F32.3, F33, F40-F42
T78709	5-hydroxytryptamine 1A receptor	Migraine	346	G43
T78709	5-hydroxytryptamine 1A receptor	Mood disorder		F30-F39
T78709	5-hydroxytryptamine 1A receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T78709	5-hydroxytryptamine 1A receptor	Parkinson's disease	332	G20
T78709	5-hydroxytryptamine 1A receptor	Premature ejaculation	302.75	F52.4
T78709	5-hydroxytryptamine 1A receptor	Psychiatric disorder	290-319	F01-F99
T78709	5-hydroxytryptamine 1A receptor	Psychotic disorders	290-299	F20-F29
T78709	5-hydroxytryptamine 1A receptor	Schizoaffective disorder; Schizophrenia	295, 295.70	F20, F25
T78709	5-hydroxytryptamine 1A receptor	Schizophrenia	295	F20
T78709	5-hydroxytryptamine 1A receptor	Severe mood disorders	296	F30-F39
T78709	5-hydroxytryptamine 1A receptor	Unspecified		
T78709	5-hydroxytryptamine 1A receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T78818	Na+-K+-ATPase transmembrane protein	Dental plaque inhibitor		K03.6
T78874	Protein kinase	Asthma		J45
T78874	Protein kinase	Glaucoma	365	H40-H42
T78874	Protein kinase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T78890	Tissue factor pathway inhibitor	Factor IX deficiency		D67
T78890	Tissue factor pathway inhibitor	Sepsis	995.91	A40, A41
T78892	mRNA of integrin alpha-4	Multiple scierosis	340	G35
T78915	Tryptophan 5-hydroxylase-1	Psychotic disorders	290-299	F20-F29
T78937	ribosome A site	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T78937	ribosome A site	Chronic or accelerated-phase chronic myeloid leukaemia	208.9	C91-C95
T78981	Complement C5	Autoimmune diabetes		E08-E13
T78981	Complement C5	Cardiovascular disorder		I00-I99
T78981	Complement C5	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T78981	Complement C5	Glomerulonephritis	580-582	N00, N01, N03, N18
T78981	Complement C5	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T78981	Complement C5	Macular degeneration	362.5	H35.3
T78981	Complement C5	Rheumatoid arthritis	710-719, 714	M05-M06
T79001	Chorismate synthase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T79027	Cytidine deaminase	Solid tumours	140-199, 210-229	C00-D48
T79062	5-hydroxytryptamine 7 receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T79062	5-hydroxytryptamine 7 receptor	Schizophrenia	295	F20
T79062	5-hydroxytryptamine 7 receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
T79068	Enoyl-[acyl-carrier-protein] reductase [NADH]	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T79068	Enoyl-[acyl-carrier-protein] reductase [NADH]	Malaria		B54
T79068	Enoyl-[acyl-carrier-protein] reductase [NADH]	Mycobacterium tuberculosis infection		A15-A19
T79068	Enoyl-[acyl-carrier-protein] reductase [NADH]	Tuberculosis	010-018	A15-A19
T79157	Epiregulin (EREG)	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
T79160	Glial cell neurotrophic factor ligand	Lateral sclerosis		G12.2
T79200	Factor H binding protein	Meningitis	320-322	G00-G03
T79232	Vasopressin V1a receptor	Acute and chronic heart failure	428	I50
T79232	Vasopressin V1a receptor	Anxiety disorder	300, 311	F32, F40-F42
T79232	Vasopressin V1a receptor	Autism	299	F84.0
T79232	Vasopressin V1a receptor	Cardiotonic		I50
T79232	Vasopressin V1a receptor	Dysmenorrhea	625.3	N94.4-N94.6
T79232	Vasopressin V1a receptor	Euvolemic hyponatremia	276.1	E87.1
T79232	Vasopressin V1a receptor	Hypertension	401	I10-I16
T79232	Vasopressin V1a receptor	Hyponatraemia		E87.1
T79232	Vasopressin V1a receptor	Infertility	628	N97.0
T79232	Vasopressin V1a receptor	Localisation		
T79232	Vasopressin V1a receptor	Septic shock	785.52	A41.9
T79249	mRNA of thymidylate synthase	Cancer	140-229	C00-C96
T79422	M1 prime segment of membrane IgE	Asthma		J45
T79473	Lutropin-choriogonadotropic hormone receptor	Breast cancer	174, 175	C50
T79473	Lutropin-choriogonadotropic hormone receptor	Cancer	140-229	C00-C96
T79473	Lutropin-choriogonadotropic hormone receptor	Female infertility	628	N97.0
T79473	Lutropin-choriogonadotropic hormone receptor	Fertility		N00-N99
T79473	Lutropin-choriogonadotropic hormone receptor	Heart disease	390-429	I00-I52
T79473	Lutropin-choriogonadotropic hormone receptor	Infertility	628	N97.0
T79473	Lutropin-choriogonadotropic hormone receptor	Leukemia	208.9	C90-C95
T79473	Lutropin-choriogonadotropic hormone receptor	Myelodysplastic syndrome	238.7	D46
T79534	Cytochrome P-450-dependent ergosterol synthesis	Fungal infections	110-118	B35-B49
T79591	Thyroid hormone receptor alpha	Hypothyroidism	244	E03
T79591	Thyroid hormone receptor alpha	Hypothyroidism of any etiology		R68, T68
T79617	Facilitating dopamine (DA) release, inhibiting monoamine oxidase type B (MAO-B) and DA (re) up-take and stimulating aromatic L-amino acid decarboxylase (AADC)	Migraine	346	G43
T79798	MAP kinase p38	Diabetic nephropathy	250.4	E11.21
T79798	MAP kinase p38	Inflammatory bowel disease	555, 556	K50, K51
T79798	MAP kinase p38	Inflammatory bowel disease; Rheumatoid arthritis; Cardiovascular disorders; Psoriasis	390-459, 555, 556, 696, 710-719, 714	I00-I99, K50, K51, L40, M00-M25, M05-M06
T79798	MAP kinase p38	Osteoarthritis; Pain	338, 715,780	M15-M19, M47, R52, G89
T79798	MAP kinase p38	Rheumatoid arthritis; Myelodysplastic syndrome	710-719, 714, 238.7	M05-M06, D46
T79826	Wnt pathway	Osteoarthritis	715	M15-M19, M47
T79873	HIV-1 integrase	Human immunodeficiency virus infection	279.3	B20-B26
T79961	Acetylcholine receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T79961	Acetylcholine receptor	Amnesia		F04
T79961	Acetylcholine receptor	Brain diseases		G00-G99
T79961	Acetylcholine receptor	Central and peripheral nervous diseases		G96.9
T79961	Acetylcholine receptor	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T79961	Acetylcholine receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T79961	Acetylcholine receptor	Colitis	556.9	K50-K52
T79961	Acetylcholine receptor	Dysmenorrhea	625.3	N94.4-N94.6
T79961	Acetylcholine receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T79961	Acetylcholine receptor	Myasthenia gravis	358	G70.0
T79961	Acetylcholine receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T79961	Acetylcholine receptor	Schizophrenia	295	F20
T79961	Acetylcholine receptor	Stomach ulcer		K25-K27
T79961	Acetylcholine receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T80011	mRNA of eIF4E-BP2	Cancer	140-229	C00-C96
T80024	Gene thrapy-delivered myostatin	Macular degeneration	362.5	H35.3
T80031	Nuclear transcription mechanisms that govern and regulate inflammation	Cardiovascular disorder		I00-I99
T80276	PI3K alpha	Cancer	140-229	C00-C96
T80276	PI3K alpha	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T80276	PI3K alpha	Solid tumours	140-199, 210-229	C00-D48
T80338	Activin type-IIB receptor	Muscle wasting disease		M62.50
T80387	Gamma-aminobutyric acid receptor subunit beta-2	Epileptic seizures	345.9, 780.3	G40, P90, R56
T80387	Gamma-aminobutyric acid receptor subunit beta-2	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T80387	Gamma-aminobutyric acid receptor subunit beta-2	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T80387	Gamma-aminobutyric acid receptor subunit beta-2	Muscle spasm		M62.838
T80387	Gamma-aminobutyric acid receptor subunit beta-2	Premenstrual syndrome		N94.3
T80452	Mucin	Ocular disease		H00-H59
T80452	Mucin	Xerophthalmia		E50.6-E50.7
T80496	Sodium calcium channel	Epilepsy		G40
T80701	Hydroxyapatite	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T80775	COX-2 transcription	Lupus nephritis	583.81	M32.1, N08.5
T80782	mRNA of VEGFR1	Exudative age-related macular degeneration	362.5	H35.3
T80782	mRNA of VEGFR1	Neovascular age-related macular degeneration	362.5	H35.3
T80896	Estrogen receptor beta	Cancer	140-229	C00-C96
T80896	Estrogen receptor beta	Cushing's disease	255	E24.0
T80896	Estrogen receptor beta	Hepatitis virus infection	573.3	K75.9
T80896	Estrogen receptor beta	Hot flashes		N95.1
T80896	Estrogen receptor beta	Inflammatory bowel disease	555, 556	K50, K51
T80896	Estrogen receptor beta	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T80896	Estrogen receptor beta	Menopause symptoms		N95.0
T80896	Estrogen receptor beta	Ocular disease		H00-H59
T80896	Estrogen receptor beta	Prostate cancer	185	C61
T80896	Estrogen receptor beta	Prostate hyperplasia		N40
T80896	Estrogen receptor beta	Sepsis	995.91	A40, A41
T80896	Estrogen receptor beta	Vasomotor symptoms	627.2	N95.1
T80942	Matrix metalloprotease	Arthritis	710-719	M00-M25
T80942	Matrix metalloprotease	Cancer	140-229	C00-C96
T80942	Matrix metalloprotease	Inflammatory bowel disease	555, 556	K50, K51
T80942	Matrix metalloprotease	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T80942	Matrix metalloprotease	Osteoarthritis	715	M15-M19, M47
T80942	Matrix metalloprotease	Rheumatoid arthritis	710-719, 714	M05-M06
T80975	Vascular endothelial growth factor receptor 2	Advanced malignancies	140-229	C00-C96
T80975	Vascular endothelial growth factor receptor 2	Advanced renal cell carcinoma	189	C64
T80975	Vascular endothelial growth factor receptor 2	Angiogenesis disorder		I00-I99
T80975	Vascular endothelial growth factor receptor 2	Biliary cancer		C22, C24
T80975	Vascular endothelial growth factor receptor 2	Breast cancer	174, 175	C50
T80975	Vascular endothelial growth factor receptor 2	Breast cancer; Liver cancer	174, 175, 140-229, 155, 203.0	C50, C22
T80975	Vascular endothelial growth factor receptor 2	Cancer	140-229	C00-C96
T80975	Vascular endothelial growth factor receptor 2	Cardiovascular disorder		I00-I99
T80975	Vascular endothelial growth factor receptor 2	Colorectal cancer	153, 154	C18-C21
T80975	Vascular endothelial growth factor receptor 2	Cutaneous Melanoma		C43-C44
T80975	Vascular endothelial growth factor receptor 2	Fallopian tube cancer; Ovarian cancer; Peritoneal cavity cancer	140-229, 158, 183, 183.2, 221.0	C48.1, C48.2, C56, C57, D28
T80975	Vascular endothelial growth factor receptor 2	Gastric cancer	151	C16
T80975	Vascular endothelial growth factor receptor 2	Gastric cancer; Renal cell carcinoma; Squamous cell cancer of head and neck	140-229, 151, 189	C16, C64
T80975	Vascular endothelial growth factor receptor 2	Gastrointestinal cancers; Advanced renal cell carcinoma	150-159, 189	C15-C26, C64
T80975	Vascular endothelial growth factor receptor 2	Glioma; Solid tumours	140-199, 191	C00-C75, C71, C7A, C7B
T80975	Vascular endothelial growth factor receptor 2	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T80975	Vascular endothelial growth factor receptor 2	Hepatocellular carcinoma; NSCLC; Melanoma	155, 162, 172	C22.0, C33, C34, C43
T80975	Vascular endothelial growth factor receptor 2	Medullary thyroid cancer	193	C73
T80975	Vascular endothelial growth factor receptor 2	Melanoma	172	C43
T80975	Vascular endothelial growth factor receptor 2	Metastatic breast cancer		C50
T80975	Vascular endothelial growth factor receptor 2	Metastatic castration-resistant prostate cancer; Ovarian cancer	140-229, 183, 185	C56, C61
T80975	Vascular endothelial growth factor receptor 2	Metastatic colorectal cancer	153, 154	C18-C21
T80975	Vascular endothelial growth factor receptor 2	Myelodysplastic syndrome; AML; Head and neck cancer; Breast cancer; Pancreatic cancer	140-149, 140-229, 157, 183, 205.0	C07-C14, C25, C32, C33, C56, C92.0
T80975	Vascular endothelial growth factor receptor 2	Non-small cell lung cancer		C33-C34
T80975	Vascular endothelial growth factor receptor 2	Non-small-cell lung cancer; Ovarian cancer; Solid tumours	140-199, 140-229, 162, 183, 210-229	C33-C34, C56, D10-D36, D3A
T80975	Vascular endothelial growth factor receptor 2	Ovarian cancer	183	C56
T80975	Vascular endothelial growth factor receptor 2	Renal cancer	140-229, 189	C64
T80975	Vascular endothelial growth factor receptor 2	Solid tumours	140-199, 210-229	C00-D48
T80975	Vascular endothelial growth factor receptor 2	Thyroid cancer; Renal cell carcinoma	140-229, 189, 193	C64, C73
T81077	Bacterial 70S ribosome subunit	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T81077	Bacterial 70S ribosome subunit	Tuberculosis	010-018	A15-A19
T81100	mRNA of sodium-glucosetransporter-2	Type 2 diabetes	250	E11
T81103	mRNA of Caspase-2	Glaucoma	365	H40-H42
T81183	Alpha-1 adrenergic receptor	Cardiotonic		I50
T81183	Alpha-1 adrenergic receptor	Congestive heart failure	428	I50
T81183	Alpha-1 adrenergic receptor	Headache	339, 784.0	G43-G44, R51
T81183	Alpha-1 adrenergic receptor	Hypertension	401	I10-I16
T81183	Alpha-1 adrenergic receptor	Hypertension; Symptomatic benign prostatic hyperplasia; Severe congestive heart failure		I10-I16
T81183	Alpha-1 adrenergic receptor	Obesity	278	E66
T81183	Alpha-1 adrenergic receptor	Orthostatic hypotension	458	I95.1
T81311	Endoplasmin	Non-small cell lung cancer		C33-C34
T81358	CDC7 protein kinase	Hematological malignancies	200-209	C81-C86
T81360	Phosphodiesterase (PDE) 1	Cancer	140-229	C00-C96
T81386	Positive transcription elongation factor B (P-TEFb)	Cancer	140-229	C00-C96
T81403	mRNA of bcl2	Advanced melanoma	172	C43
T81403	mRNA of bcl2	Metastatic colorectal cancer	153, 154	C18-C21
T81403	mRNA of bcl2	Multiple myeloma	203	C90
T81403	mRNA of bcl2	Relapsed acute leukemia	204-208	C91-C95
T81403	mRNA of bcl2	Small-cell lung cancer	162.9	C33-C34
T81443	Toll-like receptor 4	Allergy	995.3	T78.4
T81443	Toll-like receptor 4	Autoimmune diabetes		E08-E13
T81443	Toll-like receptor 4	Cancer	140-229	C00-C96
T81443	Toll-like receptor 4	Hepatitis virus infection	573.3	K75.9
T81443	Toll-like receptor 4	Melanoma	172	C43
T81443	Toll-like receptor 4	Sepsis	995.91	A40, A41
T81443	Toll-like receptor 4	Septic shock	785.52	A41.9
T81548	Mycobacterium bovis heat shock protein 65	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
T81694	Rhinovirus protein 1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T81695	Membrane glycoprotein OX2	Chronic lymphocytic leukaemia		C91
T81735	DNA-dependent protein kinase catalytic subunit	Cancer	140-229	C00-C96
T81735	DNA-dependent protein kinase catalytic subunit	Prostate cancer	185	C61
T81774	Tubulin polymerization	Prostate cancer	185	C61
T81850	Squalene synthetase	Arteriosclerosis	440	I70
T81850	Squalene synthetase	Hypercholesterolemia		E78
T81850	Squalene synthetase	Hyperlipidaemia	272.0-272.4	E78
T81892	mRNA of Inhibitor of apoptosis protein	Cancer	140-229	C00-C96
T81900	Insulin-degrading Enzyme	Retinitis pigmentosa		H35.5
T81900	Insulin-degrading Enzyme	Skin infections	680-709	L00-L99
T81905	Histamine receptor	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T81905	Histamine receptor	Allergy	995.3	T78.4
T81905	Histamine receptor	Asthma		J45
T81905	Histamine receptor	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
T81905	Histamine receptor	Diagnostic imaging	331	G30, I73.9
T81905	Histamine receptor	Fibromyalgia	729.1	M79.7
T81905	Histamine receptor	Seasonal allergic rhinitis	472.0, 477	J00, J30, J31.0
T81916	Kruppel like factor 4	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T81937	Oxysterols receptor LXR	Arteriosclerosis	440	I70
T81937	Oxysterols receptor LXR	Cardiovascular disease; Metabolic disorders	270-279, 390-459	E70-E89, I00-I99
T82028	Sodium/hydrogen exchanger 1	Angina pectoris	413	I20
T82028	Sodium/hydrogen exchanger 1	Myocardial infarction	410	I21, I22
T82051	mRNA of p53	Acute myeloid leukemia	205	C92.0
T82051	mRNA of p53	Hearing disorder		H90.5
T82078	Toll-like receptor 2	Autoimmune diabetes		E08-E13
T82078	Toll-like receptor 2	Cancer	140-229	C00-C96
T82078	Toll-like receptor 2	Melanoma	172	C43
T82078	Toll-like receptor 2	Myelodysplastic syndrome	238.7	D46
T82078	Toll-like receptor 2	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T82078	Toll-like receptor 2	Prostate cancer	185	C61
T82078	Toll-like receptor 2	Radiation sickness	990	T66
T82078	Toll-like receptor 2	Solid tumours	140-199, 210-229	C00-D48
T82146	Retinoic acid receptor gamma	Acne vulgaris	706.1	L70.0
T82146	Retinoic acid receptor gamma	Emphysema	492	J43
T82146	Retinoic acid receptor gamma	Kaposi's sarcoma	176	C46
T82146	Retinoic acid receptor gamma	Psoriasis	696	L40
T82240	Fc gamma receptor III	Idiopathic thrombocytopenic purpura	287.31	D69.3
T82266	Voltage-dependent L-type calcium channel	Gastric motility disorder		K22.4
T82266	Voltage-dependent L-type calcium channel	High blood pressure	401	I10-I16
T82266	Voltage-dependent L-type calcium channel	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T82266	Voltage-dependent L-type calcium channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T82277	NY-ESO-1	Cancer	140-229	C00-C96
T82277	NY-ESO-1	Melanoma	172	C43
T82277	NY-ESO-1	Non-small cell lung cancer		C33-C34
T82277	NY-ESO-1	Solid tumours	140-199, 210-229	C00-D48
T82309	TRESK background K(+) channel	T-cell mediated immune dysfunction	279.1	D83.1
T82349	Bacterial cell wall	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T82383	Tyrosine-protein kinase receptor UFO	Metastasis		C00-C97
T82383	Tyrosine-protein kinase receptor UFO	Non-small cell lung cancer		C33-C34
T82391	Mitochondrial complex I	Myocardial disease		I21-I22, I40-I42
T82393	ADAM 17	Autoimmune diabetes		E08-E13
T82393	ADAM 17	Breast cancer	174, 175	C50
T82393	ADAM 17	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T82393	ADAM 17	Inflammatory bowel disease; Rheumatoid arthritis	555, 556, 710-719, 714	K50, K51, M00-M25, M05-M06
T82393	ADAM 17	Rheumatoid arthritis	710-719, 714	M05-M06
T82494	T cell receptor	Multiple scierosis	340	G35
T82499	CAMP-phosphodiesterase	Asthma		J45
T82514	NK receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T82519	PSA/PAP-based modified vaccinia anakara MVA	Prostate cancer	185	C61
T82577	Angiotensin-converting enzyme	Cardiovascular disorder		I00-I99
T82577	Angiotensin-converting enzyme	Congestive heart failure	428	I50
T82577	Angiotensin-converting enzyme	Congestive heart failure; Hypertension	428	I50
T82577	Angiotensin-converting enzyme	Hypertension	401	I10-I16
T82577	Angiotensin-converting enzyme	Hypertension; Renal failure; Heart failure; Diabetic nephropathy	250, 401, 428, 580-599, 584, 585	E08-E13, I10-I16, I50, N00-N29, N17, N18, N19
T82577	Angiotensin-converting enzyme	Hypotension	458, 796.3	I95
T82577	Angiotensin-converting enzyme	Luid retention	782.3	R60.9
T82577	Angiotensin-converting enzyme	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T82577	Angiotensin-converting enzyme	Unspecified		
T82624	Inositol 1,4,5-trisphosphate receptor	Hypertension	401	I10-I16
T82702	Pregnane X receptor	Atherosclerosis	414.0, 440	I70
T82723	3-oxoacyl-[acyl-carrier-protein] synthase II	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T82723	3-oxoacyl-[acyl-carrier-protein] synthase II	Malaria		B54
T82723	3-oxoacyl-[acyl-carrier-protein] synthase II	Urinary tract and intraperitoneal bacterial infection		N39.0
T82739	Plasma kallikrein	Retinal venous occlusion		H34.8
T82795	Beta-catenin	Cancer	140-229	C00-C96
T82795	Beta-catenin	Familial adenomatous polyposis		C18, D12
T82841	insulin	Diabetes	253.5, 588.1	E23.2, N25.1
T82841	insulin	Malaria		B54
T82841	insulin	Measure kidney function		N00-N39
T82841	insulin	Metabolic syndrome x; Type 2 diabetes	277.7, 250	E88.81, E11
T82841	insulin	Type 1 diabetes	250	E10
T82841	insulin	Type 1/2 diabetes	250, 278	E08-E13
T82841	insulin	Type 2 diabetes	250	E11
T82841	insulin	Unspecified		
T82913	Elongation factor 1-alpha 1	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T82958	Human cytomegalovirus glycoprotein B	Cytomegalovirus infection		B25
T83001	Dopamine reuptake	Anesthesia; Ocular disease	338	R20.0, H00-H59
T83001	Dopamine reuptake	Attention deficit hyperactivity disorder; Depression; Cocaine addiction	303-304, 304.2, 311, 314.00, 314.01	F10-F19, F14.2, F32, F90
T83001	Dopamine reuptake	Attention deficit hyperactivity disorder; Severe mood disorders	296, 314.00, 314.01	F30-F39, F90
T83001	Dopamine reuptake	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T83001	Dopamine reuptake	Neuropathic pain	356.0, 356.8	G64, G90.0
T83001	Dopamine reuptake	Obesity	278	E66
T83001	Dopamine reuptake	Severe mood disorders	296	F30-F39
T83011	Amine oxidase [flavin-containing] B	Alzheimer disease	331	G30
T83011	Amine oxidase [flavin-containing] B	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T83011	Amine oxidase [flavin-containing] B	Central nervous system disease		G00-G99
T83011	Amine oxidase [flavin-containing] B	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T83011	Amine oxidase [flavin-containing] B	Dementia	290-294	F01-F07
T83011	Amine oxidase [flavin-containing] B	Depression; Anxiety disorder	311, 300	F30-F39, F32, F40-F42
T83011	Amine oxidase [flavin-containing] B	Idiopathic parkinson's disease	332	F02.3, G20
T83011	Amine oxidase [flavin-containing] B	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T83011	Amine oxidase [flavin-containing] B	Major depressive episode without melancholia		F30-F39
T83011	Amine oxidase [flavin-containing] B	Moderate to severe hypertension		I10-I16
T83011	Amine oxidase [flavin-containing] B	Motor symptoms; Parkinson's disease	332, 335.2	F02.3, G12.2, G20
T83011	Amine oxidase [flavin-containing] B	Neurodegenerative disease	330-337	G30-G32
T83011	Amine oxidase [flavin-containing] B	Obesity	278	E66
T83011	Amine oxidase [flavin-containing] B	Parkinson's disease	332	G20
T83011	Amine oxidase [flavin-containing] B	Unspecified		
T83051	Bacterial ribosome	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T83051	Bacterial ribosome	Influenza virus		J11.1
T83059	Tankyrase	Cancer	140-229	C00-C96
T83103	Interleukin ligand	Systemic lupus erythematosus	710	M32
T83145	Nuclear factor NF-kappa-B	Acute myeloid leukemia	205	C92.0
T83145	Nuclear factor NF-kappa-B	Asthma		J45
T83145	Nuclear factor NF-kappa-B	Atopic dermatitis	691.8, 692.9	L00-L99
T83145	Nuclear factor NF-kappa-B	Autoimmune diabetes		E08-E13
T83145	Nuclear factor NF-kappa-B	Cystic fibrosis	277	E84
T83145	Nuclear factor NF-kappa-B	Multiple myeloma	203	C90
T83145	Nuclear factor NF-kappa-B	Multiple scierosis	340	G35
T83145	Nuclear factor NF-kappa-B	Rheumatoid arthritis	710-719, 714	M05-M06
T83174	Protein kinase C iota	Cancer	140-229	C00-C96
T83192	Ciliary neurotrophic factor	Huntington's disease	294.1, 333.4	F02.2, G10
T83192	Ciliary neurotrophic factor	Ovarian cancer	183	C56
T83193	Vanilloid receptor 1	Acute migraine	346	G43
T83193	Vanilloid receptor 1	Acute or chronic pain	338,780	R52, G89
T83193	Vanilloid receptor 1	Asthma		J45
T83193	Vanilloid receptor 1	Atopic dermatitis	691.8, 692.9	L00-L99
T83193	Vanilloid receptor 1	Chronic pathological pain	338,780	R52, G89
T83193	Vanilloid receptor 1	Cough	786.2	R05
T83193	Vanilloid receptor 1	Diabetic neuropathy; Postherpetic neuralgia	053.19, 250, 250.6, 356.0, 356.8	E11.21, G44.847, G53.0, G64, G90.0
T83193	Vanilloid receptor 1	Esophagus sensitivity; Gastroesophageal reflux disease	530, 140-229	K20-K22, K21
T83193	Vanilloid receptor 1	Musculoskeletal pain	338,780	R52, G89
T83193	Vanilloid receptor 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T83193	Vanilloid receptor 1	Overactive bladder disorder	188, 596.51	C67, N32.81
T83193	Vanilloid receptor 1	Overactive bladder disorder; Pain	188, 596.51, 338, 356.0, 356.8, 780	C67, N32.81, G64, G90.0, R52, G89
T83193	Vanilloid receptor 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T83193	Vanilloid receptor 1	Unspecified		
T83193	Vanilloid receptor 1	Urinary incontinence	788.3	N39.3, N39.4, R32
T83335	HIV transmission	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T83369	Coagulation factor IX	Blood forming organ disorders		D75.9
T83369	Coagulation factor IX	Factor IX deficiency		D67
T83369	Coagulation factor IX	Factor IX deficiency; Haemophilia B	286.1	D67
T83369	Coagulation factor IX	Hemophilia	286	D66-D68
T83369	Coagulation factor IX	Hemophilia A	286	D66
T83369	Coagulation factor IX	Sepsis	995.91	A40, A41
T83369	Coagulation factor IX	Thrombosis; Coronary artery disease; Vascular diseases	325, 410-414, 429.2, 430-459, 437.6, 453, 671.5, 671.9	G45-G46, I20-I25, I60-I95, I80-I82
T83369	Coagulation factor IX	Unspecified		
T83376	Tumor suppressor candidate 2	Non-small cell lung cancer		C33-C34
T83386	Folate receptor alpha	Acute malaria	84	B50-B54
T83386	Folate receptor alpha	Cancer	140-229	C00-C96
T83386	Folate receptor alpha	Ovarian cancer	183	C56
T83386	Folate receptor alpha	Platinum-resistant ovarian cancer	140-229, 183	C56
T83386	Folate receptor alpha	Renal cancer	140-229, 189	C64
T83386	Folate receptor alpha	Solid tumours	140-199, 210-229	C00-D48
T83391	Fructose-1,6-bisphosphatase	Type 2 diabetes	250	E11
T83561	Hypoxia-inducible gene DDIT4	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
T83585	Wiskott-Aldrich syndrome protein	Wiskott-Aldrich syndrome		D82.0
T83611	HLA class II histocompatibility antigen, DRB1-1	Multiple scierosis	340	G35
T83687	Tumor necrosisfactor receptor superfamily member 13C	Primary sjogren's syndrome		M35.00
T83717	Nicotinic acetylcholine receptor alpha subunit	Spasms; Pain	338,780	R52, G89
T83793	Negative factor	Human immunodeficiency virus infection	279.3	B20-B26
T83797	Hepatocyte growth factor	Advanced malignancies	140-229	C00-C96
T83797	Hepatocyte growth factor	Angina pectoris; Peripheral arterial disease	413, 443	I20, I73
T83797	Hepatocyte growth factor	Grade IV malignant glioma; Glioblastoma multiforme	191	C71
T83813	5-hydroxytryptamine 2C receptor	Aggressive non-hodgkin's lymphoma	200, 201, 202, 202.8, 208.9	C81, C81-C86, C82-C85, C91-C95
T83813	5-hydroxytryptamine 2C receptor	Alcohol use disorders	303	F10.2
T83813	5-hydroxytryptamine 2C receptor	Anxiety disorder	300, 311	F32, F40-F42
T83813	5-hydroxytryptamine 2C receptor	Depression	311	F30-F39
T83813	5-hydroxytryptamine 2C receptor	Drug abuse	303-304	F10-F19
T83813	5-hydroxytryptamine 2C receptor	Generalized anxiety disorder; Major depressive disorder	300, 300.02, 311, 296.2, 296.3, 710.0	F32, F40-F42, F41.1, F33, M32
T83813	5-hydroxytryptamine 2C receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T83813	5-hydroxytryptamine 2C receptor	Metabolic disorders	270-279	E70-E89
T83813	5-hydroxytryptamine 2C receptor	Migraine headaches	346	G43
T83813	5-hydroxytryptamine 2C receptor	Mood disorder		F30-F39
T83813	5-hydroxytryptamine 2C receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T83813	5-hydroxytryptamine 2C receptor	Obesity	278	E66
T83813	5-hydroxytryptamine 2C receptor	Obesity; Diabetes	250, 278	E08-E13, E66
T83813	5-hydroxytryptamine 2C receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T83813	5-hydroxytryptamine 2C receptor	Psychotic disorders	290-299	F20-F29
T83813	5-hydroxytryptamine 2C receptor	Sleep initiation and maintenance disorders; Primary insomnia; Schizophrenia	295, 307.41, 307.42, 327.0, 780.51, 780.52	F20, F51.0, G47.0
T83813	5-hydroxytryptamine 2C receptor	Unspecified		
T83875	Amine oxidase [flavin-containing] A	Alcohol use disorders	303	F10.2
T83875	Amine oxidase [flavin-containing] A	Alzheimer disease	331	G30
T83875	Amine oxidase [flavin-containing] A	Anxiety disorder	300, 311	F32, F40-F42
T83875	Amine oxidase [flavin-containing] A	Depression	311	F30-F39
T83875	Amine oxidase [flavin-containing] A	Epilepsy		G40
T83875	Amine oxidase [flavin-containing] A	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T83875	Amine oxidase [flavin-containing] A	Mood disorder		F30-F39
T83875	Amine oxidase [flavin-containing] A	Neuropathic pain	356.0, 356.8	G64, G90.0
T83875	Amine oxidase [flavin-containing] A	Parkinson's disease; Major depressive disorder	332, 296.2, 296.3, 710.0	G20, F32, F33, M32
T83875	Amine oxidase [flavin-containing] A	Vitiligo	709.01	L80
T83904	Sirtuin	Retinopathy	362.0-362.2	H35-H35.2
T83905	Cadherin-3	Cancer	140-229	C00-C96
T83947	Water	Medical conditions characterized by insufficient tear production		
T84040	Transient receptor potential cation channel subfamily A member 1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T84040	Transient receptor potential cation channel subfamily A member 1	Throat irritation	478.29	J39.2
T84133	Phosphodiesterase 10A (PDE10A)	Huntington's disease	294.1, 333.4	F02.2, G10
T84133	Phosphodiesterase 10A (PDE10A)	Schizoaffective disorder; Schizophrenia	295, 295.70	F20, F25
T84133	Phosphodiesterase 10A (PDE10A)	Schizophrenia	295	F20
T84160	5-Hydroxytryptamine 3 receptor	Alcohol use disorders	303	F10.2
T84160	5-Hydroxytryptamine 3 receptor	Anxiety disorder	300, 311	F32, F40-F42
T84160	5-Hydroxytryptamine 3 receptor	Chemotherapy-induced emesis	787	R11
T84160	5-Hydroxytryptamine 3 receptor	Chemotherapy-induced nausea	787, 787.0	R11
T84160	5-Hydroxytryptamine 3 receptor	Dementia; Obesity	290-294, 278	F01-F07, E66
T84160	5-Hydroxytryptamine 3 receptor	Emesis	787	R11
T84160	5-Hydroxytryptamine 3 receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T84160	5-Hydroxytryptamine 3 receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T84160	5-Hydroxytryptamine 3 receptor	Nausea		R11
T84160	5-Hydroxytryptamine 3 receptor	Nausea and vomiting		D46, C91-C95, C90
T84160	5-Hydroxytryptamine 3 receptor	Nausea and vomiting associated with chemotherapy		R11
T84160	5-Hydroxytryptamine 3 receptor	Nausea; Vomiting; Testicular germ cell tumor; Emesis	140-199, 183, 186, 210-229, 220, 222.0, 787, 787.0	C00-C75, C56, C62, C7A, C7B, D10-D36, D27, D29.2, D3A, R11
T84160	5-Hydroxytryptamine 3 receptor	Schizophrenia	295	F20
T84160	5-Hydroxytryptamine 3 receptor	Sleep apnea		G47.3
T84160	5-Hydroxytryptamine 3 receptor	Vomiting and nausea	787, 787.0	R11
T84173	Glucosylceramidase	Metabolic disease	270-279	E70-E89
T84173	Glucosylceramidase	Metabolic disorders	270-279	E70-E89
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Cardiovascular disorder		I00-I99
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Generalized anxiety disorder	300, 300.02, 311	F32, F40-F42, F41.1
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Hypertension	401	I10-I16
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Hypertension; Angina	401, 413	I10-I16, I20
T84316	Voltage-dependent calcium channel subunit alpha-2/delta-1	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T84397	Tubulin beta-1 chain	Lung cancer	162	C33-C34
T84397	Tubulin beta-1 chain	Solid tumours	140-199, 210-229	C00-D48
T84486	Oxytocin receptor	Androgen decline		E20-E35
T84486	Oxytocin receptor	Autism	299	F84.0
T84486	Oxytocin receptor	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T84486	Oxytocin receptor	Female sexual dysfunction	302.7	F52
T84486	Oxytocin receptor	Miscarriage		O03
T84486	Oxytocin receptor	Postpartum haemorrhage	666	O72
T84486	Oxytocin receptor	Premature ejaculation	302.75	F52.4
T84486	Oxytocin receptor	Threatened pre-term labour		O60.1, P07.3
T84575	Samarium	Pain associated with bone cancer		R52, G89
T84581	Thioredoxin reductase, cytoplasmic	Cancer	140-229	C00-C96
T84581	Thioredoxin reductase, cytoplasmic	Malaria		B54
T84584	Sarcoglycan alpha	Unspecified		
T84621	Cytochrome P450 11B1, mitochondrial	Congestive heart failure; Myocardial fibrosis; Hyperaldosteronism	255.1, 425.0, 425.3, 428, 428.0, 709.2	E26, I42.0, I42.5, I50, L90.5
T84621	Cytochrome P450 11B1, mitochondrial	Cushing's disease	255	E24.0
T84631	Coagulation factor Xa	Acute coronary syndrome	444	I74
T84631	Coagulation factor Xa	Angina pectoris	413	I20
T84631	Coagulation factor Xa	Atrial fibrillation	272, 427.31	E78, I48
T84631	Coagulation factor Xa	Attention deficit hyperactivity disorder	314	F90
T84631	Coagulation factor Xa	Bleeding	444, 453	I74, I80-I82
T84631	Coagulation factor Xa	Blood coagulation disorders		D65-D68
T84631	Coagulation factor Xa	Cerebrovascular ischaemia	434.91	I61-I63
T84631	Coagulation factor Xa	Coagulation		I80-I82
T84631	Coagulation factor Xa	Deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
T84631	Coagulation factor Xa	Deep venous clots	453.4	I80.2
T84631	Coagulation factor Xa	Haemophilia B; Christmas disease	286.1	D67
T84631	Coagulation factor Xa	Hematology		D50-D77
T84631	Coagulation factor Xa	Hemophilia	286	D66-D68
T84631	Coagulation factor Xa	Prophylaxis of deep vein thrombosis	437.6, 453, 453.40, 671.5, 671.9	I80-I82, I80.2
T84631	Coagulation factor Xa	Renal cancer	140-229, 189	C64
T84631	Coagulation factor Xa	Thromboembolic disorders	437.6, 453, 671.5, 671.9	I80-I82
T84631	Coagulation factor Xa	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T84631	Coagulation factor Xa	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T84631	Coagulation factor Xa	Unspecified		
T84631	Coagulation factor Xa	Venous thromboembolism	453	I80-I82
T84631	Coagulation factor Xa	Venous thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T84634	Cytochrome P450 26	Dermatological disease		L00-L99
T84634	Cytochrome P450 26	Psoriasis	696	L40
T84665	Tromboxane A2 synthesis	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T84703	BDNF/NT-3 growth factors receptor	Neurodegenerative disease	330-337	G30-G32
T84726	Rho associated protein kinase	Asthma		J45
T84726	Rho associated protein kinase	Glaucoma	365	H40-H42
T84726	Rho associated protein kinase	Solid tumours	140-199, 210-229	C00-D48
T84726	Rho associated protein kinase	Spinal cord injury		S14, S24, S34
T84780	Inhibitor of apoptosis protein 2	Lymphoma	202.8, 208.9	C81-C86
T84803	Antigen-specific immunotherapeutic	Leukemia	208.9	C90-C95
T84885	Picornavirus capsid protein VP1	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T84886	Solute carrier family 12 member 3	Hypertension; Edema	401	I10-I16, R60.9
T84894	Casein kinase 2	Cancer	140-229	C00-C96
T84894	Casein kinase 2	Cervical cancer	180	C53
T84972	Elongation factor G	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T85025	Interleukin-7 receptor alpha chain	Acquired immune deficiency syndrome	42	B20
T85037	IgE-regulated calcium channels	Asthma		J45
T85072	Humanpapillomavirus E7 protein	Cervical intraepithelial neoplasia	233.1, 622.10	D06, N87
T85072	Humanpapillomavirus E7 protein	Cervical intraepithelial neoplasia; Human papillomavirus infections	233.1, 622.10, 078.1079.4	D06, N87, B97.7
T85072	Humanpapillomavirus E7 protein	Papillomavirus infections		B97.7
T85072	Humanpapillomavirus E7 protein	Recurrent cervical cancer; Cervical intraepithelial neoplasia	140-229, 180, 233.1, 622.10	C53, D06, N87
T85129	Gamma secretase	Solid tumours	140-199, 210-229	C00-D48
T85158	Lymphotoxin alpha	Rheumatoid arthritis	710-719, 714	M05-M06
T85228	mRNA of CCR3 chemokine	Allergic asthma	493, 995.3	J45, T78.4
T85402	Interleukin-2-inducible T cell kinase	Inflammatory disorder		
T85435	Insulin receptor	Alzheimer disease	331	G30
T85435	Insulin receptor	Autoimmune diabetes		E08-E13
T85435	Insulin receptor	Breast cancer	174, 175	C50
T85435	Insulin receptor	Crohn's disease	555	K50
T85435	Insulin receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T85435	Insulin receptor	Hunter syndrome		E76.1
T85435	Insulin receptor	Hypercholesterolemia		E78
T85435	Insulin receptor	Hyperglycaemia in type 2 diabetes	250, 790.29	E11, R73.9
T85435	Insulin receptor	Hyperlipidaemia	272.0-272.4	E78
T85435	Insulin receptor	Hypoglycemia	250.8, 251.0, 251.1, 251.2, 270.3, 775.6, 962.3	E16.0-E16.2
T85435	Insulin receptor	Lymphoma	202.8, 208.9	C81-C86
T85435	Insulin receptor	Non-insulin dependent diabetes		E11.9
T85435	Insulin receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T85435	Insulin receptor	Type 1 diabetes	250	E10
T85435	Insulin receptor	Type 1/2 diabetes	250, 278	E08-E13
T85435	Insulin receptor	Type 2 diabetes	250	E11
T85467	Prostaglandin E2 receptor EP3 subtype	Asthma		J45
T85467	Prostaglandin E2 receptor EP3 subtype	Glaucoma	365	H40-H42
T85467	Prostaglandin E2 receptor EP3 subtype	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T85467	Prostaglandin E2 receptor EP3 subtype	Peripheral vascular disease	443.9	I73.9
T85523	Cardiac myosin	Heart failure	428	I50
T85529	T-cell-specific surface glycoprotein CD28	Autoimmune diabetes		E08-E13
T85529	T-cell-specific surface glycoprotein CD28	Heart transplant rejection	996	T86
T85529	T-cell-specific surface glycoprotein CD28	Immune disorder		D80-D89
T85529	T-cell-specific surface glycoprotein CD28	Kidney transplant rejection	996.81	T86.1
T85554	CD27	Lymphoma; Leukemia; Solid tumor	140-199, 202, 204-208	C00-C75, C7A, C7B, C81-C86
T85574	Angiotensin II receptor	Anemia	280-285	D50-D64
T85574	Angiotensin II receptor	Hypertension	401	I10-I16
T85581	Na-K-Cl symporter	Chronic heart failure	428	I50
T85605	5-hydroxytryptamine receptor	Anxiety disorder	300, 311	F32, F40-F42
T85605	5-hydroxytryptamine receptor	Carcinoid syndrome		E34.0
T85605	5-hydroxytryptamine receptor	Cerebrovascular ischaemia	434.91	I61-I63
T85605	5-hydroxytryptamine receptor	Headache	339, 784.0	G43-G44, R51
T85605	5-hydroxytryptamine receptor	Hyperprolactinemia; Migraine	253.1, 346	E22.1, G43
T85605	5-hydroxytryptamine receptor	Migraine; Cluster headaches	339.00, 339.01, 339.02, 346	G43, G44.0
T85605	5-hydroxytryptamine receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T85605	5-hydroxytryptamine receptor	Obesity	278	E66
T85605	5-hydroxytryptamine receptor	Psychotic disorders	290-299	F20-F29
T85605	5-hydroxytryptamine receptor	Schizophrenia	295	F20
T85605	5-hydroxytryptamine receptor	Vomiting and nausea	787, 787.0	R11
T85616	Thioredoxin	Cancer	140-229	C00-C96
T85651	mRNA of Myc proto-oncogene protein	Cancer; Coronary artery restenosis	140-229	C00-C96, I51.89
T85651	mRNA of Myc proto-oncogene protein	Coronary artery disease	410-414, 429.2	I20-I25
T85653	meningococcal groups ACWYconjugate	Meningococcal infection	36.9	A39
T85670	Beta-nerve growth factor	Alzheimer disease	331	G30
T85670	Beta-nerve growth factor	Chronic pain	338.2,780	R52.1-R52.2, G89
T85670	Beta-nerve growth factor	Neurodegenerative disease	330-337	G30-G32
T85670	Beta-nerve growth factor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T85733	DNA topoisomerase II, beta isozyme	Chemoprotection	191	C71
T85733	DNA topoisomerase II, beta isozyme	Solid tumours	140-199, 210-229	C00-D48
T85799	Cell division protein kinase 4	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T85799	Cell division protein kinase 4	Cancer	140-229	C00-C96
T85799	Cell division protein kinase 4	Hematological malignancies	200-209	C81-C86
T85799	Cell division protein kinase 4	Mantle cell lymphoma	200.4, 202.8, 203.0, 208.9	C81-C86, C85.7, C90.0, C91-C95
T85799	Cell division protein kinase 4	Small-cell lung cancer	162.9	C33-C34
T85799	Cell division protein kinase 4	Solid tumours	140-199, 210-229	C00-D48
T85857	Thymic stromal lymphopoietin	Asthma		J45
T85889	Phosphate	Hyperphosphatemia	275.3	E22.1
T85943	Proto-oncogene tyrosine-protein kinase SRC	Advanced breast cancer	174, 175	C50
T85943	Proto-oncogene tyrosine-protein kinase SRC	Brain cancer	191, 225.0	C71, D33
T85943	Proto-oncogene tyrosine-protein kinase SRC	Cancer	140-229	C00-C96
T85943	Proto-oncogene tyrosine-protein kinase SRC	Chronic myelogenous leukaemia	205.1	C92.1
T85943	Proto-oncogene tyrosine-protein kinase SRC	Glioblastoma multiforme	191	C71
T85943	Proto-oncogene tyrosine-protein kinase SRC	Ischemia	459.89	I99.8
T85943	Proto-oncogene tyrosine-protein kinase SRC	Multiple myeloma	203	C90
T85943	Proto-oncogene tyrosine-protein kinase SRC	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T85943	Proto-oncogene tyrosine-protein kinase SRC	Osteosarcoma; Hematological malignancies; Solid tumours	140-199, 140-239, 170, 200-209, 210-229	C40-C41, C81-C86, D10-D36, D3A
T86014	Sphingosine kinase	Arteriosclerosis	440	I70
T86014	Sphingosine kinase	Late-stage ovarian cancer; Lymphoma	140-229, 183, 188, 202.8, 208.9	C56, C67, C81-C86
T86014	Sphingosine kinase	Vascular disease	325, 430-459	G45-G46, I60-I95
T86052	Telomerase reverse transcriptase	Acute myeloid leukemia	205	C92.0
T86052	Telomerase reverse transcriptase	Brain cancer	191, 225.0	C71, D33
T86052	Telomerase reverse transcriptase	Breast cancer; Head and neck cancer; Liver cancer	174, 175, 140-149, 140-229, 155, 203.0	C50, C07-C14, C32-C33, C22
T86052	Telomerase reverse transcriptase	Melanoma	172	C43
T86052	Telomerase reverse transcriptase	Multiple myeloma	203	C90
T86052	Telomerase reverse transcriptase	Ocular inflammation	370.33	H16.229
T86052	Telomerase reverse transcriptase	Ovarian cancer	183	C56
T86052	Telomerase reverse transcriptase	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T86052	Telomerase reverse transcriptase	Prostate cancer	185	C61
T86057	Solute carrier family 22 member 12	Gout	274.00274.1274.8274.9	M10
T86057	Solute carrier family 22 member 12	Hyperuricaemia	274, 274.00274.1274.8274.9, 790.6	E79.0, M10
T86067	Unspecified receptor	Cancer	140-229	C00-C96
T86067	Unspecified receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T86067	Unspecified receptor	Skin burns	940-949	T20-T31
T86115	mRNA of ApoC-III	Inflammation; High triglycerides; Atherosclerosis; Metabolic syndrome	277.7, 414.0, 440	E88.81, I70
T86130	Integrin alpha-4/beta-1	Arthritis	710-719	M00-M25
T86130	Integrin alpha-4/beta-1	Asthma		J45
T86130	Integrin alpha-4/beta-1	Crohn's disease	555	K50
T86130	Integrin alpha-4/beta-1	Inflammatory bowel disease	555, 556	K50, K51
T86130	Integrin alpha-4/beta-1	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T86130	Integrin alpha-4/beta-1	Multiple scierosis	340	G35
T86130	Integrin alpha-4/beta-1	Multiple sclerosis; Rheumatoid arthritis	340, 710-719, 714	G35, M00-M25, M05-M06
T86130	Integrin alpha-4/beta-1	Relapsing forms of multiple sclerosis	340	G35
T86161	Prolyl endopeptidase	Celiac disease	579	K90.0
T86161	Prolyl endopeptidase	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T86161	Prolyl endopeptidase	Human immunodeficiency virus infection	279.3	B20-B26
T86161	Prolyl endopeptidase	Non-small cell lung cancer		C33-C34
T86161	Prolyl endopeptidase	Parkinson's disease	332	G20
T86187	Akt-mToR pathway	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T86192	KCNQ voltage-gated potassium channel	Cancer pain; Fibromyalgia	140-229, 338, 780, 729.1	R52, G89, M79.7
T86192	KCNQ voltage-gated potassium channel	Neuropathic pain	356.0, 356.8	G64, G90.0
T86194	GABA B receptor	Autism; Fragile X syndrome	299, 332, 759.83	F84.0, F02.3, G20, Q99.2
T86194	GABA B receptor	Epilepsy		G40
T86194	GABA B receptor	Fragile X syndrome	332, 759.83	F02.3, G20, Q99.2
T86194	GABA B receptor	Gastroesophageal reflux disease	140-229, 530	K21
T86194	GABA B receptor	Hypertonia		P94.1
T86194	GABA B receptor	Unspecified		
T86254	Tenascin	Brain cancer	191, 225.0	C71, D33
T86254	Tenascin	Cancer	140-229	C00-C96
T86254	Tenascin	Hematological malignancies	200-209	C81-C86
T86254	Tenascin	Solid tumours	140-199, 210-229	C00-D48
T86264	Ferroportin	Anemia	280-285	D50-D64
T86271	KCa2.2	Myeloma disease	203	C90
T86273	TGR5	Metabolic disorders	270-279	E70-E89
T86273	TGR5	Type 2 diabetes	250	E11
T86350	Receptor protein-tyrosine kinase erbB-3	Breast cancer	174, 175	C50
T86350	Receptor protein-tyrosine kinase erbB-3	Cancer	140-229	C00-C96
T86350	Receptor protein-tyrosine kinase erbB-3	Colorectal cancer; Head and neck cancer	140-149, 153, 154	C18-C21, C07-C14, C32-C33
T86350	Receptor protein-tyrosine kinase erbB-3	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T86350	Receptor protein-tyrosine kinase erbB-3	Metastatic epithelial tumors	140-199	C00-C75, C7A, C7B
T86350	Receptor protein-tyrosine kinase erbB-3	Non-small cell lung cancer		C33-C34
T86350	Receptor protein-tyrosine kinase erbB-3	Psoriasis	696	L40
T86350	Receptor protein-tyrosine kinase erbB-3	Solid tumours	140-199, 210-229	C00-D48
T86355	Bacterial 50S ribosome subunit	Syphilis		A50-A53
T86364	Vasoactive intestinal polypeptide receptor 1	Chronic obstructive pulmonary disease; Pulmonary arterial hypertension	401, 416.0, 490-492, 494-496	I10-I16, I27.0, I27.2, J40-J44, J47
T86364	Vasoactive intestinal polypeptide receptor 1	Respiratory disease		J00-J99
T86385	Cathepsin G	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T86385	Cathepsin G	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T86399	Bromodomain-containing protein 2	Myelodysplastic syndrome	238.7	D46
T86428	Protein farnesyltransferase beta subunit	Cancer	140-229	C00-C96
T86428	Protein farnesyltransferase beta subunit	Colorectal cancer	153, 154	C18-C21
T86428	Protein farnesyltransferase beta subunit	Solid tumours	140-199, 210-229	C00-D48
T86462	TTR	Cardiomyopathy		I42.0
T86462	TTR	TTR amyloidosis	277.3	E85
T86528	Geranyltranstransferase	Bone disease		M00-M99
T86528	Geranyltranstransferase	Cancer	140-229	C00-C96
T86541	Amiloride sensitive cation channel 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Acute liver failure		K72
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Acute lung injury	518	J80
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Adult respiratory distress syndrome	518.5, 518.82	J80
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Alopecia	704.09	L65.9
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Arthritis	710-719	M00-M25
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Autoimmune diabetes		E08-E13
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Glioblastoma multiforme	191	C71
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Inflammatory bowel disease	555, 556	K50, K51
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Multiple scierosis	340	G35
T86552	Tumour necrosis factor receptor-1 (TNFR1)	Rheumatoid arthritis	710-719, 714	M05-M06
T86591	Peroxisome proliferator activated receptor alpha	Arteriosclerosis	440	I70
T86591	Peroxisome proliferator activated receptor alpha	Cardiovascular disorder		I00-I99
T86591	Peroxisome proliferator activated receptor alpha	Diabetes	253.5, 588.1	E23.2, N25.1
T86591	Peroxisome proliferator activated receptor alpha	Dyslipidaemias	272	E78
T86591	Peroxisome proliferator activated receptor alpha	Gout	274.00274.1274.8274.9	M10
T86591	Peroxisome proliferator activated receptor alpha	Heart failure	428	I50
T86591	Peroxisome proliferator activated receptor alpha	High cholesterol level; High triglyceride level	272.0, 272.1	E78.0, E78.1, E78.2, E78.3
T86591	Peroxisome proliferator activated receptor alpha	Hyperlipidaemia	272.0-272.4	E78
T86591	Peroxisome proliferator activated receptor alpha	Hyperlipoproteinemia; Atherosclerosis	272.0-272.4, 414.0, 440	E78, I70
T86591	Peroxisome proliferator activated receptor alpha	Lipid metabolism disorder		E75-E78
T86591	Peroxisome proliferator activated receptor alpha	Metabolic disorders	270-279	E70-E89
T86591	Peroxisome proliferator activated receptor alpha	Non-alcoholic fatty liver disease	571.8	K76.0
T86591	Peroxisome proliferator activated receptor alpha	Rheumatoid arthritis	710-719, 714	M05-M06
T86591	Peroxisome proliferator activated receptor alpha	Type 1 diabetes	250	E10
T86591	Peroxisome proliferator activated receptor alpha	Type 2 diabetes	250	E11
T86591	Peroxisome proliferator activated receptor alpha	Unspecified		
T86609	Glycosidase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T86652	mRNA of proprotein convertase subtilisin/kexin type 9	Cardiovascular disorder		I00-I99
T86652	mRNA of proprotein convertase subtilisin/kexin type 9	Coronary artery disease	410-414, 429.2	I20-I25
T86652	mRNA of proprotein convertase subtilisin/kexin type 9	Hypercholesterolemia		E78
T86652	mRNA of proprotein convertase subtilisin/kexin type 9	Metabolic disorders	270-279	E70-E89
T86674	Hemagglutinin	Infections disease		A00-B99
T86674	Hemagglutinin	Influenza A virus H5N1	487, 488	J10, J11
T86674	Hemagglutinin	Influenza virus		J11.1
T86674	Hemagglutinin	Unspecified		
T86674	Hemagglutinin	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T86679	Adenosine A2b receptor	Apnea	786.03	R06.81
T86679	Adenosine A2b receptor	Asthma		J45
T86679	Adenosine A2b receptor	Herpes simplex virus infection	54	B00
T86679	Adenosine A2b receptor	Hypertension	401	I10-I16
T86679	Adenosine A2b receptor	Non-insulin dependent diabetes		E11.9
T86679	Adenosine A2b receptor	Paroxysmal supraventricular tachycardia	427, 427.0, 427.1, 427.89, 785.0	I47-I49, I47.1, I47.2, R00.0
T86682	Jun N terminal kinase	Cancer	140-229	C00-C96
T86682	Jun N terminal kinase	Idiopathic pulmonary fibrosis; Discoid lupus erythematosus	516.3, 695.4	J84.1, L93.0
T86682	Jun N terminal kinase	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T86702	Stromelysin-1	Corneal ulcers	370	H16.0
T86702	Stromelysin-1	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T86702	Stromelysin-1	Ischemic stroke	434.91	I61-I63
T86702	Stromelysin-1	Osteoarthritis; Myocardial infarction	410, 715	I21, I22, M15-M19, M47
T86702	Stromelysin-1	Rheumatoid arthritis	710-719, 714	M05-M06
T86704	Phosphodiesterase (PDE) 3	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T86704	Phosphodiesterase (PDE) 3	Allergy	995.3	T78.4
T86704	Phosphodiesterase (PDE) 3	Arteriosclerosis	440	I70
T86704	Phosphodiesterase (PDE) 3	Asthma		J45
T86704	Phosphodiesterase (PDE) 3	Cardiotonic		I50
T86704	Phosphodiesterase (PDE) 3	Cardiovascular disorder		I00-I99
T86704	Phosphodiesterase (PDE) 3	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T86704	Phosphodiesterase (PDE) 3	Congestive heart failure	428	I50
T86704	Phosphodiesterase (PDE) 3	Cough	786.2	R05
T86704	Phosphodiesterase (PDE) 3	Heart failure	428	I50
T86704	Phosphodiesterase (PDE) 3	Intermittent claudication	440.21	I73.9
T86704	Phosphodiesterase (PDE) 3	Septic shock	785.52	A41.9
T86723	Hepatitis B 1018-ISS conjugate	HBV infection	070.2-070.3	B16, B18.0, B18.1
T86734	Glutaminase	Leukemia	208.9	C90-C95
T86748	Endosialin	Colorectal cancer	153, 154	C18-C21
T86748	Endosialin	Colorectal cancer; Melanoma; Sarcoma	153, 154, 172, 202.8	C18-C21, C43, C81-C86
T86803	mRNA of STAT3	Cancer	140-229	C00-C96
T86814	Two specific enzymes that are active in the skin	Psoriatic disorder	696	L40
T86836	Human DNA	Acute myeloid leukemia; Grade IV malignant glioma	205, 191	C92.0, C71
T86836	Human DNA	Brain cancer	191, 225.0	C71, D33
T86836	Human DNA	Breast cancer	174, 175	C50
T86836	Human DNA	Cancer	140-229	C00-C96
T86836	Human DNA	Colorectal cancer	153, 154	C18-C21
T86836	Human DNA	Gastric cancer	151	C16
T86836	Human DNA	Grade IV astrocytoma	191	C71
T86836	Human DNA	Head and neck cancer	140-149, 140-229	C07-C14, C32-C33
T86836	Human DNA	Human immunodeficiency virus infection	279.3	B20-B26
T86836	Human DNA	Influenza A virus H1N1; Influenza A virus H5N1	487, 488	J10, J11
T86836	Human DNA	Influenza A virus H5N1	487, 488	J10, J11
T86836	Human DNA	Leukemia	208.9	C90-C95
T86836	Human DNA	Liver cancer	140-229, 155, 203.0	C22
T86836	Human DNA	Malaria		B54
T86836	Human DNA	Metastatic pancreatic		C25.9
T86836	Human DNA	Multiple myeloma	203	C90
T86836	Human DNA	Mycobacterium tuberculosis infection		A15-A19
T86836	Human DNA	Myelodysplastic syndrome	238.7	D46
T86836	Human DNA	Myeloproliferative disease	205.1, 238.4, 289.89, 289.9	D47.1
T86836	Human DNA	Non-invasive bladder cancer	188	C67
T86836	Human DNA	Ovarian cancer	183	C56
T86836	Human DNA	Prostate cancer	185	C61
T86836	Human DNA	Skin disease		L00-L99
T86836	Human DNA	Soft tissue sarcoma	171	C00-D49
T86836	Human DNA	Solid tumours	140-199, 210-229	C00-D48
T86836	Human DNA	Unspecified		
T86885	Beta-2-glycoprotein 1	Hughes syndrome	289.81	D68.8
T86992	Recombinant fusion protein	Tuberculosis	010-018	A15-A19
T87023	Platelet-activating factor receptor	Allergy	995.3	T78.4
T87023	Platelet-activating factor receptor	Asthma		J45
T87023	Platelet-activating factor receptor	Brain ischaemia	435, 437	G45.9, I67.8
T87023	Platelet-activating factor receptor	Cardiac arrhythmias	427	I47-I49
T87023	Platelet-activating factor receptor	Cerebral infarction		I63
T87023	Platelet-activating factor receptor	Conjunctivitis	372	H10
T87023	Platelet-activating factor receptor	Inflammatory bowel disease	555, 556	K50, K51
T87023	Platelet-activating factor receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T87023	Platelet-activating factor receptor	Nerve injury		T14.4
T87023	Platelet-activating factor receptor	Ocular allergy	360-379	H00-H59
T87023	Platelet-activating factor receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T87023	Platelet-activating factor receptor	Psoriasis	696	L40
T87023	Platelet-activating factor receptor	Septic shock	785.52	A41.9
T87023	Platelet-activating factor receptor	Solid tumours	140-199, 210-229	C00-D48
T87023	Platelet-activating factor receptor	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T87023	Platelet-activating factor receptor	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T87023	Platelet-activating factor receptor	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T87023	Platelet-activating factor receptor	Unspecified		
T87024	Amyloid beta A4 protein	Age related macular degeneration	362.5	H35.3
T87024	Amyloid beta A4 protein	Alzheimer disease	331	G30
T87024	Amyloid beta A4 protein	Amyloidosis	277.3	E85
T87024	Amyloid beta A4 protein	Brain injury		S09.90
T87024	Amyloid beta A4 protein	Cancer	140-229	C00-C96
T87024	Amyloid beta A4 protein	Cerebral amyloid angiopathy		I68.0
T87024	Amyloid beta A4 protein	Diagnostic imaging	331	G30, I73.9
T87024	Amyloid beta A4 protein	Geographic retinal atrophy; Macular degeneration	362.5	H35.3
T87024	Amyloid beta A4 protein	Glioma	191	C71
T87024	Amyloid beta A4 protein	Mild cognitive impairment	331.83	F06.7
T87024	Amyloid beta A4 protein	Mild to moderate alzheimer disease	331	G30
T87024	Amyloid beta A4 protein	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T87024	Amyloid beta A4 protein	Unspecified		
T87075	T-cell surface glycoprotein CD3 epsilon chain	Advanced breast cancer	174, 175	C50
T87075	T-cell surface glycoprotein CD3 epsilon chain	Breast cancer	174, 175	C50
T87075	T-cell surface glycoprotein CD3 epsilon chain	Melanoma	172	C43
T87075	T-cell surface glycoprotein CD3 epsilon chain	Organ rejection	279.5, 996	D89.8, T86
T87075	T-cell surface glycoprotein CD3 epsilon chain	Solid tumours	140-199, 210-229	C00-D48
T87108	Mesothelin-ADC	Cancer	140-229	C00-C96
T87108	Mesothelin-ADC	Mesothelioma	163	C45
T87108	Mesothelin-ADC	Mesothelioma; Metastatic pancreatic cancer	163, 185	C45, C61
T87108	Mesothelin-ADC	Ovarian cancer	183	C56
T87108	Mesothelin-ADC	Solid tumours	140-199, 210-229	C00-D48
T87119	Fungal outer membrane	Candidiasis infection; Athlete's foot	001-139, 112, 110.4	B37, B35.3
T87119	Fungal outer membrane	Conjunctivitis	372	H10
T87165	Radioactive plutonium, americium, and curium	Acute radiation syndrome	990	T66
T87166	Glucokinase	Diabetes	253.5, 588.1	E23.2, N25.1
T87166	Glucokinase	Non-insulin dependent diabetes		E11.9
T87166	Glucokinase	Obesity; Diabetes	250, 278	E08-E13, E66
T87166	Glucokinase	Type 2 diabetes	250	E11
T87166	Glucokinase	Unspecified		
T87176	MHC class II antigen DR (HLA-DR)	Solid tumours	140-199, 210-229	C00-D48
T87206	S100 calcium-binding protein B	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T87237	Cell differentiation	Hematological malignancies	200-209	C81-C86
T87259	mRNA of Integrin alpha V	Multiple scierosis	340	G35
T87350	PDGF-B ligand	Cystic fibrosis	277	E84
T87350	PDGF-B ligand	Diabetic foot ulcer	707	L88-L89
T87350	PDGF-B ligand	Macular degeneration	362.5	H35.3
T87394	SMN2 pre-mRNA	Spinal muscular atrophy	335.0-335.1	G00-G99
T87467	Folate receptor	Dietary shortage	260-269	E40-E46
T87467	Folate receptor	Vitamin deficiency		E56
T87526	Bacterial cell membrane	Atopic dermatitis	691.8, 692.9	L00-L99
T87526	Bacterial cell membrane	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T87526	Bacterial cell membrane	Fungal infections	110-118	B35-B49
T87526	Bacterial cell membrane	Infections disease		A00-B99
T87526	Bacterial cell membrane	Methicillin-resistant staphylococcus aureus infection		B95.62
T87526	Bacterial cell membrane	Mycobacterium tuberculosis infection		A15-A19
T87526	Bacterial cell membrane	Staphylococcus aureus infection		B95.6
T87526	Bacterial cell membrane	Unspecified		
T87608	Mitochondrial gene transcription	Cancer	140-229	C00-C96
T87675	Aurora kinase A	Acute myeloid leukemia	205	C92.0
T87675	Aurora kinase A	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T87675	Aurora kinase A	Cancer	140-229	C00-C96
T87675	Aurora kinase A	Haematological malignancies	200-209	C81-C86
T87675	Aurora kinase A	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T87675	Aurora kinase A	Solid tumours	140-199, 210-229	C00-D48
T87686	DOT1L	Leukemia	208.9	C90-C95
T87689	C-type natriuretic peptide ligand	Achondroplasia	756.4	Q77.4
T87742	Gap junction protein	Atrial fibrillation	272, 427.31	E78, I48
T87742	Gap junction protein	Cardiac arrhythmias	427	I47-I49
T87749	Growth/differentiation factor 8	Disuse muscle atrophy; Cancercachexia	140-229, 799.4	R64
T87749	Growth/differentiation factor 8	Duchenne muscular dystrophy		G71.0
T87749	Growth/differentiation factor 8	Muscle atrophy		M62.5
T87749	Growth/differentiation factor 8	Muscular atrophy	728.2	M62.5
T87749	Growth/differentiation factor 8	Muscular dystrophy		G71.0
T87831	FMLP receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T87831	FMLP receptor	Peptic ulcer	531-534	K25-K27
T87875	mRNA of Glucagon receptor	Type 2 diabetes	250	E11
T87939	mRNA of Plasma kallikrein	Amyloid polyneuropathy		
T87946	Cytokine receptor	Alzheimer disease	331	G30
T87946	Cytokine receptor	Cancer	140-229	C00-C96
T87946	Cytokine receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T87946	Cytokine receptor	Septic shock	785.52	A41.9
T87975	Fungal proton pump on cell membrane	Seborrhoeic dermatitis		L21.9
T88023	Tumor necrosis factor receptor superfamily member 8	Autoimmune diabetes		E08-E13
T88023	Tumor necrosis factor receptor superfamily member 8	Cancer	140-229	C00-C96
T88023	Tumor necrosis factor receptor superfamily member 8	Hodgkin's lymphoma		C81
T88023	Tumor necrosis factor receptor superfamily member 8	Hodgkin's lymphoma; Systemic anaplastic large cell lymphoma	201, 202.8	C81, C81-C86
T88023	Tumor necrosis factor receptor superfamily member 8	Lymphoma	202.8, 208.9	C81-C86
T88182	Vitamin K-dependent gamma-carboxylase	Vitamin K deficiency; Bleeding	269, 444, 453	E56.1, I74, I80-I82
T88221	HIV-MAG DNA	Human immunodeficiency virus infection	279.3	B20-B26
T88240	Dihydropteroate synthetase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T88240	Dihydropteroate synthetase	Bacterial respiratory tract infection		J13, J15
T88240	Dihydropteroate synthetase	Dermatitis herpetiformis	694	L12.2, L13
T88240	Dihydropteroate synthetase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T88240	Dihydropteroate synthetase	Infection of P. falciparum 	84	B50-B54
T88240	Dihydropteroate synthetase	Infections by gram-negative bacilli particularly Pseudomonas aeruginosa		B96.5
T88240	Dihydropteroate synthetase	Malaria		B54
T88240	Dihydropteroate synthetase	Pseudomonas aeruginosa infection	001-139	B96.5
T88240	Dihydropteroate synthetase	Rheumatic fever; Meningococcal meningitis		R50.9
T88240	Dihydropteroate synthetase	Tuberculosis	010-018	A15-A19
T88240	Dihydropteroate synthetase	Urinary tract infections	599	N39.0
T88240	Dihydropteroate synthetase	Urinary tract infections; Cystitis	599	N39.0, N30
T88240	Dihydropteroate synthetase	Urinary tract infections; Meningococcal meningitis; Acute otitis media		N39
T88304	DNMT1	Acute myeloid leukemia	205	C92.0
T88304	DNMT1	Acute myeloid leukemia; Myelodysplastic syndrome	205, 238.7	C92.0, D46
T88304	DNMT1	Cancer	140-229	C00-C96
T88304	DNMT1	Glioblastoma multiforme	191	C71
T88304	DNMT1	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T88304	DNMT1	Myelodysplastic syndrome	238.7	D46
T88304	DNMT1	Non-small cell lung cancer		C33-C34
T88304	DNMT1	Soft tissue sarcoma	171	C00-D49
T88318	Protein kinase C	Cancer	140-229	C00-C96
T88318	Protein kinase C	Diabetic foot ulcer	707	L88-L89
T88318	Protein kinase C	HIV-1 infection	001-139, 042	B20-B24
T88318	Protein kinase C	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T88318	Protein kinase C	Melanoma	172	C43
T88318	Protein kinase C	Parkinson's disease	332	G20
T88318	Protein kinase C	Psoriasis	696	L40
T88318	Protein kinase C	Transplant rejection	279.5, 996	D89.8, T86
T88318	Protein kinase C	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T88322	Facilitates chromatin transcription complex (FACT)	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T88322	Facilitates chromatin transcription complex (FACT)	Hepatocellular carcinoma	155	C22.0
T88338	23S rRNA	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T88338	23S rRNA	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T88338	23S rRNA	Pneumonia; Bacterial infections	001-009, 001-139, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104, 480-486, 770.0	J12-J18
T88360	Respiratory syncytial virus N protein	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T88452	Corticosteroid-binding globulin	Asthma; Obstructive airway diseases	490-492, 494-496	J45, J40-J44, J47
T88452	Corticosteroid-binding globulin	Diabetic macular edema	250, 362.01, 362.07, 362.53, 782.3	E08-E13, E08.3, E09.3, E10.3, E11.3, E13.3, H35.8, R60.9
T88452	Corticosteroid-binding globulin	Diabetic retinopathy	250.5	H36, E10.3, E11.3, E13.3
T88452	Corticosteroid-binding globulin	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T88505	Nuclear factor erythroid 2-related factor 2	Non-small cell lung cancer		C33-C34
T88505	Nuclear factor erythroid 2-related factor 2	Ocular inflammation	370.33	H16.229
T88531	G-protein coupled receptor-39	Diabetes	253.5, 588.1	E23.2, N25.1
T88656	Notch-2 receptor	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T88697	mRNA of ANGPTL3	Hyperlipidaemia	272.0-272.4	E78
T88714	mRNA of adenosine A1 receptor	Asthma		J45
T88752	Ras-related C3 botulinum toxin substrate 1	Alzheimer disease	331	G30
T88806	Integrin alpha-V/beta-1	Renal cancer	140-229, 189	C64
T88847	mRNA of Dystrophin	Duchenne muscular dystrophy		G71.0
T88887	Plastid RNA polymerase beta-subunit	Infections disease		A00-B99
T88887	Plastid RNA polymerase beta-subunit	Unspecified		
T88975	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Asthma		J45
T88975	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Bronchial asthma	493	J45
T88975	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Cardiovascular disorder		I00-I99
T88975	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Heart failure	428	I50
T88975	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Thrombocythemia	289.9	D75.8
T89034	Plasminogen	Alzheimer disease	331	G30
T89034	Plasminogen	Bleeding	444, 453	I74, I80-I82
T89034	Plasminogen	Cancer	140-229	C00-C96
T89034	Plasminogen	Cerebrovascular ischaemia	434.91	I61-I63
T89034	Plasminogen	Chronic angina	413	I20
T89034	Plasminogen	Excessive bleeding	459	R58
T89034	Plasminogen	Excessive postoperative bleeding	459	R58
T89034	Plasminogen	Heart attack; Myocardial infarction	410	I21, I22
T89034	Plasminogen	Ischemic stroke	434.91	I61-I63
T89034	Plasminogen	Macular degeneration	362.5	H35.3
T89034	Plasminogen	Menorrhagia	627	N92.0
T89034	Plasminogen	Myocardial infarction	410	I21, I22
T89034	Plasminogen	Myocardial infarction; Acute coronary thrombosis	410, 414.8	I21, I22, I24.0
T89034	Plasminogen	Otitis media		H65-H67
T89034	Plasminogen	Pulmonary embolism	415.1	I26
T89034	Plasminogen	Unspecified		
T89041	17 alpha-hydroxylase-C17, 20-lyase 	Metastatic castration-resistant prostate cancer	140-229, 185	C61
T89041	17 alpha-hydroxylase-C17, 20-lyase 	Prostate cancer	185	C61
T89055	MEK-2 protein kinase	Cancer	140-229	C00-C96
T89086	Reduction of cumulative renal toxicity of cisplatin and toxic effects of radiation on normal oral tissues	Mucositis		K92.81
T89147	Mitochondrial manganese superoxide dismutase (MnSOD)	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T89213	Neuropeptide Y receptor type 1	Cardiovascular disorder		I00-I99
T89213	Neuropeptide Y receptor type 1	Eating disorder	278, 307.5, 401, 428.0	E66, F50, I10-I16, I50
T89213	Neuropeptide Y receptor type 1	Eating disorders reduction in food intake	307.5	F50
T89213	Neuropeptide Y receptor type 1	Eating disorders reduction in food intake obesity anxiety	307.5	F50
T89213	Neuropeptide Y receptor type 1	Hypertension	401	I10-I16
T89213	Neuropeptide Y receptor type 1	Hypertension; Obesity; Heart disease	278, 390-429	E66, I00-I52
T89213	Neuropeptide Y receptor type 1	Obesity	278	E66
T89360	Inosine-5'-monophosphate dehydrogenase 2	Organ transplant rejection	279.5, 996	D89.8, T86
T89360	Inosine-5'-monophosphate dehydrogenase 2	Pemphigus vulgaris	694.4	L10.0
T89361	Cell division protein kinase 6	Cancer	140-229	C00-C96
T89361	Cell division protein kinase 6	Hormone receptor-positive and HER2-negative advanced or metastatic breast cancer		C50
T89515	Dihydrofolate reductase	Advanced cancers	140-229	C00-C96
T89515	Dihydrofolate reductase	Gram-positive bacterial infection	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	
T89515	Dihydrofolate reductase	Leukemia	208.9	C90-C95
T89515	Dihydrofolate reductase	Malaria		B54
T89515	Dihydrofolate reductase	Malaria; Anxiety disorder	300, 311	B54, F32, F40-F42
T89515	Dihydrofolate reductase	Peripheral T-cell lymphoma; Breast cancer	202.7, 174, 175	C84.4, C50
T89515	Dihydrofolate reductase	Toxoplasmosis; Pneumocystis carinii pneumonia		B58
T89529	mRNA of Protein tyrosine phosphatase-1B	Colour dead tissues		
T89529	mRNA of Protein tyrosine phosphatase-1B	Infections	001-139	A00-B99
T89529	mRNA of Protein tyrosine phosphatase-1B	Type 2 diabetes	250	E11
T89534	Estrogen receptor	Acne vulgaris	706.1	L70.0
T89534	Estrogen receptor	Adrenocortical carcinoma	194	C74.0
T89534	Estrogen receptor	Advanced prostate cancer	185	C61
T89534	Estrogen receptor	Arthralgia		M25.5
T89534	Estrogen receptor	Atrophic vaginitis	627.3	N95.2
T89534	Estrogen receptor	Atrophy		M62.571
T89534	Estrogen receptor	Autoimmune diabetes		E08-E13
T89534	Estrogen receptor	Brain cancer	191, 225.0	C71, D33
T89534	Estrogen receptor	Breast cancer	174, 175	C50
T89534	Estrogen receptor	Breast cancer; Prostate cancer; Female infertility	174, 175, 185, 628	C50, C61, N97.0
T89534	Estrogen receptor	Cancer	140-229	C00-C96
T89534	Estrogen receptor	Carcinoma	230-234	D00-D09
T89534	Estrogen receptor	Contraception		Z30
T89534	Estrogen receptor	Dysmenorrhea	625.3	N94.4-N94.6
T89534	Estrogen receptor	Dyspareunia		N94.1
T89534	Estrogen receptor	Estrogen deficiency		E28.39
T89534	Estrogen receptor	Eye disorders		H00-H59
T89534	Estrogen receptor	Female hypogonadism	253, 256	E23, E28
T89534	Estrogen receptor	Female infertility	628	N97.0
T89534	Estrogen receptor	Female infertility due to anovulation		N97.0
T89534	Estrogen receptor	Female sexual dysfunction	302.7	F52
T89534	Estrogen receptor	Gonorrheal vaginitis; Cancer	98, 140-229	A54, C00-C96
T89534	Estrogen receptor	Hormone deficiency		E00-E90
T89534	Estrogen receptor	Hormone replacement therapy	V07.4	Z79.890
T89534	Estrogen receptor	Hyperlipidaemia	272.0-272.4	E78
T89534	Estrogen receptor	Hypogonadism	257.2	E23.0, E28.3, E29.1
T89534	Estrogen receptor	Infertility	628	N97.0
T89534	Estrogen receptor	Irregularities		N92.6
T89534	Estrogen receptor	Leukemia	208.9	C90-C95
T89534	Estrogen receptor	Menopausal disorder; Postmenopausal disorder	627	N95
T89534	Estrogen receptor	Menopause symptoms		N95.0
T89534	Estrogen receptor	Menopause symptoms; Hormone refractory prostate cancer	140-229, 185	N95.0, C61
T89534	Estrogen receptor	Menorrhagia	627	N92.0
T89534	Estrogen receptor	Multiple scierosis	340	G35
T89534	Estrogen receptor	Multiple scierosis; Hormone deficiency	340	G35, E00-E90
T89534	Estrogen receptor	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T89534	Estrogen receptor	Oral contraceptives		Z30
T89534	Estrogen receptor	Osteopetrosis		Q78.2
T89534	Estrogen receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T89534	Estrogen receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T89534	Estrogen receptor	Post-menopausal vaginal atrophy	627.3	N95.2
T89534	Estrogen receptor	Trematode infection		B66.9
T89534	Estrogen receptor	Unspecified		
T89534	Estrogen receptor	Vagina disease		N76.0
T89629	Protein tyrosine kinase	Diabetes	253.5, 588.1	E23.2, N25.1
T89629	Protein tyrosine kinase	HIV-1 infection	001-139, 042	B20-B24
T89629	Protein tyrosine kinase	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T89629	Protein tyrosine kinase	Psoriasis	696	L40
T89697	Indoleamine 2,3-dioxygenase	Cancer	140-229	C00-C96
T89697	Indoleamine 2,3-dioxygenase	Depression	311	F30-F39
T89747	mRNA of Abl	Chronic myelogenous leukaemia	205.1	C92.1
T89772	Vesicular acetylcholine transporter	Amyotrophic lateral sclerosis	335.2	G12.2
T89846	Herpesvirus DNA polymerase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T89873	Ferritin	Lymphoma	202.8, 208.9	C81-C86
T89883	Ryanodine receptor	Malignant hyperthermia	995.86	T88.3
T89918	Glycinamide ribonucleotide formyltransferase	Cancer	140-229	C00-C96
T89950	Calcitonin gene-related peptide	Asthma		J45
T89950	Calcitonin gene-related peptide	Migraine	346	G43
T89988	C-C chemokine receptor type 2	Alzheimer disease	331	G30
T89988	C-C chemokine receptor type 2	Arteriosclerosis	440	I70
T89988	C-C chemokine receptor type 2	Arthritis	710-719	M00-M25
T89988	C-C chemokine receptor type 2	Atherosclerosis	414.0, 440	I70
T89988	C-C chemokine receptor type 2	Chronic obstructive pulmonary disease	490-492, 494-496	J40-J44, J47
T89988	C-C chemokine receptor type 2	Diabetic nephropathy	250.4	E11.21
T89988	C-C chemokine receptor type 2	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T89988	C-C chemokine receptor type 2	Metastatic cancer; Multiple scierosis	140-199, 140-229, 210-229, 340	D10-D36, D3A, G35
T89988	C-C chemokine receptor type 2	Multiple scierosis	340	G35
T89988	C-C chemokine receptor type 2	Neuropathic pain	356.0, 356.8	G64, G90.0
T89988	C-C chemokine receptor type 2	Obese insulin-resistant disorders; Rheumatoid arthritis	250, 710-719, 714	E11, M05-M06
T89988	C-C chemokine receptor type 2	Rheumatoid arthritis	710-719, 714	M05-M06
T90074	Triple angiokinase	Idiopathic pulmonary fibrosis; Non-small cell lung cancer	516.3	J84.1, C33-C34
T90074	Triple angiokinase	Ovarian cancer	183	C56
T90080	Multidrug-resistance	Cancer	140-229	C00-C96
T90194	HCMV terminase	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T90391	mRNA of CYP3A4	Anxiety disorder	300, 311	F32, F40-F42
T90482	Phosphodiesterase (PDE)	Asthma		J45
T90482	Phosphodiesterase (PDE)	Bronchodilator	493	J45
T90482	Phosphodiesterase (PDE)	Cardiac failure		I50
T90482	Phosphodiesterase (PDE)	Cardiotonic		I50
T90482	Phosphodiesterase (PDE)	Cerebrovascular ischaemia	434.91	I61-I63
T90482	Phosphodiesterase (PDE)	Diabetes	253.5, 588.1	E23.2, N25.1
T90482	Phosphodiesterase (PDE)	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T90482	Phosphodiesterase (PDE)	Septic shock	785.52	A41.9
T90553	MARK3	Mesothelioma	163	C45
T90648	mRNA of B-Raf	Cancer	140-229	C00-C96
T90648	mRNA of B-Raf	Parkinson's disease	332	G20
T90768	mRNA of HIV Tar and Tat/Rev	Human immunodeficiency virus infection	279.3	B20-B26
T90828	Interleukin-5 receptor subunit alpha	Asthma; Chronic obstructive pulmonary disease	490-492, 493, 494-496	J40-J44, J47, J45
T90828	Interleukin-5 receptor subunit alpha	Asthma; Chronic obstructive pulmonary disease; Hypereosinophilic syndrome; asthma; Eosinophilic chronic rhinosinusitis		D72.1, J40-J44, J45
T90989	FGF-4 receptor	Cancer	140-229	C00-C96
T90989	FGF-4 receptor	Obesity	278	E66
T90989	FGF-4 receptor	Solid tumours	140-199, 210-229	C00-D48
T91023	Roof plate-specific spondin 1	Gastrointestinal disease		K00-K93
T91286	STEAP1	Prostate cancer	185	C61
T91331	FGF-3 receptor	Advanced or metastatic renal cell cancer	189	C64
T91331	FGF-3 receptor	Alzheimer disease	331	G30
T91331	FGF-3 receptor	Cancer	140-229	C00-C96
T91331	FGF-3 receptor	Hepatocellular carcinoma	155	C22.0
T91331	FGF-3 receptor	Multiple myeloma	203	C90
T91331	FGF-3 receptor	Retinoblastoma		C69.2
T91331	FGF-3 receptor	Solid tumours	140-199, 210-229	C00-D48
T91442	Varicella-zoster virus DNA polymerase	Herpes simplex virus infection	54	B00
T91450	Poly-N-acetylglucosamine (PNAG)	Serious infections	001-139	A00-B99
T91480	Sulfonylurea receptor 1	Atrial fibrillation	272, 427.31	E78, I48
T91480	Sulfonylurea receptor 1	Diabetes	253.5, 588.1	E23.2, N25.1
T91480	Sulfonylurea receptor 1	Non-insulin dependent diabetes		E11.9
T91480	Sulfonylurea receptor 1	Type 1 diabetes	250	E10
T91546	Inhibiting the induction of nitric oxide synthase	Postoperative pain		G89
T91661	Adenosine kinase	Convulsions	780.3	R56.0
T91661	Adenosine kinase	Epilepsy		G40
T91661	Adenosine kinase	Epileptic seizures	345.9, 780.3	G40, P90, R56
T91661	Adenosine kinase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T91696	Fibronectin	Colorectal cancer	153, 154	C18-C21
T91761	Tyrosine-protein kinase itk/tsk	Allergy	995.3	T78.4
T91894	Proto-oncogene Mas	Diabetic foot ulcer	707	L88-L89
T91894	Proto-oncogene Mas	Sarcoma	202.8	C81-C86
T92030	Human pro-islet peptide	Liver failure		K72.9
T92030	Human pro-islet peptide	Type 1/2 diabetes	250, 278	E08-E13
T92035	HCV internal ribosome entry site (IRES)	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T92042	GDNF receptor alpha-3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T92057	Receptor protein-tyrosine kinase erbB-4	Cancer	140-229	C00-C96
T92057	Receptor protein-tyrosine kinase erbB-4	Non-small cell lung cancer		C33-C34
T92057	Receptor protein-tyrosine kinase erbB-4	Solid tumours	140-199, 210-229	C00-D48
T92072	Adenosine A1 receptor	Acute and chronic heart failure	428	I50
T92072	Adenosine A1 receptor	Allergy	995.3	T78.4
T92072	Adenosine A1 receptor	Atrial fibrillation	272, 427.31	E78, I48
T92072	Adenosine A1 receptor	Atrial fibrillation; Cardiac arrhythmias	272, 427.31, 427	E78, I48, I47-I49
T92072	Adenosine A1 receptor	Autoimmune diabetes		E08-E13
T92072	Adenosine A1 receptor	Cardiac arrhythmias	427	I47-I49
T92072	Adenosine A1 receptor	Cardiac disease		I00-I99
T92072	Adenosine A1 receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T92072	Adenosine A1 receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T92072	Adenosine A1 receptor	Fatigue; Orthostatic hypotension	458.0, 780.7	I95.1, R53
T92072	Adenosine A1 receptor	Glaucoma	365	H40-H42
T92072	Adenosine A1 receptor	Heart failure	428	I50
T92072	Adenosine A1 receptor	Hyperlipidaemia	272.0-272.4	E78
T92072	Adenosine A1 receptor	Hypertension	401	I10-I16
T92072	Adenosine A1 receptor	Hypertriglyceridemia	272.1, 427	E78.1, E78.2, E78.3, I47-I49
T92072	Adenosine A1 receptor	Multiple scierosis	340	G35
T92072	Adenosine A1 receptor	Neuropathic pain	356.0, 356.8	G64, G90.0
T92072	Adenosine A1 receptor	Parkinson's disease	332	G20
T92072	Adenosine A1 receptor	Renal failure	584, 585	N17, N18, N19
T92072	Adenosine A1 receptor	Sepsis	995.91	A40, A41
T92076	Extracellular calcium-sensing receptor	Cardiovascular disease; Kidney disease	390-459, 580-589	I00-I99, N00-N29
T92076	Extracellular calcium-sensing receptor	Cerebrovascular ischaemia	434.91	I61-I63
T92076	Extracellular calcium-sensing receptor	Hyperparathyroidism	252.02, 588.81	E21.1
T92076	Extracellular calcium-sensing receptor	Myelodysplastic syndrome	238.7	D46
T92076	Extracellular calcium-sensing receptor	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T92076	Extracellular calcium-sensing receptor	Secondary hyperparathyroidism		E21.1
T92078	Dihydropyrimidinase related protein 2	Convulsions	780.3	R56.0
T92078	Dihydropyrimidinase related protein 2	Epilepsy		G40
T92078	Dihydropyrimidinase related protein 2	Painful diabetic neuropathy	250.6,338,780	E10.4, E11.4, E13.4, G89, R52
T92124	Tumor necrosis factor receptor superfamily member 4	Prostate cancer	185	C61
T92138	Phosphodiesterase	Angina pectoris	413	I20
T92144	Angiopoietin 1 receptor	Arthritis; Myelodysplastic syndrome	710-719, 238.7	M00-M25, D46
T92144	Angiopoietin 1 receptor	Cancer	140-229	C00-C96
T92144	Angiopoietin 1 receptor	Ischemia	459.89	I99.8
T92144	Angiopoietin 1 receptor	Solid tumours	140-199, 210-229	C00-D48
T92220	Virus capside protein	Human immunodeficiency virus infection	279.3	B20-B26
T92281	Neuronal pentraxin-2	Macular degeneration	362.5	H35.3
T92308	DNA (cytosine-5)-methyltransferase	Myelodysplastic syndrome	238.7	D46
T92328	Ryanodine receptor 1	Heart failure	428	I50
T92403	Sodium/hydrogen exchanger 3	Cardiac arrhythmias	427	I47-I49
T92403	Sodium/hydrogen exchanger 3	Cheyne-stokes respiration		R06.3
T92403	Sodium/hydrogen exchanger 3	Chronic kidney disease	403, 585.1-585.5, 585.9	N18
T92403	Sodium/hydrogen exchanger 3	Constipation	564	K59.0
T92403	Sodium/hydrogen exchanger 3	Heart arrhythmia		I47-I49
T92403	Sodium/hydrogen exchanger 3	Renal disease		N00-N29
T92424	Integrin alpha-V/beta-5	Ocular disease		H00-H59
T92424	Integrin alpha-V/beta-5	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T92458	Cytochrome P450 24	Psoriasis	696	L40
T92500	Haemopilus ifluenze type b	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T92609	Alpha-1A adrenergic receptor	Benign prostatic hyperplasia	600	N40
T92609	Alpha-1A adrenergic receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T92609	Alpha-1A adrenergic receptor	Female sexual dysfunction	302.7	F52
T92609	Alpha-1A adrenergic receptor	Glaucoma	365	H40-H42
T92609	Alpha-1A adrenergic receptor	Hypertension	401	I10-I16
T92609	Alpha-1A adrenergic receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T92609	Alpha-1A adrenergic receptor	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T92609	Alpha-1A adrenergic receptor	Post-traumatic stress disorder	309.81	F43.1
T92609	Alpha-1A adrenergic receptor	Prostate cancer; Benign prostatic hyperplasia	140-229, 185, 600	C61, N40
T92609	Alpha-1A adrenergic receptor	Prostate disease		N42.9
T92609	Alpha-1A adrenergic receptor	Prostate hyperplasia		N40
T92609	Alpha-1A adrenergic receptor	Stress urinary incontinence		N39.3
T92609	Alpha-1A adrenergic receptor	Unspecified		
T92609	Alpha-1A adrenergic receptor	Urinary incontinence	788.3	N39.3, N39.4, R32
T92640	Lysophosphatidic acid receptor Edg-2	Idiopathic pulmonary fibrosis	516.3	J84.1
T92653	Neuropeptide Y receptor	Mood disorder		F30-F39
T92687	H+ K+ ATPase	Duodenal ulcers		K25-K27
T92687	H+ K+ ATPase	Gastroesophageal reflux disease	140-229, 530	K21
T92687	H+ K+ ATPase	Gastrointestinal disease		K00-K93
T92687	H+ K+ ATPase	Nsaid-related gastric ulcer	531	K25
T92687	H+ K+ ATPase	Peptic ulcer	531-534	K25-K27
T92687	H+ K+ ATPase	Ulcerative colitis	556	K51
T92687	H+ K+ ATPase	Unspecified		
T92750	Complement factor I	Cerebrovascular ischaemia	434.91	I61-I63
T92777	Maltase-glucoamylase, intestinal	Acquired immune deficiency syndrome	42	B20
T92777	Maltase-glucoamylase, intestinal	Cardiovascular disorder		I00-I99
T92777	Maltase-glucoamylase, intestinal	Dengue fever	61	A90
T92777	Maltase-glucoamylase, intestinal	Diabetes	253.5, 588.1	E23.2, N25.1
T92777	Maltase-glucoamylase, intestinal	Hyperglycemia	790.29	R73.9
T92777	Maltase-glucoamylase, intestinal	Muscle disease		M60-M63
T92777	Maltase-glucoamylase, intestinal	Pompe's disease		E74.02
T92777	Maltase-glucoamylase, intestinal	Type 2 diabetes	250	E11
T92828	Endothelin B receptor	Arrhythmia	427	I47-I49
T92828	Endothelin B receptor	Cancer	140-229	C00-C96
T92828	Endothelin B receptor	Cardiovascular disorder		I00-I99
T92828	Endothelin B receptor	Hypertension	401	I10-I16
T92828	Endothelin B receptor	Pulmonary arterial hypertension	416	I27.0, I27.2
T92828	Endothelin B receptor	Solid tumours	140-199, 210-229	C00-D48
T92963	Natriuretic peptide receptor	Chronic heart failure	428	I50
T93062	Multidrug resistance protein 3	Acute myeloid leukemia	205	C92.0
T93062	Multidrug resistance protein 3	Cancer	140-229	C00-C96
T93122	Neurotrophic factor production	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T93198	Methyltransferase	Leukemia	208.9	C90-C95
T93262	mRNA of PKC-epsilon	Human immunodeficiency virus infection	279.3	B20-B26
T93283	Prostatic acid phosphatase	Prostate cancer	185	C61
T93344	Squalene monooxygenase	Coronary artery disease	410-414, 429.2	I20-I25
T93344	Squalene monooxygenase	Dermatomycosis		B36.0
T93344	Squalene monooxygenase	Hypercholesterolemia		E78
T93344	Squalene monooxygenase	Jock itch; Athlete's foot	110.3, 110.4	B35.3, B35.6
T93368	Outer membrane protein	Haemophilus influenza		B96.3
T93430	ATP binding cassette	Insulin resistance		E00-E90
T93440	Interleukin-6 receptor	Ankylosing spondylitis	720	M08.1, M45
T93440	Interleukin-6 receptor	Autoimmune diabetes		E08-E13
T93440	Interleukin-6 receptor	Cutaneous lupus erythematosus	710	M32
T93440	Interleukin-6 receptor	Juvenile idiopathic arthritis	714.3	M08.0
T93440	Interleukin-6 receptor	Melanoma	172	C43
T93440	Interleukin-6 receptor	Multiple myeloma	203	C90
T93440	Interleukin-6 receptor	Rheumatoid arthritis	710-719, 714	M05-M06
T93440	Interleukin-6 receptor	Severely active rheumatoid arthritis		M05-M06
T93450	Interleukin-24 ligand	Solid tumours	140-199, 210-229	C00-D48
T93485	HBV protein priming reaction and the packaging reaction	Viral infections	054.0, 054.1, 054.2, 054.3, 075, 771.2, 052, 053	B01, B02, A60, B00, B27, G05.1, P35.2
T93509	Calcitonin gene-related peptide 1	Neuropathic pain	356.0, 356.8	G64, G90.0
T93515	P2Y purinoceptor 2	Constipation	564	K59.0
T93515	P2Y purinoceptor 2	Cystic fibrosis	277	E84
T93515	P2Y purinoceptor 2	Dry eye disease	370.33	H16.229
T93515	P2Y purinoceptor 2	Lung cancer	162	C33-C34
T93566	mRNA of human 5-lipoxygenase	Asthma		J45
T93627	HIV GAG protein	HIV-1 infection	001-139, 042	B20-B24
T93627	HIV GAG protein	Human immunodeficiency virus infection	279.3	B20-B26
T93661	mRNA of Smad7	Crohn's disease	555	K50
T93662	Hyaluronidase	Immunodeficiency	279.3	D84.9
T93662	Hyaluronidase	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T93662	Hyaluronidase	Schizophrenia; Bipolar disorder	295, 296	F20, F31
T93683	Lipid peroxidation	Ischemia	459.89	I99.8
T93683	Lipid peroxidation	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T93703	Cytokine	Allergic rhinitis	472.0, 477, 995.3	J00, J30, J31.0, T78.4
T93783	HIV-1 Tat protein	Human immunodeficiency virus infection	279.3	B20-B26
T93783	HIV-1 Tat protein	Rheumatoid arthritis	710-719, 714	M05-M06
T93788	Glucose-dependent insulinotropic receptor	Diabetes	253.5, 588.1	E23.2, N25.1
T93788	Glucose-dependent insulinotropic receptor	Gastric cancer; Type 2 diabetes	151, 250	C16, E11
T93788	Glucose-dependent insulinotropic receptor	Non-insulin dependent diabetes		E11.9
T93788	Glucose-dependent insulinotropic receptor	Peripheral arterial disease; Type 2 diabetes	443, 250	I73, E11
T93788	Glucose-dependent insulinotropic receptor	Type 2 diabetes	250	E11
T93878	Solute carrier family 12 member 1	Edema associated with congestive heart failure	428.0, 782.3	I50, R60.9
T93878	Solute carrier family 12 member 1	High blood pressure	401	I10-I16
T93878	Solute carrier family 12 member 1	Hypertension; Edema	401	I10-I16, R60.9
T93878	Solute carrier family 12 member 1	Hypokalemia	276.8	E87.6
T93878	Solute carrier family 12 member 1	Oedema and hypertension	401, 782.3	I10, I11, I12, I13, I15, R60.9
T93903	Caspase-9	Cancer	140-229	C00-C96
T93903	Caspase-9	Cystic fibrosis	277	E84
T93923	CD137 antigen	Immune disorder		D80-D89
T93923	CD137 antigen	Non-hodgkin's lymphoma		C85
T93923	CD137 antigen	Solid tumours	140-199, 210-229	C00-D48
T93955	Mannitol-1-phosphate 5-dehydrogenase	Renal failure; Bronchiectasis	584, 585, 494, 748.61	N17, N18, N19, J47, Q33.4
T94033	Coagulation factor IIa	Angina pectoris	413	I20
T94033	Coagulation factor IIa	Atopic dermatitis	691.8, 692.9	L00-L99
T94033	Coagulation factor IIa	Atrial fibrillation; Venous thromboembolism; Myocardial infarction	410, 427.31, 453	I21, I22, I48, I80-I82
T94033	Coagulation factor IIa	Bleeding	444, 453	I74, I80-I82
T94033	Coagulation factor IIa	Blood coagulation disorders		D65-D68
T94033	Coagulation factor IIa	Blood forming organ disorders		D75.9
T94033	Coagulation factor IIa	Cancer	140-229	C00-C96
T94033	Coagulation factor IIa	Cardiovascular disorder		I00-I99
T94033	Coagulation factor IIa	Coagulation		I80-I82
T94033	Coagulation factor IIa	Heart arrhythmia		I47-I49
T94033	Coagulation factor IIa	Multiple scierosis	340	G35
T94033	Coagulation factor IIa	Myocardial infarction	410	I21, I22
T94033	Coagulation factor IIa	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T94033	Coagulation factor IIa	Nonvalvular atrial fibrillation; Thrombosis	427.31, 437.6, 453, 671.5, 671.9	I48, I80-I82
T94033	Coagulation factor IIa	Solid tumours	140-199, 210-229	C00-D48
T94033	Coagulation factor IIa	Stroke in atrial fibrillation	427.31, 434.91	I48, I61-I63
T94033	Coagulation factor IIa	Thrombocytopenia	287.3, 287.4, 287.5	D69.6, P61.0
T94033	Coagulation factor IIa	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T94033	Coagulation factor IIa	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T94033	Coagulation factor IIa	Unspecified		
T94033	Coagulation factor IIa	Venous thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T94085	Retinoic acid receptor alpha	Acquired immune deficiency syndrome	42	B20
T94085	Retinoic acid receptor alpha	Alzheimer disease	331	G30
T94085	Retinoic acid receptor alpha	Colorectal cancer	153, 154	C18-C21
T94085	Retinoic acid receptor alpha	Solid tumours	140-199, 210-229	C00-D48
T94306	Integrin alpha-5/beta-1	Melanoma	172	C43
T94306	Integrin alpha-5/beta-1	Non-small cell lung cancer		C33-C34
T94306	Integrin alpha-5/beta-1	Ocular disease		H00-H59
T94306	Integrin alpha-5/beta-1	Solid tumours	140-199, 210-229	C00-D48
T94309	Triacylglycerol lipase, pancreatic	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T94309	Triacylglycerol lipase, pancreatic	Cystic fibrosis	277	E84
T94309	Triacylglycerol lipase, pancreatic	Exocrine pancreatic insufficiency		K86.8
T94309	Triacylglycerol lipase, pancreatic	Obesity	278	E66
T94324	Histone Deacetylase 10	Cancer	140-229	C00-C96
T94429	Human cytomegalovirus terminase subunit UL56	Cytomegalovirus infection		B25
T94444	Aldehyde oxidase	Cancer	140-229	C00-C96
T94444	Aldehyde oxidase	Vitamin K deficiency	269	E56.1
T94479	Ribosomal protein S6 kinase	Cancer	140-229	C00-C96
T94479	Ribosomal protein S6 kinase	Ulcerative colitis	556	K51
T94482	Interleukin-20	Psoriasis	696	L40
T94493	HIV adenovector Ad35	Human immunodeficiency virus infection	279.3	B20-B26
T94517	Falcipain-3	Malaria		B54
T94692	Low-density lipoprotein receptor	Non-small cell lung cancer		C33-C34
T94718	LAG3	Allergy	995.3	T78.4
T94718	LAG3	Autoimmune diabetes		E08-E13
T94718	LAG3	Cancer	140-229	C00-C96
T94977	Cardiotrophin-1	Acute liver failure		K72
T95139	Cysteine protease	Trypanosomiasis	086.5-086	B56-B57
T95212	Micelle	Otitis media		H65-H67
T95212	Micelle	Ulcer	531-534	K25-K27
T95286	Myelin-associated glycoprotein	Stroke	434.91, 437.6, 453, 671.5, 671.9	I61-I63, I80-I82
T95302	Melanocortin MC5 receptor	Acne vulgaris	706.1	L70.0
T95302	Melanocortin MC5 receptor	Seborrhea		L21
T95339	Inhibit the formation of beta-hematin by forming a complex with hemin	Malaria		B54
T95371	IFN-alphaR	HBV infection	070.2-070.3	B16, B18.0, B18.1
T95371	IFN-alphaR	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T95371	IFN-alphaR	Ovarian cancer	183	C56
T95385	Interleukin-12 ligand	Breast cancer	174, 175	C50
T95385	Interleukin-12 ligand	Cancer	140-229	C00-C96
T95385	Interleukin-12 ligand	Crohn's disease	555	K50
T95385	Interleukin-12 ligand	Fallopian tube cancer; Peritoneal cancer; Ovarian cancer	140-229, 183.2, 221.0, 183	C57, D28, C56
T95385	Interleukin-12 ligand	Melanoma	172	C43
T95385	Interleukin-12 ligand	Moderate-to-severe plaque psoriasis	696	L40
T95385	Interleukin-12 ligand	Rheumatoid arthritis	710-719, 714	M05-M06
T95399	Myophosphorylase	Chronic lymphocytic leukaemia		C91
T95399	Myophosphorylase	Type 2 diabetes	250	E11
T95400	High affinity immunoglobulin epsilon receptor	Asthma; Chronic idiopathic urticaria		J45, L50
T95400	High affinity immunoglobulin epsilon receptor	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T95400	High affinity immunoglobulin epsilon receptor	Chronic idiopathic urticaria	708	L50
T95417	Transporter	Toxicity		T36-T50, T51-T65
T95446	Cytochrome P450 reductase	Breast cancer	174, 175	C50
T95446	Cytochrome P450 reductase	Dermatitis	692.9	L20-L30
T95446	Cytochrome P450 reductase	Pruritus	698	L29
T95479	Somatostatin	Nephropathic cystinosis		E72.04
T95488	Interleukin-1	Rheumatoid arthritis	710-719, 714	M05-M06
T95498	Nrf2 pathway	Multiple scierosis	340	G35
T95515	mRNA of Keratin 6A	Pachyonychia		Q84.5
T95558	Diacylglycerol O-acyltransferase 2	Dyslipidaemias	272	E78
T95558	Diacylglycerol O-acyltransferase 2	Lipid disorder; Cardiovascular disease	272, 390-459	E78, I00-I99
T95678	Influenza A virus M2 protein	Influenza A infection		J10, J11
T95678	Influenza A virus M2 protein	Influenza virus		J11.1
T95878	ribosomal protein S6 kinase, 90kDa, polypeptide 6	Chronic lymphocytic leukaemia		C91
T95899	mRNA of Clusterin	Prostate cancer; Breast cancer; Lung cancer	140-229, 162, 174, 175, 185	C00-C96, C33-C34, C50, C61
T95913	Phosphoinositide 3 kinase	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T95913	Phosphoinositide 3 kinase	Advanced solid tumor; Non-hodgkin's lymphoma	140-199, 200, 202, 202.8, 210-229	C00-C75, C7A, C7B, C81-C86, C82-C85, D10-D36, D3A
T95913	Phosphoinositide 3 kinase	Angioedema; Myocardial infarction	277.6, 410, 995.1	D84.1, I21, I22, T78.3
T95913	Phosphoinositide 3 kinase	Arthritis	710-719	M00-M25
T95913	Phosphoinositide 3 kinase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T95913	Phosphoinositide 3 kinase	Breast cancer	174, 175	C50
T95913	Phosphoinositide 3 kinase	Cancer	140-229	C00-C96
T95913	Phosphoinositide 3 kinase	Cardiovascular disorder		I00-I99
T95913	Phosphoinositide 3 kinase	Diffuse large B-cell lymphoma	200	C83.3
T95913	Phosphoinositide 3 kinase	Endometrial cancer	182	C54.1
T95913	Phosphoinositide 3 kinase	Enthesopathy; Type 2 diabetes	726, 250	M76-M77.9, E11
T95913	Phosphoinositide 3 kinase	Glioma	191	C71
T95913	Phosphoinositide 3 kinase	Hematologic malignancies	200-209	C81-C86
T95913	Phosphoinositide 3 kinase	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T95913	Phosphoinositide 3 kinase	Lymphoma	202.8, 208.9	C81-C86
T95913	Phosphoinositide 3 kinase	Metastatic breast cancer; Endometrial cancer; Lymphoma	140-199, 140-229, 174, 175, 182.0, 202.8, 210-229	C50, C81-C86
T95913	Phosphoinositide 3 kinase	Non-hodgkin's lymphoma		C85
T95913	Phosphoinositide 3 kinase	Prostate cancer	185	C61
T95913	Phosphoinositide 3 kinase	Solid tumours	140-199, 210-229	C00-D48
T95913	Phosphoinositide 3 kinase	Type 2 diabetes	250	E11
T95923	Lysophosphatidate-3 receptor	Fibrosis	709.2	L90.5
T95947	Acid-sensing ion channel ASIC3	Fibromyalgia	729.1	M79.7
T95947	Acid-sensing ion channel ASIC3	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T95998	Cholinephosphate cytidylyltransferase	Solid tumours	140-199, 210-229	C00-D48
T96079	C-X-C chemokine receptor 4	Acute lymphoblastic leukemia	204.0, 556	C91.0
T96079	C-X-C chemokine receptor 4	Acute myeloid leukemia	205	C92.0
T96079	C-X-C chemokine receptor 4	Acute myeloid leukemia; B-cell chronic lymphocytic leukemia	202.8, 203.0, 204.1, 205.0, 208.9	C81-C86, C90.0, C91-C95, C91.1, C92.0
T96079	C-X-C chemokine receptor 4	Autoimmune diabetes		E08-E13
T96079	C-X-C chemokine receptor 4	Bone marrow transplantation	279.5, 996	D89.8, T86
T96079	C-X-C chemokine receptor 4	Cancer	140-229	C00-C96
T96079	C-X-C chemokine receptor 4	Hematological malignancies	200-209	C81-C86
T96079	C-X-C chemokine receptor 4	Hematopoietic		D50-D89
T96079	C-X-C chemokine receptor 4	HIV-1 infection	001-139, 042	B20-B24
T96079	C-X-C chemokine receptor 4	Human immunodeficiency virus infection	279.3	B20-B26
T96079	C-X-C chemokine receptor 4	Human immunodeficiency virus infection; Non-hodgkin's lymphoma; Late-stage solid tumors	279.3, 140-199, 200, 202, 202.8, 210-229	B20-B26, C00-C75, C7A, C7B, C81-C86, C82-C85, D10-D36, D3A
T96079	C-X-C chemokine receptor 4	Macular degeneration	362.5	H35.3
T96079	C-X-C chemokine receptor 4	Peripheral vascular disease	443.9	I73.9
T96079	C-X-C chemokine receptor 4	Sarcoma	202.8	C81-C86
T96079	C-X-C chemokine receptor 4	Solid tumours	140-199, 210-229	C00-D48
T96127	Alpha particle-emitting radioactive therapeutic	Castration-resistant prostate cancer	185	C61
T96144	DNA topoisomerase II	Acute lymphoblastic leukemia	204.0, 556	C91.0
T96144	DNA topoisomerase II	Acute myeloid leukemia	205	C92.0
T96144	DNA topoisomerase II	Acute otitis media; Otitis externa	017.40, 055.2, 380, 381.0, 381.1, 381.2, 381.3, 381.4, 382	H60, H65-H67
T96144	DNA topoisomerase II	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T96144	DNA topoisomerase II	Bladder cancer	188	C67
T96144	DNA topoisomerase II	Breast cancer	174, 175	C50
T96144	DNA topoisomerase II	Breast cancer; Prostate cancer	174, 175, 185	C50, C61
T96144	DNA topoisomerase II	Cancer	140-229	C00-C96
T96144	DNA topoisomerase II	Colorectal cancer	153, 154	C18-C21
T96144	DNA topoisomerase II	Condyloma		A51.3
T96144	DNA topoisomerase II	Diffuse large B-cell lymphoma; Follicular lymphoma; Multiple scierosis	200.0, 202.0, 202.8, 340	C81-C86, C82, C83.3, C85.1, G35
T96144	DNA topoisomerase II	Endocarditis	421	I33
T96144	DNA topoisomerase II	External genital and perianal warts		A63.0
T96144	DNA topoisomerase II	Fungal urinary tract infection		N39.0
T96144	DNA topoisomerase II	Gastric cancer	151	C16
T96144	DNA topoisomerase II	Gonococcal urethritis	98	A54
T96144	DNA topoisomerase II	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T96144	DNA topoisomerase II	Leukemia	208.9	C90-C95
T96144	DNA topoisomerase II	Liver cancer	140-229, 155, 203.0	C22
T96144	DNA topoisomerase II	Lung cancer	162	C33-C34
T96144	DNA topoisomerase II	Lung metastatic tumors	162	C33, C34
T96144	DNA topoisomerase II	Lymphoma	202.8, 208.9	C81-C86
T96144	DNA topoisomerase II	Mild alzheimer disease	331	G30
T96144	DNA topoisomerase II	Ovarian cancer	183	C56
T96144	DNA topoisomerase II	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T96144	DNA topoisomerase II	Psoriasis	696	L40
T96144	DNA topoisomerase II	Solid tumours	140-199, 210-229	C00-D48
T96144	DNA topoisomerase II	Tuberculosis	010-018	A15-A19
T96144	DNA topoisomerase II	Unspecified		
T96144	DNA topoisomerase II	Urinary tract infections	599	N39.0
T96215	Glutamate dehydrogenase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T96235	Glutamate receptor 4	Parkinson's disease	332	G20
T96257	Haemophilus influenzae type B CRM 197 conjugate	Influenza virus		J11.1
T96257	Haemophilus influenzae type B CRM 197 conjugate	Pneumococcal infections	001-139	A00-B99
T96281	Viral envelope glycoprotein	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T96299	Wnt ligand	Ovarian cancer	183	C56
T96299	Wnt ligand	Scar tissue		L00-L99
T96413	Reducing beta-glucuronidase level	Periodontal disease		K05
T96476	Plasmodium falciparum merozoite surface protein 1	Malaria		B54
T96592	Phosphatase	Cancer	140-229	C00-C96
T96627	Macrophage inflammatory protein-2-alpha	Multiple scierosis	340	G35
T96721	Vascular endothelial growth factor	Multiple myeloma	203	C90
T96736	Transforming protein RhoA	Solid tumours	140-199, 210-229	C00-D48
T96747	Galactosyltransferase	Melanoma	172	C43
T96747	Galactosyltransferase	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T96760	Growth differentiation factor-5	Periodontal disease		K05
T96788	mRNA of HER2	Cancer	140-229	C00-C96
T96788	mRNA of HER2	Chronic pain	338.2,780	R52.1-R52.2, G89
T96816	5-enopyruvyl shikimate 3-phosphate synthase	Malaria		B54
T96894	Leukemia inhibitory factor receptor	Infertility	628	N97.0
T96916	Dickkopf-3	Prostate cancer	185	C61
T96946	Glucosaminylmuramyl dipeptide	Infections	001-139	A00-B99
T97035	Tyrosine oxidase	Melanoma	172	C43
T97035	Tyrosine oxidase	Melasma		L81.1
T97035	Tyrosine oxidase	Rheumatoid arthritis	710-719, 714	M05-M06
T97035	Tyrosine oxidase	Vitiligo	709.01	L80
T97036	Connecting peptide (C-peptide)	Diabetic complication		E08-E13
T97071	Glutamate carboxypeptidase II	Brain injury		S09.90
T97071	Glutamate carboxypeptidase II	Cancer	140-229	C00-C96
T97071	Glutamate carboxypeptidase II	Influenza virus		J11.1
T97071	Glutamate carboxypeptidase II	Metastatic prostate cancer; Non-metastatic prostate cancer	140-229, 185	C61
T97071	Glutamate carboxypeptidase II	Neuropathic pain	356.0, 356.8	G64, G90.0
T97071	Glutamate carboxypeptidase II	Prostate cancer	185	C61
T97071	Glutamate carboxypeptidase II	Prostate cancer diagnosis	140-229, 185	C61
T97071	Glutamate carboxypeptidase II	Solid tumours	140-199, 210-229	C00-D48
T97111	CD37	Chronic lymphocytic leukaemia		C91
T97111	CD37	Metastatic non-hodgkin's lymphoma	200, 202, 202.8	C81-C86, C82-C85
T97141	Myosin light chain kinase, smooth muscle and non-muscle isozymes	Duodenal ulcers		K25-K27
T97155	Serine threonine protein kinase ATR	Cancer	140-229	C00-C96
T97155	Serine threonine protein kinase ATR	Chronic lymphocytic leukaemia		C91
T97155	Serine threonine protein kinase ATR	Solid tumours	140-199, 210-229	C00-D48
T97174	Mannose-6-phosphate receptor	Pompe's disease; Type 2 glycogen storage disease	271	E74.02, E74.0
T97196	ATM serine/threonine kinase	Non-small cell lung cancer		C33-C34
T97257	Transforming growth factor beta 1	Arthritis	710-719	M00-M25
T97257	Transforming growth factor beta 1	Idiopathic pulmonary fibrosis	516.3	J84.1
T97257	Transforming growth factor beta 1	Lesion		S00-T98
T97257	Transforming growth factor beta 1	Macular degeneration	362.5	H35.3
T97257	Transforming growth factor beta 1	Osteoarthritis	715	M15-M19, M47
T97353	Integrin alpha-2/beta-1	Cancer	140-229	C00-C96
T97353	Integrin alpha-2/beta-1	Inflammatory bowel disease	555, 556	K50, K51
T97353	Integrin alpha-2/beta-1	Multile sclerosis		G35
T97353	Integrin alpha-2/beta-1	Multiple scierosis	340	G35
T97388	Uridine phosphorylase	Mucositis		K92.81
T97413	Bombesin bb3 receptor	Obesity	278	E66
T97587	Integrin alpha-4	Asthma		J45
T97587	Integrin alpha-4	Autoimmune diabetes		E08-E13
T97587	Integrin alpha-4	Crohn's disease; Inflammatory bowel disease	555, 556	K50, K51
T97587	Integrin alpha-4	Multiple scierosis	340	G35
T97587	Integrin alpha-4	Ulcerative colitis	556	K51
T97587	Integrin alpha-4	Ulcerative colitis; Crohn's disease	555, 556, 556.9	K50, K50-K52, K51
T97589	Mitogen-activated protein kinase kinase kinase 5	Diabetic nephropathy	250.4	E11.21
T97592	Aurora protein kinase	Advanced solid tumor	140-199	C00-C75, C7A, C7B
T97592	Aurora protein kinase	Cancer	140-229	C00-C96
T97592	Aurora protein kinase	Hematological malignancies	200-209	C81-C86
T97592	Aurora protein kinase	Leukemia	208.9	C90-C95
T97592	Aurora protein kinase	Prostate cancer	185	C61
T97592	Aurora protein kinase	Solid tumours	140-199, 210-229	C00-D48
T97613	Melatonin receptor	Anxiety disorder	300, 311	F32, F40-F42
T97613	Melatonin receptor	Circadian rhythm sleep disorder	327.3, 780.55	G47.2
T97613	Melatonin receptor	Insomnia	307.41, 307.42, 327.0, 780.51, 780.52	F51.0, G47.0
T97613	Melatonin receptor	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T97613	Melatonin receptor	Sleep disorders	307.4, 327, 780.5	F51, G47
T97682	mRNA of Tumour protein p53	Delayed graft function; Acute kidney injury	584	N17
T97713	Inosine-5'-monophosphate dehydrogenase 1	Organ transplant rejection	279.5, 996	D89.8, T86
T97740	Palmitoyl-protein thioesterase 1	Multiple myeloma	203	C90
T97752	mRNA of ebola virus VP24	Ebola virus infection	001-139, 042-075, 065.8	A00-B99, A80-A99, A98.4, B00-B34
T97752	mRNA of ebola virus VP24	Marburg virus infection		A98.3
T97759	Hepatitis C virus E2 glycoprotein	HCV infection	070.4, 070.5, 070.70	B17.1, B18.2
T97765	Small inducible cytokine A3	Bone marrow transplantation	279.5, 996	D89.8, T86
T97822	Prostaglandin synthetase	Inflammation		E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89
T97873	CCR9 chemokine receptor	Crohn's disease	555	K50
T97873	CCR9 chemokine receptor	Sjogren's syndrome	710.2	M35.0
T97947	Guanylyl cyclase C	Chronic idiopathic constipation	564	K59
T97947	Guanylyl cyclase C	Constipation	564	K59.0
T97947	Guanylyl cyclase C	Constipation; Postoperative ileus	537.2, 560.1, 560.31, 564.0, 777.1, 777.4	K31.5, K56.0, K56.3, K56.7, K59.0, P76.1
T97947	Guanylyl cyclase C	Crohn's disease	555	K50
T97947	Guanylyl cyclase C	Diabetes	253.5, 588.1	E23.2, N25.1
T97947	Guanylyl cyclase C	Gastrointestinal cancers	150-159	C15-C26
T97947	Guanylyl cyclase C	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T98015	Sodium, potassium transport	Diuretic		Y54.5
T98022	Carboxypeptidase B2	Acute ischemic stroke	434.91	I61-I63
T98022	Carboxypeptidase B2	Cerebrovascular ischaemia	434.91	I61-I63
T98022	Carboxypeptidase B2	Thromboembolism	437.6, 453, 671.5, 671.9	I80-I82
T98022	Carboxypeptidase B2	Thrombosis	437.6, 453, 671.5, 671.9	I80-I82
T98052	SLAM family member 7 (SLAMF7) (CS1)	Cancer	140-229	C00-C96
T98052	SLAM family member 7 (SLAMF7) (CS1)	Multiple myeloma	203	C90
T98062	Glycogen phosphorylase, muscle form	Type 2 diabetes	250	E11
T98089	Deoxycytidine kinase	Unspecified		
T98157	Arylsulfatase A	Metachromatic leukodystrophy		E75.25
T98179	Phosphopantetheine adenylyltransferase	Bacterial infections	001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104	A00-B99
T98196	Cyclic pyranopterinmonophosphate	Molybdenum cofactor deficiency		E00-E90
T98269	Interleukin-1 beta convertase	Epilepsy		G40
T98269	Interleukin-1 beta convertase	Fibrosis	709.2	L90.5
T98269	Interleukin-1 beta convertase	Rheumatoid arthritis	710-719, 714	M05-M06
T98293	PAK-4 protein kinase	Cancer	140-229	C00-C96
T98397	Thymidylate synthase	Unspecified		
T98468	NADPH oxidase	Arthritis	710-719	M00-M25
T98494	Galanin receptor	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T98708	Parathyroid hormone ligand	Bone disease		M00-M99
T98708	Parathyroid hormone ligand	Osteogenesis imperfecta	756.51	Q78.0
T98708	Parathyroid hormone ligand	Osteoporosis	733.0, V07.4	M80-M81, Z79.890
T98708	Parathyroid hormone ligand	Parathyroid disease		E20-E21
T98708	Parathyroid hormone ligand	Unspecified		
T98896	Aggrecanase	Osteoarthritis	715	M15-M19, M47
T98906	Polymerase	Pediatric cancer	140-229	C00-C96
T98913	Macrophage colony-stimulating factor receptor	Alzheimer disease	331	G30
T98913	Macrophage colony-stimulating factor receptor	Autoimmune diabetes		E08-E13
T98913	Macrophage colony-stimulating factor receptor	Bone cancer		C41.0
T98913	Macrophage colony-stimulating factor receptor	Cancer	140-229	C00-C96
T98913	Macrophage colony-stimulating factor receptor	Cardiovascular disorder		I00-I99
T98913	Macrophage colony-stimulating factor receptor	Inflammatory disease	140-229, 147, 173, 573.3, 710-719	C11, C44, K75.9, M00-M25
T98913	Macrophage colony-stimulating factor receptor	Leukemia	208.9	C90-C95
T98913	Macrophage colony-stimulating factor receptor	Neutropenia	288	D70
T98913	Macrophage colony-stimulating factor receptor	Non-myeloid cancer	140-199	C00-C75, C7A, C7B
T98913	Macrophage colony-stimulating factor receptor	Pancreatic cancer	140-199, 140-229, 157, 210-229	C25
T98913	Macrophage colony-stimulating factor receptor	Severe neutropaenia in non-myeloid malignancies	140-239	C00-C96
T98919	Birch pollen allergen	Allergy	995.3	T78.4
T98933	Thyroid hormone receptor beta-1	High cholesterol levels in blood		E78.0
T98933	Thyroid hormone receptor beta-1	Hyperlipidaemia	272.0-272.4	E78
T98933	Thyroid hormone receptor beta-1	Hyperthyroidism	242	E05
T98933	Thyroid hormone receptor beta-1	Hypothyroidism	244	E03
T98933	Thyroid hormone receptor beta-1	Lipid metabolism disorder		E75-E78
T98933	Thyroid hormone receptor beta-1	Wound healing		T14.0-T14.1
T99031	Dual specificity mitogen-activated protein kinase kinase	Solid tumours	140-199, 210-229	C00-D48
T99089	B-Raf proto-oncogene serine/threonine-protein kinase	Cancer	140-229	C00-C96
T99089	B-Raf proto-oncogene serine/threonine-protein kinase	Late-stage solid tumors	140-199, 210-229	C00-C75, C7A, C7B, D10-D36, D3A
T99089	B-Raf proto-oncogene serine/threonine-protein kinase	Melanoma	172	C43
T99089	B-Raf proto-oncogene serine/threonine-protein kinase	Metastatic melanoma; Solid tumors	140-199, 172, 210-229	C00-C75, C43, C7A, C7B, D10-D36, D3A
T99089	B-Raf proto-oncogene serine/threonine-protein kinase	Metastatic melanoma; Thyroid cancer	172, 140-229, 193	C43, C73
T99347	Metabotropic glutamate receptor 5	Alzheimer disease	331	G30
T99347	Metabotropic glutamate receptor 5	Anxiety disorder	300, 311	F32, F40-F42
T99347	Metabotropic glutamate receptor 5	Autism	299	F84.0
T99347	Metabotropic glutamate receptor 5	Central nervous system disease		G00-G99
T99347	Metabotropic glutamate receptor 5	Chronic neuropathic pain	338, 356.0, 356.8, 530,780	G64, G90.0, K21, R52, G89
T99347	Metabotropic glutamate receptor 5	Fragile X syndrome	332, 759.83	F02.3, G20, Q99.2
T99347	Metabotropic glutamate receptor 5	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T99347	Metabotropic glutamate receptor 5	Major depressive disorder; GERD; Chronic neuropathic pain	296.2, 296.3, 338, 356.0, 356.8, 530,780	F32, F33, G64, G90.0, K21, R52, G89
T99347	Metabotropic glutamate receptor 5	Mood disorder		F30-F39
T99347	Metabotropic glutamate receptor 5	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T99347	Metabotropic glutamate receptor 5	Neuropathic pain; Migraine	338, 346,780	G43, R52, G89
T99347	Metabotropic glutamate receptor 5	Unspecified		
T99402	Metabotropic glutamate receptor 4	Anxiety disorder	300, 311	F32, F40-F42
T99402	Metabotropic glutamate receptor 4	Neurological disease	338, 338.2, 410, 782.3,780	I21, I22, R52, R52.1-R52.2, R60.9, G89
T99524	Trace amine-associated receptor-1	Attention deficit disorder with hyperactivity		F90
T99524	Trace amine-associated receptor-1	Attention deficit hyperactivity disorder	314	F90
T99524	Trace amine-associated receptor-1	Attention deficit hyperactivity disorder; Narcolepsy		F90, G47.4
T99524	Trace amine-associated receptor-1	Diagnostic evaluation of horner's syndrome		G90.2
T99524	Trace amine-associated receptor-1	Major depressive disorder	296.2, 296.3, 710.0	F32, F33, M32
T99524	Trace amine-associated receptor-1	Unspecified		
T99532	HLA class II antigen DR10	Lymphoma	202.8, 208.9	C81-C86
T99566	Free radicals	Ischemia	459.89	I99.8
T99566	Free radicals	Lymphoma	202.8, 208.9	C81-C86
T99616	Trypanothione reductase	Kinetoplastids	085, 086	B55, B56, B57
T99641	Acetaldehyde dehydrogenase	Alcohol use disorders	303	F10.2
T99721	Voltage-dependent potassium channel type 7 K+ (KV7) channels	Parkinson's disease	332	G20
T99727	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel	Angina pectoris	413	I20
T99727	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel	Cardiac arrhythmias	427	I47-I49
T99727	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channel	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T99732	FGF-18 ligand	Arthropathy		M00-M14
T99740	mRNA of Myb proto-oncogene protein	Myeloid leukemia	208.9	C92
T99799	Cholinesterase	Alzheimer disease	331	G30
T99799	Cholinesterase	Cognitive disorders	290-294, 294.0, 780.09, 780.9, 780.93	F01-F07, F04, F05, R41.3
T99799	Cholinesterase	Neurotoxicity drug-induced		T36-T50
T99799	Cholinesterase	Pain	338, 356.0, 356.8,780	G64, G90.0, R52, G89
T99799	Cholinesterase	Poison intoxication		T36-T50
T99799	Cholinesterase	Spasms; Pain	338,780	R52, G89
T99799	Cholinesterase	Toxicity		T36-T50, T51-T65
T99816	Gastrin-releasing peptide receptor	Breast cancer	174, 175	C50
T99816	Gastrin-releasing peptide receptor	Cancer	140-229	C00-C96
T99816	Gastrin-releasing peptide receptor	Irritable bowel syndrome	564.1, 787.91	A09, K58, K59.1
T99816	Gastrin-releasing peptide receptor	Solid tumours	140-199, 210-229	C00-D48
T99840	Gamma-secretase	Alzheimer disease	331	G30
T99840	Gamma-secretase	Alzheimer disease; Cancer	331, 140-229	G30, C00-C96
T99840	Gamma-secretase	Breast cancer	174, 175	C50
T99840	Gamma-secretase	Parkinson's disease	332	G20
T99905	Polyvalent human immunoglobulin G	Immune disorder		D80-D89
T99907	Viral matration	HIV-1 infection	001-139, 042	B20-B24
T99909	Mortalin	Solid tumours	140-199, 210-229	C00-D48
T99929	Wnt signalling pathway	Liver cancer	140-229, 155, 203.0	C22
T99935	Unspecified GPCR	Alzheimer disease	331	G30
T99935	Unspecified GPCR	Emesis	787	R11
T99935	Unspecified GPCR	Erectile dysfunction	302.72, 607.84	F52.2, N48.4
T99935	Unspecified GPCR	Overactive bladder disorder	188, 596.51	C67, N32.81
T99935	Unspecified GPCR	Prostate hyperplasia		N40
T99954	Prostacyclin receptor	Aborting second-trimester pregnancy	779.6	O04
T99954	Prostacyclin receptor	Asthma		J45
T99954	Prostacyclin receptor	Chronic renal failure	585.9585.1-585.5403	N18
T99954	Prostacyclin receptor	Gout	274.00274.1274.8274.9	M10
T99954	Prostacyclin receptor	Hypertension	401	I10-I16
T99954	Prostacyclin receptor	Medical abortion	779.6	O04
T99954	Prostacyclin receptor	Pulmonary arterial hypertension	416	I27.0, I27.2
T99954	Prostacyclin receptor	Pulmonary arterial hypertension; Thrombosis	416, 437.6, 453, 671.5, 671.9	I27.0, I27.2, I80-I82
T99954	Prostacyclin receptor	Pulmonary hypertension	416	I27.0, I27.2
T99954	Prostacyclin receptor	Solid tumours	140-199, 210-229	C00-D48